UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(A) OFProxy Statement Pursuant to Section 14(a) of
THE SECURITIES EXCHANGE ACT OFthe Securities Exchange Act of 1934
þFiled by the Registrant
oþ
Filed by a Party other than the Registranto
Check the appropriate box:
o  Preliminary Proxy Statement
o  Confidential, for Use of the Commission Only (as permitted byRule 14a-6(e)(2))
þ  Definitive Proxy Statement
o  Definitive Additional Materials
o  Soliciting MaterialsMaterial Pursuant to Sec 240.14a-11(c)§240.14a-12
NOVELIS INC.Novelis Inc.
(Name of Registrant as Specified inIn Its Charter)
Not Applicable
(Name of Person(s) Filing Proxy Statement)Statement, if other than the Registrant)
PAYMENT OF FILING FEE
Payment of Filing Fee (Check the appropriate box):
o  No fee required.
þNo fee required.
o  Fee computed on table below per Exchange Act RuleRules 14a-6(i)(1) and0-11.
 1)(1)  Title of each class of securities to which transactionstransaction applies:
Common shares, no par value
 2)(2)  Aggregate number of securities to which transactionstransaction applies:
75,191,430 common shares, including 2,179,838 common shares reserved for issuance upon the exercise of options with exercise prices below $44.93 per share.
 3)(3)  Per unit price or other underlying value of transaction computed pursuant to Exchange ActRule 0-11.0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
The filing fee was determined based upon the sum of (a) 75,191,430 common shares outstanding multiplied by $44.93 per share; (b) 2,179,838 common shares subject to outstanding options with exercise prices below $44.93, multiplied by $21.7647 per share (which is the excess of $44.93 over the weighted average exercise price per share); (c) $7,393,146 to be paid upon cancellation of stock appreciation rights; (d) $6,931,342 to be paid upon cancellation of stock price appreciation units; (e) $8,105,372 to be paid upon cancellation of performance share units; and (f) $5,033,901 to be paid upon cancellation of deferred share units. In accordance with Section 14(g)(1)(A) of the Securities Exchange Act of 1934, as amended, the filing fee was determined by multiplying 0.0000307 by the sum of the amounts calculated pursuant to clauses (a), (b), (c), (d), (e) and (f) of the preceding sentence.
 4)(4)  Proposed maximum aggregate value of Transaction:transaction:
$3,453,258,232
o(5)  Total fee paid:
$106,016
þ  Fee paid previously with preliminary materials.
o  Check box if any part of the fee is offset as provided by Exchange ActRule 0- 11(a)0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
1)Amount previously paid:
 2)(1)  Amount Previously Paid:
(2)  Form, Schedule or Registration Statement No.:
 3)(3)  Filing Party:
 4)(4)  Date Filed:
 


(NOVELIS INC. LOGO)
(NOVELIS INC. LOGO)
NOVELIS INC.April 5, 2007
Dear Shareholder:
You are cordially invited to attend a special meeting of the shareholders of Novelis Inc. (the “Company,” “Novelis,” “we,” “us” or “our”), which will be held at the offices of King & Spalding LLP located at 1180 Peachtree Street, N.E., Atlanta, Georgia 30309 on May 10, 2007, beginning at 8:30 a.m., Eastern time.
At the special meeting, we will ask you to consider and approve a statutory arrangement pursuant to section 192 of the Canada Business Corporations Act, whereby AV Metals Inc. (“Acquisition Sub”), a subsidiary of Hindalco Industries Limited (“Hindalco”), will acquire all of the outstanding common shares of Novelis for US$44.93 per share. If the arrangement is completed, we will become a subsidiary of Hindalco and you will receive US$44.93 in cash, without interest and less any applicable withholding taxes, for each Novelis common share that you own, and you will cease to have an ownership interest in the continuing business of Novelis. A copy of the arrangement agreement is attached as Annex B to the proxy statement/management information circular accompanying this letter. You are encouraged to read it in its entirety.
After careful consideration, our board of directors has approved the arrangement agreement and determined that the arrangement is fair to our shareholders and is in our best interests.OUR BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE “FOR” THE RESOLUTION APPROVING THE ARRANGEMENT.
Your Vote is Very Important.  To be effective, the arrangement must be approved by a resolution passed by at least 662/3% of the votes cast at the special meeting. The arrangement agreement is also subject to certain usual and customary conditions, including the approval of the Ontario Superior Court of Justice.
The accompanying Notice of Special Meeting of Shareholders and proxy statement/management information circular provides you with information about the arrangement and the special meeting. Please read this information carefully, and if you require assistance, consult your financial, legal or other professional advisor.
Whether or not you plan to attend the special meeting in person, please complete, sign, date and return promptly the enclosed proxy card so that your common shares can be voted at the special meeting in accordance with your instructions. You may also vote your shares by telephone or internet in accordance with the instructions provided in the enclosed proxy card. We also encourage you to complete, sign, date and return the enclosed letter of transmittal so that if the arrangement is approved payment for your common shares can be sent to you as soon as possible. If you hold common shares through a broker or other nominee, you should follow the procedures provided by your broker or nominee.
If you have any questions or need assistance voting your common shares, please call Georgeson Inc., which is assisting us, toll-free at866-834-6791.
On behalf of our board of directors, I thank you in advance for your cooperation and continued support.
Yours very truly,
William T. Monahan
Chairman of the Board
Neither the Securities and Exchange Commission nor any state securities regulatory agency nor any Canadian securities regulatory authority has approved or disapproved the arrangement, passed upon the merits or fairness of the arrangement or passed upon the adequacy or accuracy of the disclosure in this document. Any representation to the contrary is a criminal offense.
This proxy statement/management information circular is dated April 5, 2007 and is first being
mailed to shareholders on or about April 10, 2007.


(NOVELIS INC. LOGO)
 
NOTICE OF ANNUALSPECIAL MEETING OF SHAREHOLDERS
TO BE HELD ON MAY 10, 2007
TO THE SHAREHOLDERS OF NOVELIS INC:
 
NOTICE IS HEREBY GIVENthat the 2006 annuala special meeting of shareholders of Novelis Inc. (the “Meeting”“Company,” “Novelis,” “we,” “us,” or “our”) will be held at The Westin Buckheadthe offices of King & Spalding LLP located at 1180 Peachtree Street, N.E., Atlanta, 3391 Peachtree Road, Atlanta, GA 30326,Georgia 30309, on October 26, 2006,May 10, 2007, beginning at 10:008:30 a.m., (EDT) for:Eastern time, for the following purposes:
 
1. receivingto consider, pursuant to an interim order of the consolidatedOntario Superior Court of Justice dated April 5 (the “Interim Order”) and, combined financial statementsif deemed advisable, to pass, with or without variation, a special resolution (the “Arrangement Resolution”) to approve an arrangement (the “Arrangement”) under section 192 of the Canada Business Corporations Act involving Novelis, its shareholders and other securityholders, Hindalco Industries Limited (“Hindalco”) and AV Metals Inc. (“Acquisition Sub”), a subsidiary of Hindalco, involving, among other things, the acquisition by Acquisition Sub of all of the outstanding common shares of Novelis for US$44.93 in cash for each common share, all as more particularly described in the year ended December 31, 2005, together with the independent registered public accounting firm’s report thereon;accompanying proxy statement/management information circular of Novelis (the “Proxy Statement/Circular”); and
 
2. electing directors;
3. appointing the independent registered public accounting firm and authorizing directors to fix the independent registered public accounting firm’s remuneration;
4. approving the Novelis Inc. 2006 Incentive Plan; and
5. transactingtransact such other business as may properly be broughtcome before the Meetingspecial meeting or any adjournment or postponement thereof.thereof (the “Meeting”).
 
The directors have fixed September 19, 2006, as the record date for the determination of the holders of common shares of Novelis Inc. entitled to receive notice of the Meeting. Only the holdersshareholders of record as of our common shares at the close of business on September 19, 2006 areMarch 20, 2007 will be entitled to notice of, and to vote at, the Meeting and any adjournment or postponement of the Meeting. We anticipate that the information circular
The Arrangement and the Arrangement Resolution are described in this Proxy Statement/Circular and the full text of the Arrangement Resolution is set out in Annex A to this Proxy Statement/Circular. The Proxy Statement/Circular, a form of proxy and a letter of transmittal accompany this Notice of Special Meeting of Shareholders.
Registered shareholders of Novelis unable to attend the Meeting in person are requested to complete, date, sign and return the accompanying form of proxy card will firstin the envelope provided for that purpose. To be mailedused at the Meeting, proxies must be received by our registrar and transfer agent, CIBC Mellon Trust Company, 320 Bay Street, Banking Hall, Toronto, ON M5H 4A6 Canada before 5:00 p.m. (Eastern time) on May 9, 2007 or, in the case of any adjournment or postponement of the Meeting, no later than 5:00 p.m. (Eastern time) on the business day before the date of the reconvened Meeting. Non-registered beneficial shareholders of Novelis must seek instructions on how to holderscomplete their form of ourproxy and vote their common shares onfrom their broker, trustee, financial institution or about September 22, 2006.other nominee.
Your attention is directed to the information circular provided with this notice.
 
Your vote is important. Whether or notimportant, regardless of the number of common shares you own. To be effective, the Arrangement must be approved by a resolution passed by at least 662/3% of the votes cast at the Meeting. Even if you plan to attend the Meeting in person, please submit your proxy as soon as possible. You can vote by telephone, on the Internet or by mail withwe request that you complete, sign, date and return the enclosed proxy card. Voting by any of these three methods willand thus ensure that you areyour common shares will be represented at the Meeting even if you are not there in person. Please review the instructions on theunable to attend. If you sign, date and mail your proxy card regarding eachwithout indicating how you wish to vote, your vote will be counted as a vote “FOR” the approval of these voting options. Shareholders who have previously voted, but attendthe Arrangement and in accordance with the discretion of the persons named as proxies on any other matters properly brought before the Meeting may change their vote at the Meeting.for a vote.
 
BY ORDER OF THE BOARD OF DIRECTORS
-s- Nichole Robinson
Nichole Robinson
Corporate Secretary
September 22, 2006
Atlanta, GeorgiaPursuant to the Interim Order, registered holders of common shares of Novelis have a right to dissent in respect of the Arrangement Resolution and to be paid an amount equal to the fair value of their common shares. This right is described in the Proxy Statement/Circular. See the section entitled “Dissenting Holders’ Rights” in the Proxy Statement/Circular and Annex F to the Proxy Statement/Circular. The dissent procedures require that a registered


(NOVELIS INC. LOGO)
holder of common shares who wishes to dissent must send to Novelis (1) at 3399 Peachtree Road NE, Suite 1500, Atlanta, Georgia, 30326 or (2) by facsimile transmission to(404) 814-4219 (Attention: Corporate Secretary) to be received no later than 5:00 p.m. (Toronto time) on May 9, 2007 (or 5:00 p.m. (Toronto time) on the day which is one business day immediately preceding the date that any adjourned or postponed meeting is reconvened), a written notice of objection to the Arrangement Resolution and must otherwise strictly comply with the dissent procedures described in this Proxy Statement/Circular.Failure to strictly comply with these dissent procedures may result in the loss or unavailability of the right to dissent.  Non-registered beneficial owners of common shares registered in the name of a broker, trustee, financial institution or other nominee who wish to dissent should be aware thatonly registered owners of common shares are entitled to dissent.
-s- NICHOLE ROBINSON
Nichole Robinson
Corporate Secretary
April 5, 2007


(NOVELIS INC. LOGO)
NOVELIS INC.TABLE OF CONTENTS
 
INFORMATION CIRCULAR
WHAT’S INSIDE
   
 Page
 
 1
1
 69
 614
14
15
15
16
 616
 1116
 1216
16
17
17
17
18
18
18
19
19
27
29
35
42
43
44
44
45
52
52
56
56
60
60
60
60
61
61
62
63
64
64
64
64
65
70
70
 1773
 2173
 2174
 2176
 76


22
Page
 24
25
25
26
27
28
2877
 2977
 3078
 3178
 3778
 3879
 39
3979
 3979
 3979
 A-1
 B-1
 C-1
 D-1
 E-1
 F-1
F-1G-1
H-1


ii


MANAGEMENT INFORMATION CIRCULAR
This Proxy Statement/Circular and accompanying forms are furnished in connection with the solicitation of proxies by and on behalf of our management for use at the Meeting and any adjournment or postponement thereof and for the purposes set forth in the accompanying Notice of Meeting. Except where otherwise indicated, the information in this Proxy Statement/Circular is given as of March 20, 2007.
All currency amounts referred to in this Proxy Statement/Circular are expressed in United States dollars, unless otherwise indicated.
SUMMARY
This summary highlights selected information from this Proxy Statement/Circular and may not contain all of the information that is important to you. To understand the Arrangement fully, and for a more complete description of the legal terms of the Arrangement, you should carefully read this entire Proxy Statement/Circular, the annexes attached to this Proxy Statement/Circular and the documents to which we refer. An arrangement agreement, dated as of February 10, 2007, among Hindalco, AV Aluminum Inc. and Novelis (the “Arrangement Agreement”), is attached as Annex B to this Proxy Statement/Circular. On March 30, 2007 AV Aluminum Inc. assigned its interest in the Arrangement Agreement to Acquisition Sub. We have included page references in parentheses to direct you to the appropriate place in this Proxy Statement/Circular for a more complete description of the topics presented in this summary.
Each capitalized term used in this Proxy Statement/Circular and not otherwise defined shall have the meaning set forth in the Arrangement Agreement.
The Parties to the Arrangement Agreement (Page 18)
Novelis is the world’s leading aluminum rolled products producer based on shipment volume in 2006, with total aluminum rolled products shipments of approximately 2,960 kilotonnes. With operations on four continents comprised of 33 operating plants as well as three research facilities in 11 countries as of December 31, 2006, Novelis is the only company of its size and scope focused solely on aluminum rolled products markets and capable of local supply of technically sophisticated products in all of these geographic regions. Novelis is a corporation incorporated under the laws of Canada, and its common shares are traded on the New York Stock Exchange (“NYSE”) and the Toronto Stock Exchange (“TSX”) under the symbol “NVL.” Novelis’ executive offices are located at 3399 Peachtree Road NE, Suite 1500, Atlanta, Georgia 30326 and its telephone number is(404) 814-4200.
Hindalco is Asia’s largest integrated primary producer of aluminum and a leading integrated producer of copper. Hindalco’s integrated operations and operating efficiency have positioned the company among the most cost-efficient aluminum producers globally. Hindalco is incorporated under the laws of India and its stock is publicly traded on the Bombay Stock Exchange (“BSE”), the National Stock Exchange of India Ltd (“NSE”) and the Luxembourg Stock Exchange (“GDR”). Hindalco’s executive offices are located at Aditya Birla Centre, S. K. Ahire Marg, Worli, Mumbai-400 030 India and its telephone number is91-22-6652 5000 / 2499 5000.
Acquisition Sub is AV Metals Inc., a corporation incorporated under the laws of Canada. It is a subsidiary of Hindalco, incorporated solely for the purpose of facilitating the Arrangement. It has not conducted any activities to date other than activities incidental to its formation, organization and in connection with the transactions contemplated by the Arrangement Agreement.
The Arrangement (Page 19)
You are being asked to vote to approve an Arrangement Resolution providing for, among other things, the acquisition of all of the outstanding common shares of Novelis by Acquisition Sub in accordance with the Arrangement Agreement. Upon the terms, and subject to the conditions contained in the Arrangement Agreement, Acquisition Sub will become the owner of all the outstanding shares of Novelis. It is the intention


1


(NOVELIS INC. LOGO)
of Acquisition Sub to transfer the common shares of Novelis acquired by it to its wholly-owned subsidiary AV Aluminum Inc. As a result of the Arrangement, our common shares will cease to be publicly traded and we will become an indirect subsidiary of Hindalco.
3399Purchase Price (Page 60)
If the Arrangement is completed, each holder of common shares outstanding immediately prior to the Arrangement will be entitled to receive $44.93 in cash, without interest and less any required withholding taxes, for each common share.
Effect on Stock Options, Stock Appreciation Rights, Stock Price Appreciation Units, Performance Share Units and Deferred Share Units (Page 61)
At the effective time of the Arrangement, each outstanding stock option, stock appreciation right and stock price appreciation unit will (1) unconditionally vest and be transferred to Novelis for a cash payment equal to the excess, if any, of $44.93 over the exercise price per share of the respective stock option, stock appreciation right and stock price appreciation unit, as applicable, without interest and less any applicable withholding taxes and (2) be cancelled and all agreements related thereto will be terminated.
Each outstanding performance share unit and deferred share unit will be cancelled in exchange for a cash payment in the amount of $44.93 per performance share unit or deferred share unit, as applicable, without interest and less any applicable withholding taxes.
Conditions to the Arrangement (Page 61)
The Arrangement is subject to the satisfaction or waiver of various conditions, which include the following:
• the adoption of the Arrangement Resolution by our shareholders at the Meeting in accordance with the Interim Order;
• the Interim Order and the Final Order shall each have been obtained on terms consistent with the Arrangement Agreement and in a form satisfactory to each of Novelis and Hindalco, acting reasonably, and shall not have been set aside or modified in a manner unacceptable to such parties, acting reasonably;
• no governmental entity shall have enacted, issued, enforced or entered any law which is then in effect that makes the Arrangement illegal or otherwise prevents, prohibits or enjoins the closing of the Arrangement; and
• the required regulatory approvals shall have been obtained or satisfied.
We are not obligated to effect the Arrangement unless the following conditions are satisfied or waived:
• all covenants of Hindalco and Acquisition Sub under the Arrangement Agreement to be performed on or before the effective time shall have been performed by Hindalco and Acquisition Sub in all material respects;
• all representations and warranties of Hindalco and Acquisition Sub under the Arrangement Agreement shall have been true and correct (without giving effect to qualifications or limitations as to materiality) as of the effective date as if made on and as of such time (except to the extent such failures to be true and correct would not have a material adverse effect on Hindalco’s or Acquisition Sub’s ability to close the transactions contemplated by the Arrangement Agreement and the Plan of Arrangement and perform their obligations under the Arrangement Agreement and except such representations and warranties that speak solely as of an earlier date, in which event such representations and warranties shall be true and correct to such extent as of such earlier date); and
• Acquisition Sub shall have deposited with the Depositary in escrow at or prior to the time of filing of the Articles of Arrangement the funds required to effect payment in full for all of the securities to be


2


acquired pursuant to the Arrangement and the Depositary shall have confirmed to us the receipt of these funds.
Hindalco and Acquisition Sub are not obligated to effect the Arrangement unless the following conditions are satisfied or waived:
• all of our covenants under the Arrangement Agreement to be performed on or before the effective time shall have been performed by us in all material respects;
• all of our representations and warranties under the Arrangement Agreement shall have been true and correct (without giving effect to any qualifications or limitations as to materiality) as of the effective date as if made on and as of such date (except (1) to the extent such representations and warranties speak solely as of an earlier date, in which event such representations and warranties shall be true and correct to such extent as of such earlier date, (2) (other than in (3) below) to the extent that facts or matters as to which such representations and warranties are not so true and correct as of such dates, individually or in the aggregate, have not had and would not have a material adverse effect and (3) in the case of representations and warranties related to Novelis’ capitalization, such representations shall be true and correct in all material respects);
• there shall not have occurred and be continuing a material adverse effect with respect to us; and
• there shall be no action, investigation, proceeding or litigation instituted or commenced by any governmental entity that is reasonably likely to (1) set aside, appeal or challenge the validity of the Interim Order or the Final Order, (2) restrain, enjoin, prevent, prohibit or make illegal the closing of the Arrangement or any of the transactions related thereto, or (3) result in a material adverse effect.
Effective Date and Effective Time of the Arrangement (Page 60)
The Arrangement Agreement provides that the effective date is the date shown on the certificate of arrangement issued by the director appointed pursuant to the Canada Business Corporations Act (the “CBCA”). The effective time means the date and time of the issuance of the articles of arrangement by the director. The articles of arrangement are required by the CBCA to be filed with the director after the Final Order is made in order for the Arrangement to become effective.
Termination of the Arrangement Agreement (Page 63)
The Arrangement Agreement may be terminated and the Arrangement may be abandoned at any time prior to the filing of the Articles of Arrangement, whether before or after any approval and authorization of the Arrangement Agreement by the shareholders:
• by mutual written consent of us and Hindalco to terminate, duly authorized by our board of directors and Hindalco’s board of directors;
• by either Hindalco or us if the effective time of the Arrangement shall not have occurred on or before July 7, 2007, or at the option of Hindalco, July 31, 2007 if the expiration date of the commitment letters provided in connection with Hindalco’s financing of its acquisition of us is extended to or beyond July 31, 2007 (as applicable, the “Outside Date”); provided, however, that the right to terminate the Arrangement Agreement under this provision is not available to any party whose failure to fulfill any obligation under the Arrangement Agreement has been the cause of, or resulted in, the failure of the effective time to occur on or before July 31, 2007;
• by either Hindalco or us if any governmental entity shall have enacted, issued, promulgated, enforced or entered any law or order which has become final and nonappealable and has the effect of making the Arrangement illegal or otherwise preventing or prohibiting closing of the Arrangement;
• by either Hindalco or us if the Arrangement Resolution shall have failed to receive the requisite vote for approval at the Meeting or at any adjournment or postponement thereof in accordance with the Interim Order;


3


• by Hindalco, if: (1) our board of directors withdraws, modifies or qualifies in any manner adverse to Hindalco or Acquisition Sub its recommendation that our shareholders vote in favor of the Arrangement; (2) our board of directors approves, adopts or recommends an “acquisition proposal,” as defined on page 68 that constitutes a superior proposal (as defined on page 68); or (3) we enter into any binding agreement effecting or in connection with an acquisition proposal that constitutes a superior proposal;
• by us, if we enter into any binding agreement effecting an acquisition proposal in compliance with the provisions of the Arrangement Agreement, in which case we are obligated to make the company termination payment of $100 million to Acquisition Sub prior to or concurrently with such termination;
• by Hindalco, if there has been a breach of or failure to perform any representation, warranty, covenant or agreement on our part set forth in the Arrangement Agreement, which breach or failure to perform: (1) would cause the condition relating to the performance of our covenants and the accuracy of our representations and warranties not to be satisfied (subject to certain exceptions); and (2) is incapable of being cured within the lesser of 30 days after Hindalco gives notice of such breach or failure to perform and the period between Hindalco’s giving notice and the day prior to the Outside Date; or
• by us, if there has been a breach of or failure to perform any representation, warranty, covenant or agreement on the part of Hindalco or Acquisition Sub set forth in the Arrangement Agreement, which breach or failure to perform (1) would cause the condition relating to the performance of Hindalco’s covenants and the accuracy of its representations and warranties not to be satisfied and (2) is incapable of being cured within the lesser of 30 days after Hindalco we give of such breach or failure to perform and the period between our giving notice and the day prior to the Outside Date.
In certain other circumstances, as set out in the Arrangement Agreement, we will also be obligated to pay (1) the termination fee of $100 million to Acquisition Sub, or (2) reimburse the costs and expenses, to a maximum of $15 million, incurred by Hindalco and its affiliates in connection with the transactions contemplated by the Arrangement Agreement.
No Solicitation (Page 67)
The Arrangement Agreement contains non-solicitation provisions that prohibit us from soliciting or engaging in discussions or negotiations regarding a competing proposal to the Arrangement. There are exceptions to these prohibitions if we receive an unsolicited superior proposal from a third party under certain circumstances set forth in the Arrangement Agreement.
Recommendation of Our Board of Directors (Page 10)
After due discussion and due consideration, including consultation with financial and legal advisors and with senior management, our board of directors has determined that the Arrangement and the Arrangement Agreement are fair to our shareholders and are in our best interests. Accordingly, our board of directors unanimously recommends that you vote“FOR” the Arrangement Resolution to approve and adopt the Arrangement.
Reasons for the Arrangement (Page 27)
In making its recommendation that you vote“FOR” the approval of the Arrangement Resolution, our board considered a number of factors, including, among others, the following:
• our business, competitive position, strategy and prospects, the position of our current and likely competitors and current industry, economic and market conditions;
• the attractiveness of the Arrangement compared to alternatives reasonably available to us (including the possibility of our continued operation as an independent entity and the desirability and perceived risks of that alternative);


4


• the $44.93 per share in cash to be paid as consideration for the Arrangement, which represents a 17% premium to the closing price of our common shares on February 9, 2007 and a 49% premium to the closing price of our common shares on January 25, 2007, the day before we announced that we were negotiating with potential buyers;
• the fact that the Arrangement consideration of $44.93 per share was achieved through a competitive, multi-party auction process;
• the fact that the consideration will be paid in cash, which allows our shareholders to immediately realize fair value, in cash, for their investment and provides such shareholders certainty of value for their shares;
• the financial and other terms of the Arrangement Agreement as reviewed by our board of directors, which, among other things, permit our board of directors, under certain circumstances, to consider unsolicited acquisition proposals and to change its recommendation with respect to the Arrangement;
• the fact that the Arrangement is not subject to a financing condition;
• our board’s belief in the high probability that the Arrangement will be completed based on, among other things, the lack of significant regulatory risk; and
• the financial analyses and written opinions prepared by our financial advisors, Morgan Stanley & Co. Incorporated (referred to herein as “Morgan Stanley”) and Evercore Group LLC (referred to herein as “Evercore”) to the effect that, as of February 10, 2007 and based upon and subject to the factors set forth therein, the $44.93 in cash per share of our common shares to be received by the holders of outstanding shares of our common shares pursuant to the Arrangement Agreement is fair from a financial point of view to such holders.
Special Meeting; Quorum; Arrangement Resolution Vote (Page 15)
We will hold the special meeting at the offices of King & Spalding LLP located at 1180 Peachtree Road NE
Suite 1500
Street, N.E., Atlanta, Georgia 3032630309 on May 10, 2007, beginning at 8:30 a.m., Eastern time. The holders of 25% or more of the outstanding common shares entitled to vote must be present, either in person or by proxy, to constitute a quorum at the Meeting. The approval of the Arrangement Resolution requires the affirmative vote of at least 662/3% of the votes cast for or against the Arrangement Resolution at the Meeting.
Opinions of Morgan Stanley and Evercore (Page 29 and Page 35 and Annex D and Annex E)
Morgan Stanley and Evercore delivered written opinions each dated February 10, 2007, to the effect that, as of the date of the opinions and based upon and subject to the matters stated in the opinions, the Arrangement consideration to be received by our shareholders in the Arrangement is fair, from a financial point of view, to our shareholders. The full text of the written opinions of Morgan Stanley and Evercore, setting forth the assumptions made, procedures followed, matters considered and qualifications and limitations of the review undertaken in connection with the opinions, are attached as Annex D and Annex E, respectively, to this Proxy Statement/Circular and are incorporated by reference in this Proxy Statement/Circular. You should read the opinions of Morgan Stanley and Evercore carefully and in their entirety. Morgan Stanley’s and Evercore’s written opinions are directed to our board of directors, address only the consideration to be paid in the Arrangement and do not address any other aspect of the Arrangement (including how any shareholders should vote with respect to the approval of the Arrangement Resolution or the availability of the proposed financing for the transaction).
Material Tax Consequences of the Arrangement (Page 52)
U.S. Federal Income Tax Consequences
For U.S. federal income tax purposes, the Arrangement will be treated as a sale of our common shares by each of our shareholders. As a result, in general, each U.S. shareholder will recognize gain or loss equal to the difference, if any, between the amount of cash received from the Arrangement and such U.S. shareholder’s


5


adjusted tax basis in the shares surrendered. Such gain or loss will be capital gain or loss if the common shares surrendered are held as a capital asset in the hands of such U.S. shareholder, and will be long-term capital gain or loss if the common shares have a holding period of more than one year at the time the common shares are surrendered.
Canadian Federal Income Tax Consequences
For Canadian federal income tax purposes, generally, a resident holder who holds common shares as capital property will realize a capital gain (or capital loss) equal to the amount by which the cash received by such holder, net of any reasonable costs of disposition, exceeds (or is less than) the adjusted cost base to the holder of such common shares. Generally, a non-resident holder whose common shares do not constitute “taxable Canadian property” for purposes of theIncome Tax Act(Canada) and the regulations thereunder (the “Tax Act”) will not be subject to tax under the Tax Act on any gain realized on the disposition of such common shares under the Arrangement.
The foregoing are brief summaries of United States and Canadian federal income tax consequences only. Shareholders should read carefully the information in this Proxy Statement/Circular under the heading “Material Tax Consequences of the Arrangement,” which qualifies the summaries set forth above.Shareholders are urged to consult their own tax advisors to determine the particular tax consequences to them of the Arrangement.
Interests of Our Directors and Executive Officers in the Arrangement (Page 45)
Our directors and executive officers may have interests in the Arrangement that are different from, or in addition to, yours, including the following:
• our executive officers will receive cash consideration for their stock options, stock appreciation rights and stock price appreciation units, as applicable, equal to the difference, if any, between $44.93 per share and the exercise price underlying such stock options, stock appreciation rights and stock price appreciation units, less any applicable withholding taxes;
• our executive officers will receive cash consideration in an amount equal to $44.93 per performance share unit, less any applicable withholding taxes;
• our non-employee directors will receive cash consideration for their deferred share units in an amount equal to $44.93 per unit, less any applicable withholding taxes;
• our executive officers are parties to employment agreements, recognition agreementsand/or change in control agreements that provide certain severance payments and other benefits if, during a specific time period following the Arrangement, their employment is terminated;
• our employees (including our executive officers) who remain with us, Hindalco or any of our or their subsidiaries following the Arrangement will be entitled for a period of 24 months after the Arrangement to compensation and employee benefits that are substantially equivalent in the aggregate to the compensation and benefits provided to them on the date of the Arrangement Agreement; and
• the Arrangement Agreement provides for indemnification and liability insurance arrangements for each of our current and former directors and officers.
Our board of directors was aware of these interests and considered them, among other matters, in making its decisions.
Dissenting Holders’ Rights (Page 52)
Pursuant to section 190 of the CBCA, as modified by the Plan of Arrangement and the Interim Order, our shareholders have the right to dissent from the Arrangement Resolution and to receive a cash payment for the fair value of their common shares determined as of the day prior to approval of the Arrangement Resolution. The determined fair value under section 190 of the CBCA could be greater than, equal to or less than the


6


$44.93 in cash per share that our shareholders are entitled to receive in the Arrangement. Shareholders that wish to exercise their dissenting holders’ rights must not vote in favor of the approval of the Arrangement Resolution and must strictly comply with all of the procedures required by the CBCA, as modified by the Plan of Arrangement and the Interim Order.
Financing Arrangements (Page 56)
Hindalco estimates the total amount of funds necessary to be paid to our shareholders and holders of our other equity-based interests to complete the Arrangement is approximately $3.45 billion. Additional funds will be required to pay fees and expenses in connection with the Arrangement, the financing arrangements and the related transactions. Additional funds may be required to refinance our existing indebtedness which may be required to be repaid, or which Hindalco may elect to repay in connection with the Arrangement. These payments are expected to be funded by Hindalco using available cash and debt financing.
Hindalco has delivered to Novelis true, correct and complete copies of executed commitment letters, pursuant to which:
• ABN AMRO Bank N.V., Banc of America Securities Asia Limited, UBS AG, Singapore Branch and UBS AG Hong Kong Branch, have agreed to provide a bridge facility in an aggregate principal amount of $2.8 billion to one or more subsidiaries of Hindalco, the proceeds of which will be invested as equity or subordinated debt in Acquisition Sub; and
• UBS Loan Finance LLC and ABN AMRO Bank N.V. have agreed to provide (1) if Novelis’ existing credit agreement is amended in accordance with the requirements set forth in the commitment letters, an incremental term loan facility of up to the amount by which $1.6 billion exceeds the aggregate amount of the existing term loans outstanding under the credit agreement, (2) if Novelis’ credit agreement is not amended in accordance with the requirements set forth in the commitment letters, new term loan facilities in the aggregate principal amount of up to $1.6 billion and a new revolving credit facility in the aggregate principal amount of up to $400 million and (3) a bridge loan facility in the aggregate principal amount of up to $800 million. Such credit facilities are available for the purpose of prepaying all outstanding indebtedness and all other amounts then due and owing under the credit agreement (to the extent required), purchasing all or a portion of Novelis’ Senior Notes tendered pursuant to the change of control offer required to be made for the Senior Notes within 30 days following the closing, and paying fees and expenses related thereto.
Pursuant to the terms of our 71/4% senior notes (“Senior Notes”), we are obligated, within 30 days of a change of control, to make an offer to purchase the Senior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to (but excluding) the date the Senior Notes are purchased. In addition, Acquisition Sub has indicated that it may cause us to take other steps to repay, retire or redeem the Senior Notes after the closing of the Arrangement. The closing of the Arrangement in accordance with its terms does not require the consent or approval of the holders of the Senior Notes.
The commitment letters contemplate that, in connection with any change of control offer or other repayment, retirement or redemption of the Senior Notes, up to $800 million aggregate gross proceeds of new notes may be issued pursuant to a public offering or Rule 144A or other private placement upon the terms and conditions set forth in the commitment letters (in addition to borrowings under the incremental or replacement term loan facility). To the extent new notes are not issued at such time, borrowings by Novelis under the bridge facility described above (in addition to borrowings under the incremental or replacement term loan facilities) will be available to finance any required repurchase of the existing notes of Novelis.
The structure and documentation for the debt facilities has not been finalized and, therefore, the structure and terms of the financing may differ from those described in this Proxy Statement/Circular.
The commitments of the lenders with respect to the $2.8 billion bridge facility contemplated by the commitment letters shall terminate upon the earliest to occur of (1) execution of definitive documentation relating to such facilities by all parties thereto, (2) April 12, 2007 and (3) the date of termination of the Arrangement Agreement, unless the lenders and arrangers shall, in their discretion, agree to an extension.


7


Once definitive documentation is executed, the bridge facility is available for a further 90 days. The commitments of the lenders with respect to the incremental facility to be entered into in connection with the amendment to Novelis’ credit agreement, the new term loan and revolving loan facility and the $800 million bridge facility contemplated by the commitment letters shall terminate upon the earliest to occur of (a) execution of definitive documentation relating to such facilities by all parties thereto, (b) July 31, 2007 and (c) the date of termination of the Arrangement Agreement, unless the lenders and arrangers shall, in their discretion, agree to an extension. The facilities contemplated by the commitment letters are also subject to other customary conditions, as described in further detail under “The Arrangement — Financing the Arrangement — Debt Financing”.
Hindalco has agreed to use its reasonable best efforts to obtain the debt financing on the terms and conditions described in the commitment letters. The closing of the Arrangement is not conditioned on the receipt of the debt financing by Hindalco or Acquisition Sub. If all other conditions to closing of the Arrangement have been satisfied, Hindalco will be required to consummate the Arrangement regardless of whether Hindalco or Acquisition Sub has obtained debt financing on the terms and conditions described in the commitment letters, and the failure by Hindalco to consummate the Arrangement in such circumstances would constitute a breach of the Arrangement Agreement.
Hindalco and certain of its affiliates have agreed to make equity contributions and subordinated loans to one or more subsidiaries of Hindalco in an aggregate amount of no less than $600 million which will be further contributed to Acquisition Sub in order to consummate the Arrangement and settle the consideration payable in respect thereof in full.
Pursuant to discussions between Hindalco and the arrangers of the $2.8 billion bridge facility, it is anticipated that the bridge facility will be increased to $3.1 billion, that Hindalco and its affiliates’ required equity and subordinated debt contribution will be reduced from $600 million to $450 million, and that the term of the commitment for the bridge facility will be extended to July 31, 2007.
Regulatory Approvals (Page 56)
We and Hindalco will not complete the Arrangement unless we receive the regulatory approvals specified in the Arrangement Agreement as conditions to closing of the Arrangementand/or until the expiration of all applicable waiting periods, including antitrust approvals under the Competition Act (Canada), theHart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”), the European Union or the relevant antitrust authorities in the applicable European Union member states, as well as approval under the Investment Canada Act and approval by the Agência Nacional de Energia Eléctrica for the transfer of power generation concessions/authorizations in Brazil.


8


QUESTIONS AND ANSWERS ABOUT THE ARRANGEMENT AND THE MEETING
 
This information circular (this “Circular”)Proxy Statement/Circular is provided in connection with the solicitation of proxies by the board of directors andour management of Novelis Inc. (“Novelis”) for use at the first annual meeting of shareholders of Novelis or at any adjournment or postponement thereof (the “Meeting”).Meeting. In this Proxy Statement/Circular, “you” and “your” referrefers to the shareholders of Novelis,Novelis.
The following are some questions regarding the Meeting and “Novelis,” the “Company,” “we,” “us” or “our” referproposed Arrangement that you may have and answers to Novelis. The Meeting willthose questions. These questions and answers are not meant to be held at The Westin Buckhead Atlanta, 3391 Peachtree Road, Atlanta, GA 30326, on October 26, 2006, at 10:00 a.m. (EDT)a substitute for the purposes set forthinformation contained in the foregoing Noticeremainder of Annual Meeting of Shareholders. this Proxy Statement/Circular. We urge you to read this entire Proxy Statement/Circular, its annexes and the documents referred to or incorporated by reference in this Proxy Statement/Circular before making any decision.
We anticipate that this Proxy Statement/Circular and the accompanying proxy card will first be mailed to holders of our common shares (the “Shares”)shareholders on or about September 22, 2006.April 10, 2007. Except where otherwise indicated, the information contained herein is provided as of August 31, 2006,March 20, 2007, and all dollar amounts are in U.S. dollars.
QUESTIONS & ANSWERS ON VOTING AND PROXIES
 
Q:WHY AMWhy am I RECEIVING THIS CIRCULAR?receiving this Proxy Statement/Circular?
A:You are receiving this Proxy Statement/Circular and the accompanying proxy card and letter of transmittal from Novelis because you are a record holder of our Sharescommon shares on September 19, 2006March 20, 2007 (the “Record Date”). This Proxy Statement/Circular is furnished in connection with the solicitation of shareholder proxies by the board of directors andour management of Novelis for use at the Meeting. This Proxy Statement/Circular describes issues on which we would like you, as a shareholder, to vote. It also gives you information on these issues so that you can make an informed decision.
Q:Who is soliciting my proxy?
A:This proxy is being solicited by our management.
 
Q:HOW WILL MY PROXY BE SOLICITED?How will my proxy be solicited?
A:The solicitation of proxies will be made primarily by mail, but may also be made by electronic means, by telephone or in person. The cost of soliciting proxies will be borne by Novelis. Georgeson Inc. (“Georgeson”) has been retained by Novelis in Canada and the United States to assist in the solicitation of proxies from shareholders. For these services, Georgeson Inc. is expected to receive from Novelis fees of approximately $7,500$17,500 plus reimbursement of reasonable out-of pocket expenses. In addition, employees of Novelis may solicit proxies without compensation. CIBC Mellon Trust Company (“CIBC Mellon”), our registrar and transfer agent, is responsible for the tabulation of proxies.
Q:WHAT AMWhat am I VOTING ON?voting on?
 
A:ShareholdersYou are being asked to vote to approve the Arrangement Resolution and thereby approve the Arrangement, which, among other things, will be voting on the:result in the acquisition of all of the outstanding common shares of Novelis by Acquisition Sub. Once the Arrangement Resolution has been approved and adopted by our shareholders, the other conditions to closing of the Arrangement Agreement have been satisfied or waived (where permitted) and the necessary court order implementing the Arrangement has been obtained, Acquisition Sub will acquire Novelis. Novelis will become an indirect subsidiary of Hindalco.
 
• electionIn addition, you are being asked to consider and vote on the transaction of our directors;any other business that may properly come before the Meeting.
 
Q:• appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firmWhat will I receive in exchange for the fiscal year ending December 31, 2006, and to authorize the directors to fix the independent registered public accounting firm’s remuneration;my common shares?
 
A:• approvalFollowing the completion of the Arrangement, if you hold common shares, you will receive $44.93 in cash, without interest and less any required withholding taxes, for each common share that you own. You will not own shares in Novelis Inc. 2006 Incentive Plan (the “Incentive Plan”); andfollowing the completion of the Arrangement.
 
Q:• such other business as may properlyWhat will happen to my common shares after the completion of the Arrangement?
A:Upon completion of the Arrangement, your common shares will be brought beforetransferred to Acquisition Sub and you will only be entitled to receive your portion of the MeetingArrangement consideration of $44.93 per common share, or any adjournment or postponement thereof.the fair value of your common shares if you seek dissenting holders’ rights. In addition, trading


9


in common shares on the New York Stock Exchange and Toronto Stock Exchange will cease and price quotations for common shares will no longer be available.
Q:HOW DOHow will I VOTE?get paid?
A:If you are a registered shareholder, once you surrender to the Depositary for cancellation the certificate(s), which immediately prior to the closing of the Arrangement represented one or more common shares, together with the letter of transmittal and such additional documents as the Depositary may reasonably require, you shall be entitled to receive, and the Depositary shall deliver to you as soon as practicable after the effective time, a check representing the cash which you have the right to receive under the Arrangement, less any amounts withheld. If you are a non-registered shareholder, you should carefully follow the instructions from the broker, investment dealer, bank or other intermediary that holds common shares on your behalf in order to submit your common shares.
Q:Am I entitled to receive notice of the Meeting and attend the Meeting?
A:Yes, if you are a shareholder of record as of the close of business on March 20, 2007, which is the record date for the Meeting, you are entitled to receive notice of the Meeting and attend the Meeting. All such shareholders are entitled to receive notice of, attend and be heard at the Meeting.
Q:Where and when is the special meeting?
A:The special meeting will take place at the offices of King & Spalding LLP located at 1180 Peachtree Street, N.E., Atlanta, Georgia 30309, on May 10, 2007, at 8:30 a.m., Eastern time.
Q:Am I entitled to vote?
A:Yes, if you are a shareholder as of the close of business on March 20, 2007, you are entitled to one vote per common share on the Arrangement Resolution. On March 20, 2007, there were 75,350,963 common shares outstanding. Your vote is important regardless of the number of common shares you own.
Q:Are holders of Options, SPAUs, SARs, PSUs and DSUs able to vote at the Meeting?
A:No. Only holders of common shares are eligible to vote at the Meeting.
Q:What vote is required to approve the Arrangement Resolution?
A:The Arrangement Resolution must be passed by at least 662/3% of the votes cast at the Meeting in person or by proxy and entitled to vote.
Q:What is the quorum requirement?
A:A quorum consists of the presence, in person or by proxy, of the holders of 25% or more of the common shares entitled to vote at the Meeting. A quorum is necessary to conduct business at the Meeting. You are part of the quorum if you have voted by proxy.
Q:How does the Novelis board of directors recommend that I vote?
A:Our board of directors unanimously recommends that our shareholders vote“FOR”approval and adoption of the Arrangement Resolution. After due discussion and due consideration, our board of directors has determined that the Arrangement is fair to our shareholders and in our best interests. In considering the recommendation of our board of directors with respect to the Arrangement, you should be aware that, as a result of the Arrangement, certain of Novelis’ directors will receive payment for equity based interests in Novelis that they hold in addition to common shares. You should read “The Arrangement — Reasons for the Arrangement” for a discussion of certain material factors that our board of directors considered in deciding to recommend the approval and adoption of the Arrangement Resolution.
Q:How do I vote?
 
A:If you are a registered shareholder (that is, if your Sharescommon shares are registered in your name with our transfer agent), you can vote your Sharescommon shares at the Meeting, by proxy, by telephone at 1-866-271-1207(866) 271-1207 or on the Internet athttp://www.eproxy.com/www.eproxyvoting.com/novelis. More information regarding telephone and Internet voting is provided on the proxy card. Voting or transmitting voting authority by electronic means is generally recognized as a valid exercise of those rights in Canada.


10


Registered shareholders may also vote by mail. Simply complete, sign and date the enclosed proxy card. Use either the enclosed return envelope or the address provided in the instructions on the proxy card to return the proxy card.
 
If you are a non-registered shareholder (that is, if your Sharescommon shares are held in the name of an intermediary, such as a bank, broker, trust company or other nominee), your broker or other nominee will provide you with separate instructions on how to vote your Shares.common shares. Many brokers or other nominees make telephone or Internet voting available, but the specific processes available will depend on your broker’s or other nominee’s specific arrangements.
 
If you are a participant in the Novelis Savings and Retirement Plan or the Novelis Hourly Savings Plan, you must provide the trustee of the Novelis Savings and Retirement Plan or the Novelis Hourly Savings Plan with your voting instructions in advance of the Meeting according to the instructions provided by the trustee. You cannot vote the Sharescommon shares you hold through the Novelis Savings and Retirement Plan or the Novelis Hourly Savings Plan in person at the Meeting; the trustee is the only person who can vote your Shares.common shares. The trustee will vote your Sharescommon shares as you have instructed. If the trustee does not receive your voting instructions by the specified time, subject to applicable laws, your Sharescommon shares will be voted in the same proportion as the Sharescommon shares for which the trustee has received voting instructions.
 
Q:HOW MAYHow may I VOTE?vote?
 
A:In respect of approval of the election of directors,Arrangement Resolution, you may:
 
• VoteFOR“FOR”the electionapproval of the nominees for director;Arrangement Resolution; or
 
• WITHHOLDyour vote for Vote“AGAINST”the nominees for director.approval of the Arrangement Resolution.
 
In respect of the appointment of the independent registered public accounting firmIf you sign and return your proxy but do not indicate how you want to authorize the directors to fix the independent registered accounting firm’s remuneration, you may:
• VoteFORthe appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2006, and authorize the directors to fix the independent registered public accounting firm’s remuneration; or
• WITHHOLDvote, your vote for the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
In respect of approval of the Incentive Plan, you may:
• VoteFORproxy will be voted“FOR”the approval of the Incentive Plan;
• VoteAGAINSTArrangement Resolution and in accordance with the approvaldiscretion of the Incentive Plan; or
• ABSTAINfrom voting onpersons named as proxies as to any other matters properly brought before the approval of the Incentive Plan.Meeting for a vote.
 
Q:WHAT HAPPENS WHENWhat happens when I SIGN AND RETURN THE PROXY?sign and return the proxy?
 
A:Signing the enclosed proxy card gives authority to the named proxyholdersproxyholder on the proxy card, or to another person you have appointed, to vote your Sharescommon shares at the Meeting in accordance with the voting instructions you provide.


2


Q:CANCan I APPOINT SOMEONE OTHER THAN THE NAMED PROXYHOLDERS TO VOTE MY SHARES?appoint someone other than the named proxyholders to vote my common shares?
 
A:Yes. Write the name of the person you wish to appoint, who need not be a shareholder, in the blank space provided on the proxy card. It is important to ensure that the person you appoint attends the Meeting and is aware that he or she has been appointed to vote your Shares.common shares. Proxyholders should, upon their arrival at the Meeting, present themselves to a representative of CIBC Mellon. Please note that if you choose to vote your Sharescommon shares on the Internet or by telephone, only the persons selected by Novelis and named on the proxy card may be appointed.
 
Q:HOW WILL MY SHARES BE VOTED IFHow will my common shares be voted if I RETURN MY PROXY?return my proxy?
 
A:The persons named in the proxy card will vote or withhold from voting your Sharescommon shares in accordance with your instructions. In the absence of such instructions, however, your Sharescommon shares will be voted:voted“FOR”the approval and adoption of the Arrangement Resolution.
 
Q:• FORthe election of the director nominees;When should I return my proxy?
 
A:• FORthe appointment of the independent registered public accounting firm for the fiscal year ending December 31, 2006, and to authorize the directors to fix the independent registered public accounting firm’s remuneration;
• FORapproval of the Incentive Plan; and
• Subject to applicable laws, in the discretion of the proxyholdersYou should return your proxy card as to any other matterssoon as possible so that may properlyyour common shares will be brought beforevoted at the Meeting.
 
Q:IFIf I CHANGE MY MIND, CANchange my mind, can I TAKE BACK MY PROXY ONCEtake back my proxy once I HAVE GIVEN IT?have given it?
 
A:Yes. You may revoke your proxy by depositing a written notice, signed by you or your attorney as authorized in writing or, if you are a corporation, by an officer or attorney of the corporation duly authorized. You must deliver this written notice either to our registered office at Suite 1510, 70 York Street, Toronto,


11


Ontario MSJ 159 no later than 5:00 p.m. on May 9, 2007 or to the chair of the Meeting on the day of the Meeting or any time before it is exercised atadjournment thereof, prior to the start of the Meeting. You may do so by executing and returning a proxy card dated later than the previous one you have submitted or by properly submitting a later proxy via telephone or the Internet. You also may revoke your proxy in any other manner permitted by casting your vote by ballot at the Meeting. The participation in person by a shareholder in a vote by ballot at the Meeting will automatically revoke any proxy that has been previously given by the shareholder.law.
Q:HOW WILL MY SHARES BE VOTED IFHow will my common shares be voted if I DO NOT SIGN AND RETURN THE PROXY?do not sign and return the proxy?
 
A:If you are a registered shareholder and you do not sign and return your proxy card or vote in person at the Meeting, your Sharescommon shares will not be voted at the Meeting nor will they be used for purposes of establishing a quorum. If you are a non-registered shareholder and you do not follow the instructions provided by your broker or other nominee to vote your Shares, your United States broker or other nominee may, under certain circumstances, vote your Shares. On certain “routine” matters, such as the election of directors in an uncontested election and the appointment of the independent registered public accounting firm, your United States broker or other nominee has authority under New York Stock Exchange rules to vote your Shares if you do not provide voting instructions. On “non-routine” matters, such as approval of the Incentive Plan, if your United States broker or other nominee has not received voting instructions from you, the broker or other nominee does not have authority to vote your Shares. If your broker or other nominee has not received voting instructions on a non-routine matter, these Shares will be considered “broker non-votes” to the extent that the broker or other nominee submits a proxy. Broker non-votes will be counted for purposes of establishing a quorum to conduct business at the Meeting but not for determining the number of Shares votedFORorAGAINST approval of the Incentive Plan proposal. Broker non-votes will not be counted as “voted” in determining whether the New York Stock Exchange requirement that the Incentive Plan proposal be voted on by more than 50% of the Shares entitled to vote is satisfied.
Therefore, if you are a non-registered shareholder and you do not return your proxy, your Shares may be voted by your United States broker or other nominee with respect to the election of director nominees and the appointment of the independent registered public accounting firm in the absence of your instructions but will not be voted with respect to the approval of the Incentive Plan.
 
We encourage you to provide instructions to your broker or other nominee by returning your proxy. This action ensures that your Sharescommon shares will be voted at the Meeting.
Q:What is the difference between holding common shares as a shareholder of record and as a non-registered beneficial shareholder?
A.:Most of our shareholders hold their common shares through a broker, trustee or other nominee (such as a bank) rather than directly in their own name. As summarized below, there are some distinctions between common shares owned of record and those owned beneficially.
• Shareholder of Record.  If your common shares are registered directly in your name with our transfer agent, CIBC Mellon, you are considered to be the shareholder of record with respect to those common shares and these proxy materials are being sent directly to you. As the shareholder of record, you have the right to grant your proxy directly to us or to vote in person at the Meeting. We have enclosed a proxy card for you to use.
• Non-Registered Beneficial Shareholder.  If your common shares are held in a brokerage account, by a trustee or by another nominee (such as a bank), you are considered a non-registered shareholder, the beneficial owner of common shares held in “street name,” and these proxy materials are being forwarded to you together with a voting instruction card. As the beneficial owner, you have the right to direct your broker, trustee or nominee how to vote and are also invited to attend the Meeting.
Since a non-registered shareholder is not the shareholder of record, you may not vote your common shares in person at the Meeting unless you obtain a “legal proxy” from the broker, trustee or nominee that holds your common shares, giving you the right to vote the common shares at the meeting. Your broker, trustee or nominee has enclosed or provided voting instructions for you to use in directing the broker, trustee or nominee to vote your common shares.
Q:If I hold my shares as a non-registered beneficial shareholder, will my broker or other nominee vote my shares for me?
A:Yes, but only if you provide specific instructions to your broker or other nominee on how to vote. If you are a non-registered beneficial shareholder and you do not follow the instructions provided by your broker or other nominee to vote your shares, your broker or other nominee will not vote your shares.


3


Q:WHAT IF I ABSTAIN FROM VOTING?What if ownership of common shares has been transferred after March 20, 2007?
A:Abstentions with respect to a proposal are counted for purposes of establishing a quorum to conduct business at the Meeting but not for determining the number of Shares votedFORorAGAINSTa proposal. If a quorum is present, abstentions have no effectOnly persons on the outcomelist of a vote on the electionregistered shareholders prepared by Novelis as of directors or the appointment of the independent registered public accounting firm. Abstentions will not be counted as Shares “voted” in determining whether the New York Stock Exchange requirement that the Incentive Plan proposal be voted on by more than 50% of the SharesMarch 20, 2007 are entitled to vote is satisfied.at the Meeting.
Q:WHAT IFWhat if I PLAN TO ATTEND THE MEETING AND VOTE IN PERSON?plan to attend the Meeting and vote in person?
 
A:If you plan to attend the Meeting and wish to vote your Sharescommon shares in person at the Meeting, it is not necessary for you to complete or return the proxy card. Your vote will be taken and counted at the Meeting. However, we urge you to vote by proxy even if you plan to attend the Meeting to help us determine that enough votes will be present to establish a quorum.
 
Please register with theour transfer agent, CIBC Mellon, upon your arrival at the Meeting. Your participation in person in a vote by ballot at the Meeting will automatically revoke any proxy that you have previously given. Non-registered shareholders wishing to attend the Meeting should obtain admission material from their broker or other nominee and have their broker or other nominee appoint them as proxyholder, or bring evidence of ownership as of the record date, such as a bank or brokerage account statement, to the


12


Meeting. In all cases you must bring photo identification to the Meeting for admission and if you do not provide an admission ticket, a registration process will be required.
 
Q:WHAT IF AMENDMENTS ARE MADE TO THE MATTERS TO BE CONSIDERED AT THE MEETING OR IF OTHER MATTERS ARE BROUGHT BEFORE THE MEETING?What does it mean if I get more than one proxy card or vote instruction card?
 
A:The persons namedIf your common shares are registered differently or are in more than one account, you will receive more than one proxy card. Please complete and return all of the proxy card will have discretionary authority, subjectcards or vote instruction cards you receive (or submit your proxies by telephone or the Internet, if available to applicable laws, with respectyou) to amendments or variations to matters identified in the Noticeensure that all of Annual Meeting of Shareholders and to other matters which may properly come before the Meeting. As of the date of this Circular, the management of Novelis knows of no such amendment, variation or other matter expected to come before the Meeting. If any other matters properly come before the Meeting, the persons named in the proxy card will vote on them in accordance with their best judgment.your common shares are voted.
 
Q:HOW WILL THE PROPOSALS BE DECIDED AT THE MEETING?Should I send in the letter of transmittal?
 
A:A majorityIf you are a registered shareholder, we encourage you to complete, sign, date and return the enclosed letter of transmittal so that, if the Arrangement Resolution is approved, payment for your common shares can be sent to you as soon as possible following the implementation of the votes cast in favor, by proxyArrangement. If you are a non-registered shareholder, you should carefully follow the instructions from the broker, investment dealer, bank or in person, will constitute approval for (i) the election of the director nominees, (ii) the appointment of our independent registered public accounting firm and (iii) the Incentive Plan. In addition, under New York Stock Exchange rules, the proposal to approve the Incentive Plan must be votedother intermediary that holds common shares on by more than 50% of the Shares entitled to vote on the proposal.your behalf.
 
Q:WHAT CONSTITUTES A QUORUM FOR THE MEETING?When will the Arrangement be implemented?
A:A quorum consistsNovelis, Hindalco and Acquisition Sub will implement the Arrangement when all of the presence, in person or by proxy,conditions to closing of the holdersArrangement have been satisfied or waived (where permitted). Because the Arrangement is subject to a number of 25% or moreconditions, some of which are beyond Novelis’, Hindalco’s, and Acquisition Sub’s control, the exact timing of the Shares entitled to vote at the Meeting. A quorum is necessary to conduct business at the Meeting. You are partimplementation of the quorum if you have voted by proxy. Abstentions and broker non-votes are counted for purposes of establishing a quorum.
Q:WHO IS ENTITLED TO VOTE?
A:OnArrangement cannot be predicted, although it is expected that the Record Date, 74,005,649 Shares were outstanding. Shareholders of record asclosing of the close of businessArrangement will occur on the Record Date are entitled to receive notice of the Meeting and either they or their duly appointed proxyholders will be entitled to attend the Meeting and vote.
Each holder of Shares is entitled to one vote at the Meeting for each Share registered in the holder’s name at the close of business on the Record Date.about May 15, 2007.


4


Q:WHAT IS THE FINAL DATE TO SUBMIT A SHAREHOLDER PROPOSAL FOR THEAm I entitled to dissenting holders’ rights?
A:Yes. Pursuant to the section 190 of the CBCA, as modified by the Plan of Arrangement and the Interim Order, shareholders have a right to dissent in respect of the Arrangement. Registered shareholders who properly exercise their dissenting holders’ rights will be entitled to be paid the fair value of their common shares. This amount may be the same as, more than or less than the $44.93 in cash per common share offered under the Arrangement. If you wish to dissent, you must provide written notice to Novelis at or before 5:00 p.m. (Eastern time) on May 9, 2007 ANNUAL MEETING?(or on the day that is one business day immediately preceding any adjourned or postponed Meeting) in the manner described under the heading “Dissenting Holders’ Rights”. It is important that you strictly comply with this requirement, otherwise your dissenting holders’ right may not be recognized. You must also strictly comply with the other requirements of the dissent procedure. Only registered shareholders may exercise dissenting holders’ rights.
Q:What are the tax consequences of the Arrangement to me?
 
A:The final date for submitting shareholder proposals to Novelis for inclusion in the information circular for the 2007 Annual Meeting of Shareholders is December 15, 2006. If you haveare a proposalU.S. person, your receipt of the consideration under the Arrangement in exchange for your common shares will be a taxable transaction for U.S. federal income tax purposes. If you are a Canadian resident, the disposition of your common shares under the Arrangement will be a disposition for Canadian federal income tax purposes that may give rise to a tax liability. For a discussion of the material U.S. and Canadian federal income tax consequences of the Arrangement, see “Material Tax Consequences of the Arrangement”. Your tax consequences will depend on your particular situation. You should consult your own tax advisor for a full understanding of the applicable federal, provincial, territorial, state, local, foreign and other tax consequences to you would like us to consider atresulting from the 2007 Annual Meeting of Shareholders, and you do not want the Company’s proxyholders to be allowed to use their discretionary voting authority to vote against this shareholder proposal when and if raised, you must submit your proposal to us no later than March 1, 2007. Proposals should be sent to our principal executive offices located at 3399 Peachtree Road NE, Suite 1500, Atlanta, GA 30326, Attention: Corporate Secretary.Arrangement.
 
Q:WHAT DOCUMENTS ARE AVAILABLE TO SHAREHOLDERS?How can I obtain a separate set of voting materials?
A:If you share an address with another shareholder, you may receive only one set of proxy materials, unless you have provided contrary instructions. However, each shareholder will receive his or her own proxy card. If you wish to receive a separate set of proxy materials, please call Georgeson toll-free at (866) 834-6791. You will be provided with a separate copy of the materials, free of charge, if you request them. In addition, shareholders who share a single address but receive our Annual Report onForm 10-K formultiple copies of the year ended December 31, 2005, which includes our consolidated and combined financial statements and management’s discussion and analysis of financial condition and results of operations forproxy materials may request that in the year ended December 31, 2005 and this Circular.future they receive a single copy by contacting Georgeson at the phone number set forth above.


13


Copies of our Annual Report onForm 10-K for the year ended December 31, 2005 and consolidated and combined financial statements for the year ended December 31, 2005 filed with the Canadian and U.S. securities regulators can be found on the Company’s website atwww.novelis.com or may be obtained, without charge, on request from: Novelis Inc., 3399 Peachtree Road NE, Suite 1500, Atlanta, GA 30326, Attention: Corporate Secretary. Requests for information can also be sent from the Company’s website:www.novelis.com.
Q:WHERE DOHow can I FIND THE VOTING RESULTS OF THE MEETING?
A:We will announcecontact the preliminary voting results at the Meeting and will publish the final results in our quarterly report onForm 10-Q for the third quarter of 2006, which will be filed with the U.S. Securities and Exchange Commission (the “SEC”), and will be available by contacting: Novelis Inc., 3399 Peachtree Road NE, Suite 1500, Atlanta, GA 30326, Attention: Corporate Secretary. Our quarterly report onForm 10-Q for the third quarter of 2006 will also be available on our website atwww.novelis.com, on the Canadian Securities Administrators SEDAR system atwww.sedar.com, and on the SEC’s EDGAR system atwww.sec.gov.
Q:HOW CAN I CONTACT THE TRANSFER AGENT?transfer agent?
 
A:You can contact the transfer agent at:
CIBC Mellon Trust Company
P.O. Box 7010
Station A
Adelaide Street Postal Station
Toronto, Ontario, Canada M5C 2W9
Telephone:(416) 643-5500
                    1-800-387-0825(800) 387-0825 (toll free(toll-free throughout Canada and the U.S.)
Telecopier: (416)(416) 643-5501
Q:Who can help answer my other questions?
A:If you have additional questions about the Meeting or the Arrangement, including the procedures for voting your common shares, or you would like additional copies, without charge, of this Proxy Statement/Circular, you should contact our proxy solicitation agent, Georgeson at (866) 834-6791, toll-free. If your broker holds your common shares, you may also call your broker for additional information.
 
Q:WHO ARE THE PRINCIPAL SHAREHOLDERS OF THE COMPANY?In addition to approval by shareholders, are there any other approvals required for the Arrangement?
A:ToThe Arrangement requires a final court order (the “Final Order”) approving the knowledgetransaction. The notice of application for the Final Order is attached as Annex H to this Proxy Statement/Circular. Prior to the mailing of this Proxy Statement/Circular, we obtained the Interim Order authorizing and directing us to call, hold and conduct the meeting and to submit the Arrangement Resolution to shareholders for approval. A copy of the directors and executive officersInterim Order is attached as Annex G to this Proxy Statement/Circular. Subject to the approval of the Company, asArrangement Resolution by the required vote of September 8, 2006, no person or company beneficially owns or exercises control or direction over more than 5%shareholders, the hearing in respect of the outstanding SharesFinal Order is expected to take place on May 14, 2007. In determining whether to grant the Final Order, the Court will consider, among other things, whether the Arrangement is fair and reasonable. Whether an arrangement is fair and reasonable depends on procedural and substantive considerations. See “Principal Legal Matters — Court Approval of the Company other than FMR Corp, which reported to the SEC that it owned or exercised control or direction over 15.4%Arrangement and Completion of the Shares on February 14, 2006; McLean Budden Ltd., which reported toArrangement”. Certain other regulatory approvals are required as described in “Principal Legal Matters — Regulatory Matters” before the SEC that it owned or exercised control or direction over 9.8%closing of the Shares on August 11, 2006; and Kensico Capital Management Corporation, which reported to the SEC that it owned or exercised control or direction over 6.27% of the Shares on September 8, 2006.Arrangement can occur.
NOTICE TO SHAREHOLDERS IN THE UNITED STATES
Novelis is a corporation incorporated under the laws of Canada. The solicitation of proxies and the transactions contemplated in this Proxy Statement/Circular involve securities of a Canadian corporation and are being effected in accordance with Canadian corporate and Canadian and U.S. securities laws. Shareholders should be aware that requirements under Canadian laws may differ from requirements under U.S. corporate and securities laws.
Shareholders should be aware that the transaction contemplated in this Proxy Statement/Circular may have tax consequences both in the United States and Canada. Such consequences for shareholders who are resident in, or citizens of, the United States or Canada may not be fully described herein. See “The Arrangement — Material Tax Consequences of the Arrangement”.
Please read the information in this Proxy Statement/Circular carefully, and if you require assistance, consult your financial, legal or other professional advisor.
CAUTION REGARDING FORWARD-LOOKING STATEMENTS AND MARKET DATA
This Proxy Statement/Circular, and the documents to which we refer to in this Proxy Statement/Circular, contain forward-looking statements based on current expectations, estimates, forecasts and projections about the industry in which we operate, and beliefs and assumptions made by our management that are protected under applicable securities laws. Such statements include, in particular, statements concerning possible or our assumed future results of operations, the expected completion and timing of the transactions contemplated by the Arrangement Agreement and other information relating to the Arrangement and the Arrangement


514


BUSINESS TO BE TRANSACTED AT THE MEETINGAgreement. Words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are based on beliefs and assumptions of our management, which in turn are based on currently available information. These statements are not guarantees of future performance and involve assumptions and risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. We do not intend, and we disclaim any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.
 
(See Notice of Annual Meeting of Shareholders)You should read these forward-looking statements carefully as they involve known and unknown risks over which we have no control. Those risks include, without limitation:
 
1.  Presentation• the occurrence of Financial Statementsany event, change or other circumstance that could give rise to the termination of the Arrangement Agreement, including a termination under circumstances that could require us to pay a $100 million termination fee to Acquisition Sub or an expense reimbursement fee of up to $15 million to Hindalco;
• the risk that the Arrangement may not be completed in a timely manner or at all, which may adversely affect our business and the price of our common shares;
• the potential adverse effect on our business, properties and operations because of certain covenants we agreed to in the Arrangement Agreement;
• increases in costs resulting from the expenses related to the proposed Arrangement;
• our inability to retain and, if necessary, attract key employees, particularly in light of the proposed Arrangement;
• risks related to diverting management’s attention from ongoing business operations;
• the risk that we may be subject to litigation in connection with the proposed Arrangement;
• the failure to satisfy the conditions to consummate the Arrangement, including the approval of the Arrangement Agreement by our shareholders and obtaining the requisite regulatory approvals;
• the failure of Hindalco to obtain the necessary debt financing arrangements set forth in commitment letters received in connection with the Arrangement Agreement;
• the failure of the Arrangement to close for any reason; and
• the effect of the announcement of the Arrangement Agreement on our customer relationships, operating results and business generally, including the risk that we may be subject to litigation should those relationships deteriorate.
 
Our consolidatedThe above list of factors is not exhaustive. These and combined financial statements for the year ended December 31, 2005 and the Auditor’s Report for 2005 will be submitted to you at the Meeting, but no vote with respect thereto is required or proposed to be taken. The consolidated and combined financial statementsother factors are includeddiscussed in more detail under “Item 1A. Risk Factors” our Annual Report onForm 10-K for the year ended December 31, 2005 that is being mailed to you with the Notice of Annual Meeting of Shareholders and this Circular.2006. See “Additional Information” on page 79.
 
2.  
THE MEETING
Election of Directors
Thirteen directors are to be elected to serve until the close of the next annual meeting of the Company or until their successors shall be elected. Mr. J.E. Newall, O.C., who has served on our board of directors since January 2005, retired from the board of directors in July 2006 and will not be standing for re-election. Brian W. Sturgell also served on our board of directors from January 2005 through August 29, 2006. Edward A. Blechschmidt, Jacques Bougie, O.C., Charles G. Cavell, Clarence J. Chandran, C. Roberto Cordaro, Helmut Eschwey, David J. FitzPatrick, Suzanne Labarge, William T. Monahan, Rudolf Rupprecht, Kevin M. Twomey, John D. Watson and Edward V. Yang have, upon the recommendation of the Nominating and Corporate Governance Committee, been nominated to stand for election at the Meeting. Our board of directors recommends the election of all these nominees.
 
Unless authorityThis Proxy Statement/Circular is withheld,furnished in connection with the persons designatedsolicitation of proxies in connection with the accompanying proxy card intend to vote FOR the election of these nominees.Meeting.
Date, Time and Place The persons nominated are, in the opinion of our board of directors, well qualified to act as directors of the Company for the ensuing year. Our board of directors does not contemplate that any of these nominees will be unable to serve as a director, but should that occur for any reason before the Meeting, the persons designated in the accompanying proxy card reserve the right to vote for another nominee at their discretion unless the shareholder who has given such proxy has directed that their Shares be withheld from voting on the election of directors.
 
To better alignWe will hold the interestsspecial meeting at the offices of our board of directors with those of our shareholders, with the exception of our Chairman and Interim Chief Executive Officer, William T. Monahan, all of the nominees for election to the board of directors are independent. In determining whether a director is “independent”King & Spalding LLP located at 1180 Peachtree Street, N.E., the board of directors applies the standards developed by the Canadian Securities Administrators and the New York Stock Exchange and the additional standards adopted by the board of directors. These standards are set out in the GuidelinesAtlanta, Georgia 30309 on the Independence of the Board of Directors of Novelis Inc. (“Guidelines on Independence”) attached to this Circular as Schedule C and are also available on our websiteMay 10, 2007, atwww.novelis.com. 8:30 a.m., Eastern time.


615


Purpose of the Meeting
At the Meeting, we will ask you to (1) consider, adopt and approve the Arrangement Resolution and thereby approve the Arrangement Agreement and the transactions contemplated thereby and (2) transact any other business that is properly brought before the Meeting. We are not aware of any additional business that may come before the Meeting.
Recommendation of Novelis’ Board of Directors
Our board of directors unanimously (1) approved and adopted the Arrangement Agreement and (2) determined that the Arrangement is fair to the Novelis shareholders and is in our best interest. Accordingly, our board of directors unanimously recommends that you vote“FOR”the Arrangement Resolution.
Record Date; Shares Entitled to Vote; Quorum
Only holders of record of our common shares on the close of business on March 20, 2007, the record date, are entitled to notice of and to vote at the Meeting. On the record date, 75,350,963 common shares were issued and outstanding and held by approximately 9,440 holders of record. Each holder of record of our common shares will be entitled to one vote per common share at the Meeting on the proposal to approve the Arrangement Resolution.
The following table sets out certain biographical information, includingholders of 25% or more of the outstanding common shares entitled to vote must be present, either in person or by proxy, to constitute a brief descriptionquorum at the Meeting. If a quorum is not present at the Meeting, the holders of principal occupation and business experience duringthe common shares represented at the Meeting may adjourn the special meeting to solicit additional proxies. If a quorum is not present at the Meeting, we expect to adjourn or postpone the Meeting to solicit additional proxies.
If you are a non-registered shareholder (that is, if your common shares are held in the name of an intermediary, such as a bank, broker, trust company or other nominee), your broker or other nominee will provide you with separate instructions on how to vote your common shares.
Vote Required
The approval of the Arrangement Resolution requires the affirmative vote of at least 662/3% of the past five years, directorshipsvotes cast at the Meeting.
Voting of public companies (other than Novelis) presently held, and certain other information regarding the nominees for election as directors. This information has been furnished to us by the respective nominees.Proxies
 
Name, Age,(1) Residence, and Business Experience
To vote your common shares, you should mark, sign, date and return the enclosed proxy in the enclosed postage-paid envelope.Your proxy card must be received by us before 5:00 p.m. (Eastern time) on May 9, 2007 or, in the case of any adjournment or postponement of the Meeting, no later than 5:00 p.m. (Eastern time) on the business day before the date of the reconvened Meeting. Voting your proxy does not limit your right to vote in person should you decide to attend the Meeting. If your common shares are held in the name of a bank, broker or other nominee, you will be provided voting instructions from the nominee and, in order to vote at the Meeting, you must obtain a legal proxy, executed in your name, from the nominee.
If you return your proxy card and it is completed, signed and dated, your common shares will be voted at the Meeting in accordance with your instructions. If you return your proxy card and it is unsigned, then your vote cannot be counted. If you return your proxy card and it is signed and dated, but you do not fill out the voting instructions on the proxy card, the common shares represented by your proxy will be voted“FOR” the approval of the Arrangement Resolution and in accordance with the discretion of the persons named as proxies on any other matters properly brought before the Meeting for a vote.
Independence, Committee Membership, Other Directorships
William T. Monahan,59

West Chester, Pennsylvania, USA

Mr. Monahan is Chairman of our board of directors and Interim Chief Executive Officer. Mr. Monahan has served on the board of directors since January 6, 2005, and became Interim Chief Executive Officer on August 29, 2006. Mr. Monahan is the retired chairman and chief executive officer of Imation Corporation (imaging and data storage), where he served in that capacity from its spin-off from 3M Co. (industrial, medical, consumer and office products) in 1996 to May 2004. Prior to that, he held numerous executive positions at 3M, including Group Vice President, Senior Vice President of 3M Italy and Vice President of the data storage division.
Mr. Monahan is:
Not Independent

Director of:

• Pentair, Inc. (water industry)

• Hutchinson Technology Inc. (computer industry)

• Mosaic, Inc. (chemicals)
Edward A. Blechschmidt, 54

Villanova, Pennsylvania, USA

Mr. Blechschmidt has served on the board of directors since June 30, 2006. Mr. Blechschmidt was Chairman, Chief Executive Officer and President of Gentiva Health Services, Inc., (pharmaceutical and home health care services) from March 2000 to June 2002. From March 1999 to March 2000, Mr. Blechschmidt served as Chief Executive Officer and a director of Olsten Corporation (staffing services), the conglomerate from which Gentiva Health Services was spun off and taken public. He served as President of Olsten Corporation from October 1998 to March 1999. He also served as President and Chief Executive Officer of Siemens Nixdorf Americas and Siemens Pyramid Technologies (information technology) from July 1996 to October 1998. Prior to Siemens, he spent more than 20 years with Unisys Corporation (information technology), including serving as its Ch ief Financial Officer.
Mr. Blechschmidt is:
Independent

Member of:

• Audit Committee

• Customer Relations Committee

Director of:

• HealthSouth Corp. (healthcare)

• Lionbridge Technologies, Inc. (software)

• Option Care, Inc. (healthcare)

• Columbia Laboratories, Inc. (pharmaceuticals)
Jacques Bougie, O.C., 59

Verdun, Quebec, Canada

Mr. Bougie has served on the board of directors since January 6, 2005. Mr. Bougie was President and Chief Executive Officer of Alcan Inc. from 1993 to 2001, at which time he retired. Mr. Bougie is also Chairman of the International Advisory Council of CGI Group Inc. (information technology).
Mr. Bougie is:
Independent

Member of:

• Nominating and Corporate Governance Committee

• Human Resources Committee

Director of:

• NOVA Chemicals Corporation (chemical and plastics manufacturing)

• Abitibi Consolidated Inc. (paper)


716


Name, Age,(1) Residence, and Business Experience
Independence, Committee Membership, Other Directorships
Charles G. Cavell
Revocability of Proxies,64

Westmount, Quebec, Canada

Mr. Cavell has served on the board of directors since January 6, 2005. Mr. Cavell is a retired former President and Chief Executive Officer of Quebecor World Inc., one of the world’s largest commercial printers, with plants throughout Europe, South America and North America. He served in such capacity from 1989 to his retirement in 2003. He currently serves on the board of several private companies and charitable institutions and he is Vice Chairman of the Board of Governors of Concordia University.
Mr. Cavell is:
Independent

Member of:

• Human Resources Committee

• Nominating and Corporate Governance Committee
Clarence J. Chandran,57

Miami Beach Florida, USA

Mr. Chandran has served on the board of directors since January 6, 2005. Mr. Chandran has served on the board of directors since January 6, 2005. Mr. Chandran is Chairman of Chandran Family Foundation Inc. (health care research and education) and, since 2001, Chairman of Conros Corporation (private mass market consumer products company — including LePages USA and PineMountain). He retired as President, Business Process Services, of CGI Group Inc. (information technology) in 2004 and retired as Chief Operating Officer of Nortel Networks Corporation (communications) in 2001. Mr. Chandran is a member of the Duke University Board of Visitors and the Strategic Plan Executive Committee of the Pratt School of Engineering at Duke.
Mr. Chandran is:
Independent

Member of:

• Human Resources Committee, Chair

• Customer Relations Committee
C. Roberto Cordaro,56

Boston, Massachusetts, USA

Mr. Cordaro has served on the board of directors since January 6, 2005. Mr. Cordaro has been President and Chief Executive Officer of Nuvera Fuel Cells, Inc. (fuel cell power systems manufacturing) since 2002. He was Chief Executive Officer of Motor Coach Industries International (coach manufacturing) from 2000 to 2001 and was Executive Vice President and Group President — Automotive of Cummins Inc. (engine manufacturing) from 1996 to 1999.
Mr. Cordaro is:
Independent

Member of:

• Human Resources Committee

• Customer Relations Committee, Chair

Director of:

• Nuvera Fuel Cells, Inc.


8


Name, Age,(1) Residence, and Business Experience
Independence, Committee Membership, Other Directorships
Helmut Eschwey,57

Homburg, Germany

Mr. Eschwey has served on the board of directors since January 6, 2005. Mr. Eschwey has been Chairman of the Board of Management of Heraeus Holding GmbH (precious metals) in Germany since 2003. From 1994 to 2003, Dr. Eschwey was the head of the plastics technology business at SMS AG (engineering). Before he joined SMS AG, he held management positions at Freudenberg Group of Companies (industrial products), Pirelli & C. S.p.A. (tires) and the Henkel Group (chemicals).
Mr. Eschwey is:
Independent

Member of:

• Nominating and Corporate Governance Committee

• Human Resources Committee

Director of:

• Heraeus Holding GmbH
David J. FitzPatrick,52

Farmington, Connecticut, USA

Mr. FitzPatrick has served on the board of directors since March 24, 2005. Mr. FitzPatrick was the senior advisor to the chief executive officer of Tyco International Ltd. (Tyco) (fire, security, electronics, healthcare and other industrial products) from March 2005 until December 2005, at which time he retired. Previously, he was Executive Vice President and Chief Financial Officer of Tyco, a post he held from September 2002 until March 2005. He was Senior Vice President and Chief Financial Officer of United Technologies Corporation (aerospace and building) from June 1998 until September 2002.
Mr. FitzPatrick is:
Independent

Member of:

• Audit Committee

• Nominating and Corporate Governance Committee
Suzanne Labarge,59

Toronto, Ontario, Canada

Ms. Labarge has served on the board of directors since January 6, 2005. Ms. Labarge retired in 2004 from her position as Vice Chairman and Chief Risk Officer of the Royal Bank of Canada, which she held since 1999. She was Executive Vice President, Corporate Treasury, of the Royal Bank of Canada from 1995 to 1998. She is a member of the Board of Governors of McMaster University.
Ms. Labarge is:
Independent

Member of:

• Audit Committee, Chair

• Customer Relations Committee

Rudolf Rupprecht,66

Augsburg, Germany

Mr. Rupprecht has served on the board of directors since January 6, 2005. Mr. Rupprecht was the chairman of the executive board of MAN AG (mechanical engineering and trucks), in Germany from 1996 until the end of 2004, at which time he retired. Prior to that, Dr. Rupprecht was chairman of various supervisory boards within that company which he joined in 1966.
Mr. Rupprecht is:
Independent

Member of:

• Customer Relations Committee

Director of:

• Salzgitter AG (steel mill)

• MAN AG

• KME AG (copper manufacturer)

• Bayerische Staatsforsten (forestry and related products)

• SMS GmbH (steel mill equipment)


9


Name, Age,(1) Residence, and Business Experience
Independence, Committee Membership, Other Directorships
Kevin M. Twomey, 59

Ponte Vedra Beach, Florida, USA

Mr. Twomey has served on the board of directors since May 25, 2006. He recently retired as President and Chief Operating Officer of The St. Joe Company (real estate), having joined the company in 1999. He currently serves as a consultant to The St. Joe Company. Mr. Twomey formerly served as Vice Chairman and Chief Financial Officer or H.F. Ahmanson & Company and its principal subsidiary, Home Savings of America (financial services). Prior to joining Ahmanson in 1993, Mr. Twomey was Chief Financial Officer at First Gibraltar Bank, a company held by MacAndrews and Forbes Holdings of New York. Mr. Twomey also held management positions with MCorp and Bank of America. Mr. Twomey is a trustee of the University of North Florida and serves on the board of trustees of the United Way of Northeast Florida, the Navy Supply Corps Foundation and the Schultz Center for Teaching and Leadership Executive Board.
Mr. Twomey is:
Independent

Member of:

• Audit Committee

• Nominating and Corporate Governance Committee

Director of:

• PartnerRe Ltd. (reinsurance)

• Intergraph Corporation (computer software)

John D. Watson, 61

Calgary, Alberta, Canada

Mr. Watson is an Executive Advisor of EnCana Corporation (oil and gas) after retiring in February 2006 as Executive Vice President and Chief Financial Officer of EnCana Corporation, a position he had held since 2002. Prior to that, he was Vice President, Finance, and Chief Financial Officer of an EnCana Corporation’ predecessor, Alberta Energy Company Ltd, from 1987 to 2002. Mr. Watson serves as the chair of the Calgary Police Commission, and is a member of the Audit Committee for the Province of Alberta.
Mr. Watson is:
Independent

Director of:

• UTS Energy Corporation (energy)

• Nortel Networks Corporation (communications)
Edward V. Yang,61

Hong Kong, China

Mr. Yang has served on the board of directors since January 6, 2005. Mr. Yang has been chairman of Cross Shore Acquisition Corporation (service outsourcing) since April 2006. From 2001 to 2006 he has been a senior advisor at ING Barings Private Equity Partners Asia (financial services). He was formerly Vice Chairman and Chief Executive Officer of the Netstar Group (network management services) from 2002 to 2006. Prior to this role, Mr. Yang was also a corporate senior vice president and the president of Asia Pacific at Electronic Data Systems Corporation (information technology outsourcing) from 1992 to 2000.
Mr. Yang is:
Independent

Member of:

• Human Resources Committee

• Customer Relations Committee

Director of:

• Cross Shore Acquisition Corporation
 
If you hold your common shares in your name, you have the right to revoke your proxy by delivering a written notice, signed by you or your attorney as authorized in writing, or if you are a corporation, by an officer or attorney of the corporation duly authorized, to:
 
(1)• our Corporate Secretary, at our registered office located at Suite 1510, 70 York Street, Toronto, Ontario MSJ 159 no later than 5:00 p.m. on May 9, 2007; or
The age
• the chair of the directors is provided asMeeting on the day of August 31, 2006.the Meeting or any adjournment thereof, prior to the start of the Meeting.
You may also revoke your proxy in any other manner permitted by law. Revocation of your proxy, without any further action, will mean your common shares will not be voted at the Meeting or counted towards satisfying the quorum requirements.
If you have instructed your broker to vote your common shares, you must follow directions received from your broker to change your vote. If your common shares are held in the name of a bank, broker or other nominee, you cannot vote your common shares by returning a proxy card directly to us or by voting in person at the Meeting, unless you obtain a legal proxy from your bank or broker.
Solicitation of Proxies and Depositary
Our management is soliciting your proxy. In addition to the solicitation of proxies by use of mail, officers and other employees of Novelis may solicit the return of proxies by personal interview, telephone,e-mail or facsimile. We will not pay additional compensation to our officers and employees for their solicitation efforts. We will request that brokerage houses and other custodians, nominees and fiduciaries forward solicitation materials to the beneficial owners of the common shares registered in their names. We will bear all costs of preparing, assembling, printing and mailing the Notice of Special Meeting of Shareholders, this Proxy Statement/Circular, the enclosed letter of transmittal and any additional materials, as well as the cost of forwarding solicitation materials to the beneficial owners of common shares and all other costs of solicitation.
Georgeson is acting as our proxy solicitation agent, for which it will be paid a fee of approximately $17,500 plus reimbursement for reasonable out-of-pocket expenses.
We and Hindalco have engaged CIBC Mellon to act as Depositary for the receipt of certificates in respect of common shares and related letters of transmittal deposited pursuant to the Arrangement. The Depositary will receive reasonable and customary compensation for its services in connection with the Arrangement, will be reimbursed for certainout-of-pocket expenses and will be indemnified by Novelis against certain liabilities under applicable securities laws and expenses in connection therewith.
No fee or commission is payable by any shareholder who transmits its common shares directly to the Depositary. Except as set forth above, Novelis will not pay any fees or commissions to any broker or dealer or any other person for soliciting deposits of common shares pursuant to the Arrangement.
Letter of Transmittal
The letter of transmittal contains important information relating to the Arrangement and how to submit your common shares and should be reviewed carefully.
If you are a registered shareholder, you should have received with this Proxy Statement/Circular a letter of transmittal. In order to receive the payment for common shares, registered shareholders must complete and sign the letter of transmittal enclosed with this Proxy Statement/Circular and deliver it and the other documents required by it to the Depositary in accordance with the instructions contained in the letter of transmittal. You can request additional copies of the letter of transmittal by contacting the Depositary. The letter of transmittal is also available at the EDGAR and SEDAR websites atwww.sec.gov andwww.sedar.com, respectively.


1017


If you are a non-registered shareholder, you should carefully follow the instructions from the broker, investment dealer, bank or other intermediary that holds common shares on your behalf in order to submit your common shares.
Where a certificate for our common shares has been destroyed, lost or stolen, the registered shareholder of that certificate should immediately contact CIBC Mellon. A recordreplacement certificate will be issued upon the registered shareholder satisfying our requirements and the requirements of attendanceour transfer agent relating to replacement common share certificate(s).
Holders of outstanding stock options (“Options”), stock appreciation rights (“SARs”), stock price appreciation units (“SPAUs”), performance share units (“PSUs”) and deferred share units (“DSUs”) need not complete any documentation to receive the cash consideration for the securities held by them (other than common shares).
Assistance
Shareholders who have questions regarding the materials, need assistance voting their common shares or require additional copies of the Proxy Statement/Circular or proxy card, should contact or call (toll-free):
Georgeson Inc.
17 State Street, 10th Floor
New York, NY 10004
Toll-free at(866) 834-6791
Other Business
We are not currently aware of any business to be acted upon at the Meeting other than the matters discussed in this Proxy Statement/Circular. Under the CBCA, business transacted at the Meeting is limited to matters specifically designated in the Notice of Special Meeting of Shareholders, which is provided at the beginning of this Proxy Statement/Circular. If other matters do properly come before the Meeting, we intend that common shares represented by properly submitted proxies will be voted by the persons named as proxies on the proxy card in accordance with their discretion.
In addition, the grant of a proxy will confer discretionary authority on the persons named as proxies on the proxy card to vote in accordance with their best judgment on procedural matters incident to the conduct of the Meeting. If the persons named as proxies on the proxy card are asked to vote for matters incidental to the conduct of the Meeting, such persons will have the authority to vote in their discretion on such matters.
THE PARTIES TO THE ARRANGEMENT AGREEMENT
Novelis Inc.
Novelis is the world’s leading aluminum rolled products producer based on shipment volume in 2006, with total aluminum rolled products shipments of approximately 2,960 kilotonnes. With operations on four continents comprised of 33 operating plants including three research facilities in 11 countries as of December 31, 2006, Novelis is the only company of its size and scope focused solely on aluminum rolled products markets and capable of local supply of technically sophisticated products in all of these geographic regions. Novelis is a corporation incorporated under the laws of Canada, and its common shares are traded on the New York Stock Exchange and the Toronto Stock Exchange under the symbol “NVL.” PricewaterhouseCoopers LLP is Novelis’ independent registered public accounting firm. Novelis’ executive offices are located at 3399 Peachtree Road NE, Suite 1500, Atlanta, Georgia 30326 and its telephone number is(404) 814-4200.


18


Hindalco
Hindalco Industries Limited is Asia’s largest integrated primary producer of aluminum and a leading integrated producer of copper. Hindalco’s integrated operations and operating efficiency have positioned the company among the most cost-efficient aluminum producers globally. Hindalco is a corporation organized under the laws of India and its stock is publicly traded on the BSE, the NSE and the GDR. Hindalco’s executive offices are located at Aditya Birla Centre, S. K. Ahire Marg, Worli, Mumbai-400 030 India and its telephone number is91-22-6652 5000 / 2499 5000.
Acquisition Sub
Acquisition Sub is AV Metals Inc., a corporation incorporated under the laws of Canada. It is a subsidiary of Hindalco, incorporated solely for the purpose of facilitating the Arrangement. It has not conducted any activities to date other than activities incidental to its formation and organization and in connection with the transactions contemplated by the Arrangement Agreement.
THE ARRANGEMENT
Background of the Arrangement
Since our inception as a public company in January 2005 following our spin-off from Alcan Inc., we have considered a variety of strategic alternatives, including the continued execution of our strategic operating plan, value-creating corporate transactions, such as acquisitions or joint ventures, and divestitures of non-core assets.
In late 2005, our former chief executive officer, Mr. Brian Sturgell, was contacted by the senior management of a company, which we refer to as “Company A”, regarding their interest in better understanding the business of Novelis and the aluminum rolled products industry. Company A referred to past investments and acquisitions it had made in industrial companies, and a desire to develop a relationship with us. On January 31, 2006, Mr. Sturgell met with members of the senior management of Company A and described our business and industry to them. Mr. Sturgell agreed to maintain contact with and meet with Company A representatives later in 2006.
In April 2006, we were contacted by a financial advisor for a company, which we refer to as “Company B”, concerning its client’s interest in a potential business combination or other negotiated transaction with us. We made arrangements to meet with and understand Company B’s potential interest in our company. In April 2006, our senior management also contacted Company A in order to further discuss the development of a relationship between the two companies and the potential for Company A to participate in an investment being contemplated by us.
On May 3, 2006, we entered into a mutual confidentiality agreement with Company A. After preliminary discussions with Company A in early May 2006, Company A informed us that, while they remained interested in our company and the aluminum rolled products industry, they were not prepared to enter into a transaction with us at that time. No further discussions were held with Company A until October 2006.
During May and June 2006, we met on separate occasions with representatives of Company B to discuss possible strategic transactions. During these meetings, no non-public information was exchanged and our senior management explained to representatives of Company B our concern that our ongoing financial restatement and review process had resulted in a decline in our common share price, and we were of the belief that our share price was not reflective of the value of our company. However, as a result of these ongoing discussions, we entered into a mutual confidentiality agreement with Company B on June 9, 2006. The confidentiality agreement included a customary standstill provision.


19


At a meeting of our board of directors on June 29, 2006, members of our senior management briefed our board on discussions with Company B. The board of directors instructed our senior management to continue discussions with Company B and to keep the board of directors apprised of developments in the discussions.
On June 30, 2006, members of our senior management met with senior management from Company B to discuss the proposed structure of a potential transaction with Company B, including a merger transaction, an all cash purchase of Company B by us, or an all cash purchase of us by Company B. Company B also discussed their preliminary view of the potential synergies that could be realized in the combination of our two companies. We reiterated to Company B, that, in our management’s view, our share price at the time did not reflect the ongoing value and prospects of our company. After this meeting, we agreed to continue discussions with Company B; however, we had limited contact with Company B until August 2006 as it subsequently became apparent that Company B was engaged in the process of being acquired by a third party. As of the close of trading on June 30, 2006, the market price of our common shares was $21.58 per share.
In July 2006, we received a letter from Mr. Debu Bhattacharya, the managing director of Hindalco, requesting a meeting with our senior management. A meeting took place on August 2, 2006 between our senior management and representatives from Hindalco and the associated Aditya Birla Group of companies, during which Hindalco indicated that they had performed a significant evaluation of Novelis based upon publicly available information, and proposed a potential all cash acquisition of us by Hindalco. Our senior management indicated their view that our common share price did not reflect the future value of our stand alone strategic plan, but that we would consider Hindalco’s position and communicate with them after further consideration of the meeting. The parties did not exchange any non-public information at the meeting.
We formally engaged King & Spalding LLP, who we refer to as King & Spalding, to serve as our legal advisors and Morgan Stanley to serve as our financial advisors in connection with our potential alternatives in July and September 2006, respectively.
On August 5, 2006, Mr. Bhattacharya sent a letter to Mr. Sturgell outlining Hindalco’s proposal to acquire us in an all-cash transaction, which he stated contemplated the payment of a significant premium above our then current share price. No specific price was referenced by Mr. Bhattacharya in the letter.
During the evening of August 6, 2006, the chief executive officer of Company B contacted Mr. Sturgell to inform us that Company B was entering into an agreement to sell itself to a third party, which we refer to as Company B’s parent. Company B entered into the definitive acquisition agreement the next day. In early September 2006, the financial advisors for Company B, as was permitted by their acquisition agreement, contacted Morgan Stanley to inquire whether we were interested in acquiring Company B. Our senior management, in consultation with Morgan Stanley, evaluated the opportunity and concluded that at that time we were not interested in acquiring Company B at or above the per share price contemplated in Company B’s definitive acquisition agreement. At the direction of our senior management, Morgan Stanley reported this conclusion to Company B’s financial advisors.
On August 7, 2006, Mr. Sturgell responded to Mr. Bhattacharya’s letter of August 5, 2006 and restated his view that our then current common share price was not consistent with the long term value of the company given the capital markets’ focus on the non-operating financial difficulties related to the review and restatement of our financial statements for the first and second quarters of 2005 and the resulting delay in filing certain other periodic reports with the SEC. In subsequent communications between Mr. Bhattacharya and Mr. Sturgell in August 2006, we agreed to continue discussions with Hindalco, but expressed that our board of directors was focused on pursuing our current strategic plan.
At a meeting of our board of directors on August 23, 2006, our board discussed ongoing business initiatives and possible strategic alternatives. At the meeting, Morgan Stanley presented a preliminary capital markets review of Novelis. Following a brief overview of the fiduciary duties of directors and a review of the decision process a board must undertake in the face of an unsolicited takeover bid, Mr. Les Parrette, our general counsel, then introduced to the board our Canadian legal counsel, Osler, Hoskin & Harcourt LLP, who we refer to as Osler. Osler then reviewed with our board our takeover preparedness generally and our board’s


20


fiduciary duties should an offer be received. At this meeting, the board also instructed our senior management to continue discussions with Hindalco and to keep the board apprised should there be further developments in the discussions.
On August 28, 2006, a meeting of our board of directors took place during which our directors accepted Mr. Sturgell’s resignation as chief executive officer. Mr. William Monahan, the chairman of our board of directors, was appointed as interim chief executive officer, and our board established an office of the chairman comprised of Mr. Blechschmidt, Mr. Clarence Chandran and Mr. Monahan. Following this meeting, the board engaged Faegre & Benson LLP, who we refer to as Faegre & Benson, to act as special legal counsel to the board relative to its observance of its fiduciary duties.
The chief executive officer of Company B contacted Mr. Monahan on August 28, 2006, and, referencing the resignation of Mr. Sturgell, reiterated Company B’s interest in pursuing a transaction with us. Mr. Monahan also spoke with Mr. Bhattacharya on August 29, 2006, and Mr. Bhattacharya also confirmed Hindalco’s continuing interest in pursuing a transaction with us.
On September 12, 2006, senior management of Company B contacted Mr. Monahan via telephone, and indicated that, subject to the completion of its acquisition by Company B’s parent, Company B would be willing to pay $26.00 to $26.50 per share in cash to acquire all of our common shares. As of the close of trading on September 12, 2006, the market price of our common shares was $21.50. Mr. Monahan responded that he would consider the proposal and respond to Company B. After discussing the proposal with Messrs. Blechschmidt and Chandran and Morgan Stanley, Mr. Monahan called senior management of Company B on September 14, 2006 and stated that, in his view, the proposed range of consideration failed to reflect the stand-alone value of our company and did not represent a meaningful premium to our common share price at the time. The parties agreed that Mr. Steven Fisher, our vice president, corporate development, and a designated member of Company B’s senior management would begin discussions to determine if Company B could improve their indicative bid and meetings between our companies were scheduled for early October 2006.
On September 13, 2006, Messrs. Blechschmidt, Monahan, Chandran and Fisher met with representatives of Hindalco and the Aditya Birla Group of companies to further discuss a possible sale of us to Hindalco. During this meeting there was no indication of the amount that Hindalco would be willing to pay in a possible acquisition, but representatives of Hindalco and the Aditya Birla Group of companies reiterated that the amount contemplated a payment of a significant premium above our trading price and stated that Hindalco would be able to provide an indication of price by mid-October 2006, following further meetings between the two companies.
On September 15, 2006, at a meeting of our board of directors, Messrs. Monahan and Fisher updated the board on the discussions with Company B and Hindalco. At this meeting, our board of directors instructed our senior management to continue discussions with Company B and Hindalco and to keep the board apprised should there be further developments in these discussions. The board also directed Morgan Stanley and management to prepare an information packet about us and to deliver such packet to Company B and Hindalco.
On September 26, 2006, we entered into a mutual confidentiality agreement with Hindalco in connection with a possible negotiated transaction. Pursuant to the terms of the confidentiality agreement, Hindalco was subject to a customary standstill provision.
The morning of September 29, 2006, our management participated in a teleconference call with investors and equity research analysts to provide guidance on our estimated results for 2006 and 2007 and to provide an update on our management’s projected timing for becoming current with our SEC filings. Our closing share price on September 29, 2006 of $25.59 was 11% higher than the previous day’s closing price.
Morgan Stanley and our senior management prepared and delivered the information packet, containing business and financial information about us, to Hindalco and to Company B on October 1, 2006 and October 3, 2006, respectively.


21


On October 5, 2006, members of our senior management and Morgan Stanley met with senior management of Company B and its financial advisor to discuss our business, results of operations and financial outlook.
On October 19, 2006, members of our senior management and Morgan Stanley met with representatives of Hindalco to discuss their review of the information provided in our information packet.
On or about October 19, 2006, at the request of our senior management, Morgan Stanley contacted Company A to inquire as to whether Company A was interested in pursuing a strategic transaction with us. Company A responded to Morgan Stanley on October 24, 2006, indicating that they were interested in conducting preliminary due diligence regarding a transaction with us. Accordingly, on October 24, 2006, we entered into a letter agreement with Company A amending the confidentiality agreement with Company A that we had entered into on May 3, 2006. The amendments to the confidentiality agreement included the insertion of a customary standstill provision.
Separately, on October 24, 2006, Mr. Monahan sent a letter to Hindalco requesting clarification of their position in relation to an acquisition of us and requested they provide a non-binding bid proposal by early November 2006.
At a meeting of the board on October 25, 2006, Mr. Fisher updated our board of directors on the status of communications with Company A, Company B and Hindalco.
On November 3, 2006, members of our senior management and Morgan Stanley provided Company A with an information packet about us and met with Company A’s chief executive officer and other senior managers of Company A to discuss our business, results of operations and financial outlook and a potential transaction with Company A.
We continued our discussions with Company B throughout November 2006. During a meeting with our senior management, Morgan Stanley and the senior management of Company B, Company B stated that it could not provide an indicative bid until completion of its acquisition by Company B’s parent, which was scheduled to take place in December 2006. However, Company B stated that its indicative bid could be higher than $30.00 per share in cash. We entered into a confidentiality agreement with Company B’s parent dated November 14, 2006, which contained a customary standstill provision.
Messrs. Monahan, Chandran, Fisher and Morgan Stanley met with senior management of Hindalco and representatives of the Aditya Birla Group of companies on November 8, 2006, during which Hindalco provided an indicative non-binding bid of $28.50 to $31.30 per share in cash. Following correspondence between Mr. Bhattacharya and Mr. Monahan on November 9, 2006, and further review by Hindalco of information that it had received from us, Mr. Bhattacharya indicated that Hindalco would adjust its indicative bid to $31.30 per share in cash. Mr. Monahan responded that Hindalco’s proposed price would, in his view, need to be further increased in order to be acceptable to us, but that we would continue our discussions with Hindalco. As of the close of trading on November 9, 2006, the market price of our common shares was $24.91 per share.
At a meeting of our board of directors on November 17, 2006, in order to provide for more efficiency in the bid process, our board formed an ad hoc committee of the board to assist the board and management in evaluating a possible transaction. Mr. Blechschmidt, Mr. Chandran, Mr. David Fitzpatrick and Mr. John Watson were appointed to the ad hoc committee. The ad hoc committee also determined at this time that Faegre & Benson would act as legal counsel to the ad hoc committee, as well as the board, in connection with any possible transaction.
At a meeting of the ad hoc committee of the board on November 20, 2006, Mr. Monahan provided an update on the status of the potential sale process, including our recent discussions with each of Company A, Company B and Hindalco.


22


On November 28 and 30, 2006, the ad hoc committee of our board met and Mr. Monahan provided an update on the status of discussions with each of Company A, Company B and Hindalco. Morgan Stanley reviewed with the ad hoc committee a draft of the materials they intended to present at the upcoming meeting of the board of directors on December 6 and 7, 2006. Separately, on that day our senior management met with representatives of Company B to conduct management presentations.
On December 5, 2006, Company A contacted Morgan Stanley and provided an indicative offer of $32.50 per share in cash. Company A proposed conducting due diligence during December 2006 and providing a more detailed proposal in early January 2007.
A meeting of our board of directors was held on December 6 and December 7, 2006. Morgan Stanley presented to our board its preliminary analysis of our stand-alone strategic plan and its views regarding the valuation of our company. The board of directors discussed the presentation with Morgan Stanley, including the company’s valuation in the capital markets and a review of risk factors related to our strategic plan. In light of the risks and challenges identified in our current strategic plan, our board of directors considered whether a change of control transaction may be in our best interests and the best interests of our shareholders. Morgan Stanley and Mr. Fisher also updated the board on the status of the sale process and discussed whether additional potential bidders should be approached by us. Morgan Stanley expressed its view that the bidders that were currently involved in the sale process represented the three most likely acquirors of our company and a competitive process could be achieved with these bidders. The board concurred with Morgan Stanley’s assessment and concluded that we should continue to monitor the process to determine if other bidders should be invited to participate in the sale process. Following further discussion, our board of directors instructed our senior management to continue its work to build its strategy to continue as an independent company and to simultaneously continue discussions with each of the bidders. At the meeting, the board was also given a brief summary of significant regulatory and contractual consents and approvals and other material impediments to a change of control transaction.
Throughout December, each of the three bidders continued to conduct business, financial and operational due diligence, including visits to certain of our sites.
On December 12, 2006, at a meeting of our board of directors, the board and Faegre & Benson agreed that in light of the increased frequency of the meetings of the board of directors and its committees, as well asto discuss the numberstatus of the proposed sale process, further meetings of the ad hoc committee of the board andwould be duplicative. Accordingly, at that time the board committee meetings held duringresolved to dissolve the year ended December 31, 2005, are set out in Schedule A to this Circular.ad hoc committee.
 
Except with respect to the cease trade orders imposed upon Novelis, its directors and certain of its officers by Canadian securities regulators in connection with the Company’s delayed filings of itsForm 10-Q for the quarter ended September 30, 2005, its Annual Report onForm 10-K for the year ended December 31, 2005 and its quarterly reports onForm 10-Q for the first two quarters of 2006 (which orders affected eachAfter completion of the nominees for electionacquisition of Company B by Company B’s parent, on December 19, 2006 Messrs. Monahan and Fisher and Morgan Stanley met with representatives of Company B during which Company B provided a non-binding indicative bid of $32.00 per share in cash and requested that we negotiate with Company B exclusively. Mr. Monahan stated to Company B that its non-binding indicative bid was not sufficient to distinguish Company B from the other bidders, and we would not agree to negotiate exclusively with them. On that same day, a meeting of the board of directors other than Messrs. Twomey, Blechschmidt and Watson), totook place, during which Mr. Monahan updated the knowledgeboard on the status of discussions with each of the Companypotential bidders and based upon information providedsenior management answered the board’s questions concerning the transaction process, including inquiries related to it bycontractual and other legal and regulatory impediments to pursuing a transaction with the nominees for election to thebidders and whether we should approach other possible bidders. Our board of directors no such nominee is or has been,instructed senior management to continue to pursue discussions with each of Company A, Company B and Hindalco and to keep our board apprised of developments in the last 10 years,discussions.
On December 22, 2006, Morgan Stanley sent a director orbid process letter to each of Company B and Hindalco informing them that their final bids would be due at the end of January 2007. On December 26, 2006, we granted the bidders access to an on-line data room containing further information about our business and operations.
On December 28, 2006, at a meeting of our board of directors, Mr. Fisher updated the board on the progress of the potential transaction with each of Company A, Company B and Hindalco. Also at this meeting, our board appointed Mr. Blechschmidt as acting chief executive officer, of any company that, while such person was acting in that capacity: (a) was the subject of a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, for a period of more than 30 consecutive days; (b) was subject to an event that resulted, after that person ceased to be a director or executive officer, in the company being the subject of a cease trade or similar order or an order that denied the relevant company access to any exemption under securities legislation, for a period of more than 30 consecutive days; or (c) within a year of that person ceasing to act in that capacity, became bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency or was subject to or instituted any proceedings, arrangement or compromise with creditors or had a receiver, receiver manager or trustee appointed to hold its assets.
3.  Appointment of the Independent Registered Public Accounting Firm
In 2005, fees for audit, audit-related, taxreplacing Mr. Monahan, and all other services provided to the Company by PricewaterhouseCoopers LLP were as follows:
     
  Year Ended
 
  December 31, 2005 
 
Audit Fees $6,757,191 
Audit-Related Fees $0 
Tax Fees $0 
All Other Fees $0 
     
Total
 $6,757,191 
     
Audit Fees
PricewaterhouseCoopers LLP has served as our independent registered public accounting firm since our spin-off from Alcan on January 6, 2005. In 2005, fees for audit services provided to the Company by PricewaterhouseCoopers LLP totalled $6,757,191.
PricewaterhouseCoopers LLP did not perform any other services for the Company during 2005.
Pre-Approval of Audit and Permissible Non-Audit Services
Effective May 9, 2005, the Audit Committee established a policy requiring its pre-approval of all audit and permissible non-audit services provided by our independent registered public accounting firm. The policy gives detailed guidance to management as to the specific services that are eligible for general pre-approval and provides specific cost limits for certain services on an annual basis. Pursuant to the policy and the Audit Committee charter, the Audit Committee has granted to its chair the authority to address any requests for pre-approval of individual services. None of the services provided by our independent registered public accounting firm for 2005 that were approved by the Audit Committee made use of the de minimus exception to pre-approval set forth in applicable rules of the SEC.dissolved


1123


Boardthe office of Directors’ Recommendationthe chairman of the board, effective January 2, 2007. Mr. Monahan remained as chairman of our board of directors.
On January 3, 2007, Company A delivered a letter to us providing a non-binding indicative bid of $32.50 per share in cash. Company A stated their proposal did not have any financing conditions and that they felt there were limited to no regulatory issues related to the acquisition of us by Company A. The letter also stated that Company A required compensation for its time, effort and expenses, including its due diligence expenses, to be incurred if they continued in the process and were not the successful bidder.
 
In accordancea series of conversations between Company A, senior management and Morgan Stanley, Company A indicated that it may be willing to increase its non-binding indicative bid from $32.50 per share in cash, but that it required the implementation of a fee arrangement as referred to in their letter of January 3, 2007 to continue their investigation of a transaction.
On January 5, 2007, Messrs Blechschmidt and Fisher had a conversation with representatives of Company A regarding their proposed fee arrangement and were informed by representatives of Company A that it would not continue in the process unless some form of fee arrangement was implemented.
On January 4 and January 5, 2007, members of our senior management met with representatives of Company B for a series of management presentations. On the evening of January 4, 2007, Company B’s parent contacted Morgan Stanley and requested that they be permitted to add another financial sponsor to their buying group in order to improve the competitiveness of their bid proposal. After consultation with Morgan Stanley, our senior management approved Company B’s request. During the week of January 7, 2007, Company B continued to conduct operational due diligence and visited certain of our operating plants.
On January 8, 2007, at a meeting of our board of directors, Mr. Blechschmidt updated the board on his discussions with representatives of Company B and the board discussed the terms of Company A’s fee proposal. In the discussion, it was noted that retaining Company A in the process was important, in view of (1) the significance of maintaining the competitive nature of the sale process, (2) the attractiveness of Company A’s indicative offer of $32.50 per share in cash relative to the prices indicated by the other two interested parties, which were in the range of $31.30 to $32.00 per share in cash, and a willingness of Company A to consider a higher price depending upon the results of its due diligence investigation and (3) the likely degree of certainty of closing in a transaction with Company A and the time frame within which Company A could close a transaction compared to certain other bidders. After further discussion, our board agreed that senior management should continue their negotiation with Company A, with a view towards reaching agreement on the terms of Company A’s continued involvement in the sale process.
On January 12, 2007, we convened a meeting of our board of directors, during which Morgan Stanley presented a revised analysis of our stand-alone plan based on management’s latest financial projections. Following further discussion with senior management and Morgan Stanley, our board agreed that we should continue to explore the possibility of our entering into a change of control transaction. Mr. Blechschmidt then provided an update on the progress of discussions with each of Company A, Company B and Hindalco.
On January 12, 2007, Company A sent us a letter containing a revised non-binding, indicative proposal of $33.00 per share in cash. Company A’s proposal reiterated their request for compensation for their time, effort and expenses to continue their evaluation of a transaction. On January 13, 2007, after further confirmation that Company A was unwilling to proceed any further in the sale process without an agreement to compensate it for its time, effort and expense incurred in the process, we reached an oral agreement with Company A providing for the payment of a total fee of up to $20 million in order to assure that Company A would continue to participate in the sale process through February 7, 2007. We executed a formal fee agreement with Company A on January 17, 2007.
On January 17, 2007, Morgan Stanley distributed an updated bid process letter to Company A, Company B and Hindalco. The updated bid process letter required that each bidder’s final binding proposal be submitted to Morgan Stanley on Wednesday, February 7, 2006.


24


At a meeting of our board of directors on January 22, 2007, Mr. Blechschmidt updated our board on the progress of discussions with Company A, Company B and Hindalco. Presentations were made concerning the potential impediments to our ability to enter into a change of control transaction, an overview of the potential regulatory review process involved and an analysis of the related regulatory considerations relevant to each bidder. Our board also discussed the potential for significant regulatory issues raised by a transaction with Company B.
On January 25, 2007, media reports indicated that the Aditya Birla Group of companies was exploring the possibility of acquiring us for a total transaction value of $5 to $6 billion. On January 26, 2006, our common share price increased significantly on heavy volume until trading was halted on both the NYSE and the TSX. Shortly following the trading halt, we announced that we were in discussions with various parties that could lead to our potential sale. We also stated that there could be no assurance that any transaction would occur or as to the timing of any such potential transaction.
At a meeting of our board of directors on January 31, 2007, Mr. Blechschmidt described the recent media speculation concerning our proposed change of control transaction and the resulting press release we issued on January 26, 2007. After discussions regarding the significant increase in the trading price of our common shares following these events, the board approved engaging Evercore to act as an additional financial advisor to provide an opinion as to whether any consideration received in connection with any possible transaction was fair to our shareholders from a financial point of view. Mr. Fisher also described the status of discussions with each of Company A, Company B and Hindalco at the meeting.
On February 5, 2007, Company B’s chief executive officer contacted Mr. Blechschmidt, proposing astock-for-stock combination with Company B instead of an all cash acquisition of us by Company B. On February 6, 2007, we received a letter from Company B confirming its proposal of astock-for-stock transaction. The letter from Company B also stated that based on Company B’s analysis and assumptions, including assumptions relating to synergies, its proposedstock-for-stock transaction could result in a value of $45.00 per share to our shareholders in the form of continued ownership in the combined company. Later on the same day, Company B provided additional information about its proposal in an email to us that, based on Company B’s analysis and assumptions, ascribed a purported value to our shareholders in the range of as high as $49.00 to $62.00 per share.
A meeting of our board of directors was also held on February 6, 2007, and the board discussed Company B’s revised proposal. Morgan Stanley and the board noted that the value ascribed to Company B’s proposal by Company B relied upon achieving significant synergies in the operations of the two companies, at a level not previously discussed by Company B with us or by us and in circumstances where the risk of achieving these synergies would be borne, in part, by our shareholders. In addition, the board of directors noted that pursuing a potentialstock-for-stock combination with Company B would take substantial time, due to the requirement for us to perform due diligence on Company B and the increased complexity of negotiating astock-for-stock transaction. It was also discussed that Company B’s proposed transaction presented significant regulatory issues and uncertainties. Based on these discussions, the board of directors instructed senior management to respond to Company B by indicating that at this time the board did not intend to alter the bid process in light of Company B’s proposal, and that Company B’s proposal would be evaluated in the context of any proposals we received.
On February 7, 2007, we received proposals from Hindalco and Company A. Hindalco indicated that it was willing to pursue a transaction for a purchase price of $45.20 per share in cash, subject to customary regulatory approvals and no financing condition. Company A indicated that it was willing to pursue a transaction for a purchase price of $33.25 per share in cash, subject to customary regulatory approvals, certain third party consents and no financing condition.
On February 8, 2007, Morgan Stanley contacted Hindalco and Company A and asked, in each case, whether the bid submitted represented their best and final offer. Both parties confirmed to Morgan Stanley that they were unwilling to increase their price.


25


On that same day, King & Spalding and Torys LLP, Hindalco’s legal counsel and who we refer to as Torys, discussed the key terms of the Arrangement Agreement, financing commitments and related documentation with respect to Hindalco’s proposal. Based on these discussions, King & Spalding and Novelis delivered a revised draft of the Arrangement Agreement and related documentation to Torys and Hindalco during the evening of February 8, 2007.
Novelis and King & Spalding also discussed the Arrangement Agreement and related issues with Company A and its representatives on February 8, 2007 and February 9, 2007.
King & Spalding and Torys held further discussions on February 9, 2007 regarding the definitive documentation related to a proposed transaction with Hindalco and Hindalco’s financing. Based on these discussions, most substantive issues were resolved and legal counsel expressed the view that a definitive agreement could be reached between the parties within a short timeframe.
In addition, on February 9, 2007 Company B delivered a second letter to us reiterating its interest in pursuing a potentialstock-for-stock acquisition of Company B by us and re-asserting a purported valuation for our shareholders in the range of $49.00 to $62.00 per share. The proposal suggested further synergies were available in addition to those previously asserted. Following receipt of this letter, our senior management and Morgan Stanley again reviewed Company B’s proposal of a potentialstock-for-stock transaction. Our senior management and Morgan Stanley discussed Company B’s revised proposal, noting that the significant uncertainty of achieving the purported value had not been mitigated and pursuing the proposal could put at risk the more certain value to our shareholders of the all-cash bids we had received.
During the evening of February 9, 2007, Mr. Blechschmidt contacted Mr. Bhattacharya to explain that he was prepared to present Hindalco’s proposal to our board of directors, provided that the parties were able to complete draft documentation and reach agreement on all significant deal points in advance of our board meeting scheduled for the next day. During the conversation, Mr. Blechschmidt disclosed the terms of the fee letter that we had entered into with Company A. After discussion, Mr. Blechschmidt and Mr. Bhattacharya agreed to present the transaction to their respective boards at a price of $44.93 per share in cash, reflecting a $0.27 reduction of Hindalco’s original bid for the cost of the fee payable to Company A.
On the morning of February 10, 2007, King & Spalding and Torys held further discussions on the definitive documentation related to the transaction and reached agreement on all significant deal points.
Our board of directors met on February 10, 2007 at the offices of King & Spalding.
Osler and Faegre & Benson reviewed with the Canada Business Corporations Act,directors their fiduciary duties with respect to the proposed transaction.
Mr. Blechschmidt explained that Company A was unwilling to increase their bid proposal. Mr. Blechschmidt also noted that Company A’s proposed Arrangement Agreement terms, as reflected in its submittedmark-up of the Arrangement Agreement and in discussions with legal counsel, were significantly more conditional in nature than those submitted by Hindalco.
Mr. Blechschmidt then briefed our board of directors on the proposal received from Company B. Morgan Stanley and the board noted and discussed again the significant assumptions in Company B’s proposal, including the significant synergies assumed. The board and Morgan Stanley discussed the risk to our shareholders appointthat such value would not be reflected in the Company’s independent registeredmarket price of the combined company and therefore not realized by our shareholders. In addition, the board discussed that pursuing Company B’s proposed transaction would take substantial time, presented potentially significant regulatory issues, and might place at risk the ability to consummate an all cash transaction with Company A or Hindalco.
Mr. Blechschmidt then discussed Hindalco’s proposal. In particular, he noted the premium offered by Hindalco’s bid over both Company A’s bid and the current trading price to our common shares. At Mr. Blechschmidt’s request, King & Spalding reviewed with the board the terms of Hindalco’s proposed Arrangement Agreement. Following this discussion, Mr. Blechschmidt noted that Hindalco’s proposal did not contain a financing condition, posed very limited regulatory concerns and provided a relatively high degree of deal certainty.


26


Morgan Stanley presented their financial analysis of the proposals received and an analysis of the valuation of Novelis as a standalone company. During this discussion, the board noted the risks and challenges in executing our current strategic plan and realizing value for the shareholders in excess of the value offered by the Hindalco bid. The board also noted the fact that no additional bidders emerged following the public accounting firm.announcement on January 26, 2007 that we were in discussions related to a potential sale of Novelis.
Each of Morgan Stanley and Evercore then presented an analysis of the proposed transaction with Hindalco and delivered opinions indicating that, as of the date thereof and based upon and subject to the factors and assumptions set forth in the opinions, the $44.93 per share in cash to be received by our shareholders pursuant to the Arrangement Agreement in the Hindalco proposal was fair from a financial point of view to our shareholders.
Following this discussion, the board unanimously determined to approve the Arrangement and the Arrangement Agreement and to recommend that our shareholders approve the Arrangement Resolution.
During the evening of February 10, 2007, the Arrangement Agreement and the related documents were finalized, and the Arrangement Agreement was executed. The parties issued a press release announcing the execution of the Arrangement Agreement on February 11, 2007.
Reasons for the Arrangement
Our board of directors, acting with the advice and assistance of its legal and financial advisors and our management, evaluated Hindalco’s proposal, including the terms and conditions of the Arrangement Agreement with Hindalco and Acquisition Sub. After careful deliberation, at a February 10, 2007 meeting described above under “Background of the Arrangement,” our board of directors by a unanimous vote determined that the Arrangement is fair to our shareholders and is in our best interest. In carrying outreaching these determinations, our board considered the following factors and potential benefits of the Arrangement, each of which the board believes supported its responsibilities,decision:
• the board’s belief, after a thorough, independent review, that the value offered to shareholders in the Arrangement was more favorable to shareholders than the potential value that might have resulted from other strategic opportunities reasonably available to Novelis, including remaining an independent company and pursuing the current strategic plan, pursuing acquisitions or pursuing a sale to Company A or Company B or another company in the same or a related industry, or a stock-for-stock business combination with Company B or another company in the same or a related industry, in each case taking into consideration the potential rewards, risks and uncertainties associated with those other options;
• the current and historical market prices of our common shares relative to those of other industry participants and general market indices, and the fact that the $44.93 per share in cash to be paid as consideration for the Arrangement represents a 17% premium to closing price of our common shares on February 9, 2007 and a 49% premium to the closing price of our common shares on January 25, 2007, the day before we announced that we were negotiating with potential buyers;
• the fact that the Arrangement consideration of $44.93 per common share was achieved through a competitive, multi-party process and that the course of negotiations between us and Hindalco resulted in a price per common share that was higher than the original offer price from Hindalco and in the board of directors’ judgment more favorable than any other indications of interest received by us from any other potential acquirer;
• the board’s belief that no other opportunity reasonably available to Novelis would provide greater value to its shareholders within a timeframe comparable to that in which the Arrangement is expected to be completed, and the fact that the cash consideration of $44.93 per share allows Novelis’ shareholders to realize in the near term a value, in cash, for their investment that is fair and provides our shareholders certainty of value for their shares;
• the financial and other terms of the Arrangement Agreement as reviewed by our board of directors;


27


• the fact that Hindalco’s obligation to perform under the terms of the Arrangement Agreement is not subject to a financing condition;
• the board’s belief in the high probability that the Arrangement will be completed based on, among other things, the lack of significant regulatory risks;
• our ability, under the Arrangement Agreement, under certain circumstances, to consider and respond to an unsolicited written bona fide acquisition proposal, and if, after consultation with our financial advisors, the board of directors determines in good faith that such acquisition proposal is a superior proposal, and Hindalco chooses not to propose improvements to the Arrangement Agreement to make the original Arrangement Agreement equal or superior, our ability to terminate the Arrangement Agreement and accept the superior proposal upon the payment of a termination fee of $100 million, and our belief that this termination fee is reasonable in the context ofbreak-up fees that have been negotiated in other transactions and would not preclude another party from making a competing proposal;
• our ability, under the Arrangement Agreement, to withdraw, modify or amend our recommendation that shareholders vote to approve the Arrangement Resolution under certain circumstances, subject to our payment of a termination fee of $100 million if Hindalco elects to terminate the Arrangement Agreement; and
• the financial analyses and written opinions prepared by our financial advisors, Morgan Stanley and Evercore, to the effect that, as of February 10, 2007 and based upon and subject to the factors set forth in such opinions, the $44.93 in cash per common share to be received by the holders of our outstanding common shares pursuant to the Arrangement Agreement is fair from a financial point of view to our shareholders.
Our board also considered a variety of risks and other potentially negative factors concerning the Audit Committee hasArrangement, including the following:
• the possibility that Hindalco will be unable to obtain the requisite financing proceeds, including obtaining the debt financing proceeds from its lenders;
• the risks and costs to Novelis if the Arrangement is not closed, including the diversion of management and employee attention, employee attrition and the effect on business and customer relationships;
• the fact that the our shareholders will not participate in any future earnings or growth of Novelis as we will no longer exist as an independent, publicly traded company and will not benefit from any appreciation in the value of Novelis’ common shares after the Arrangement, including any value that could be achieved in the event Novelis is acquired in the future by a strategic buyer or as a result of improvements in operations;
• the fact that an all-cash transaction would be taxable to our shareholders for U.S. and Canadian federal income tax purposes; and
• the fact that, pursuant to the Arrangement Agreement, we must generally conduct our business in the ordinary course, and that we are subject to a variety of other restrictions on the conduct of our business prior to the closing of the Arrangement or the termination of the Arrangement Agreement without the consent of Hindalco (not to be unreasonably withheld or delayed), which may delay or prevent us from pursuing business opportunities that may arise or preclude actions that would be advisable if we were to remain an independent company.
The foregoing discussion of the factors considered by our board includes the material factors considered by our board of directors in its consideration of the Arrangement Agreement and the Arrangement, but is not intended to be exhaustive. After considering these factors, the board of directors concluded that the positive factors relating to the Arrangement Agreement and the Arrangement outweighed the potential negative factors. In view of the wide variety of factors considered by the board of directors, and the complexity of these matters, our board did not find it practicable to quantify or otherwise assign relative weights to the foregoing


28


factors. In addition, individual members of the board of directors may have assigned different weights to various factors. Our board of directors by a unanimous vote approved the Arrangement Agreement and recommended that our shareholders approve the Arrangement Resolution based upon the totality of the information presented to and considered by it.
Opinion of Morgan Stanley
Pursuant to a letter agreement dated as of November 2, 2006, we engaged Morgan Stanley to provide financial advisory services in connection with our potential sale. At the meeting of our board of directors on February 10, 2007, Morgan Stanley rendered its oral opinion, subsequently confirmed in writing that, based upon and subject to the various considerations set forth in the opinion, the consideration to be received by our shareholders in the Arrangement is fair from a financial point of view to such shareholders.
The full text of the written opinion of Morgan Stanley, dated February 10, 2007, which sets forth among other things, assumptions made, procedures followed, matters considered and limitations on the scope of the review undertaken by Morgan Stanley in rendering its opinion, is attached as Annex D to this Proxy Statement/Circular. Shareholders are urged to, and should, read the opinion carefully and in its entirety. Morgan Stanley’s opinion is directed to our board of directors and it,addresses only the fairness, from a financial point of view, of the consideration to be received by our shareholders in turn, recommendsthe Arrangement as of the date of the opinion and does not address any other aspect of the Arrangement (including how any shareholders should vote with respect to the shareholders that PricewaterhouseCoopers LLP be appointed atapproval of the Meeting as independent registered public accounting firmArrangement Resolution or the availability of the proposed financing for the fiscal year ending December 31, 2006. Unless contrary instructions are indicated on the proxy card, the persons designated in the accompanying proxy card intend to voteFORthe appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2006 and to authorize the board of directors to fix the independent registered public accounting firm’s remuneration.transaction).
 
A representative of PricewaterhouseCoopers LLP will be present at the Meeting and will be available to make a statement if they desire to do so and to respond to appropriate questions.In connection with rendering its opinion, Morgan Stanley, among other things:
 
4.  Approval• reviewed certain of our publicly available financial statements and other business and financial information;
• reviewed certain of our internal financial statements and other of our financial and operating data prepared by our management;
• reviewed certain financial projections prepared by our management;
• discussed our past and current operations and financial condition and our prospects with our senior executives;
• reviewed the reported prices and trading activity for our common shares;
• compared our financial performance and the prices and trading activity of our common shares with that of certain other comparable publicly-traded companies and their securities;
• reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions;
• participated in discussions and negotiations among our representatives, Hindalco’s representatives and certain other parties and their financial and legal advisors;
• reviewed certain drafts of the Incentive PlanArrangement Agreement, the commitment letters relating to the debt and equity financing to be obtained by Hindalco and certain related documents; and
• performed such other analyses and considered such other factors as Morgan Stanley deemed appropriate.
In rendering its opinion, Morgan Stanley assumed and relied upon, without independent verification, the accuracy and completeness of the information supplied or otherwise made available to Morgan Stanley by us for the purposes of its opinion. With respect to the financial projections, Morgan Stanley assumed that they were reasonably prepared on bases reflecting the best currently available estimates and judgments of our future financial performance.
Morgan Stanley assumed that the executed versions of the Arrangement Agreement would not differ in any material respect from the last drafts reviewed by Morgan Stanley. Morgan Stanley assumed that the Arrangement will be consummated in accordance with the terms set forth in the Arrangement Agreement without any waiver, amendment or delay of any terms or conditions including, among other things, that


29


Hindalco will obtain financing for the acquisition in accordance with the terms set forth in the commitment letters. Morgan Stanley assumed that in connection with the receipt of all the necessary governmental, regulatory or other approvals and consents required for the transaction contemplated in the Arrangement Agreement, no delays, limitations, conditions or restrictions will be imposed that would have a material adverse effect on the contemplated benefits expected to be derived in the proposed transaction. Morgan Stanley is not a legal, tax or regulatory advisor and relied upon, without independent verification, the assessment of us and our legal, tax or regulatory advisors with respect to legal, tax or regulatory matters. Morgan Stanley expressed no opinion on any impact of the Arrangement on the tax treatment of any prior corporate restructuring involving us or otherwise. Morgan Stanley did not make any independent valuation or appraisal of our assets or liabilities, nor was it furnished with any such appraisals.
Morgan Stanley’s opinion was necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to it, as of February 10, 2007. Events occurring after such date may affect Morgan Stanley’s opinion and the assumptions used in preparing it, and Morgan Stanley did not assume any obligation to update, revise or reaffirm its opinion.
The following is a brief summary of the material analyses performed by Morgan Stanley in connection with its oral opinion and the preparation of its written opinion letter dated February 10, 2007. Some of these summaries of financial analyses include information presented in tabular format. In order to fully understand the financial analyses used by Morgan Stanley, the tables must be read together with the text of each summary. The tables alone do not constitute a complete description of the financial analyses.
Historical Share Price
Morgan Stanley reviewed the performance of our common shares and compared such performance with the stock performance of (1) the companies comprising a metal processing company index (the “Metal Processing Company Index”), which consists of the following companies: Reliance Steel & Aluminum Co., Quanex Corp., Gibraltar Industries, Inc., Accuride Corp. and Steel Technologies Inc. and (2) the companies comprising a rigid packaging company index (the “Rigid Packaging Company Index”), which consists of the following companies: Owens-Illinois Inc., Ball Corporation and Crown Holdings, Inc. The index companies included in this analysis were chosen because they operate in and are exposed to similar lines of business as us.
Morgan Stanley observed that during the period from January 25, 2007 (the day prior to our public announcement that we were in communications with various parties that could lead to our sale) (the “Unaffected Date”) to February 9, 2007 (the last trading day prior to the announcement of the execution of the Arrangement Agreement), the price per share of our common shares increased 27.9%. Our common shares closed at $30.13 per share (the “Unaffected Price”) on January 25, 2007 and closed at $38.54 per share on February 9, 2007. In comparison, during the period from January 25, 2007 to February 9, 2007, the Metal Processing Company Index increased 3.1% and the Rigid Packaging Company Index increased 2.3%.
Morgan Stanley also noted that the trading range for the52-week period ended January 25, 2007 for our common shares was from $18.03 per share to $30.57 per share and compared that to the consideration to be received by our shareholders in the Arrangement of $44.93 per share. Morgan Stanley noted that the implied premium of the consideration to be received by our shareholders in the Arrangement of $44.93 per share when compared to the Unaffected Price was 49.1%.
Securities Research Analysts’ Future Price Targets
Morgan Stanley reviewed the twelve-month public market trading price targets for our common shares prepared and published by securities research analysts prior to the Unaffected Date. These targets reflected each securities research analyst’s estimate of the future public market trading price of our common shares. Morgan Stanley discounted the securities research analysts’ price targets back twelve months to arrive at a range of present values of these targets. Morgan Stanley arrived at a range of present values from approximately $11 per share to $29 per share.


30


Peer Group Comparison
Morgan Stanley compared certain of our financial information with publicly-available information for peer group companies that operate in and are exposed to similar lines of business as us, namely companies in (1) the downstream metal processing industry, and (2) the rigid packaging industry. The peer group of downstream metal processing companies included:
• Reliance Steel & Aluminum Co.
• Quanex Corp.
• Gibraltar Industries, Inc.
• Accuride Corp.
• Steel Technologies, Inc.
• Aleris International, Inc.
 
The Incentive Planpeer group of rigid packaging companies included:
• Owens-Illinois, Inc.
• Ball Corporation
• Crown Holdings, Inc.
• Silgan Holdings Inc.
• Rexam plc.
For this analysis, Morgan Stanley examined estimates for the peer groups based on consensus securities analysts’ research provided by I/B/E/S International Inc. (“I/B/E/S”) and public filings for each of the companies in the peer group. The following table presents, as of February 6, 2007, the low, high and median of the ratio of aggregate value, defined as market capitalization plus total debt plus minority interests less cash and cash equivalents, to estimated calendar year 2006 earnings before interest taxes and depreciation (“EBITDA”) and to estimated calendar year 2007 EBITDA. Morgan Stanley then compared this information to similar information for us based on the Unaffected Price and based on the consideration to be received by our shareholders in the Arrangement.
Aggregate Value /
Aggregate Value /
Metal Processing
2006E EBITDA2007E EBITDA
Low4.7x4.7x
High7.4x8.5x
Median6.2x6.0x
Novelis (Unaffected Price)7.1x6.8x
Arrangement Agreement Consideration8.6x8.3x
Aggregate Value /
Aggregate Value /
Rigid Packaging
2006E EBITDA2007E EBITDA
Low7.1x6.9x
High9.5x8.2x
Median8.1x7.4x
Novelis (Unaffected Price)7.1x6.8x
Arrangement Agreement Consideration8.6x8.3x
Trading multiples for our common shares were calculated based on management’s adjusted EBITDA estimates for calendar years 2006 and 2007 (“Adjusted EBITDA”). Adjusted EBITDA was developed with our management to reflect the ongoing operating performance of the business, and excludes non-recurring, non-operational effects on our financial results, such as the negative impact of certain customer contracts with


31


aluminum price ceiling provisions (net of the realized gains on hedges implemented to off-set such negative impacts). Aggregate value for Novelis, as calculated for the purposes of this analysis, includes the present value of the negative free cash flows from the price ceiling provisions.
Morgan Stanley noted trading multiple ranges for the peer group companies of 7.0x to 8.0x 2006 EBITDA and 6.5x to 7.0x 2007 EBITDA. Morgan Stanley compared these ranges to multiples for us of 8.6x 2006 Adjusted EBITDA and 8.3x 2007 Adjusted EBITDA as implied by the consideration to be received by our shareholders in the Arrangement.
No company utilized in the peer group comparison analysis is identical to us. In evaluating the peer group, Morgan Stanley made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond our control, such as the impact of competition on our business or the industry generally, industry growth and the absence of any material adverse change in our financial condition and prospects or the industry or in the financial markets in general. Mathematical analysis, such as determining the average or median, is not in itself a meaningful method of using peer group data.
Analysis of Selected Precedent Transactions
Using publicly available information, Morgan Stanley reviewed the terms of selected precedent transactions in which the targets were companies or divisions that operate in and were exposed to similar lines of business as us. For this analysis Morgan Stanley reviewed the following transactions:
Target
Acquiror
Announcement Date
Norsk Hydro ASA, European Automotive Castings BusinessTenedora Nemak, S.A. de C.V.27 November 2006
JW Aluminum CompanyWellspring Capital Management, L.L.C.8 November 2006
Aleris International Inc. TPG Advisors IV, Inc. and TPG Advisors V, Inc.8 August 2006
Corus Group plc, Downstream Aluminum BusinessAleris International Inc.17 March 2006
JW Aluminum CompanySuperior Plus Income Fund29 September 2005
Euramax International Inc. Goldman Sachs Group, Merchant Banking Division12 April 2005
Commonwealth Industries Inc. Aleris International Inc. (formerly IMCO Recycling Inc.)17 June 2004
Sapa ABElkem ASA1 August 2004
VAW Aluminium AGNorsk Hydro ASA7 January 2002
Wells Aluminum Corp. Norsk Hydro ASA24 January 2000
Noranda Aluminum, Inc.’s
Scottsboro Rolling Facility and Excel Extrusions Inc. 
McCook Metals Group LLC and Alcoa Inc.7 January 2000
Indalex, Inc. Caradon Inc.28 July 1999
Century Aluminum Co., Fabrication BusinessPechiney Rolled Products LLC26 July 1999


32


For each of the transactions above, Morgan Stanley reviewed the price paid and calculated the ratio of aggregate value to last twelve-month (“LTM”) EBITDA. Morgan Stanley compared this information to similar information for us based on the consideration to be received by our shareholders in the Arrangement. The following table presents the high, low and median aggregate value to LTM EBITDA for the precedent transactions:
Aggregate Value/
LTM EBITDA
Low5.4x
High10.8x
Median6.3x
Arrangement Agreement Consideration8.6x
Morgan Stanley noted a multiple range of 6.5x to 7.5x of LTM EBITDA for selected precedent transactions and compared such range to a multiple for us of 8.6x LTM Adjusted EBITDA implied by the consideration to be received by our shareholders in the Arrangement.
No company or transaction utilized as a comparison in the selected precedent transactions analysis is identical to us or the Arrangement. In evaluating the transactions listed above, Morgan Stanley made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond our control, such as the impact of competition on our business or the industry generally, industry growth and the absence of any adverse material change in our financial condition and prospects or the industry or in the financial markets in general. Mathematical analysis, such as determining the average or median, is not in itself a meaningful method of using comparable transaction data.
Discounted Cash Flow Analysis
Morgan Stanley performed a discounted cash flow analysis, which is an analysis of the present value of projected unlevered free cash flows using terminal year EBITDA multiples. Morgan Stanley analyzed our business using publicly-available information, information obtained from discussions with our management and certain financial forecasts prepared by our management for the fiscal years 2006 through 2011. The terminal value was calculated by applying terminal multiples ranging from 6.5x to 7.0x to an average of the Adjusted EBITDA for calendar years 2005 through 2011 as estimated by our management. For purposes of this analysis, Morgan Stanley calculated our discounted unlevered free cash flow value using discount rates ranging from 10.0% to 12.0%. The range of discount rates was selected based upon an analysis of our weighted average cost of capital and on the experience and judgment of Morgan Stanley.
Morgan Stanley analyzed our business using three financial forecasts prepared by our management. Using a scenario that assumed consistent aluminum rolled product shipment growth and increasing profitability over the forecast period (“Case A”), the result of the discounted cash flow analysis implied a range of values for our common shares of approximately $28 to $38 per share. Using a scenario that contemplated an economic downturn occurring in 2009 (“Case B”), the result of the discounted cash flow analysis implied a range of values for our common shares of approximately $25 to $32 per share. Using a scenario that contemplated a similar economic downturn as in Case B but occurring in 2007 (“Case C”), the result of the discounted cash flow analysis implied a range of values for our common shares of approximately $21 to $28 per share.
In summary the analyses implied the following ranges of value per share of our common shares:
Value per share
Case A$28 to $38
Case B$25 to $32
Case C$21 to $28
Morgan Stanley compared the range of per share values observed in each of its discounted cash flow analyses with the consideration to be received by our shareholders in the Arrangement of $44.93 per share.


33


Leveraged Buyout Analysis
Morgan Stanley performed a leveraged buyout analysis to estimate the theoretical purchase price that a financial buyer could pay in an acquisition of us taking into account our potential pro forma leverage structure that could result from financing such acquisition under customary market terms and assuming that such financial buyer would attempt to realize a return on its investment in calendar year 2011. Estimated financial data for us were based on Cases A, B and C, as provided by our management. Estimated exit values for us were calculated by applying a range of exit value multiples of 6.5x to 7.0x to an average of the Adjusted EBITDA for calendar years 2005 through 2011 as estimated by our management. Morgan Stanley then derived a range of theoretical purchase prices based on an assumed required internal rate of return for a financial buyer of between 15 and 25%.
This analysis implied the following ranges of value per share of our common shares:
Value per share
Case A$25 to $34
Case B$22 to $30
Case C$20 to $27
In connection with the review of the Arrangement by our board of directors, Morgan Stanley performed a variety of financial and comparative analyses for purposes of its opinion given in connection therewith. The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. In arriving at its opinion, Morgan Stanley considered the results of all of its analyses as a whole and did not attribute any particular weight to any analysis or factor considered by it. Furthermore, Morgan Stanley believes that selecting any portion of its analyses, without considering all analyses as a whole, would create an incomplete view of the process underlying its analysis and opinion. In addition, Morgan Stanley may have given various analyses and factors more or less weight than other analyses and factors and may have deemed various assumptions more or less probable than other assumptions, so that the ranges of valuations resulting from any particular analysis described above should not be taken to be Morgan Stanley’s view of our actual value.
In performing its analyses, Morgan Stanley made numerous assumptions with respect to industry performance, general business and economic conditions and other matters, many of which are beyond our control. Any estimates contained in Morgan Stanley’s analyses are not necessarily indicative of future results or actual values, which may be significantly more or less favorable than those suggested by such estimates. The analyses performed were prepared solely as part of Morgan Stanley’s analysis of the fairness from a financial point of view of the consideration to be received by our shareholders in the Arrangement, and were conducted in connection with the delivery of the Morgan Stanley opinion to our board of directors. These analyses do not purport to be appraisals or to reflect the prices at which our common shares might actually trade. The consideration to be received by our shareholders in the Arrangement and other terms of the Arrangement Agreement were determined through arm’s-length negotiations between Hindalco and us and were approved by our board of directors. Morgan Stanley provided advice to us during such negotiations; however, Morgan Stanley did not recommend any specific consideration to us or that any specific consideration constituted the only appropriate consideration for the proposed transaction. In addition, as described above, Morgan Stanley’s opinion and presentation to our board of directors was one of many factors taken into consideration by our board in making its decision to approve the Arrangement Agreement. Consequently, the Morgan Stanley analyses as described above should not be viewed as determinative of the opinion of our board of directors with respect to our value or determinative of whether our board of directors would have been willing to agree to a different consideration.
Our board of directors retained Morgan Stanley based upon Morgan Stanley’s qualifications, experience and expertise and its knowledge of our business affairs. Morgan Stanley is an internationally recognized investment banking and advisory firm. Morgan Stanley, as part of its investment banking and financial advisory business, is continuously engaged in the valuation of businesses and securities in connection with mergers and acquisitions, negotiated underwritings, competitive biddings, secondary distributions of listed and unlisted securities, private placements and valuations for corporate and other purposes. In the past, Morgan


34


Stanley has provided financial advisory and financing services to us and has received fees for the rendering of these services. In the ordinary course of business, Morgan Stanley may from time to time trade in our or Hindalco’s securities or indebtedness or those of any other company, currency or commodity that may be involved in this transaction, for its own account, the accounts of investment funds and other clients under the management of Morgan Stanley and for the accounts of customers and, accordingly, may at any time hold a long or short position in such securities or indebtedness.
Pursuant to the letter agreement dated as of November 2, 2006, Morgan Stanley provided financial advisory services and a financial fairness opinion to our board of directors in connection with the Arrangement, and we agreed to pay Morgan Stanley a customary fee in connection therewith, a substantial portion of which is contingent upon the closing of the Arrangement. We also agreed to reimburse Morgan Stanley for its reasonable, documented expenses incurred in performing its services. In addition, we agreed to indemnify Morgan Stanley and its affiliates, their respective directors, officers, agents and employees and each person, if any, controlling Morgan Stanley or any of its affiliates against certain liabilities and expenses, including certain liabilities under the federal securities laws, related to or arising out of Morgan Stanley’s engagement.
Opinion of Evercore
On February 10, 2007, Evercore delivered its oral opinion to our board of directors, which opinion was subsequently confirmed in writing on February 10, 2007, to the effect that, as of such date and based upon and subject to the approvalfactors and assumptions set forth in its opinion, the $44.93 cash consideration to be received by shareholders per share, other than dissenting holders’ shares and any of our common shares that are held by Hindalco, Acquisition Sub or any of their affiliates (the “Excluded Shares”), is fair, from a financial point of view as of the shareholdersdate of such opinion, to our shareholders.
The full text of the Company.written opinion of Evercore, dated February 10, 2007, which sets forth the assumptions made, procedures followed, matters considered and qualifications and limitations on the review undertaken in connection with the opinion, is contained in Annex E to this Proxy Statement/Circular and is incorporated by reference into this Proxy Statement/Circular. We encourage you to read the opinion in its entirety.
Evercore’s opinion is directed to our board of directors, addresses only the fairness from a financial point of view of the $44.93 per share in cash consideration to be received by our shareholders, other than holders of Excluded Shares, pursuant to the Arrangement Agreement and does not address any other aspect of the Arrangement or constitute a recommendation to any of our shareholders as to how to vote at the Meeting. The Incentive Plan will replace, onfollowing is a prospective basis, the Novelis Conversion Plansummary of 2005 (the “Conversion Plan”)Evercore’s opinion and the Novelis Inc. Stock Price Appreciation Unit Plan (the “SPAU Plan”) and no future awards will be granted under such plans if the Incentive Plan is approved by the Company’s shareholders.methodology that Evercore used to render its opinion. This summary is qualified in its entirety by reference to the full text of the Incentive Plan, a copy of which is attached as Schedule F to this Circular.
As of August 31, 2006, the closing price of our Shares on the New York Stock Exchange was $20.85, per share, and on the Toronto Stock Exchange was C$23.08 per share.
Purpose
The purpose of the Incentive Plan is to promote the interests of the Company and its shareholders by aligning, motivating, attracting and retaining key employees and non-employee directors of the Company and its subsidiaries through the issuance of equity-based awards and short-term incentive compensation.
Types of Awards
The Incentive Plan authorizes the award of stock options, stock appreciation rights (“SARs”), restricted shares, restricted share units, performance shares and other stock-based incentives. The Incentive Plan also authorizes payment of short-term incentives, payable in cash or Shares, following satisfaction of pre-established performance objectives.
Administration of the Incentive Plan
The Incentive Plan will be administered by the Human Resources Committee of the board of directors (the “Human Resources Committee”), except that the full board of directors will be responsible for the administration of awards to the Company’s non-employee directors.
Shares Subject to the Incentive Plan
The number of Shares of the Company authorized to be issued under the Incentive Plan is 7,000,000 Shares. Any Shares that are subject to an award other than stock options or SARs will be counted against this limit as 1.75 Shares for every one Share subject to the award. If any Shares related to an award are forfeited, terminated, expire unexercised, tendered in connection with an exercise of an award, withheld from issuance to pay applicable tax withholding, settled in cash in lieu of Shares, or settled in any similar manner so that a portion of the Shares are not issued to the participant, then such Shares will be automatically available for future awards and will not count against the maximum share limit above.


12


Eligibility for Awards
The Human Resources Committee has the discretion to determine the employees and non-employee directors eligible to receive awards under the Incentive Plan and the type, size and conditions of such awards. As of August 31, 2006, approximately 3,000 of our employees are eligible to participate in short-term awards, and approximately 150 employees and 12 non-employee directors are eligible to participate in long-term awards under the Incentive Plan. The awards that will be granted to eligible employees under the Incentive Plan will be at the discretion of the Human Resources Committee and, therefore, are not determinable at this time. The full board of directors will determine the type, size and conditions of any awards to the Company’s non-employee directors. No employee participant may receive during any one calendar year awards representing more than 750,000 Shares or $20,000,000. The maximum number of Shares that may be granted to a non-employee director during any one calendar year shall not exceed 7,500 Shares. The maximum aggregate number of incentive stock options (discussed below) that may be granted under the Incentive Plan for all years is 3,000,000 Shares.
Stock Options
The Incentive Plan authorizes the grant of stock options. Stock options may be either nonqualified stock options or incentive stock options (“ISOs”). ISOs are options granted to employees that are designed to meet the requirements of Section 422 of the United States Internal Revenue Code of 1986, as amended (the “Code”). Any option that does not satisfy Section 422 of the Code will be treated as a nonqualified stock option. The exercise price per share under any stock option may not be less than 100% of the fair market value per share on the date of grant, and no option may be re-priced, including the cancellation of an existing option and substituting a new option with a lower exercise price, without the approval of the Company’s shareholders. Options will become vested and exercisable in accordance with the terms set forth in the participant’s award agreement, provided that in no event may an option be exercisable later than the seventh anniversary of its date of grant.
Stock Appreciation Rights
The Incentive Plan authorizes the grant of SARs. SARs represent the right to receive an amount equal to the appreciation in the Company’s Shares over a specified period of time. SARs may be settled in cash, Shares or a combination of both as set forth in the participant’s award agreement. The exercise price per share under any SAR may not be less than 100% of the fair market value per share on the date of grant, and no SAR may be re-priced, including the cancellation of an existing SAR and substituting a new SAR with a lower exercise price, without the approval of the Company’s shareholders. SARs will become vested and exercisable in accordance with the terms set forth in the participant’s award agreement, provided that in no event may a SAR be exercisable later than the seventh anniversary of its date of grant.
Restricted Shares and Restricted Share Units
The Incentive Plan authorizes the grant of restricted shares and restricted share units that are tied to the expiration of a specified period of time, the achievement of performance goals,and/or the occurrence of one or more other events. Restricted share units are similar to restricted shares except that no Shares are actually awarded to the participant at the time of award. Accordingly, the holder of restricted share units does not have dividend, voting or other ownership rights during the period that such restricted share units are outstanding although a restricted share unit award may include dividend equivalent rights payable on a current, deferred or contingent basis. Restricted share units may be paid in cash, Shares or a combination of both at the time of vesting as set forth in the participant’s award agreement.
Performance Awards
The Incentive Plan authorizes the grant of performance shares and units. Performance awards represent a conditional right to receive cash, Shares, or a combination of cash and Shares, upon the achievement of specified performance goals during one or more performance periods. Performance objectives may be described in terms of Company-wide objectives or objectives that are related to the performance of an


13


individual participant or Company subsidiary, division, department or function within the Company in which the participant is employed. Performance objectives may be measured on an absolute or relative basis. Relative performance may be measured by a group of peer companies or by a financial market index.
Short-Term Incentives
Short-term incentives may be paid in cash or Shares. Short-term incentive compensation generally will only be paid upon satisfaction of pre-established performance objectives, provided that adjustments and exceptions may be made under special circumstances.
Other Awards
The Human Resources Committee has the discretion to grant any other type of award that is based on or related to Shares or factors that may influence the value of such Shares, or to grant Shares as a bonus or payment in lieu of other obligations of the Company to a participant.
Compliance with Section 162(m) of the United States Internal Revenue Code
Section 162(m) of the Code contains special rules regarding the federal income tax deductibility of compensation paid to the Company’s Chief Executive Officer and to each of the other four most highly compensated executive officers. The general rule is that annual compensation paid to any of these covered employees will be deductible for any tax year only to the extent that such compensation does not exceed $1 million. The Company may preserve the deductibility of certain compensation in excess of $1 million, however, if the Company complies with conditions imposed by Section 162(m) of the Code, including the establishment of specified performance goals which must be achieved prior to payment.
The performance measures upon which awards intended to comply with Section 162(m) of the Code may include the following: return on equity, regional income, diluted earnings per share, net earnings, total earnings, earnings growth, return on capital, working capital turnover, return on assets, earnings before interest and taxes, sales, sales growth, gross margin return on investment, increase in the fair market value of the Shares, share price (including but not limited to, growth measures and total shareholder return), operating profit, cash flow (including, but not limited to, operating cash flow and free cash flow), cash flow return on investment (which equals net cash flow divided by total capital), inventory turns, financial return ratios, total return to shareholders, market share, earnings measures/ratios, economic value added, balance sheet measurements such as receivable turnover, internal rate of return, increase in net present value or expense targets, productivity and satisfaction of health, safety and environment compliance targets.
Taxation
The following discussion is intended to provide an overview of the U.S. federal income tax laws that are generally applicable to awards granted under the Incentive Plan as of the date of this Circular. Persons or entities in differing circumstances may have different tax consequences, and the tax laws may change in the future. This discussion is not to be construed as tax advice.
Stock Options:  The granting of a nonqualified option to an individual is not ordinarily a taxable event. Upon exercise of the option, the optionee will recognize ordinary taxable income equal to the excess of the then fair market value of the Shares over the exercise price paid for such Shares. The Company will be entitled to a tax deduction equal to the ordinary income recognized by the optionee. Upon disposition of the acquired Shares, the difference between the sale price and the optionee’s basis in the Shares will be treated as a capital gain or loss and generally will be characterized as long-term capital gain or loss if the Shares have been held for more than one year at the time of disposition.opinion.
 
In the case of an ISO, neither the granting of the option norconnection with rendering its exercise is ordinarily a taxable event to the optionee. Instead, the optionee recognizes taxable income upon the disposition of the acquired Shares. The tax treatment to the optionee and the Company will depend primarily upon whether the optionee has met certain holding period requirements at the time he or she disposes of the Shares. If an optionee exercises an


14


ISO and does not dispose of the Shares received within two years after the date such option was granted or within one year after the transfer of the Shares to him or her, any gain realized upon the disposition will be characterized as long-term capital gain. If the optionee disposes of the ISO Shares either within two years after the date the option is granted or within one year after the exercise of the option and transfer of Shares to him or her, such disposition will be treated as a disqualifying disposition and an amount equal to the lesser of (i) the fair market value of the Shares on the date of exercise minus the exercise price, or (ii) the amount realized on the disposition minus the exercise price, will be taxed as ordinary income to the optionee. The excess, if any, of the amount realized upon disposition over the fair market value at the time of the exercise of the option will be treated as capital gain. Except in the case of disqualifying dispositions, there will be no federal income tax deductions allowed to the Company upon the grant, exercise, or termination of an ISO.
SARs:  The recipient of a SAR will not recognize any taxable income at the time the SAR is granted. Instead, the appreciation inherent in the SAR will be taxable as ordinary income at the time the SAR is exercised. If the participant receives the SAR appreciation in Shares rather than cash, the participant will recognize ordinary income equal to the excess of the fair market value of the Shares on the day it is received over any amounts paid by the participant for the Shares. There will be no federal income tax deduction allowed to the Company upon the grant or expiration of a SAR. However, upon the exercise of the SAR, the Company will be entitled to a deduction for federal income tax purposes equal to the amount of ordinary income that the participant is required to recognize as a result of the exercise.
Share Awards:  The recipient of a share award will recognize ordinary income at the time the property is received equal to the excess, if any, of the fair market value of the Shares received over the amount paid by the participant in exchange for the Shares. If, however, the Shares are subject to a substantial risk of forfeiture at the time of grant (e.g., if the participant is required to work for a period of time before the Shares becomes freely transferable), the participant generally will not recognize income until the restrictions on such Shares lapse, at which time the recipient will recognize ordinary income equal to the excess, if any, of the fair market value of the Shares on the date they become vested over any amount paid by the recipient in exchange for the Shares. Upon the disposition of any Shares received as a share award under the Incentive Plan, the difference between the sale price and the recipient’s basis in the Shares will be treated as a capital gain or loss and generally will be characterized as long-term capital gain or loss if the Shares have been held for more than one year at the time of their disposition.
The Company will be entitled to a deduction for federal income tax purposes equal to the amount of ordinary income that the recipient is required to recognize, provided that the deduction is not otherwise disallowed under the Code.
Awards Settled in Cash:  The recipient of any award settled in cash will recognize ordinary income at the time the payment is received. The Company will be entitled to a corresponding deduction for federal income tax purposes in an amount equal to the ordinary income recognized by such recipient.
Change in Control
Unless otherwise specified by the Human Resources Committee, a pro rata portion of a participant’s performance-based awards and short-term incentive (both at 100% target level) will be payable to such participant within ten days following a change in control of the Company. In addition, a participant’s outstanding options and SARs will become immediately vested and exercisable and all outstanding restricted shares and restricted share units will become fully vested and non-forfeitable.
Restrictions on Transferability of Awards
No award granted under the Incentive Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the applicable laws of descent and distribution, except as otherwise permitted under the Incentive Plan and the terms of the award agreement.
New Plan Benefits
The awards that will be granted to eligible participants under the Incentive Plan will be at the discretion of the Human Resources Committee and, therefore, are not determinable at this time.


15


Amendment and Termination of the Incentive Plan
Subject to shareholder approval as required by applicable laws, regulations and rules to which the Company is subject, the Company’s board of directors may amend or terminate the Incentive Plan at any time and for any reason, provided that no amendment may, subject to certain exceptions set forth in the Incentive Plan, increase the number of Shares available for award or adversely affect any outstanding awards.
Board of Directors’ Recommendation
The board of directors recommends that the Incentive Plan be approved by the shareholders of the Company. Unless contrary instructions are indicated on the proxy card, the persons designated in the accompanying proxy card intend to voteFORapproval of the Incentive Plan.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table provides information as of December 31, 2005 regarding the Shares issuable upon the exercise of options under the Conversion Plan, as well as the number of Shares remaining available for issuance under the Conversion Plan. If the Incentive Plan is approved by our shareholders at the Meeting, then no new options will be granted under the Conversion Plan on or after the proposed effective date of the Incentive Plan. The table also shows the number of deferred share units granted pursuant to the Novelis Inc. Deferred Share Unit Plan for Non-Executive Directors.
Equity Compensation Plan Information
             
        Number of Securities
 
        Remaining Available for
 
  Number of
  Weighted-
  Future Issuance Under
 
  Securities to be
  Average
  Equity Compensation
 
  Issued Upon
  Exercise Price of
  Plans (Excluding
 
  Exercise of
  Outstanding
  Securities Reflected in
 
Plan Category
 Options/DDSUs  Options  First Column) 
 
Equity compensation plans approved by security holders(1)            
Novelis Conversion Plan of 2005(2)
  2,704,790  $21.60   2,291,937(4)
Novelis Inc. Deferred Share Unit Plan for Non-Executive Directors(3)
  57,051   N/A   N/A 
Equity compensation plans not approved by security holders  N/A   N/A   N/A 
(1)Such plans were approved by Alcan, as our sole shareholder, prior to the spin-off date.
(2)On January 5, 2005, our board of directors adopted the Conversion Plan to allow for all Alcan stock options held by employees of Alcan who became employees of Novelis following our spin-off from Alcan to be replaced with options to purchase our Shares and for new options to be granted. There were no new options granted in 2005 under the Conversion Plan. In the case of a change in control of the Company, vesting of stock options will accelerate.
(3)On January 5, 2005, our board of directors adopted the Deferred Share Unit Plan for Non-Executive Directors. Fifty percent of our non-executive directors’ compensation is required to be paid in the form of director’s deferred share units (“DDSUs”), and 50% in the form of either cash, additional DDSUs or a combination of the two at the election of each non-executive director. DDSUs are the economic equivalent of Shares. The DDSUs are redeemable only upon termination of the directorship and may be redeemed in cash, Shares or a combination of both, at the election of the non-executive director. The amount to be paid by us upon redemption will be calculated by multiplying the accumulated balance of DDSUs by the average per share closing price of our Shares on the Toronto and New York Stock Exchanges on the last five trading days prior to the redemption date. As of December 31, 2005, approximately 41,862 DDSUs had been granted with an additional 15,189 units granted on January 1, 2006, all for services rendered in 2005.


16


(4)Under the Conversion Plan, we may issue new options in aggregate not exceeding 3% of the Shares outstanding immediately after our spin-off from Alcan on January 6, 2005, provided that the total number of new options and conversion options (options granted to replace options in the share capital of Alcan held by our employees at the time of the spin-off) do not exceed 10% of the Shares outstanding immediately after the spin-off.
BOARD OF DIRECTORS AND CORPORATE GOVERNANCE MATTERS
We are committed to the highest levels of corporate governance practices, which we believe are essential to our success and to the enhancement of shareholder value. Our Shares are listed on the Toronto Stock Exchange and New York Stock Exchange and we make required filings with the Canadian and U.S. securities regulators. We make these filings available on our website atwww.novelis.com as soon as reasonably practicable after they are electronically filed. We are subject to a variety of corporate governance and disclosure requirements. Our corporate governance practices meet the Toronto Stock Exchange Corporate Governance Guidelines (the “TSX Guidelines”), the New York Stock Exchange rules and other applicable regulatory requirements to ensure transparency and effective governance of the Company. Schedule B attached to this Circular describes our current corporate governance practices under the TSX Guidelines.
Our board of directors regularly reviews corporate governance practices in light of developing requirements in this field. As new provisions come into effect, our board of directors will reassess our corporate governance practices and implement changes as and when appropriate. The following is an overview of our corporate governance practices.
Novelis Board of Directors
Our board of directors has the responsibility for stewardship of Novelis, including the responsibility to ensure that we are managed in the interest of our shareholders as a whole, while taking into account the interests of other stakeholders. Our board of directors supervises the management of our business and affairs and discharges its duties and obligations in accordance with the provisions of: (1) the Canada Business Corporations Act (“CBCA”); (2) our articles of incorporation and bylaws; (3) the charters of our board of directors and its committees; and (4) other applicable legislation and Company policies.
Our corporate governance practices require that, in addition to its statutory duties, the following matters be subject to our board of directors’ approval: (1) capital expenditure budgets and significant investments and divestments; (2) our strategic and value-maximizing plans; (3) the number of directors within the limits provided in our articles of incorporation; and (4) any matter which may have the potential for substantial impact on our business. Our board of directors reviews the composition and size of our board of directors once a year. All new directors will receive a board of directors manual containing a record of historical public information about Novelis, as well as the charters of our board of directors and its committees, and other relevant corporate and business information. Senior management makes regular presentations to our board of directors on the main areas of our business. Directors are invited to tour our various facilities.
Corporate Governance Guidelines
Our board of directors has adopted a charter that establishes various corporate governance guidelines relating to,opinion, Evercore, among other things, the composition and organization of the board of directors, the duties and responsibilities of the board of directors and the resources and authority of the board of directors (the “Board of Directors Charter”). Under the Board of Directors Charter, which is available on our website atwww.novelis.com and is available in print from our Corporate Secretary upon request, every meeting of the board of directors is to be followed by an executive session at which no executive directors or other members of management are present. These executive sessions are designed to ensure free and open discussion and communication among the non-management directors. The chairman of the board of directors leads these meetings. Mr. Monahan currently serves as chairman. Shareholders and other interested parties may communicate with the board of directors, a committee or an individual director by writing to Novelis Inc., 3399 Peachtree Rd. NE, Suite 1500, Atlanta, GA 30326, Attention: Corporate Secretary — Board


17


Communication. All such communications will be compiled by the Corporate Secretary and submitted to the appropriate director or board committee. The Corporate Secretary will reply or take other actions in accordance with instructions from the applicable board contact.
Independence of Our Board of Directors
To assist in determining the independence of its members, our board of directors has established Guidelines on the Independence of the Directors of Novelis Inc. (“Guidelines on Independence”). The definition of an Independent Director under the Guidelines on Independence, which is available on our website atwww.novelis.com and is available in print from our Corporate Secretary upon request, encompasses both the definition of an “unrelated” director within the meaning of the TSX Guidelines and of an “independent” director within the meaning of the rules of the New York Stock Exchange. Such a director: (1) must not have any relationship with us or any of our employees which is likely to be perceived to interfere with the exercise of his or her judgment in a manner that is independent from management; and (2) must not have an interest or relationship which could reasonably be perceived to materially interfere with his or her ability to act in the best interests of Novelis (an Independent Director). Under the Guidelines on Independence, the following relationships generally will be considered not to be material relationships that would impair a director’s independence: (1) if a director is an officer, partner or significant shareholder in an entity that does business with us and the annual sales or purchases, for goods or services, to or from us are less than two percent of the consolidated gross annual revenues of that entity; (2) if a director is a limited partner, a non-managing member or occupies a similar position in an entity that does business with us, or has a shareholding in such entity which is not significant, and who, in each case, has no active role in sales to or in providing services to us and derives no direct material personal benefit from the same; and (3) if a director serves as an officer, director or trustee of a charitable organization and our charitable contributions to the organization are less than two percent of that organization’s total consolidated gross annual revenues. For purposes of the Guidelines on Independence, a “significant shareholding” means direct or indirect beneficial ownership of five percent or more of the outstanding equity or voting rights of the relevant entity. Our board of directors has determined that all members of the board of directors, with the exception of our Chairman and Interim Chief Executive Officer, William T. Monahan, are Independent Directors.
The Guidelines on Independence establish standards for members of our Audit, Human Resources and Nominating and Corporate Governance Committees. These standards comply with the audit committee member independence qualifications under the U.S. Sarbanes-Oxley Act of 2002 (“SOX”). To satisfy the SOX audit committee qualifications, a director must not, directly or indirectly, accept any consulting, advisory or other compensatory fee from us (except in his or her capacity as director) and may not be an affiliated person of Novelis or any subsidiary other than in his or her capacity as a member of our board of directors or any committee of our board of directors.
Committees of Our Board of Directors
Our board of directors has established four standing committees: the Audit Committee, the Nominating and Corporate Governance Committee, the Human Resources Committee and the Customer Relations Committee. Each committee is governed by its own charter which is available on our website atwww.novelis.com and is available in print from our Corporate Secretary upon request. All four standing committees are required to be composed entirely of Independent Directors.
According to their authority as set out in their charters, our board and each of its committees may engage outside advisors at the expense of Novelis.
Audit Committee and Financial Experts
Our board of directors has a separately-designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”), the requirements of the CBCA and the New York Stock Exchange and Toronto Stock Exchange rules. Our board of directors has determined that Edward A. Blechschmidt, David J. FitzPatrick, Suzanne Labarge and Kevin M. Twomey are Audit Committee financial experts as defined by the rules of the SEC and that each member


18


of our Audit Committee is an Independent Director within the meaning of the applicable New York Stock Exchange and Toronto Stock Exchange listing standards. Our Audit Committee Charter is attached as Schedule E to this Circular, is available on our website atwww.novelis.com and is available in print upon request from our Corporate Secretary.
Our Audit Committee’s main objective is to assist our board of directors in fulfilling its oversight responsibilities for the integrity of our financial statements, our compliance with legal and regulatory requirements, the qualifications and independence of our independent registered public accounting firm and the performance of both our internal audit function and our independent registered public accounting firm. Under the Audit Committee charter, the Audit Committee is responsible for, among other matters:things:
 
 • evaluatingreviewed certain of our publicly available audited and compensating our independent registered public accounting firm;unaudited financial statements;
 
 • making recommendations to the board and shareholders relating to the appointment, retention and terminationreviewed certain of our independent registered public accounting firm;
• discussing withinternal financial statements and other of our independent registered public accounting firm their independence fromfinancial statements and non-public operating data that were prepared and furnished to Evercore by our management;
 
 • reviewing withreviewed certain financial projections relating to us prepared and furnished to Evercore by our independent registered public accounting firm the scope and results of their audit;management;
 
 • pre-approving all auditdiscussed our past and permissible non-audit services to be performed bycurrent operations, financial projections and current financial condition with our independent registered public accounting firm;management;
 
 • overseeingreviewed the financial reporting processreported prices and discussing with management andtrading activity of our independent registered public accounting firm the interim and annual financial statements that we file with the SEC; andcommon shares;
 
 • reviewing and monitoringreviewed the transaction process conducted on our accounting principles, accounting policies and disclosure, internal control over financial reporting and disclosure controls and procedures.
Our Audit Committee will also assist us in ensuring that our process for monitoring compliance with, and dealing with violations of, our Code of Conduct, which is described below, is established and updated. In particular, our Audit Committee has established procedures in relation to complaints or concerns that we may receive involving accounting, internal accounting controls or audit matters, including the anonymous handling thereof. Such procedures are available atwww.novelis.com under our Code of Conduct.
Nominating and Corporate Governance Committee
Our Nominating and Corporate Governance Committee has the broad responsibility of regularly reviewing our corporate governance practices in general. Our Nominating and Corporate Governance Committee is composed entirely of Independent Directors.
In addition to its responsibilities for the design, implementation, review, and evaluation of our corporate governance policies and practices, our Nominating and Corporate Governance Committee oversees the composition and size of our board of directors. The committee reviews candidates for nomination as directors and recommends candidates for election to our board of directors. The committee also considers nominees submitted by shareholders to our Corporate Secretary. You may submit director nominations in writing to Novelis Inc., 3399 Peachtree Road, NE Suite 1500, Atlanta, Georgia, 30326, Attention: Corporate Secretary.
In identifying and evaluating candidates for nomination to our board of directors, our Nominating and Corporate Governance Committee considers several factors, including judgment, independence, skill, diversity, experience with businesses and other organizations of comparable size, and the requirement that, as a federal Canadian corporation, at least 25% of our directors must be resident Canadians. The qualifications and backgrounds of prospective candidates are reviewed in the context of the current composition of the board of directors to ensure it maintains the proper balance of knowledge, experience and diversity to effectively manage our business for the long-term interests of our shareholders. Our Nominating and Corporate Governance Committee is allowed to employ search firms for identifying and evaluating director nominees.
Our Nominating and Corporate Governance Committee assesses and ensures on an annual basis the effectiveness of our board of directors as a whole, of each committee of our board of directors and the


19


contribution of individual directors. Each director will complete a survey of board effectiveness on an annual basis which we anticipate will cover the subjects under the categories of board composition, responsibility, meetings and committees. As part of this survey, each of our directors will be asked to complete a self-evaluation and an evaluation of the board of directors as a whole and its committees. Our Nominating and Corporate Governance Committee also assesses our board’s relationship with management.
Human Resources Committee
Our Human Resources Committee has the broad responsibility to review human resources policy and employee relations matters and makes recommendations with respect to such matters to our board of directors or our chief executive officer, as appropriate. Our Human Resources Committee is composed entirely of Independent Directors. Its specific roles and responsibilities are set out in its charter. Our Human Resources Committee will periodically review the effectiveness of our overall management organization structure and succession planning for senior management, review recommendations for the appointment of executive officers, and consider and make recommendations to our board of directors based on trends and developments in the area of human resource management.
Our Human Resources Committee will establish our general compensation philosophy and oversee the development and implementation of compensation policies and programs. It also will review and approve the level ofand/or changes in the compensation of individual executive officers, except that in the case of the chief executive officer and chief operating officer, it will make recommendations regarding compensation and objectives to the board of directors, in each case taking into consideration individual performance and competitive compensation practices.
Our Human Resources Committee has the responsibility of reviewing our policies, management practices and performance in environment, health and safety matters and making recommendations to our board of directors on such matters in light of current and changing requirements. Our Human Resources Committee will also review, assess and provide advice to our board of directors on policy, legal, regulatory and consumer trends and developments related to the environment, as they impact us, our employees, businesses, processes and products.
Customer Relations Committee
In an advisory capacity, our Customer Relations Committee reviews information furnished by management, provides advice and counsel, and serves as a conduit for communications with our board of directors for the purposes of deepening our board’s understanding of: (1) key end-use markets served by us; (2) our existing and prospective customers in such markets; (3) the nature of our relationships with such customers (and efforts to further develop such relationships); (4) the needs of, and trends facing, our customers and key end-use markets; (5) the fact base regarding flat rolled products markets and competitive environments that, in the foreseeable future, may be served by us; and (6) our efforts to identify and implement best practices in the areas of marketing and sales.
Code of Ethics and Code of Conduct
Novelis has adopted a Code of Ethics for Senior Financial Officers (“Code of Ethics”) that applies to our senior financial officers including our chief executive officer, chief financial officer and controller. We have also adopted a Code of Conduct that governs all our employees as well as our directors. As an annex to the Code of Conduct and supplemental thereto, we have adopted additional standards specifically tailored to our business operations around the globe. Copies of the Code of Ethics and Code of Conduct are available on our website atwww.novelis.com. We will promptly disclose any future amendments to these codes on our website as well as any waivers from these codes for executive officers and directors. Copies of these codes are also available in print upon request by our shareholders from our Corporate Secretary.
We have also established “whistleblower” procedures so that an employee can anonymously report concerns that he or she may have regarding compliance with corporate policies, the Code of Conduct, the Code of Ethics, applicable laws or auditing, internal accounting controls and accounting matters. These procedures are part of the Code of Conduct.


20


REPORT OF THE AUDIT COMMITTEE
The following report does not constitute soliciting material and should not be deemed filed or incorporated by reference by any general statement incorporating by reference this Circular into any other filing under Canadian securities laws, under the United States Securities Act of 1933, as amended, or under the Exchange Act except to the extent that we specifically incorporate this information by reference.
In accordance with its charter attached as Schedule E of this Circular, our Audit Committee has oversight responsibility for Novelis’ financial reporting process and internal control functions. Management has the primary responsibility for the financial reporting process and the system of internal controls. PricewaterhouseCoopers LLP, the Company’s independent registered public accounting firm, has the responsibility to express an opinion on the consolidated and combined financial statements based on their audit in accordance with generally accepted auditing standards.
At each regular meeting, the Audit Committee meets separately with senior management, our Chief Internal Auditor and our independent registered public accounting firm to discuss any matters that the Audit Committee or any of these parties believe should be discussed privately.
The Audit Committee has reviewed and discussed with the Company’s management and PricewaterhouseCoopers LLP the consolidated and combined financial statements of the Company for the year ended December 31, 2005. The Audit Committee has also discussed with PricewaterhouseCoopers LLP the matters required to be discussed pursuant to Statement on Auditing Standards No. 61, as amended.
The Audit Committee has received and reviewed the written disclosures and the letter from PricewaterhouseCoopers LLP required by Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees), and has discussed with PricewaterhouseCoopers LLP its independence from the Company.
Based on the review and discussions referred to above, the Audit Committee recommended to the board of directors that the consolidated and combined financial statements be included in the Company’s Annual Report onForm 10-K for year ended December 31, 2005 for filing with the SEC.
Approval of this Report
The Audit Committee, whose members are set forth below, has approved the issue of this report and its inclusion in this Circular.
• Suzanne Labarge, Chairbehalf;
 
 • Edward A. Blechschmidt
• David J. FitzPatrick
• Kevin M. Twomey
HUMAN RESOURCES COMMITTEE REPORT ON EXECUTIVE COMPENSATION
The following report does not constitute soliciting material and should not be deemed filed or incorporated by reference by any general statement incorporating by reference this Circular into any other filing under Canadian securities laws, under the United States Securities Act of 1933, as amended, or under the Exchange Act except to the extent that we specifically incorporate this information by reference.
General
Our Human Resources Committee is responsible for administering the compensation program for our executive officers. Our executive compensation program is based upon apay-for-performance philosophy. Under our program, an executive’s compensation is based on three components, namely, base salary, short-term (annual) incentives and long-term incentives. Our Human Resources Committee is assisted by independent consultants.


21


The total direct compensation policy is aligned with prevalent U.S. competitive median compensation practices. U.S. compensation data is obtained from two primary sources: (1) comparison to executive compensation within a peer group of companies; and (2) published survey information that includes large multinational companies representative of the general market.
Both the short-term and long-term incentive plans are aligned with the Company’s governing objective to maximize shareholder value over time. The details of Novelis’s compensation programs are outlined below.
Compensation of the Executive Officers
Total direct compensation levels reflect both the responsibility of each position (internal equity) and competitive market levels (external competitiveness). The total direct compensation policy is targeted at the median of the competitive market level as indicated by peer group comparison and by survey information.
Base Salary
The target base salary is the median of a salary range for an executive officer and reflects the competitive level of similar positions in a compensation peer group and as reported in the survey information. Actual base salaries for executive officers reflect the individual’s performance and contribution to the Company. Base salaries of executive officers are therefore reviewed annually and any proposed changes are approved by our Human Resources Committee before implementation. The board of directors must approve base salaries for the most senior of the executive officers including those listed in the Summary Compensation Table. We have established a compensation peer group, and we utilize published survey information from established human resources consulting firms.
Short-Term (Annual) Incentives
We provide annual incentive benefits, which are administered by our Human Resources Committee. Short-term incentive awards are determined by three components, each based on a different aspect of our performance. For each position, a target award is set (expressed as “percent of base salary midpoint”) reflecting both the responsibilities of the position and the competitive compensation levels. For 2005, the short-term incentive awards were determined by performance measured against the following three components:
1. 50% of the incentive opportunity of an executive is based on our overall cash flow generation as measured against working capital turns improvement;
2. 40% of the incentive opportunity is based on our profitability as measured against economic value added targets; and
3. 10% of the incentive opportunity is based on the achievement of environment, health and safety objectives as measured against pre-established continuous improvement targets.
The overall award paid is the sum of the weighted results of each component, modified for individual performance and contribution to the Company. Currently, short-term incentive awards are paid in cash. For 2006, the three measurement criteria described above remain unchanged except that 40% of the incentive opportunity is measured against regional income targets instead of economic value added targets. If the 2006 Incentive Plan is approved by our shareholders at the 2006 annual meeting of shareholders, short-term incentive awards may be paid in cash, Shares or a combination of both. The award paid may range from zero when the results achieved are less than the minimum target thresholds set by our Human Resources Committee, up to 200% of the target award when the results achieved are at or exceed the maximum target level which was set by our Human Resources Committee. For 2005, executive officers earned short-term incentive awards that were generally above the target amounts reflecting performance on the three performance components that was above the pre-established targets.


22


Long-Term Incentives
The purpose of our long-term incentives is to attract and retain employees and to encourage them to contribute to our growth and long-term success. Long-term incentives are tied to the successful share price performance of the Company thereby aligning the interests of our executives with those of our shareholders.
Stock Options
On January 5, 2005, our board of directors adopted the Novelis Conversion Plan of 2005 (the “Conversion Plan”) to allow for all Alcan stock options held by employees of Alcan who became our employees following our spin-off from Alcan to be replaced with options to purchase our Shares. While new options may be granted under the Conversion Plan, there were no new options granted in 2005 under the plan. As of December 31, 2005 our employees held stock options covering 2,704,790 of our Shares at a weighted average exercise price per share of $21.60. No future awards will be granted under the Conversion Plan if the 2006 Incentive Plan is approved by our shareholders at the 2006 annual meeting of shareholders. All converted options that were vested on the spin-off date continued to be vested. Unvested options vest in four equal annual installments beginning on January 6, 2006, the first anniversary of the spin-off date. In the case of a change in control of Novelis, all options will become immediately exercisable.
Stock Price Appreciation Units
Our board of directors approved the Stock Price Appreciation Unit Plan, effective as of January 5, 2005. Prior to the spin-off date, a small number of Alcan employees held Alcan stock price appreciation units (“SPAUs”) entitling them to receive cash in an amount equal to the excess of the market value of an Alcan common share on the SPAU exercise date over the market value of an Alcan common share on the SPAU grant date. As of the spin-off date, we replaced all of the Alcan SPAUs held by employees of Alcan who became our employees, including our executive officers, with Novelis SPAUs. There were no new SPAUs granted in 2005 under the plan. No future awards will be granted under the Stock Price Appreciation Unit Plan if the 2006 Incentive Plan is approved by our shareholders at the 2006 annual meeting of shareholders. As of December 31, 2005, our employees held 418,777 SPAUs at a weighted average price of $22.04. All converted SPAUs that were vested on the spin-off date continued to be vested. Unvested SPAUs vest in four equal annual installments beginning on January 6, 2006, the first anniversary of the spin-off date. In the case of a change in control of Novelis, all SPAUs will become immediately exercisable.
Novelis Founders Performance Awards
On March 24, 2005, our board of directors adopted the Novelis Founders Performance Award Plan (the “Founders Plan”) to allow for an additional compensation opportunity tied to Novelis share price improvement targets for certain of our executives approved by the Human Resources Committee, including those listed in the Summary Compensation Table. Participants earn performance share units (“PSUs”) if Novelis share price improvement targets are achieved within prescribed time periods. The Founders Plan identifies three relevant performance periods. The first performance period runs from March 24, 2005 to March 23, 2008, the second performance period runs from March 24, 2006 to March  23, 2008 and the third performance period runs from March 24, 2007 to March 23, 2008. The share price improvement targets for these three tranches are $23.57, $25.31 and $27.28, respectively. Participants are eligible to receive an aggregate of 399,050 PSUs under the Founders Plan, but only if the share price improvement targets are achieved. An equal amount of PSUs may be earned during each performance period if the applicable share price improvement target is achieved during such period. As described below in footnote 1 under the caption “Long-Term Incentive Plan Table — Founders Plan,” in March 2006 Mr. Sturgell and our board of directors agreed to alter the allocation of Mr. Sturgell’s PSUs for each of the three tranches.
If earned, a particular tranche will be paid in cash on a particular “payment date,” which is defined as the later of six months from the date the specific share price improvement target is achieved or twelve months after the start of the applicable performance period. The value of a PSU equals the average of the daily closing price of our common stock as reported on the New York Stock Exchange for the last five trading days prior to


23


the payment date. For example, the share price improvement target for the performance period running from March 24, 2005 to March 23, 2008 has already been achieved and 180,350 PSUs were earned on June 20, 2005. Subsequent to June 30, 2005, 48,500 PSUs were forfeited, leaving 131,850 PSUs still active. The value of each of these PSU’s was calculated in the manner described above using a valuation date of March 24, 2006 (which is the date that is twelve months after the start of the applicable performance period). In April 2006, these PSUs were settled in cash in the amount of $2,655,459.
On March 14, 2006, the board of directors amended the Founders Plan in order to clarify when PSUs will be earned under the second and third tranches of the Founders Plan for periods beginning in 2006 and 2007, respectively. The amended Founders Plan now provides that the second and third tranches of PSUs will be earned if, during the period of each tranche, the share price reaches (or exceeds) the target price and is maintained or exceeded for 15 consecutive trading days during an open trading period for directors and executive officers. An open trading period is any period, other than a trading blackout period, in which directors and executives are free to purchase or sell Shares. Previously, the Founders Plan did not specify that the15-day vesting period must occur during an open trading period.
Incentive Plan
The Incentive Plan was approved by our board of directors, subject to the approval of the shareholders of the Company. The Incentive Plan will replace, on a prospective basis, the Conversion Plan and the SPAU Plan and no future awards will be granted under such plans if the Incentive Plan is approved by the Company’s shareholders. Short-term (annual) incentive compensation will also be paid pursuant to the Incentive Plan. This summary is qualified in its entirety by reference to the full text of the Incentive Plan, a copy of which is attached as Schedule F to this Circular.
The purpose of the Incentive Plan is to promote the interests of the Company and its shareholders by motivating, attracting and retaining key employees and non-employee directors of the Company and its subsidiaries through the issuance of equity-based awards and short-term incentive compensation.
The Incentive Plan authorizes the award of stock options, SARs, restricted shares, restricted share units, performance shares and other stock-based incentives. The Incentive Plan also authorizes payment of short-term incentives, payable in cash or Shares, following satisfaction of pre-established performance objectives.
The Incentive Plan will be administered by the Human Resources Committee, except that the full board of directors will be responsible for the administration of awards to the Company’s non-employee directors.
Compensation of the Chief Executive Officer
The CEO’s annual compensation is administered by the board of directors, based on recommendations from the Human Resources Committee according to the policies described above. Mr. Sturgell became CEO on January 6, 2005 and entered into an employment agreement with the Company. The board of directors set Mr. Sturgell’s compensation on a competitive level with other U.S. chief executive officers of global companies of similar size, and also provided Mr. Sturgell with a comparable level of compensation to that received from his previous employer.
On August 29, 2006, the Board of Directors terminated Mr. Sturgell as CEO and appointed Chairman William T. Monahan to also serve as Interim CEO until a successor for Mr. Sturgell is identified. At this time, Mr. Sturgell and the Company are still negotiating the terms of his separation agreement that are not otherwise addressed by the provisions of his existing agreements with the Company. Once the agreement is finalized and executed, the details of the separation agreement will be filed with the SEC via Item 1.01 ofForm 8-K.
Decisions pertaining to the CEO’s compensation are based on our board’s evaluation of the CEO’s performance against pre-determined financial and strategic objectives. These objectives are set and approved annually at the beginning of the year. Mr. Sturgell’s goals and objectives for 2005 included performance against pre-established targets for cash flow, economic value added, environment, health and safety. Goals and objectives also included increasing financial awareness of the investment community, succession planning and customer relations. The Human Resources Committee recommended to the board of directors that the CEO’s


24


total direct compensation (base salary, target short-term incentives and target long-term incentives) be set at the median of the U.S. market. The overall performance against the goals and objectives is reflected in establishing the actual compensation of the CEO.
In 2005, Mr. Sturgell’s base salary (representing approximately 17% of his target total direct compensation) was $985,000. It was not increased for 2006. Mr. Sturgell also received short-term incentive award for 2005 equal to $820,147. This amount is approximately 50% less than the amount he would have received ($1,681,130) based on the original short-term incentive targets established by the Company and the Company’s 2005 financial performance. The board of directors reduced Mr. Sturgell’s 2005 short-term incentive pay because of the delay in the Company’s financial reporting and overall share price performance.
Mr. Sturgell received no options in 2005. Mr. Sturgell received a grant in the aggregate of 140,550 PSUs on March 24, 2005, subject to the achievement of share price improvement targets, under the Founders Plan. On March 14, 2006, Mr. Sturgell agreed with the board of directors that, in light of our 2005 and 2006 financial reporting delay and restatement, Mr. Sturgell would forfeit 46,850 PSUs attributable to the first tranche of the award. The board of directors also approved an increase in the size of the award opportunity for Mr. Sturgell for the second and third tranches under the Founders Plan in an amount equal to 23,425 PSUs for each tranche, increasing the total award size to 70,275 PSUs for each PSU tranche. The PSUs for the second and third tranches would not have vested and become payable unless the share price improvement targets specified in the Plan ($25.31 and $27.28 respectively) were achieved. As a result of Mr. Sturgell’s termination as CEO on August 29, 2006, all of his PSUs attributable to the second and third tranches were forfeited.
Mr. Sturgell’s employment agreement provides for competitive retirement benefits. In addition, Mr. Sturgell and the Company entered into a change in control agreement dated December 5, 2005, which provides for payment and other benefits upon the termination of employment for any reason other than cause, as defined in the agreement. Pursuant to the change in control agreement, Mr. Sturgell will be entitled to an amount equal to 36 months of his base salary and target short-term incentive award (payable in 36 equal monthly instalments), plus the amount payable under provisions of the TSR Plan. Mr. Sturgell will also be entitled to continuation of certain employee benefits and additional service credits of three years under the Company’s pension plans.
Section 162(m) Limitation
The Human Resources Committee believes that the compensation program serves its intended objectives. Section 162(m) of the United States Internal Revenue Code of 1986, as amended, provides a number of exceptions to the $1 million deduction limitation on compensation paid to executives, and it is the intent of the Human Resources Committee to qualify for these exceptions to the extent feasible and in the best interests of the Company, including the exceptions with respect to performance-based compensation.
While it is the Human Resources Committee’s intention to maximize the deductibility of compensation payable to the Company’s Named Executive Officers, deductibility will be only one among a number of factors used by the Human Resources Committee in ascertaining appropriate levels or methods of compensation. The Company intends to maintain the flexibility to compensate Named Executive Officers based upon an overall determination of what it believes to be in the best interests of the Company and its shareholders.
Approval of this Report on Executive Compensation
The Human Resources Committee, whose members are set forth below, has approved the issue of this report and its inclusion in this Circular.
• Clarence J. Chandran, Chair
• Jacques Bougie, O.C.compared certain of our financial information with that of certain publicly-traded companies that Evercore deemed relevant;


2535


 
 • Charles G. Cavellreviewed the financial terms of certain business combinations and other transactions that Evercore deemed relevant and compared the valuation multiples in those transactions to those contemplated by the Arrangement;
 
 • C. Roberto Cordaroreviewed the Arrangement Agreement; and
 
 • Helmut Eschweyperformed such other analyses and examinations and considered such other factors as Evercore in its sole judgment deemed appropriate.
For purposes of its analysis and opinion, Evercore did not assume any responsibility for independently verifying the accuracy and completeness of the information reviewed by or reviewed for Evercore. With respect to our financial projections which were furnished to Evercore, Evercore assumed that such financial projections were reasonably prepared by us, on bases reflecting the best currently available estimates and good faith judgments of the future competitive, operating and regulatory environments and our related financial performance. Evercore expressed no view as to any such financial projections or the assumptions on which they were based. Evercore neither made nor assumed any responsibility for making any independent valuation or appraisal of our assets or liabilities, nor was Evercore furnished with any such appraisals. Evercore is not a legal, regulatory, accounting or tax expert and assumed the accuracy and completeness of assessments by our advisors with respect to such issues. Evercore expressed no opinion on any impact of the Arrangement on the tax treatments of any prior corporate restructuring involving us. Evercore assumed that the Arrangement will be consummated in accordance with the terms set forth in the Arrangement Agreement without any waiver, amendment or delay of any term, condition or agreement set forth therein. Evercore further assumed that all required governmental, regulatory or other consents and approvals necessary for the consummation of the Arrangement will be obtained without any material adverse effect on us.
Evercore’s opinion was necessarily based on economic, market and other conditions as in effect on, and the information and the Arrangement Agreement and related exhibits and schedules thereto made available to Evercore as of, the date of its opinion. Subsequent developments may affect Evercore’s opinion and Evercore does not have any obligation to update, revise or reaffirm its opinion. Evercore’s opinion does not address our underlying business decision to effect the Arrangement and Evercore expressed no opinion or recommendation as to how our shareholders should vote at the Meeting to be held in connection with the Arrangement.
In addition, Evercore was not requested to and did not provide advice concerning the structure, the specific amount of the consideration, or any other aspects of the Arrangement contemplated by the Arrangement Agreement, nor was Evercore requested to provide services other than the delivery of its opinion. Evercore was not authorized to solicit, and did not solicit, interest from any party with respect to an acquisition of, business combination with, or other extraordinary transaction involving, us. Evercore did not participate in the multi-party auction process conducted on our behalf or in the negotiations with respect to the terms of the Arrangement.
Evercore was not asked to pass upon, and expressed no opinion with respect to, any matter other than the fairness from a financial point of view of the Arrangement consideration to be received by our shareholders, other than holders of Excluded Shares, pursuant to the Arrangement Agreement.
Evercore provided a fairness opinion to our board of directors pursuant to a letter agreement dated February 2, 2007 and we agreed to pay Evercore a customary fee in connection therewith. In addition, we have agreed to reimburse Evercore’s reasonable and customary expenses and to indemnify Evercore against certain liabilities arising out of its engagement, including certain liabilities under the federal securities laws. No portion of Evercore’s fee or expense reimbursement is contingent upon the successful completion of the Arrangement or the conclusions reached in Evercore’s opinion.
We engaged Evercore to act as a financial advisor based on its qualifications, experience and reputation and its knowledge of our business. Evercore is an internationally recognized investment banking firm and is regularly engaged in the valuation of businesses in connection with mergers and acquisitions, leveraged buyouts, competitive biddings, private placements and valuations for corporate and other purposes. In the ordinary course of business, the affiliates of Evercore may actively trade in the debt and equity securities, or


36


options on securities, of Hindalco or us, for its own account and for the accounts of its customers and, accordingly, may at any time hold a long or short position in such securities.
Set forth below is a summary of the material financial analyses presented by Evercore to our board of directors in connection with rendering Evercore’s opinion. The following summary, however, does not purport to be a complete description of the analyses performed by Evercore. Except as otherwise noted, the following quantitative information, to the extent that it is based on market data, is based on market data as it existed on or before February 9, 2007, and is not necessarily indicative of current market conditions.
The following summary of financial analyses includes information presented in tabular format. You should read these tables together with the text of each summary. The tables alone do not constitute a complete description of the financial analyses.
Analysis of Historical Trading Prices and Implied Arrangement Premiums
Evercore reviewed the historical closing prices of our common shares since January 6, 2005, the first day of trading on a “when issued” basis of our common shares after our spin-off from Alcan Inc., and calculated the average daily closing prices of our common shares over various time periods, and noted the closing share price on selected dates including and prior to February 9, 2007. Evercore then calculated and compared the premium that the Arrangement consideration of $44.93 per share represented relative to the average daily closing prices of our common shares for the selected periods and dates. The results of these calculations are summarized below:
         
    Premium of Arrangement
    Consideration
  Historical
 of $44.93 per Share
  Share
 to Historical
  Price Share Price
 
February 9, 2007 (the last trading day prior to announcement of the Arrangement) $38.54   16.6%
January 25, 2007 (Day Prior to Announcement of Possible Sale)(1) $30.13   49.1%
January 18, 2007 (1 Week Prior to Announcement of Possible Sale) $29.51   52.3%
December 28, 2007 (4 Weeks Prior to Announcement of Possible Sale) $27.47   63.6%
1 Month Average(2) $28.61   57.0%
3 Month Average(3) $27.06   66.0%
1 Year Average(4) $22.68   98.1%
November 15, 2006(5) $24.94   80.2%
January 6, 2005 (Price at Spin-off)(6) $24.49   83.5%
February 8, 2007 (Maximum since Spin-off) $39.10   14.9%
(1)Unaffected Date.
(2)One Month Average includes trading days from December 25, 2006 through January 25, 2007.
(3)Three Month Average includes trading days from October 25, 2006 through January 25, 2007.
(4)One Year Average includes trading days from January 25, 2006 through January 25, 2007.
(5)Day prior to which our shares experienced significant share price appreciation and volume expansion with no apparent cause.
(6)Day on which our common shares began trading on a “when issued” basis on the Toronto and New York stock exchanges.


37


Discounted Cash Flow Analysis
Evercore performed a discounted cash flow analysis (“DCF”) which calculates the present value of a company’s future cash flows based upon assumptions with respect to such cash flows and assumed discount rates. Evercore’s DCF analysis of us was based upon three sets of financial projections prepared and furnished to Evercore by our management (Case A, Case B and Case C). Our management prepared the three cases of financial projections based upon different assumptions regarding business and industry trends. Management indicated that Case A reflected stable business and industry trends that would produce steady growth and improving margins for us during the projection period(2007-2011). Case B assumed a downturn in 2009 that would reduce revenues and depress margins for the remaining years in the projection period(2010-2011). Case C assumed a downturn in 2007 that would reduce revenues and depress margins for the remaining years of the projection period(2008-2011).
Evercore calculated a range of implied per share values for our common shares determined by: (1) adding (a) the implied present value of our forecasted unlevered free cash flows over the five-year period from January 1, 2007 to December 31, 2011, determined using a weighted average cost of capital range of between 10.0% and 12.0% (weighted average cost of capital is a measure of the average expected return on all of a company’s securities or loans based on the proportions of those securities or loans in such company’s capital structure), and (b) the implied present value of the terminal value of our future cash flows as of December 31, 2011, calculated as described below, and discounting the result over a five-year period using a weighted average cost of capital range of between 10.0% and 12.0%; (2) deducting our debt, net of estimated cash, as of December 31, 2006; and (3) dividing the amount resulting from the calculation described in (1) and (2) above by the number of our common shares outstanding, adjusted for certain stock options outstanding using the treasury stock method, as of the date of the Arrangement Agreement.
Evercore calculated our terminal value using two methodologies, both based on estimates of adjusted earnings before interest, taxes, depreciation and amortization, or EBITDA, which is referred to as Adjusted EBITDA. Evercore believes that Adjusted EBITDA better reflects our ongoing operating performance by excluding certain non-recurring and non-operational items, such as the negative impact of certain customer contracts with aluminum price ceiling provisions (net of realized gains on hedges implemented to offset such negative impacts). Evercore calculated the terminal values by (1) multiplying average Adjusted EBITDA for the2005-2011 period by a range of multiples of 6.0x to 7.0x and (2) multiplying Adjusted EBITDA estimated for fiscal year 2011 by a range of multiples of 5.5x to 6.5x.
This analysis yielded implied per share present values of our common shares as shown below:
(1) Price Per Share Based on Average Adjusted EBITDA
             
  Case A  Case B  Case C 
 
Low $26.92  $22.12  $18.59 
High $37.91  $32.26  $28.25 
(2) Price Per Share Based on 2011 Adjusted EBITDA
             
  Case A  Case B  Case C 
 
Low $31.00  $23.15  $21.15 
High $43.77  $34.13  $32.08 
This compares to the Arrangement consideration of $44.93 per share.
Leveraged Buyout Analysis
Evercore performed a leveraged buyout analysis of us in order to ascertain the price of our common shares which might be attractive to a potential financial buyer based upon three sets of financial projections prepared and furnished to Evercore by our management (Case A, Case B and Case C).
Evercore assumed the following in its analysis: (1) a leverage multiple of 6.5x LTM EBITDA, adjusted for certain items to reflect the ongoing profitability of the business; (2) a projected 2011 Adjusted EBITDA exit multiple ranging from 5.5x to 6.5x; (3) 5.0% of our ownership was granted to management in the form of


38


options with an exercise price equal to the transaction buy-in price; and (4) an equity investment that would achieve an annual rate of return over the four year and six month period of between 18.0% and 24.0%. This analysis yielded implied per share present values of our common shares as shown below:
             
  Case A  Case B  Case C 
 
Low $29.68  $24.69  $23.62 
High $39.67  $32.58  $31.23 
This compares to the Arrangement consideration of $44.93 per share.
Present Value of Future Share Price Analysis
Evercore performed a present value of future shares price analysis of us based upon three sets of financial projections prepared and furnished to Evercore by our management (Case A, Case B and Case C).
Evercore calculated a range of implied per share values for our common shares determined by (1) calculating the implied terminal value per share by multiplying the Adjusted EBITDA estimated for fiscal year 2011 by 5.5x, 6.0x and 6.5x adjusted for net debt and shares estimated to be outstanding on December 31, 2011 and (2) calculating the present value of the implied share price by discounting the amount resulting from the calculation described in (1) above over a5-year period using an assumed equity cost of capital of between 14.0% and 16.0%. This analysis yielded implied per share present values of our common shares as shown below:
             
  Case A  Case B  Case C 
 
Low $30.47  $24.11  $22.59 
High $39.80  $31.93  $30.28 
This compares to the Arrangement consideration of $44.93 per share.
Analysis of Selected Companies’ Trading Levels
Evercore calculated enterprise value (which represents total market equity value plus book value of total debt less cash) as a multiple of EBITDA for selected publicly-traded companies using share prices as of February 9, 2007. All of these calculations were based on publicly available financial data including I/B/E/S estimates. I/B/E/S is a data source that monitors and publishes a compilation of earnings per share and other financial data produced by selected research analysts on companies of interest to investors. Although none of the selected companies are, in Evercore’s opinion, directly comparable to us, the companies included were chosen because they are publicly traded companies with operations that for purposes of this analysis may be considered similar in certain respects to certain of our operations. Evercore then calculated this valuation multiple for us based on (1) our enterprise value as implied by the Arrangement consideration of $44.93 per share and (2) the Adjusted EBITDA for 2006 and 2007. In calculating our valuation multiples, Evercore also adjusted the enterprise value to include the present value of the liability resulting from our can price ceiling contract provisions (net of hedging gains). Evercore then compared our multiples to the mean and the median multiples derived for the selected publicly-traded companies.
The range of implied multiples that Evercore calculated is summarized below:
                         
  Primary Aluminum/
  Metal Processors/
  Rigid
 
  Integrated Aluminum(1)  Producers(2)  Packaging(3) 
  Mean  Median  Mean  Median  Mean  Median 
 
Enterprise Value / CY2006E EBITDA  5.5x  5.3x  7.1x  7.0x  8.3x  8.0x
Enterprise Value / CY2007E EBITDA  5.5x  5.3x  6.5x  6.4x  7.6x  7.6x
(1)Primary Aluminum /Integrated Aluminum Companies include Alcoa Inc., Alcan Inc., Aluminum Corporation of China Ltd., Hindalco Industries Ltd., National Aluminum Industrial Co. and Century Aluminum Co.


39


(2)Metal Processors/Producers Companies include Corus Group plc., Reliance Steel & Aluminum Co., Quanex Corp., Worthington Industries, Inc., Aleris International, Inc. (based on share price as of August 7, 2006, prior to offer from Texas Pacific Group) and Gibraltar Industries, Inc.
(3)Rigid Packaging Companies include Rexam plc., Amcor Limited, Ball Corporation and Silgan Holdings, Inc.
Novelis at Arrangement consideration of $44.93 per Share
             
  Case A  Case B  Case C 
 
Enterprise Value / CY2006E Adjusted EBITDA(1)  8.6x  8.6x  8.6x
Enterprise Value / CY2007E Adjusted EBITDA(1)  8.3x  8.3x  9.8x
(1)Enterprise value adjusted to include the present value of the liability resulting from our can price ceiling contract provisions (net of hedging gains).
Analysis of Selected Transactions
Using publicly available information, Evercore performed an analysis of selected transactions to compare certain multiples paid in other transactions to the multiples implied in the Arrangement. Evercore identified and analyzed a group of 13 acquisition transactions in the primary/integrated aluminum, metal processing/producing and rigid packaging industries that were announced between 1999 and 2007.
TargetAcquirer
International Aluminum Corp. Genstar Capital LLC
Aleris International, Inc. Texas Pacific Group, Inc.
Corus Group plc — Downstream aluminum assetsAleris International, Inc.
Ormet Corp. — Selected assetsAleris International, Inc.
JW Aluminum Holding Co. Superior Plus Inc.
ALSCO Metals Corp. Aleris International, Inc.
JW Aluminum Co. Wellspring Capital Management LLC
Pechiney SAAlcan Inc.
Precision Strip, Inc. Reliance Steel & Aluminum Co.
British Aluminum Ltd. — Selected assetsAlcoa Inc.
Wells Aluminum Corp. Norsk Hydro ASA
Easco, Inc. Caradon plc
Century Aluminum Co. — Aluminum Rolled Products businessesPechiney SA
Evercore calculated enterprise value as a multiple of LTM EBITDA implied by these transactions. Evercore then calculated the enterprise value implied by the Arrangement consideration of $44.93 per share and our multiple based on our LTM Adjusted EBITDA. Evercore then compared our multiple to the multiples derived for the selected acquisition transactions in the primary/integrated aluminum, metal processing/producing and rigid packaging industries. Although none of the selected targets are, in Evercore’s opinion, directly comparable to us, the transactions included were chosen because they involve companies with operations that for purposes of this analysis may be considered similar in certain respects to certain of our operations. The range of implied multiples that Evercore calculated is summarized below:
Enterprise Value /
LTM Adjusted EBITDA(1)
Selected Transactions — Mean6.9x
Selected Transactions — Median6.3x
Arrangement consideration of $44.93 per Share8.6x


40


(1)Enterprise value adjusted to include the present value of the liability resulting from our can price ceiling contract provisions (net of hedging gains).
Analysis of Past Premiums Paid
Evercore identified and analyzed 165 U.S. acquisition transactions across all industries with transaction values from $1.0 billion to $10.0 billion that were announced in the period from January 2005 through January 2007, of which 119 represented all cash acquisitions. Using information from Thomson Financial Securities Data, a data source that monitors and publishes information on merger and acquisition transactions, Evercore calculated the premiums paid in those transactions based on the value of the per share consideration received in the transaction relative to the closing stock price of the target company one day, one week and four weeks prior to the respective dates of announcement of the transactions. Evercore then compared the results of the analysis to the premiums implied by the Arrangement consideration of $44.93 per share relative to our common share trading levels at and prior to February 9, 2007. The results of this analysis are summarized below:
             
  Premium
 Premium
 Premium
  Paid, 1
 Paid, 1
 Paid, 4
  Day
 Week
 Weeks
  Prior Prior Prior
 
Premiums in All Acquisitions between $1.0 billion and $10.0 billion
            
Mean  22.7%  24.2%  27.0%
Median  19.2%  21.7%  24.3%
Premiums in All Cash Acquisitions between $1.0 billion and $10.0 billion
            
Mean  23.7%  25.4%  28.8%
Median  20.6%  23.8%  25.1%
Premium of Arrangement consideration of $44.93 per Share to Historical Share Price  16.6%        
Premium of Arrangement consideration of $44.93 per Share to Historical Share Price relative to January 26, 2007(1)  49.1%  52.3%  63.6%
(1)Day on which we publicly announced that we were in discussions with various parties that could lead to a potential sale of the Company.
Although none of the transactions are, in Evercore’s opinion, directly comparable to the Arrangement, the transactions included were chosen because they may be considered similar in certain respects to the Arrangement for purposes of this analysis.
Research Analyst Price Target Analysis
Evercore also analyzed Wall Street research analyst estimates of potential future value for our common shares (commonly referred to as price targets) based on publicly available equity research published on us. As of the Unaffected Date, analyst price targets for our common shares ranged from $13.00 to $28.50 and produced an average price target of $21.92 and a median price target of $22.75. Evercore then compared the results of this analysis to the Arrangement consideration of $44.93 per share.
In connection with the review of the Arrangement by our board of directors, Evercore performed a variety of financial and comparative analyses for purposes of rendering its opinion. The preparation of a fairness opinion is a complex process and is not necessarily susceptible to partial analysis or summary description. Selecting portions of the analyses or of the summary described above, without considering the analyses as a whole, could create an incomplete view of the processes underlying Evercore’s opinion. In arriving at its fairness determination, Evercore considered the results of all the analyses and did not attribute any particular weight to any factor or analysis considered by it. Rather, Evercore made its determination as to fairness on the basis of its experience and professional judgment after considering the results of all the analyses. In addition,


41


Evercore may have deemed various assumptions more or less probable than other assumptions, so that the range of valuations resulting from any particular analysis described above should therefore not be taken to be Evercore’s view of our value. No company used in the above analyses as a comparison is directly comparable to us, and no transaction used is directly comparable to the Arrangement contemplated by the Arrangement Agreement. Further, in evaluating comparable transactions, Evercore made judgments and assumptions with regard to industry performance, general business, economic, market and financial conditions and other matters, many of which are beyond the control of Evercore and us, such as the impact of competition on us and the industry generally, industry growth and the absence of any adverse material change in our financial condition or in the markets generally.
Evercore prepared these analyses for the purpose of providing an opinion to our board of directors as to the fairness from a financial point of view of the $44.93 per share of cash consideration to be received by our shareholders, other than holders of Excluded Shares. These analyses do not purport to be appraisals or to necessarily reflect the prices at which the business or securities actually may be sold. Analyses based upon forecasts of future results are not necessarily indicative of actual future results, which may be significantly more or less favorable than suggested by these analyses. Because these analyses are inherently subject to uncertainty and are based upon numerous factors, assumptions with respect to industry performance, general business and economic conditions and other matters or events beyond the control of Evercore and us, neither Evercore nor we assumes responsibility if future results are materially different from those forecast. The $44.93 per share in cash consideration to be received by our shareholders, other than holders of Excluded Shares, pursuant to the Arrangement Agreement was determined through our arm’s length negotiations with Hindalco and was approved by our board of directors. Evercore did not recommend any specific consideration to us or that any given consideration constituted the only appropriate consideration for the Arrangement.
Arrangement Mechanics
The following description is qualified in its entirety by reference to the full text of the Plan of Arrangement, which is attached as Annex C to this Proxy Statement/Circular. Upon the Arrangement becoming effective, the following transactions will occur and will be deemed to occur in the order set out in the Plan of Arrangement:
• our shareholder rights plan shall be terminated;
 
 • Edward V. Yangeach Option, SAR and SPAU (whether vested or unvested), notwithstanding the terms of the applicable plans, shall be deemed to be unconditionally vested and exercisable, and such Option, SAR or SPAU (1) shall, without any further action by or on behalf of the holder thereof, be transferred by such holder to us in exchange for a cash payment from us equal to the amount (if any) by which $44.93 exceeds the exercise price thereof, less applicable withholdings; and (2) shall immediately be cancelled and all agreements related thereto shall be terminated;
• each PSU and DSU will be cancelled in exchange for a cash payment by us of $44.93, less applicable withholdings;
• each common share outstanding at the effective time other than a common share held by (1) a Dissenting Holder who is ultimately entitled to be paid the fair value of the common shares held by such Dissenting Holder, or (2) Hindalco, Acquisition Sub or any of their affiliates (which shall not be exchanged under the Arrangement and shall remain outstanding as a common share held by Hindalco, Acquisition Sub or any of their affiliates), shall be transferred to Acquisition Sub in exchange for $44.93 per common share in cash;
• the names of the holders of the common shares transferred to Acquisition Sub shall be removed from the applicable registers of holders of common shares and Acquisition Sub shall be recorded as the registered holder of the common shares so acquired and shall be deemed the legal and beneficial owner thereof free and clear of any liens or encumbrances;
• we will pay any short-term incentive compensation payable under the 2006 Incentive Plan in connection with a change of control; and


42


• our 2006 Incentive Plan, Conversion Plan of 2005, as amended, Deferred Share Unit Plan for Non-Executive Directors, Founders Performance Award Plan, as amended, and Stock Price Appreciation Unit Plan shall be terminated.
 
Human Resources Committee InterlocksDelivery of Consideration
At or before the effective time, Acquisition Sub will deliver payment for the common shares to the Depositary to be held in escrow for the benefit of shareholders, and Insider Participationwe will deposit with the Depositary an amount of cash equal to the cash each holder of an Option, SAR, SPAU, PSUand/or DSU is entitled to receive, if any, under the Plan of Arrangement.
Upon surrender to the Depositary for cancellation of certificate(s) which immediately prior to the effective time represented one or more common shares, together with the letter of transmittal and such additional documents and instruments duly executed and completed as the Depositary may reasonably require, the holder of such surrendered certificate(s) shall be entitled to receive in exchange therefor, and the Depositary shall (unless instructed otherwise in the letter of transmittal) deliver to such shareholder as soon as practicable after the effective time, a check or other payment of immediately available funds representing the cash which such shareholder has the right to receive under the Arrangement, less any amounts withheld, and the certificate(s) so surrendered shall forthwith be cancelled. Until surrendered, each certificate which immediately prior to the effective time represented common shares shall be deemed after the effective time to represent only the right to receive upon such surrender a cash payment in lieu of such certificate, less any amounts withheld, pursuant to the Plan of Arrangement.
Unless otherwise directed in the letter of transmittal, checks to be issued will be issued in the name of the registered shareholder of the common shares so deposited. Unless the person who deposits the certificates representing the common shares instructs the Depositary to hold the check forpick-up by checking the appropriate box in the letter of transmittal, checks will be forwarded by first class mail to the address supplied in the letter of transmittal. If no address is provided, checks will be forwarded to the address of the shareholder as shown on the register of our transfer agent.
On or as soon as practicable after the effective date, the Depositary shall deliver on our behalf to each holder of Options, SARs, SPAUs, PSUsand/or DSUs, as the case may be, as reflected on our books and records, a check representing the payment to which such holder is entitled in accordance with the Plan of Arrangement (net of any applicable withholdings). Checks will be forwarded by first class mail to the address of the holder as shown in our records.
Any use of mail to transmit certificate(s) for sharesand/or letters of transmittal is at the risk of the relevant shareholder. If these documents are mailed, it is recommended that registered mail, with return receipt requested and with proper insurance, be used.
In the event of a transfer of ownership of common shares prior to the effective time that is not registered in our transfer records, a check or other payment of immediately available funds representing the proper amount of cash may be delivered to the transferee if the certificate representing such shares is presented to the Depositary, accompanied by all documents required to evidence and effect the transfer prior to the effective time.
The Depositary will act as the agent of persons who have deposited shares in connection with the Arrangement for the purpose of receiving payment from Acquisition Sub and transmitting payment from Acquisition Sub to such persons, and receipt of payment by the Depositary will be deemed to constitute receipt of payment by persons depositing common shares.
If any shareholder fails for any reason to surrender to the Depositary for cancellation the certificates formerly representing common shares, together with such other documents or instruments required to entitle the holder to receive the cash payment described above, on or before the sixth anniversary of the effective date, such certificate shall cease to represent a claim by or interest of any former shareholder of any kind or nature. On such anniversary date, all certificates representing common shares and cash to which such former holder was entitled shall be deemed to have been surrendered and forfeited to Acquisition Sub. In addition,


43


any payment made by way of check by the Depositary on behalf of Acquisition Sub or on our behalf that has not been deposited or has been returned to the Depositary or that otherwise remains unclaimed, in each case on or before the sixth anniversary of the effective date of the Arrangement, shall cease to represent a right or claim of any kind or nature and the right of the shareholder or holder of Options, SARs, SPAUs, PSUsand/or DSUs, to receive the consideration to which they are entitled pursuant to the Plan of Arrangement shall terminate and be deemed to be surrendered and forfeited to Acquisition Sub or to us, as applicable.
Novelis, Acquisition Sub and the Depositary will be entitled to deduct and withhold from any consideration otherwise payable to a shareholder or holder of Options, SARs, SPAUs, PSUsand/or DSUs, as the case may be, such amounts as we, Acquisition Sub or the Depositary is required or permitted to deduct and withhold with respect to such payment under applicable laws and all such withheld amounts will be remitted to the appropriate governmental authority in the prescribed manner and within the prescribed time.
The Depositary will receive reasonable and customary compensation for its services in connection with the Arrangement, will be reimbursed for certain out of pocket expenses and will be indemnified by us against certain liabilities under applicable securities laws and expenses in connection therewith.
Under no circumstances will interest on the consideration payable under the Arrangement accrue or be paid to persons depositing common shares, regardless of any delay in making such payment.
Certain Effects of the Arrangement
If the Arrangement Resolution is approved by our shareholders and the other conditions to closing of the Arrangement are either satisfied or (to the extent permitted by law) waived, Acquisition Sub, a subsidiary of Hindalco created solely for the purpose of engaging in the transactions contemplated by the Arrangement Agreement, will acquire all of our outstanding common shares. It is the intention of Acquisition Sub to transfer the common shares of Novelis acquired by it to its wholly-owned subsidiary AV Aluminum Inc. When the Arrangement is completed, our common shares will no longer be publicly traded and we will become an indirect subsidiary of Hindalco. Therefore, our shareholders will not participate in our future earnings growth and will not benefit from any appreciation in our value.
Our common shares are currently registered under the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act, and are traded on the New York Stock Exchange and the Toronto Stock Exchange under the symbol “NVL.” As a result of the Arrangement, we will become an indirect subsidiary of Hindalco, our common shares will cease to be traded on the NYSE and the TSX and there will be no public market for our common shares. In addition, registration of our common shares under the Exchange Act will be terminated, and we will no longer be required to file periodic reports with the SEC, except as may be required under our Senior Notes. We will also make an application to cease to be a reporting issuer (or equivalent) under the securities legislation of each of the provinces and territories in Canada.
Effects on Us if the Arrangement is Not Completed
If the Arrangement Resolution is not approved by our shareholders or if the Arrangement is not completed for any other reason, our shareholders will not receive any payment for their common shares in connection with the Arrangement. Instead, we will remain an independent public company, and our common shares will continue to be traded on the NYSE and the TSX. In addition, if the Arrangement is not completed, we expect that management will operate our business in a manner similar to that in which it is being operated today and that our shareholders will continue to be subject to the same risks and opportunities to which they are currently subject.
Accordingly, if the Arrangement is not consummated, there can be no assurance as to the effect of these risks and opportunities on the future value of your common shares. If the Arrangement is not completed, our board of directors will continue to evaluate and review our business operations, properties, dividend policy and capitalization, among other things, and will make such changes as are deemed appropriate. It will also continue to consider strategic alternatives for our company. If the Arrangement Resolution is not approved by our shareholders or if the Arrangement is not consummated for any other reason, there can be no assurance


44


that any other transaction acceptable to us will be offered or that our business, prospects or results of operations will not be adversely impacted.
If the Arrangement Agreement is terminated under certain circumstances we will be obligated to pay a termination fee of $100 million to Acquisition Sub or an expense reimbursement fee of up to $15 million to Hindalco. For a description of the circumstances triggering payment of the termination fees, see “The Arrangement Agreement — Company Termination Payment” on page 64.
Interests of Our Directors and Executive Officers in the Arrangement
 
In fiscal 2005, only Independent Directors served on our Human Resources Committee. Clarence J. Chandran wasaddition to their interests in the chairArrangement as shareholders, certain of our Human Resources Committee. The other committee members during alldirectors and executive officers have interests in the Arrangement that differ from, or partare in addition to, your interests as a shareholder. In considering the unanimous recommendation of the year were Charles G. Cavell, C. Roberto Cordaro, Helmut Eschwey, Suzanne Labarge, William T. Monahan and J.E. Newall. No member of our Human Resources Committee had any relationship with us requiring disclosure under Item 404 of SECRegulation S-K. No executive officer of Novelis served on any board of directors or compensation committeeto vote “FOR” the approval of any other company for which anythe Arrangement Resolution, you should be aware of these interests. Our board of directors was aware of, and considered the interests of, our directors servedand executive officers in approving and adopting the Arrangement Agreement, the Arrangement and the transactions contemplated by the Arrangement Agreement. Except as described below, such persons have, to our knowledge, no material interest in the Arrangement that differs from your interests generally.
Options, Stock Appreciation Rights and Stock Price Appreciation Units
The Arrangement Agreement provides that each Option, SAR and SPAU outstanding, whether or not then exercisable, will (1) unconditionally vest and be transferred to Novelis for a cash payment equal to the amount, if any, by which $44.93 exceeds the exercise price of the Option, SAR or SPAU, as applicable, without interest and less any applicable withholding taxes, and (2) be cancelled and all agreements related thereto will be terminated.
Assuming the effective time of the Arrangement occurs by May 31, 2007 and based on the number and exercise prices of vested and unvested options held on March 23, 2007 by our executive officers (including options that are expected to vest prior to the Arrangement and those that are expected to vest as a result of the Arrangement), as set forth in the following table, our executive officers will receive the following amounts (net of per share exercise price and before applicable withholding taxes) in settlement of their respective options, if the Arrangement is completed:
                         
  Options that Have Vested
  Options that Are Expected to
  Totals 
  and Are Exercisable  Vest as a Result of the Arrangement  Total
  Total
 
Name
 Shares  Payment  Shares  Payment  Shares  Payment 
 
Martha Finn Brooks    $   163,230  $3,166,662   163,230  $3,166,662 
Martha Finn Brooks  112,450   2,358,077   22,489   471,594   134,939   2,829,671 
Martha Finn Brooks  12,865   374,114   12,865   374,114   25,730   748,228 
Martha Finn Brooks  35,719   837,253   35,719   837,253   71,438   1,674,507 
Martha Finn Brooks  77,987   1,652,545   77,987   1,652,545   155,974   3,305,089 
Rick Dobson        92,500   1,794,500   92,500   1,794,500 
Arnaud de Weert                  
Kevin Greenawalt        43,530   844,482   43,530   844,482 
Kevin Greenawalt  2,778   72,200   2,778   72,200   5,556   144,400 
Kevin Greenawalt  6,614   171,303   6,614   171,303   13,228   342,605 
Kevin Greenawalt  14,883   315,371   14,883   315,371   29,766   630,742 
Tadeu Nardocci  496   12,891   496   12,891   992   25,782 
Tadeu Nardocci  3,176   82,258   1,587   41,103   4,763   123,362 
Tadeu Nardocci  1,488   43,271   1,489   43,300   2,977   86,571 
Tadeu Nardocci  4,465   104,660   4,465   104,660   8,930   209,319 
Tadeu Nardocci  9,227   195,520   9,228   195,541   18,455   391,061 
Steve Fisher        21,770   422,338   21,770   422,338 


45


                         
  Options that Have Vested
  Options that Are Expected to
  Totals 
  and Are Exercisable  Vest as a Result of the Arrangement  Total
  Total
 
Name
 Shares  Payment  Shares  Payment  Shares  Payment 
 
David Godsell        33,740   654,556   33,740   654,556 
David Godsell  1,686   43,819   1,687   43,845   3,373   87,664 
David Godsell  7,938   205,594   3,968   102,771   11,906   308,365 
David Godsell  1,454   42,282   1,455   42,311   2,909   84,594 
David Godsell  4,465   104,660   4,465   104,660   8,930   209,319 
David Godsell  9,227   195,520   9,228   195,541   18,455   391,061 
Thomas Walpole  1,389   36,100   1,389   36,100   2,778   72,200 
Thomas Walpole  3,307   85,651   3,307   85,651   6,614   171,303 
Thomas Walpole  1,454   42,282   1,455   42,311   2,909   84,594 
Thomas Walpole  3,869   90,689   3,870   90,713   7,739   181,402 
Thomas Walpole        32,650   633,410   32,650   633,410 
Leslie J. Parrette        38,090   738,946   38,090   738,946 
Robert Patterson        21,770   422,338   21,770   422,338 
Brenda Pulley  794   20,636   794   20,636   1,588   41,272 
Brenda Pulley  1,587   41,103   1,588   41,129   3,175   82,233 
Brenda Pulley  1,223   35,565   1,224   35,594   2,447   71,159 
Brenda Pulley  3,572   83,728   3,572   83,728   7,144   167,456 
Brenda Pulley  3,572   75,691   3,572   75,691   7,144   151,381 
Brenda Pulley        16,330   316,802   16,330   316,802 
Orville Lunking        20,680   401,192   20,680   401,192 
Nichole Robinson        5,450   105,730   5,450   105,730 
                         
Total
  327,687  $7,322,783   721,919  $14,793,512   1,049,599  $22,116,296 
                         
Assuming the effective time of the Arrangement occurs by May 31, 2007 and based on the number of SARs held on March 23, 2007 by our executive officers, as set forth in the following table, our executive officers will receive the following amounts (net of per share exercise price and before applicable withholding taxes) in settlement of their respective SARs, if the Arrangement is completed:
         
  SARs Totals 
  Total
  Total
 
Name
 Shares  Payment 
 
Martha Finn Brooks    $ 
Rick Dobson      
Arnaud de Weert  43,530   844,482 
Tadeu Nardocci  32,650   633,410 
Steve Fisher      
David Godsell      
Thomas Walpole      
Leslie J. Parrette      
Robert Patterson      
Brenda Pulley      
Orville Lunking      
Nichole Robinson      
         
Total
  76,180  $1,477,892 
         

46


Assuming the effective time of the Arrangement occurs by May 31, 2007 and based on the number of vested and unvested SPAUs held on March 23, 2007 by our executive officers (including SPAUs that are expected to vest prior to the Arrangement and those that are expected to vest as a result of the Arrangement), as set forth in the following table, our executive officers will receive the following amounts (net of per share exercise price and before applicable withholding taxes) in settlement of their respective SPAUs, if the Arrangement is completed:
                         
  SPAUs that
  SPAUs that Are Expected
    
  Have Vested and Are
  to Vest as a Result of
  Totals 
  Exercisable  the Arrangement  Total
  Total
 
Name
 Shares  Payment  Shares  Payment  Shares  Payment 
 
Martha Finn Brooks    $     $     $ 
Rick Dobson                  
Arnaud de Weert                  
Kevin Greenawalt  3,141   91,340   3,142   91,369   6,283   182,710 
Kevin Greenawalt  8,334   195,349   8,335   195,372   16,669   390,721 
Tadeu Nardocci                  
Steve Fisher                  
David Godsell                  
Thomas Walpole  11,013   233,365   11,014   233,387   22,027   466,752 
Leslie J. Parrette                  
Robert Patterson                  
Brenda Pulley                  
Orville Lunking                  
Nichole Robinson                  
                         
Total
  22,488  $520,054   22,491  $520,128   44,979  $1,040,183 
                         
Performance Share Units and Deferred Share Units
The Arrangement Agreement provides that each PSU and each DSU will be cancelled in exchange for a cash payment in an amount equal to $44.93 per PSU or DSU, as applicable, less applicable withholdings and the holder of such PSU or DSU will cease to be the holder of such PSU or DSU.
As of March 23, 2007, the following executive officers were eligible to receive the following numbers of PSUs, and if the Arrangement is completed, each executive officer listed below is expected to receive the following amounts in cash (assuming that the amount credited per PSU will be equal to the purchase price of $44.93 per share) and subsequently distributed:
         
  PSUs 
Name
 Units  Amount 
 
Martha Finn Brooks  47,500  $2,134,175 
Rick Dobson      
Arnaud de Weert      
Kevin Greenawalt  14,400   646,992 
Tadeu Nardocci  14,400   646,992 
Steve Fisher      
David Godsell  12,000   539,160 
Thomas Walpole  7,900   354,947 
Leslie J. Parrette  12,000   539,160 
Robert Patterson      
Brenda Pulley  4,300   193,199 
Orville Lunking  5,500   247,115 
Nichole Robinson      
         
Total
  118,000  $5,301,740 
         


47


As of March 23, 2007, the following directors were eligible to receive the following numbers of DSUs, and if the Arrangement is completed, each director listed below is expected to receive the following amounts in cash (assuming that the amount credited per DSU will be equal to the purchase price of $44.93 per share) and subsequently distributed:
         
  DSUs 
Name
 Units  Amount 
 
William T. Monahan  8,103.5404  $364,092 
Edward Blechschmidt  3,196.8944   143,636 
Charles G. Cavell  6,908.9568   310,419 
Clarence J. Chandran  13,442.9657   603,992 
C. Roberto Cordaro  6,721.4832   301,996 
Helmut Eschwey  6,721.4832   301,996 
David J. FitzPatrick  6,338.6874   284,797 
Suzanne Labarge  7,841.7301   352,329 
Rudolf Rupprecht  6,908.9568   310,419 
Kevin M. Twomey  1,891.7508   84,996 
Edward V. Yang  6,908.9568   310,419 
         
Total
  74,985.4056  $3,369,091 
         
Change-in-Control/Severance Payments
We previously entered into change in control agreements with certain of our executive officers and key employees that provide for severance payments by us upon termination of the executive officer’s employment without “cause” or by the executive officer for “good reason.” Martha Finn Brooks, Rick Dobson, Les Parrette, Arnaud de Weert, Kevin Greenawalt, David Godsell, Thomas Walpole, Tadeu Nardocci, Steven Fisher, Orville Lunking, and Robert Patterson are our executive officers who are party to change in control agreements with us. Under the change in control agreements, if an officer’s employment is terminated by Novelis during a two-year period following a change in control event, or within six months prior to a change in control event, for any reason other than for cause, or if the officer resigns for good reason, he or she will be entitled to severance compensation as follows:
• a lump sum payment in an amount equal to two times (for Ms. Brooks, Mr. Dobson, Mr. Parrette, Mr. de Weert, Mr. Greenawalt, Mr. Godsell, Mr. Walpole, Mr. Nardocci and Mr. Fisher) or one times (for Mr. Lunking and Mr. Patterson) the sum of such executive officer’s annual base salary (including all amounts of such base salary that are voluntarily deferred under an qualified and non-qualified plans of Novelis) plus the executive’s annual target short term incentive opportunity less the amount of retention and severance benefit payments, if any, paid or payable to the executive by us other than pursuant to the executive’s change in control agreement;
• all short term and long term incentive awards pursuant to the terms of the incentive plan with respect to which such awards were issued;
• if the executive is not eligible for retiree medical benefits and is covered under our group health plan, at the time of his or her termination, a lump sum payment for the purpose of assisting the executive with the cost of post-employment medical continuation coverage equal to the full monthly Consolidated Omnibus Budget Reconciliation Act (“COBRA”) premium charged for coverage under our group medical plan at such executive’s then current level of coverage for a period of twenty four months (or 12 months for Mr. Lunking and Mr. Patterson), plus an amount for the payment of taxes at an assumed tax rate of 40% group health plan;
• continued group life insurance benefits (if applicable) for two years (or one year for Mr. Lunking and Mr. Patterson) following his or her termination date;


48


• 24 months (or 12 months for Mr. Lunking and Mr. Patterson) of additional credit for benefit accrual and contribution allocation purposes under our tax-qualified and non-qualified pension, savings or other retirement plans; provided that if the law prevents payment in respect to such credit under our tax-qualified plans, such payment will be made under our non-qualified plans;
• 100% vesting under our tax-qualified and non-qualified retirement pension, saving and other retirement plans; provided that if the law prevents accelerated vesting under our tax-qualified plans, an equivalent benefit will be payable under our non-qualified plans; and
• reimbursement for any excise tax liability imposed by Section 4999 of the Code, or any interest or penalties incurred with respect to such excise tax in an amount such that after payment by the respective officer of all taxes, that officer retains an amount equal to the amount of the excise tax.
The following table summarizes the cash payments and value of continued benefits, as outlined above, that would be made to each executive officer party to a change in control agreement if the officer’s agreement was triggered by certain terminations by Novelis or the executive officer following the Arrangement. For purposes of this calculation, we have assumed the executive officer’s salary, bonus amounts, the target bonus as in effect on the date hereof, and a theoretical termination date of May 31, 2007.
             
  Amount of Potential
       
  Cash Severance
  Estimated Value of
  Estimated Tax
 
Name
 Payment  Continued Benefit  Gross-Up Payment 
 
Martha Finn Brooks $2,734,625  $448,740  $1,876,774 
Rick Dobson  1,715,625   136,750   1,160,485 
Arnaud de Weert  1,867,823   195,279    
Kevin Greenawalt  1,069,500   436,942   793,840 
Tadeu Nardocci  897,803   162,928    
Steve Fisher  818,188   96,400    
David Godsell  1,032,042   497,658   845,957 
Thomas Walpole  898,875   236,069   594,022 
Leslie J. Parrette  1,148,563   80,475    
Robert Patterson  425,750   47,900    
Orville Lunking  440,651   48,500    
             
Total
 $13,049,445  $2,387,641  $5,271,078 
             
For purposes of the change in control agreements and the recognition agreements (described below), “cause” includes the (1) willful and continuing failure to substantially perform usual and customary duties of employment, other than any such failure resulting from such executive’s incapacity due to physical or mental illness, unless such executive uses reasonable efforts to correct such failure within a reasonable time after demand for substantial performance is delivered by us that specifically identifies the manner in which we believe the executive officer has not substantially performed his or her duties, (2) the willful misconduct by the executive officer which materially injures us, monetarily or otherwise or (3) the conviction of, or entry of a plea of nolo contendere with regard to, any felony or any crime involving moral turpitude or dishonesty by the executive officer. “Good reason” generally means the occurrence, without the executive’s express written consent, of the following events following a change in control: a material reduction in the executive officer’s position, duties, responsibilities and status with us (without sole regard to any change in title or our status as a public or private entity); a reduction in base salary, short and long term incentive opportunity; or a requirement that the executive officer relocate more than 50 miles from the area in which the executive regularly performs his or her duties, except for required travel that is substantially consistent with the executive’s normal business travel obligations.


49


Recognition Agreements
We have previously entered into recognition agreements with certain of our executive officers and key employees which provide for the issuance of shares of our common stock to such employees if the employee remains employed by Novelis or any of its affiliates through December 31, 2007, with an additional award of common shares to be made if the employee remains employed with Novelis or any of its affiliates through December 31, 2008. In connection with the proposed transaction, the recognition agreements were amended to provide that if an executive officer remains continuously employed by Novelis through the vesting dates of December 31, 2007 and December 31, 2008, the executive officer is entitled to a recognition award payable in either, at the option of Hindalco, Hindalco common stock in certain circumstances (upon the approval of the executive officer) or an amount in cash in each case equivalent to the value of Novelis common shares determined at the effective time of the Arrangement. If any executive party to a recognition agreement is terminated by Novelis or any of its affiliates, other than for cause, such employee is entitled to a cash payment equal to the greater of (1) the amount that would be payable under our standard employee severance program and (2) 150% (for Ms. Brooks, Mr. Dobson, Mr. de Weert, Mr. Greenawalt, Mr. Nardocci, Mr. Fisher, Mr. Godsell, Mr. Walpole, Mr. Parrette and Ms. Pulley) or 100% (for Mr. Patterson and Mr. Lunking) of the employees’ annual base salary. The following table summarizes the cash payments that would be made to executive officers party to a recognition agreement and the value of future recognition awards, assuming a value of the effective time of the Arrangement of $44.93 per common share.
         
  Value of
    
Name
 Recognition Shares  Severance Payment 
 
Martha Finn Brooks $1,276,012  $982,500 
Rick Dobson  876,135   675,000 
Arnaud de Weert  368,426   798,120 
Kevin Greenawalt  368,426   465,000 
Tadeu Nardocci  296,538   390,349 
Steve Fisher  256,101   397,500 
David Godsell  368,426   465,000 
Thomas Walpole  314,510   405,000 
Leslie J. Parrette  404,370   517,500 
Robert Patterson  242,622   260,000 
Orville Lunking  242,622   269,100 
Brenda Pulley  193,199   292,500 
         
Total
 $5,207,387   5,917,569 
         
Employment-Related Provisions of the Arrangement Agreement
The Arrangement Agreement contains provisions restricting our ability to provide certain increases in compensation and benefits prior to the closing of the Arrangement. We have, however, takenand/or reserved the right to take the following actions which may benefit certain employees (including our executive officers):
• The Novelis Founders Performance Plan, which provides that if share price improvement targets with respect to Novelis common shares for performance periods beginning in 2005, 2006 and 2007 are achieved, then certain executive officers that are participants may be awarded PSUs which represent the right to receive a cash payment in an amount equal to the market price of one Novelis common share at the time of payment on the later of six months from the date the specific share price target is achieved or twelve months after the start of the performance period for that tranche and will be based on the average of the daily closing price of a Novelis common share on the NYSE for the last five trading days prior to the payment date. On February 10, 2007, our board recognized that the applicable share price threshold had been (or would likely be) met with respect to the second tranche and would probably be met for the third tranche, but in light of the executive officers’ awareness of the possibility of a change in control transaction, they have been subject to a trading blackout. Moreover, it is unlikely


50


that a 15 day open trading window under the Novelis disclosure and insider trading policies will arise between the date hereof and the effective date of the Arrangement contemplated by the Arrangement Agreement (e.g., by the end of the second quarter). Accordingly, our board amended the plan in order to provide that the applicable threshold for (1) the second tranche will be met as of February 28, 2007, and (2) the third tranche will be met as of March 26, 2007, for purposes of PSUs to be awarded under the plan.
• We intend to set annual bonus amounts for 2007 and pay a prorated portion of such bonuses upon closing of the Arrangement in accordance with the 2006 Incentive Plan.
• As discussed above, on February 10, 2007, our board of directors adopted resolutions to amend the recognition agreements with Ms. Brooks, Mr. Dobson, Mr. de Weert, Mr. Greenawalt, Mr. Nardocci, Mr. Fisher, Mr. Godsell, Mr. Walpole, Mr. Parrette, Mr. Patterson, Mr. Lunking and Ms. Pulley. The Board also adopted resolutions to amend recognition agreements with certain other key employees who are not executive officers of Novelis. Under the amended recognition agreements, if the officer remains continuously employed by Novelis through the vesting dates of December 31, 2007 and December 31, 2008, the officer is entitled to a recognition award payable in either, at the option of Hindalco, (1) Hindalco common shares in certain circumstances (upon the approval of the officer) or (2) an amount in cash in each case equivalent to the value of Novelis common shares determined at the effective date of the Arrangement.
• We may put new retention and severance arrangements in place prior to the effective date of the Arrangement with certain of our key personnel (other than our executive officers) who are critical to perform essential services. Our estimated cost of these payments if paid to all participants is approximately $3 million.
Acting Chief Executive Officer Performance Bonuses
In August 2006, Mr. Monahan, the chairman of our board of directors, agreed to serve as our interim chief executive officer and continued in this capacity until December 2006. Beginning in January 2006, Mr. Blechschmidt was appointed as our acting chief executive officer and Mr. Monahan remained as chairman of the board. Mr. Monahan and Mr. Blechschmidt both contributed significantly to the sale process and the successful management of our company during fiscal 2005.this period of time. In evaluating 2006 performance bonuses for our executive officers and key employees, our board awarded performance bonuses in recognition of these contributions of $250,000 and $500,000 to Mr. Monahan and Mr. Blechschmidt, respectively. The performance bonuses are payable on the later to occur of shareholder approval of the Arrangement Resolution and the receipt or satisfaction of the regulatory approvals specified in the Arrangement Agreement.
Directors’ and Officers’ Indemnification and Insurance
From and after the effective date, Hindalco shall, or shall cause us (or our successor) to, indemnify our officers and directors (or their equivalents) to the fullest extent permitted under their respective organizational documents and applicable laws. These obligations shall survive the Arrangement and shall continue in full force and effect in accordance with the terms of such organizational documents.
For a period of six years after the effective date, unless otherwise required by applicable law, the surviving corporation in the Arrangement must maintain our current officers’ and directors’ liability insurance policies in respect of acts or omissions occurring at or prior to the implementation of the Arrangement covering each such person currently covered by the our insurance policy, provided that we (or our successor) or Hindalco shall not be required to pay an aggregate amount in excess of 300% of the annual premium currently paid by us. In lieu of the foregoing, we (or our successor) may purchase, prior to, on or after the effective date, a six-year “tail” prepaid officers’ and directors’ liability insurance policy in respect of acts or omissions occurring prior to the effective date of the Arrangement covering each such officer and director, provided that such policy shall not be in an amount in excess of $4.5 million without our first obtaining Hindalco’s prior written consent.


2651


 
PERFORMANCE GRAPHDissenting Holders’ Rights
 
Pursuant to section 190 of the CBCA, as modified by the Plan of Arrangement and the Interim Order, our shareholders have the right to dissent from the Arrangement and to receive a cash payment for the determined fair value of their common shares determined as of the day prior to approval of the Arrangement Resolution. The shares price performance graph doesfair value under section 190 of the CBCA could be greater than, equal to or less than the $44.93 in cash per common share that our shareholders are entitled to receive in the Arrangement. Shareholders that wish to exercise their dissenting holders’ rights must not constitute soliciting materialvote in favor of the approval of the Arrangement Resolution and should not be deemed filed or incorporatedmust strictly comply with all of the procedures required by referencethe CBCA, as modified by any general statement incorporating by referencethe Plan of Arrangement and the Interim Order. The procedures are described in this Proxy Statement/Circular, into any other filing under Canadian securities laws, underand the provisions of the CBCA that grant dissenting holders’ rights are attached as Annex F to this Proxy Statement/Circular. You are encouraged to read these provisions carefully and in their entirety.
Material Tax Consequences of the Arrangement
Material United States Securities ActFederal Income Tax Consequences of 1933, as amended, or under the Exchange Act except to the extent that we specifically incorporate this information by reference.Arrangement
 
The following graph and tables provideis a discussion of the cumulative total shareholder return on $100 invested in Shares from January 6, 2005 through December 31, 2005 as comparedmaterial United States federal income tax consequences of the Arrangement to holders whose common shares are exchanged for cash pursuant to the cumulative total returnArrangement. The discussion is based upon the United States Internal Revenue Code of 1986, as amended (the “Code”), Treasury regulations, Internal Revenue Service rulings and judicial and administrative decisions in effect as of the Standard & Poor’s/Toronto Stock Exchange Composite Indexdate of this proxy statement, all of which are subject to change (possibly with retroactive effect) or to different interpretations. The following discussion does not purport to consider all aspects of U.S. federal income taxation that might be relevant to our shareholders. This discussion applies only to shareholders who hold common shares as a capital asset. The following discussion does not address taxpayers subject to special treatment under U.S. federal income tax laws, such as insurance companies, financial institutions, dealers in securities, tax-exempt organizations, mutual funds, real estate investment trusts, investors in pass-through entities, S corporations, certain former citizens or residents of the United States, foreign corporations that are “passive foreign investment companies” or “controlled foreign corporations” for U.S. federal income tax purposes, and taxpayers subject to the alternative minimum tax. In addition, the following discussion may not apply to shareholders who acquired their common shares upon the exercise of employee stock options or otherwise as compensation for services or through a tax-qualified retirement plan or who hold their shares as part of a hedge, straddle, conversion transaction or other integrated transaction.
If our common shares are held through a partnership (or other entity treated as a partnership for U.S. federal income tax purposes), the U.S. federal income tax treatment of a partner in the partnership will generally depend upon the status of the partner and the Standard & Poor’s Industrial Composite Index overactivities of the same periodpartnership. Partnerships that are holders of time, assuming reinvestmentour common shares and partners in such partnerships are urged to consult their own tax advisors regarding the tax consequences to them of all dividends.the Arrangement.
The following discussion does not address potential foreign, state, local and other tax consequences of the Arrangement. All shareholders are urged to consult their own tax advisors regarding the U.S. federal income tax consequences, as well as the foreign, state and local tax consequences, of the disposition of their shares in the Arrangement.
For purposes of this summary, a “U.S. holder” is a holder of our common shares, who or that is, for U.S. federal income tax purposes:
• an individual who is a citizen or resident of the United States;
• a corporation (or other entity taxable as a corporation) created or organized in or under the laws of the United States, any state of the United States or the District of Columbia;
• an estate the income of which is subject to U.S. federal income tax regardless of its source; or
• a trust if (1) a U.S. court is able to exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust; or (2) it was in


52


existence on August 20, 1996 and has a valid election in place to be treated as a domestic trust for U.S. federal income tax purposes.
A“non-U.S. holder” is a holder of our common shares that is not a U.S. holder and that is not a partnership (or other entity treated as a partnership for U.S. federal income tax purposes).
For U.S. federal income tax purposes, the Arrangement will be treated as a sale of our common shares for cash by each of our shareholders. Accordingly, in general, the U.S. federal income tax consequences to a shareholder that receives cash in exchange for shares of our common shares in the Arrangement will be as follows:
• The shareholder will recognize a capital gain or loss for U.S. federal income tax purposes in an amount equal to the difference, if any, between the amount of cash received by the holder in the Arrangement and the holder’s adjusted tax basis in the shares of our common shares surrendered in the Arrangement. Gain or loss will be determined separately for each block of shares (i.e., shares acquired at the same cost in a single transaction) surrendered by the holder for cash in the Arrangement.
• Such capital gain or loss will be long-term capital gain or loss if the shareholder’s holding period for the shares exceeds one year at the time the shares are surrendered. Long-term capital gains of individual U.S. holders generally are subject to a maximum federal tax rate of 15%. The deductibility of capital losses may be subject to limitations.
• In the case of anon-U.S. holder, any gain recognized generally will not be subject to U.S. federal income tax unless (1) the gain is effectively connected with the holder’s conduct of a U.S. trade or business in the United States, or (2) the holder is an individual who is present in the United States for 183 days or more in the taxable year in which the Arrangement occurs and certain other conditions are met.
Cash payments made pursuant to the Arrangement will be reported to our shareholders and the Internal Revenue Service to the extent required by the Code and applicable Treasury regulations. Such payments may also be subject to backup withholding at a 28% rate. Backup withholding generally will not apply, however, to a holder that (1) supplies the paying agent with its taxpayer identification number (Social Security number, in the case of an individual U.S. holder, or employer identification number, in the case of other U.S. holders), certifies that such number is correct, and otherwise complies with the backup withholding rules, or (2) otherwise establishes an exemption from backup withholding. Each U.S. holder will be asked to complete and sign a SubstituteForm W-9, which will be included in the appropriate letter of transmittal for our common shares, in order to establish its exemption from backup withholding taxes. Certainnon-U.S. holders may be required to complete and sign aForm W-8BEN, Form W-8ECI or aForm W-8EXP (or other applicable substitute tax form) and return it to the paying agent in order to establish their exemption from backup withholding taxes.
Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules will be allowed as a refund or a credit against your U.S. federal income tax liability provided the required information is timely furnished to the Internal Revenue Service.
 
The foregoing discussion of certain material U.S. federal income tax consequences is included for general informational purposes only. We urge you to consult your own tax advisor to determine the particular tax consequences to you (including the application and effect of any state, local or foreign income and other tax laws) of the receipt of cash in exchange for shares of our common stock pursuant to the Arrangement.
CUMULATIVE TOTAL RETURNMaterial Canadian Federal Income Tax Consequences of the Arrangement
The following summary describes the principal Canadian federal income tax considerations generally applicable to a beneficial owner of common shares who disposes of common shares pursuant to the Arrangement and who, at all relevant times and for purposes of the application of the Tax Act, (1) deals at arm’s length with Novelis, Hindalco and Acquisition Sub; (2) is not affiliated with Novelis, Hindalco or


Based53


Acquisition Sub; and (3) holds the common shares as capital property (a “Holder”). Generally, the common shares will be capital property to a Holder provided the Holder does not hold those shares in the course of carrying on a business or as part of an adventure or concern in the nature of trade.
This summary is not applicable to a shareholder who acquired its common shares upon the exercise of an initialoption. This summary does not address the tax consequences of the Arrangement to holders of employee stock options, SARs, SPAUs, PSUs or DSUs, nor to participants in the Novelis Savings and Retirement Plan, the Novelis Founders Performance Plan, the Novelis Hourly Savings Plan or parties to a recognition agreement. Such holders and participants should consult their own tax advisors.
This summary is based on the current provisions of the Tax Act and counsel’s understanding of the current administrative and assessing practices and policies of the Canada Revenue Agency (“CRA”) published in writing prior to the date hereof. This summary takes into account all specific proposals to amend the Tax Act publicly announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof (the “Proposed Amendments”) and assumes that all Proposed Amendments will be enacted in the form proposed. However, no assurances can be given that the Proposed Amendments will be enacted as proposed, or at all. This summary does not otherwise take into account or anticipate any changes in law or administrative or assessing practice whether by legislative, regulatory, administrative or judicial action nor does it take into account tax legislation or considerations of any province, territory or foreign jurisdiction, which may be different from those discussed herein.
This summary is of a general nature only and is not, and is not intended to be, legal or tax advice to any particular shareholder. This summary is not exhaustive of all Canadian federal income tax considerations. Accordingly, shareholders should consult their own tax advisors having regard to their own particular circumstances.
Currency Conversion
For the purpose of the Tax Act, all amounts relating to the acquisition, holding or disposition of the common shares must be converted into Canadian dollars based on the prevailing exchange rates at the relevant times.
Shareholders Resident in Canada
This portion of the summary is generally applicable to a Holder who, at all relevant times, for purposes of the application of the Tax Act, is, or is deemed to be, resident in Canada (a “Resident Holder”). Certain Resident Holders whose common shares might not otherwise be capital property may, in certain circumstances, be entitled to have the common shares and all other “Canadian securities”, as defined in the Tax Act, owned by such Resident Holder in the taxation year in which the election is made, and in all subsequent taxation years, deemed to be capital property by making the irrevocable election permitted by subsection 39(4) of the Tax Act. This portion of the summary is not applicable to a shareholder that is a “specified financial institution” or to a shareholder an interest in which is a “tax shelter investment”, as defined in the Tax Act, or, for purposes of certain rules applicable to securities held by financial institutions (referred to as the“mark-to-market” rules), a “financial institution”, as defined in the Tax Act. Such shareholders should consult their own tax advisors.
Disposition of Common Shares
Generally, a Resident Holder who disposes of common shares under the Arrangement will realize a capital gain (or capital loss) equal to the amount, if any, by which the amount received for such shares under the Arrangement, net of any reasonable costs of disposition, exceed (or are less than) the adjusted cost base to the Resident Holder of the common shares immediately before the disposition.
Generally, a Resident Holder is required to include in computing the Resident Holder’s income for a taxation year one-half of the amount of any capital gain (a “taxable capital gain”). Subject to and in accordance with the provisions of the Tax Act, a Resident Holder is required to deduct one-half of the amount


54


of any capital loss (an “allowable capital loss”) realized in a taxation year from taxable capital gains realized by the Resident Holder in the year and allowable capital losses in excess of such taxable capital gains may be carried back and deducted in any of the three preceding taxation years or carried forward and deducted in any subsequent taxation year against net taxable capital gains realized in such years.
The amount of any capital loss realized by a Resident Holder that is a corporation on the disposition of a common share may be reduced by the amount of any dividends received (or deemed to be received) by it on such common share to the extent and under the circumstances described in the Tax Act. Similar rules may apply where a common share is owned by a partnership or trust of which a corporation, trust or partnership is a member or beneficiary. Such Resident Holders should consult their own advisors.
A Resident Holder that is throughout the relevant taxation year a “Canadian-controlled private corporation”, as defined in the Tax Act, may be liable to pay a refundable tax on investment income, including taxable capital gains realized upon a disposition of Can. $100
the common shares.
Dissenting Resident Holders
A Resident Holder who exercises Dissent Rights (a “Resident Dissenting Holder”) will be deemed to have transferred such holder’s common shares to Acquisition Sub in exchange for payment by Acquisition Sub of the fair value of such common shares. In general, a Resident Dissenting Holder will realize a capital gain (or capital loss) equal to the amount by which the amount received by the Resident Dissenting Holder in respect of the fair value of such holder’s common shares (other than in respect of interest awarded by a court), net of any reasonable costs of disposition, exceeds (or is less than) the adjusted cost base to the Resident Dissenting Holder of such common shares. See “Disposition of Common Shares” above. Interest awarded by a court to a Resident Dissenting Holder will be included in the shareholder’s income for the purposes of the Tax Act.
Shareholders Not Resident in Canada
This portion of the summary is generally applicable to a Holder who, at all relevant times, for purposes of the application of the Tax Act, is not, and is not deemed to be, resident in Canada and does not use or hold the common shares in a business carried on January 6, 2005in Canada (a “Non-Resident Holder”). Special rules, which are not discussed in this summary, may apply to certain holders that are insurers carrying on an insurance business in Canada and elsewhere.
Disposition of Common Shares
A Non-Resident Holder will not be subject to tax under the Tax Act on any capital gain realized on a disposition of common shares under the Arrangement unless (i) the Shares are “taxable Canadian property” to the Non-Resident Holder at the Effective Time for purposes of the Tax Act and (ii) the Non-Resident Holder is not entitled to relief under an applicable income tax convention between Canada and the country in which the Non-Resident Holder is resident.
Generally, the common shares will not constitute taxable Canadian property to a Non-Resident Holder at the Effective Time provided that (1) the common shares are listed on a prescribed stock exchange (which includes the NYSE and the TSX) at that time, and (2) the Non-Resident Holder, persons with dividends reinvestedwhom the Non-Resident Holder does not deal at arm’s length, or the Non-Resident Holder together with all such persons, have not owned 25% or more of the issued shares of any class or series of the capital stock of Novelis at any time during the60-month period that ends at that time. Notwithstanding the foregoing, in certain circumstances set out in the Tax Act, common shares could be deemed to be taxable Canadian property.
Even if common shares are considered to be taxable Canadian property of a Non-Resident Holder at the Effective Time, any capital gain realized by the Non-Resident Shareholder on a disposition of the common shares under the Arrangement may be exempt from tax under the Tax Act pursuant to the terms of an applicable income tax treaty. Non-Resident Shareholders should consult their own tax advisors with respect to


55


the availability of any relief under the terms of any applicable income tax treaty in their particular circumstances.
If the common shares constitute taxable Canadian property of a Non-Resident Holder and any capital gain realized by the Non-Resident Holder on the disposition of common shares under the Arrangement is not exempt from tax under the Tax Act by virtue of an applicable income tax treaty, then the tax consequences described above under the heading “Shareholders Resident in Canada — Disposition of Common Shares” will generally apply.
Dissenting Non-Resident Holders
A Non-Resident Shareholder who exercises Dissent Rights (a “Non-Resident Dissenting Holder”) will be deemed to have transferred such holder’s common shares to Acquisition Sub in exchange for payment by Acquisition Sub of the fair value of such common shares. In general, the tax treatment of a Non-Resident Dissenting Holder will be similar to that of a Non-Resident Shareholder who participates in the Arrangement. See “Disposition of Common Shares” above.
The amount of any interest awarded by a court to a Non-Resident Dissenting Holder will be subject to Canadian withholding taxes at a rate of 25% unless the rate is reduced under the provisions of an applicable income tax treaty. Non-Resident Dissenting Holders should consult their own tax advisors with respect to the availability of any relief under the terms of an applicable income tax treaty in their particular circumstances.
Regulatory Approvals
We and Hindalco will not complete the Arrangement unless we receive the regulatory approvals specified in the Arrangement Agreement as conditions to closing of the Arrangementand/or until the expiration of all applicable waiting periods, including antitrust approvals under the Competition Act (Canada), the HSR Act, the European Union or the relevant antitrust authorities in the applicable European Union Member States, as well as approvals under the Investment Canada Act and from the Agência Nacional de Energia Elétrica (Brazil’s power regulators of “ANEEL”).
We and Hindalco have further agreed to use reasonable best efforts to take or cause to be taken all actions necessary, proper or advisable consistent with the applicable provisions in the Arrangement Agreement to obtain all necessary regulatory approvals as soon as practicable. We and Hindalco have also agreed, subject to applicable law, to cooperate with each other and to share information in connection with obtaining all necessary regulatory approvals.
In addition, we and Hindalco have agreed to use our reasonable best efforts to defend any lawsuits or other legal proceedings challenging the Arrangement Agreement or the transactions contemplated thereby, including seeking to have any stay or temporary restraining or interim order entered by any court or other governmental entity lifted, mitigated or reversed.
Hindalco, Acquisition Sub and Novelis have also agreed to take all steps and to incur any costs to defend any lawsuits or other legal proceedings challenging the Arrangement Agreement or the transactions contemplated thereby. In addition, Hindalco and Acquisition Sub have agreed to take all steps necessary and to make any necessary divestitures, licenses or other arrangements as may be required in order to obtain any necessary regulatory approvals without any set-off or reduction in the purchase price.
Financing Arrangements
 
ComparisonFinancing the Arrangement
Hindalco estimates the total amount of Cumulative Total Returnfunds necessary to be paid to our shareholders and holders of our other equity-based interests to complete the arrangement is approximately $3.45 billion. Additional funds will be required to pay fees and expenses in connection with the arrangement, the financing arrangements and the related transactions. In addition, additional funds may be required to refinance our existing indebtedness which


56


may be required to be repaid, or which Hindalco may elect to repay, in connection with the Arrangement. These payments are expected to be funded by Hindalco using available cash and debt financing.
Debt Financing
 
Pursuant to the arrangement agreement, Hindalco is obligated to use its reasonable best efforts to obtain the debt financing described below or alternative arrangements it may elect to pursue, including to negotiate definitive agreements with respect to the debt financing and to satisfy on a timely basis all conditions applicable to Hindalco in the definitive agreements that are within Hindalco’s control. If any portion of the debt financing becomes unavailable on the terms and conditions contemplated in the commitments in respect thereof, Hindalco is obligated to arrange to obtain alternative financing. Under the Arrangement Agreement, Hindalco may also elect to pursue other alternative financing arrangements.
 
Canadian Dollar Data:  amounts in the following table are expressed in Canadian dollarsHindalco has delivered to Novelis true, correct and reflect the data in the above graph.complete copies of executed commitment letters, pursuant to which:
 
           
   January 6,
  December 31,
   2005  2005
Novelis Inc.   C$100.00   C$82.72 
S&P/TSX Composite Index  C$100.00   C$126.49 
S&P Industrial Composite Index  C$100.00   C$99.95 
           
• ABN AMRO Bank N.V., Banc of America Securities Asia Limited, UBS AG, Singapore Branch and UBS AG Hong Kong Branch, have agreed to provide a bridge facility in an aggregate principal amount of $2.8 billion to one or more subsidiaries of Hindalco, the proceeds of which will be invested as equity or subordinated debt in Acquisition Sub; and
• UBS Loan Finance LLC and ABN AMRO Bank N.V. have agreed to provide (1) if Novelis’ existing credit agreement is amended in accordance with the requirements set forth in the commitment letters, an incremental term loan facility of up to the amount by which $1.6 billion exceeds the aggregate amount of the existing term loans outstanding under the credit agreement, (2) if Novelis’ credit agreement is not amended in accordance with the requirements set forth in the commitment letters, new term loan facilities in the aggregate principal amount of up to $1.6 billion and a new revolving credit facility in the aggregate principal amount of up to $400 million and (3) a bridge loan facility in the aggregate principal amount of up to $800 million. Such credit facilities are available for the purpose of prepaying all outstanding indebtedness and all other amounts then due and owing under the credit agreement (to the extent required), purchasing all or a portion of Novelis’ Senior Notes tendered pursuant to the change of control offer required to be made for the Senior Notes within 30 days following the closing, and paying fees and expenses related thereto.
 
U.S. Dollar Data:  for purposes of comparison, amounts in the following table show cumulative total shareholder returns in U.S. dollars with differences from the Canadian dollar data attributablePursuant to the relative differences interms of our 71/4% Senior Notes, we are obligated, within 30 days of a change of control, to make an offer to purchase the valuesSenior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to (but excluding) the date the Senior Notes are purchased. In addition, Acquisition Sub has indicated that it may cause us to take other steps to repay, retire or redeem the Senior Notes after the closing of the two currencies overArrangement. The closing of the period presented.Arrangement in accordance with its terms does not require the consent or approval of the holders of the Senior Notes.
           
   January 6,
  December 31,
   2005  2005
Novelis Inc.   $100.00   $86.79 
S&P/TSX Composite Index  $100.00   $134.55 
S&P Industrial Composite Index  $100.00   $106.31 
           
 
Shareholder returns overThe commitment letters contemplate that in connection with any change of control offer or other repayment, retirement or redemption of the period shownSenior Notes, up to $800 million aggregate gross proceeds of new notes may be issued pursuant to a public offering or Rule 144A or other private placement upon the terms and conditions set forth in the graphcommitment letters (in addition to borrowings under the incremental or replacement term loan facility). To the extent new notes are not issued at such time, borrowings by Novelis under the bridge loan facility described above (in addition to borrowings under the incremental or replacement term loan facilities) will be available to finance any required repurchase of the existing notes of Novelis.
The structure and tables shoulddocumentation for the debt financing has not been finalized and, therefore, the structure and terms of the financing may differ from those described in this Proxy Statement/Circular.
The commitments of the lenders with respect to the $2.8 billion bridge facility contemplated by the commitment letters shall terminate upon the earliest to occur of (a) execution of definitive documentation relating to such facilities by all parties thereto, (b) April 12, 2007 and (c) the date of termination of the Arrangement Agreement, unless the lenders and arrangers shall, in their discretion, agree to an extension. Once definitive documentation is executed, the bridge facility is available for a further 90 days. The


57


commitments of the lenders with respect to the incremental facility to be entered into in connection with the amendment to Novelis’ credit agreement, the new term loan and revolving loan facility and the $800 million bridge facility contemplated by the commitment letters shall terminate upon the earliest to occur of (a) execution of definitive documentation relating to such facilities by all parties thereto, (b) July 31, 2007 and (c) the date of termination of the Arrangement Agreement, unless the lenders and arrangers shall, in their discretion, agree to an extension.
The facilities contemplated by the commitment letters are also conditioned on other customary conditions, including:
• receipt by the Acquisition Sub of equity contributionsand/or subordinated loans sufficient to consummate the Arrangement, but in no event in an aggregate amount less than $600 million;
• execution of satisfactory definitive documentation;
• lender satisfaction with the final structure for the acquisition, and no amendments to the Arrangement Agreement that are materially adverse to the lenders;
• delivery of certain financial statements of Hindalco and Novelis to the lenders;
• the Arrangement being completed and all of the conditions precedent to the closing of the Arrangement being satisfied or waived, except that no condition material to the interests of the lenders may be waived except with the consent of the lenders;
• the amendment or refinancing, as applicable, of certain of Novelis’ existing indebtedness occurring substantially concurrently with the funding of the facilities;
• the absence of a material adverse effect on Novelis since September 30, 2006;
• all costs, fees, expenses and other compensation payable to the lenders contemplated by the agreements relating to the debt financing having been paid;
• the lenders having received customary legal opinions, corporate documents, certificates and other customary closing documentation;
• governmental, regulatory and certain third party approvals;
• delivery of satisfactory certificates, reports and returns required to be filed by Hindalco and the other guarantors pursuant to applicable laws and regulations of India;
• any intercompany subordinated loans being subordinated on terms reasonably satisfactory to the lenders;
• the lenders having at least 30 days following the delivery of a confidential information memorandum by Hindalco or Novelis, as applicable, to market and syndicate the debt financing; and
• in the case of Novelis, commercially reasonable efforts to obtain monitored public ratings of the debt financing and any new notes and a corporate rating issued from Moody’s and S&P at least 30 days prior to the closing of the debt financing.
The commitments of the lenders with respect to the new term loans and revolving loan facility are subject to the conditions that all documents required to perfect the lenders’ security interests must be executed and delivered.
The commitments of the lenders with respect to the incremental term loan are subject to the following additional conditions precedent:
• specified amendments and waivers being approved by Novelis’ existing credit agreement lenders at least 10 business days prior to closing of the Arrangement;
• all documents required to perfect the lenders’ security interests being executed and delivered;


58


• any required “change of control” offer in respect of the Senior Notes being commenced within 30 days after the closing of the Arrangement; and
• receipt of sufficient proceeds from the sale of new notes or borrowings under the $800 million bridge facility to retire Senior Notes tendered under any “change of control” offer, to the extent required over and above the incremental facility.
The commitments of the lenders with respect to the $800 million bridge loan are subject to the following additional conditions precedent:
• if the amendments to Novelis’ existing credit agreement have not been obtained, Novelis shall have received funds sufficient to refinance the existing credit agreement, and the incremental term loan facility or the new term loan facility shall have been concurrently funded;
• Novelis shall have engaged an investment bank to issue new notes as required to refinance the Senior Notes, delivered an offering memorandum within 10 days after commencing a “change of control” offer for the Senior Notes and allowed for a customary marketing period in respect of the new notes; and
• any required “change of control” offer in respect of the Senior Notes must be commenced within 30 days after the closing of the Arrangement.
Although the debt financing commitments described in this proxy statement are not subject to due diligence or a “market out”, such financing may not be considered indicativeassured. As of future shareholder returns.the date of this Proxy Statement/Circular, no alternative financing arrangements or alternative financing plans have been made if the debt financing described herein is not available as anticipated.
If all other conditions to the closing of the Arrangement have been satisfied, Hindalco will be required to consummate the Arrangement regardless of whether Hindalco has obtained debt financing on the terms and conditions described in the debt financing commitments, and the failure by Hindalco to consummate the Arrangement in such circumstances would constitute a breach of the Arrangement Agreement.
Hindalco and certain of its affiliates have agreed to make equity contributions and subordinated loans to one or more subsidiaries of Hindalco in an aggregate amount of no less than $600 million which will be further contributed to Acquisition Sub in order to consummate the Arrangement and settle the consideration payable in respect thereof in full.
Pursuant to discussions between Hindalco and the arrangers of the $2.8 billion bridge facility, it is anticipated that the bridge facility will be increased to $3.1 billion, that Hindalco and its affiliates’ required equity and subordinated debt contribution will be reduced from $600 million to $450 million, and that the term of the commitment for the bridge facility will be extended to July 31, 2007.


2759


 
NOVELIS SHARE OWNERSHIPTHE ARRANGEMENT AGREEMENT
The Arrangement Agreement and the Plan of Arrangement are the legal documents that govern the Arrangement. This section of the Proxy Statement/Circular describes the material provisions of the Arrangement Agreement but may not contain all of the information about the Arrangement Agreement that is important to you. The Arrangement Agreement is included as Annex B to this Proxy Statement/Circular to provide you with information regarding its terms and is incorporated into this Proxy Statement/Circular by reference. On March 30, 2007 AV Aluminum Inc. assigned its interest in the Arrangement Agreement to Acquisition Sub. We encourage you to read the Arrangement Agreement in its entirety. It is an agreement that establishes and governs the legal relationships between us and Hindalco with respect to the transactions described in this Proxy Statement/Circular. It is not intended to be a source of factual, business or operational information about us or Hindalco. The representations, warranties and covenants made by us and Hindalco are qualified and subject to important limitations agreed to by us and Hindalco. Furthermore, the representations and warranties may be subject to standards of materiality applicable to us and Hindalco that may be different from those which are applicable to you. These representations and warranties may or may not have been accurate as of any specified date and do not purport to be accurate as of the date of this Proxy Statement/Circular. Accordingly, you should not rely on the representations and warranties as characterizations of the actual state of facts at the time they were made or otherwise.
Form of the Arrangement
Subject to the terms and conditions of the Arrangement Agreement and in accordance with Canadian law, at the effective time of the Arrangement, among other things, Acquisition Sub will acquire all of our common shares pursuant to the Plan of Arrangement attached hereto as Annex C. It is the intention of Acquisition Sub to transfer the common shares of Novelis acquired by it to its wholly-owned subsidiary AV Aluminum Inc. We will become an indirect subsidiary of Hindalco.
Effective Date and Effective Time of the Arrangement
The Arrangement Agreement provides that the effective date is the date shown on the certificate of arrangement issued by the director appointed pursuant to the CBCA. The effective time means the date and time of the issuance of the articles of arrangement that are required by the CBCA to be filed with the director after the Final Order is made in order for the Arrangement to become effective.
Purchase Price
At the effective time of the Arrangement, each of our outstanding common shares, other than (1) common shares owned directly by Hindalco or Acquisition Sub and (2) common shares held by dissenting shareholders who duly exercise their dissenting holders’ rights under Canadian law and do not withdraw and are not deemed to have withdrawn their dissent, will be transferred to Acquisition Sub for $44.93 per common share in cash, without interest and less any applicable withholding taxes. Our shareholders will receive the purchase price per common share after exchanging their stock certificates in accordance with the instructions contained in the letter of transmittal accompanying this Proxy Statement/Circular. The price of $44.93 per common share was determined through negotiations between Hindalco and us.
Hindalco, Acquisition Sub, Novelis and the Depositary will be entitled to deduct and withhold from the consideration otherwise payable to any holder of our common shares, Options, SARs, SPAUs, PSUs and DSUs such amounts that Hindalco, Acquisition Sub, Novelis or the Depositary determines are required to be deducted or withheld with respect to such payment under the Income Tax Act (Canada) or the United States Internal Revenue Code of 1986, as amended, or any other applicable federal, provincial, territorial, state, local or foreign or other tax law.


60


Effect on Stock Options, Stock Appreciation Rights, Stock Price Appreciation Units, Performance Share Units and Deferred Share Units
We have taken all necessary action such that, immediately prior to the effective time of the Arrangement, (1) each outstanding Option, SAR and SPAU will, to the extent not then vested, accelerate and become fully vested and exercisable, and (2) each outstanding Option, SAR, SPAU, PSU and DSU will be cancelled.
At the effective time of the Arrangement, each Option, SAR and SPAU will (1) be transferred to us in exchange for the right to receive a cash payment equal to the amount, if any, by which $44.93 exceeds the exercise price of the Option, SAR or SPAU, as applicable, without interest, and less any applicable withholding taxes and (2)  immediately be cancelled and all agreements related thereto will be terminated.
Each outstanding PSU and DSU will be cancelled in exchange for a cash payment in the amount of $44.93 per performance share unit or deferred share unit, as applicable, and less any applicable withholding taxes.
Conditions to the Arrangement
Conditions to Each Party’s Obligation
Each party’s obligation to complete the Arrangement is subject to the satisfaction or waiver of the following conditions:
(a) the Arrangement Resolution shall have been approved and adopted at the Meeting by the shareholders in accordance with the Interim Order;
(b) the Interim Order and the Final Order shall each have been obtained on terms consistent with the Arrangement Agreement and in a form satisfactory to each of Novelis and Hindalco, acting reasonably, and shall not have been set aside or modified in a manner unacceptable to such parties, acting reasonably;
(c) no governmental entity shall have enacted, issued, enforced or entered any law which is then in effect that makes the Arrangement illegal or otherwise prevents, prohibits or enjoins closing of the Arrangement; and
(d) the required regulatory approvals shall have been obtained or satisfied and shall not have been revoked and reasonably satisfactory evidence of the regulatory approvals shall have been delivered.
Additional Conditions to Our Obligations
Our obligations to complete the Arrangement shall also be subject to fulfillment of each of the following conditions precedent (each of which is for our exclusive benefit and may be waived by us):
(a) all covenants of Hindalco and Acquisition Sub under the Arrangement Agreement to be performed on or before the effective time shall have been performed by Hindalco and Acquisition Sub in all material respects;
(b) all representations and warranties of Hindalco and Acquisition Sub under the Arrangement Agreement shall have been true and correct (without giving effect to qualifications or limitations as to materiality) as of the effective date of the Arrangement as if made on and as of such time (except to the extent such failures to be true and correct would not have a material adverse effect on Hindalco’s ability to close the transactions contemplated by the Arrangement Agreement and Plan of Arrangement and perform its obligations under the Arrangement Agreement and except such representations and warranties that speak solely as of an earlier date, in which event such representations and warranties shall be true and correct to such extent as of such earlier date); and
(c) Acquisition Sub shall have deposited with the Depositary in escrow at or prior to the time of filing of the Articles of Arrangement the funds required to effect payment in full for all of the securities


61


to be acquired pursuant to the Arrangement and the Depositary shall have confirmed to us the receipt of these funds.
Additional Conditions to Hindalco’s Obligations
The obligations of Hindalco to complete the Arrangement shall also be subject to the fulfillment of each of the following conditions precedent (each of which is for Hindalco’s exclusive benefit and may be waived by Hindalco in Hindalco’s sole discretion):
(a) all of our covenants under the Arrangement Agreement to be performed on or before the effective time shall have been performed by us in all material respects;
(b) all of our representations and warranties under the Arrangement Agreement shall have been true and correct (without giving effect to any qualifications or limitations as to materiality) as of the effective date as if made on and as of such date (except (1) to the extent such representations and warranties speak solely as of an earlier date, in which event such representations and warranties shall be true and correct to such extent as of such earlier date, (2) (other than in (3) below) to the extent that facts or matters as to which such representations and warranties are not so true and correct as of such dates, individually or in the aggregate, have not had and would not have a material adverse effect and (3) in case of representations and warranties related to Novelis’ capitalization, such representations shall be true and correct in all material respects);
(c) prior to the completion of the Arrangement, there shall not have occurred and be continuing a material adverse effect; and
(d) there shall be no action, investigation, proceeding or litigation instituted or commenced by any governmental entity that is reasonably likely to (1) set aside, appeal or challenge the validity of the Interim Order or the Final Order, (2) restrain, enjoin, prevent, prohibit or make illegal closing of the Arrangement or any of the transactions related thereto, or (3) result in a material adverse effect.
As a result of the conditions to the completion of the Arrangement, even if the requisite shareholder approval is obtained, there can be no assurance that the Arrangement will be completed.
Material Adverse Effect
For purposes of the Arrangement Agreement, certain of our representations and certain of the conditions to complete the Arrangement are qualified by a “material adverse effect” clause, which means, in the case of Novelis, any change, effect, event, occurrence, state of facts or development which individually or in the aggregate (1) is or would reasonably be expected to be materially adverse to our business, operations, results of operations, liabilities or obligations (whether absolute, accrued, conditional, contingent or otherwise), capitalization, or financial condition of us and our subsidiaries, taken as a whole; or (2) is or would reasonably be expected to impair in any material respect our ability to consummate the transactions contemplated by the Arrangement Agreement or to perform its obligations under the Arrangement Agreement on a timely basis.
None of the following, however, shall be deemed, either individually or in the aggregate, to constitute a material adverse effect: any change, effect, event, occurrence, state of facts or development (A) in the financial, banking, credit, securities, or commodities markets, the economy in general or prevailing interest rates of the United States, Canada or any other jurisdiction, where we have operations or significant revenues, (B) in any industry in which we or our subsidiaries operate, (C) in our stock price or trading volume, (D) arising as a result of a change in U.S. GAAP or regulatory accounting principles or interpretations thereof, (E) in law or interpretations thereof by any Governmental Entity, (F) arising or resulting from the announcement of the Arrangement Agreement, the pendency of the transactions contemplated herein, or compliance by any party with the covenants and agreements therein, (G) arising or resulting from any failure by us to meet any internal or published projections, forecasts or revenue or earnings predictions, (H) any continuation of an adverse trend or condition or the escalation of, or any developments with respect to, any dispute listed on the Company Disclosure Schedule, (I) arising or resulting from any act of war or terrorism (or, in each case, escalation thereof) or declaration of a national emergency, or (J) arising or resulting from the acts or omissions of Hindalcoand/or its affiliates; except in the cases of clauses (A), (B) and (I), to the extent such change,


62


effect, event, occurrence, state of facts or development has or would reasonably be expected to have a disproportionate effect on us and our subsidiaries, taken as a whole, as compared to other persons in the industries in which we and our subsidiaries operate unless such disproportionate change, effect, event, occurrence, state of facts or development arises from any metal price ceiling in any of our customer contracts; provided that any change, effect, event, occurrence, state of facts or development that is cured prior to the termination of this Agreement in accordance with its terms shall not be considered a material adverse effect.
In addition, any change, effect, event, occurrence, state of facts or development that is cured prior to termination of the Arrangement Agreement shall not be considered a material adverse effect.
Termination of the Arrangement Agreement
The Arrangement Agreement may be terminated and the Arrangement may be abandoned at any time prior to the filing of the Articles of Arrangement, whether before or after any approval and authorization of the Arrangement Resolution by the shareholders:
(a) by mutual written consent of us and Hindalco to terminate, duly authorized by our board of directors and Hindalco’s board of directors;
(b) by either Hindalco or us if the effective time of the Arrangement shall not have occurred on or before July 7, 2007, or at the option of Hindalco, July 31, 2007, if the expiration date of the commitment letters provided in connection with Hindalco’s financing of its acquisition of us is extended to or beyond July 31, 2007 (as applicable, the “Outside Date”); provided, however, that the right to terminate under this provision is not available to any party whose failure to fulfill any obligation under the Arrangement Agreement has been the cause of, or resulted in, the failure of the effective time to occur on or before July 31, 2007;
(c) by either Hindalco or us if any governmental entity shall have enacted, issued, promulgated, enforced or entered any law or order which has become final and nonappealable and has the effect of making the Arrangement illegal or otherwise preventing or prohibiting closing of the Arrangement;
(d) by either Hindalco or us if the Arrangement Resolution shall have failed to receive the requisite vote for approval at the Meeting or at any adjournment or postponement thereof in accordance with the Interim Order;
(e) by Hindalco, if: (1) our board of directors withdraws, modifies or qualifies, in any manner adverse to Hindalco or Acquisition Sub, its recommendation that our shareholders vote in favor of the Arrangement; or (2) our board of directors approves, adopts or recommends an acquisition proposal that constitutes a superior proposal; or (3) we enter into any binding agreement effecting or in connection with an acquisition proposal that constitutes a superior proposal;
(f) by us, if we enter into any binding agreement effecting an acquisition proposal in compliance with the provisions of the Arrangement Agreement, in which case we are obligated to make a termination payment of $100 million to Acquisition Sub prior to or concurrently with such termination;
(g) by Hindalco, if there has been a breach of or failure to perform any representation, warranty, covenant or agreement on our part set forth in the Arrangement Agreement, which breach or failure to perform: (i) would cause the condition that our covenants be performed in all material respects and our representations and warranties be true and correct (subject to certain exceptions) not to be satisfied; and (ii) is incapable of being cured within the lesser of 30 days after Hindalco gives notice of such breach or failure to perform and the period between Hindalco’s giving notice and the day prior to the Outside Date; or
(h) by us, if there has been a breach of or failure to perform any representation, warranty, covenant or agreement on the part of Hindalco or Acquisition Sub set forth in the Arrangement Agreement, which breach or failure to perform (i) would cause the condition that Hindalco’s covenants be performed in all material respects and its representations and warranties be true and correct (subject to certain exceptions) not to be satisfied and (ii) is incapable of being cured within the lesser of 30 days after we give notice of


63


such breach or failure to perform and the period between our giving notice and the day prior to the Outside Date.
Expenses
Other than as set forth under “Expense Reimbursement”, generally, all fees and expenses incurred in connection with the Arrangement Agreement and the other transactions contemplated by the Arrangement Agreement will be paid by the party incurring such fees and expenses, except that Hindalco shall be responsible for paying all filing fees in connection with obtaining the regulatory approvals, and each party shall share equally all fees and expenses incurred in connection with the preparation, filing and mailing of this Proxy Statement/Circular.
Company Termination Payment
We must pay a termination payment to Acquisition Sub of $100 million if:
(a) the Arrangement Agreement is terminated in the circumstances set out in paragraphs (e) or (f) in the section above titled “Termination of the Arrangement Agreement”; or
(b) (A) prior to the Meeting a proposal to acquire 50% or more of our assets or common shares is publicly announced; (B) the holders of our common shares fail to approve the Arrangement Resolution and the transactions contemplated thereby; and (C) during the period between February 10, 2007 and twelve (12) months following the termination of the Arrangement Agreement (X) the proposal is consummated by the person who publicly announced such proposal, or (Y) Novelis enters into a definitive agreement with respect to such proposal and that proposal is subsequently consummated at any time thereafter.
Expense Reimbursement
If Hindalco terminates the Arrangement Agreement for our failure to perform any representation, warranty, covenant or agreement in the Arrangement Agreement, we are required to pay a reimbursement amount equal to the aggregate of all reasonable out of pocket costs and expenses incurred by Hindalco and its affiliates in connection with the Arrangement and any transactions contemplated thereby (including all reasonable fees and expenses of financial, legal, accounting and other advisors and of potential lenders) up to a maximum of $15 million. If after the payment of the reimbursement amount, the events set forth in item (b) above occur, we shall pay an amount equal to the difference between the company termination payment and the reimbursement amount to Hindalco.
Representations and Warranties
The Arrangement Agreement contains customary representations and warranties made by each of the parties regarding facts pertinent to the Arrangement. These representations and warranties relate to the following subject matters with respect to each party:
(a) corporate existence and good standing; and
(b) corporate power and authorization to enter into and carry out the obligations of the Arrangement Agreement, the enforceability of the Arrangement Agreement and the absence of any conflict with or violation of organizational documents, third party contracts or laws as a result of entering into and carrying out the obligations of the Arrangement Agreement.
In addition, we made additional representations and warranties with respect to the following subject matters:
(a) our capitalization;
(b) absence of consents and approvals required;
(c) our filings and reports with the SEC;


64


(d) our financial statements and our reporting requirements and our internal control over financial reporting and disclosure controls and procedures;
(e) the absence of undisclosed liabilities or certain changes or events with respect to us and our subsidiaries;
(f) absence of litigation;
(g) compliance with laws;
(h) absence of defaults under contracts;
(i) compliance with securities laws matters;
(j) status of customer relations;
(k) compliance with foreign corrupt practices laws;
(l) rights to intellectual property;
(m) title and validity of rights with respect to property;
(n) labor and other employment matters;
(o) employee benefit plans;
(p) tax matters;
(q) environmental matters;
(r) product warranty matters;
(s) absence of affiliate transactions;
(t) the receipt of the fairness opinions from each of Morgan Stanley and Evercore; and
(u) deferring the separation time under our shareholder rights plan.
Hindalco and Acquisition Sub made additional representations and warranties related to the following subject matters:
(a) ownership of shares of Acquisition Sub;
(b) no governmental consent;
(c) availability of sufficient funds to complete the Arrangement;
(d) absence of ownership of our shares by Hindalco or Acquisition Sub; and
(e) absence of material litigation.
Covenants Under the Arrangement Agreement
Conduct of Business During the Pre-Effective Date Period
Prior to the closing of the Arrangement, without the consent of Hindalco or as otherwise permitted by the Arrangement Agreement, we agreed to conduct our business substantially in the ordinary course and consistent with past practice, and we will use our reasonable best efforts to preserve our goodwill, which includes preserving our current relationships with customers, suppliers, distributors, joint venture partners, licensors, employees and other persons having significant business relationships with us.
In addition, prior to the closing of the Arrangement, we have agreed to specific restraints relating to the following (with certain exceptions):
(a) splitting, consolidating or reclassifying any of our outstanding securities or undertaking any other capital reorganization, or declaring dividends or making other distributions, other than quarterly cash


65


dividends in accordance with our past practice or dividends by one of our wholly owned subsidiaries to us or one of our subsidiaries;
(b) amending or modifying our organizational documents or any outstanding securities, indebtedness and credit facility;
(c) issuing any securities or new options to acquire our capital stock, or redeem or offer to purchase any of our outstanding securities, other than pursuant to any existing plan or contract;
(d) subject to item (g) below, and except for the transactions contemplated by the Arrangement Agreement, not enter into, adopt or consummate any liquidation, dissolution, merger, amalgamation, arrangement, consolidation or reorganization of us or any of our subsidiaries;
(e) terminating, amending or waiving any material term of any material contract, entering into or extending the scope of any contract that purports to restrict our ability to engage in any line of business or our geographic scope, or entering into a material contract that would be breached by or would require the consent of a third party in order to continue in full force following the implementation of the Arrangement (provided that we must advise Hindalco prior to entering into, amending, terminating or waiving any material term of a significant metal supply agreement or significant customer contract);
(f) entering into, adopting, amending, or taking any other action with respect to any bonus, profit sharing, incentive, salary or other compensation arrangement, subject to certain exceptions;
(g) selling, leasing or otherwise disposing of any capital assets or a group of related assets having a value in excess of $20 million, subject to certain exceptions;
(h) other than borrowing under existing lines of credit, or indebtedness or guarantees owing to us or our subsidiaries, incurring or committing to incur any indebtedness for borrowed money or issuing any debt securities, or incurring, guaranteeing or otherwise becoming responsible for any other material liability of any other person or business organization;
(i) granting or amending the terms of any Options, SARs, SPAUs, PSUs or DSUs;
(j) other than in the ordinary course of business and consistent with past practice, waiving, releasing, settling or otherwise compromising any material litigation or arbitration, satisfying any material liabilities substantially prior to being due, and other than in the ordinary course of business, entering into any interest rate, currency or commodity swaps, hedges or similar financial instruments;
(k) incurring or committing to capital expenditures, other than capital expenditures contemplated by our budget or capital plan for 2007, or otherwise not in excess of $35 million (provided that we must advise Hindalco in advance of our incurring or committing to any capital expenditures in excess of $15 million in the aggregate);
(l) making any changes to existing accounting policies unless required by U.S. GAAP, or as recommended by our independent registered public accountant, or pursuant to written instructions from any securities regulatory authority;
(m) acquiring or agreeing to acquire any person or other business organization, subject to certain exceptions;
(n) making, rescinding or changing material elections with respect to taxes, filing any material amended tax return, waiving or settling any material tax dispute, or extending the statute of limitations relating to taxes or other than in the ordinary course of business consistent with past practice, entering into any closing agreement regarding taxes, surrendering any right to claim a material tax refund or amending our transfer pricing policies;
(o) amending our shareholder rights plan or adopting or implementing any other shareholder rights plan other than in connection with a superior proposal; or


66


(p) taking any materially adverse employment actions outside the ordinary course of business with respect to our employees employed in Europe, except in consultation with the applicable works councils.
Access to Information; Certain Notices
Upon reasonable notice and subject to applicable law and the terms of our contracts, we agree to provide Hindalco with reasonable access (without disruption to our conduct of business) during normal business hours to all books, records, information and files in our possession and control and access to our personnel on an as reasonably requested basis as well as reasonable access to our properties and our subsidiaries’ properties to allow Hindalco to conduct such investigations as Hindalco may consider necessary for strategic and transition planning.
Hindalco acknowledges that certain information provided to it may be confidentialand/or proprietary in nature and except as permitted by the confidentiality agreement entered into by Hindalco and us, Hindalco shall not, without our prior consent, disclose such confidential and proprietary information and shall not use it for any purpose other than those contemplated in the Arrangement Agreement.
No Solicitation
We have agreed that we will not, and we will use our reasonable best efforts to cause our representatives not to:
(a) directly or indirectly solicit, initiate, knowingly encourage or knowingly facilitate any acquisition proposal;
(b) enter into, continue or participate in negotiations regarding, or furnish any information in connection with any acquisition proposal;
(c) except as provided below, withdraw, modify or qualify, in any manner adverse to Hindalco or Acquisition Sub, the recommendation in favor of the Arrangement of our board of directors or any committee thereof; or
(d) except as provided below, approve, adopt or recommend an acquisition proposal, or enter into any binding agreement effecting an acquisition proposal.
Further, we shall, and shall use our reasonable best efforts to cause our representatives to:
(a) immediately cease and cause to be terminated all existing discussions or negotiations with any person conducted before entering into the Arrangement Agreement with respect to any acquisition proposal and we will not to release any third party from, waive or otherwise forbear in the enforcement of any confidentiality, non-solicitation or standstill agreement to which we and such third party are parties, except that this restriction does not prohibit our board of directors from otherwise considering and accepting a superior proposal, and
(b) immediately cease to provide any other person with access to information concerning us and our subsidiaries and shall immediately request the returnand/or destruction of all information provided to any third parties that have entered into a confidentiality agreement with us relating to any potential acquisition proposal and shall use all reasonable efforts to ensure that such requests are honored.
However, this covenant will not prohibit us from (i) furnishing information regarding us to a person making an acquisition proposal (subject to the execution of a confidentiality agreement) that our board of directors determines in good faith is reasonably likely to lead to a superior proposal and (ii) participating in discussions or negotiations with the person making such acquisition proposal.
At any time prior to obtaining the approval of our shareholders for the Arrangement Resolution, if our board of directors determines in good faith (after consultation with its financial advisor and legal advisors) that the failure to take such action would not be in our best interests, in response to an acquisition proposal that the board of directors determines in good faith after consulting with its legal and financial advisors is reasonably likely to lead to a superior proposal, the board of directors may withdraw its recommendation that


67


the shareholders approve the Arrangement Resolutionand/or cause us to enter into an agreement for a superior proposal. Our board of directors, however, may not withdraw its recommendation in the context of a possible superior proposal unless:
(a) we have complied in all material respects with our covenant regarding non-solicitation;
(b) we have provided Hindalco three business days’ prior written notice advising Hindalco that the board of directors intends to withdraw its recommendationand/or enter into an agreement for a superior proposal and specifying the reasons therefor, including the terms and conditions of the superior proposal;
(c) we have during such three business day period, if requested by Hindalco, afforded Hindalco a reasonable opportunity to amend the Arrangement Agreement so that the acquisition proposal no longer constitutes a superior proposal;
(d) if Hindalco agrees to amend the Arrangement Agreement, our board of directors has considered the terms of the amendment to determine whether such acquisition proposal continues to be a superior proposal; and
(e) at the end of such three business day period, such acquisition proposal has not been withdrawn and continues to constitute a superior proposal.
In the event of any material revisions to any applicable superior proposal, we will be required to deliver a new written notice to Hindalco and to comply with the requirements described above with respect to the new written notice. In addition, we are also required to notify Hindalco orally and in writing within one business day after receipt of any acquisition proposal and the terms thereof.
We are not entitled to enter into any contract (other than an acceptable confidentiality agreement) with respect to a superior proposal unless the Arrangement Agreement has been or is concurrently terminated by its terms and we have paid to Acquisition Sub the termination fee of $100 million.
As long as we comply with the restrictions described above, the Arrangement Agreement also does not prohibit us from taking and disclosing to our shareholders a position contemplated byRule 14d-9 orRule 14e-2(a) under the Exchange Act.
As described in this Proxy Statement/Circular, “acquisition proposal” means (i) any merger, tender offer, take-over bid, amalgamation, plan of arrangement, business combination, consolidation or recapitalization that, if consummated, would result in any person beneficially owning more than 35% of common shares, or any liquidation orwinding-up in respect of Novelis; (ii) any sale or acquisition of 35% or more of the fair market value of our assets on a consolidated basis; (iii) any acquisition of 35% or more of the common shares (or rights thereto) or any acquisition of 35% or more of the equity interests (or rights thereto) in any of our material subsidiaries; or (iv) any proposal or offer to do, or public announcement of an intention to do, any of the foregoing from any person other than Hindalco or Acquisition Sub.
As described in this Proxy Statement/Circular, “superior proposal” means any bona fide written acquisition proposal that was not solicited in breach of our obligations under the Arrangement Agreement by a third party that if consummated would result in such person (or its shareholders) owning, directly or indirectly, more than 50% of our common shares then outstanding or more than 50% of the assets of Novelis on a consolidated basis, which our board of directors determines, acting in good faith and after consultation with our financial advisors and outside legal counsel, taking into account all financial, legal, regulatory and other aspects of such proposal (including anybreak-up fee, expense reimbursement provisions, due diligence and other conditions to closing and financing terms, including the committed status thereof) and the person making the proposal, to be more favorable to the shareholders from a financial point of view than the transactions contemplated by the Arrangement Agreement.
Our Shareholder Rights Plan
Our board of directors has resolved to defer the “Separation Time” (as defined in our shareholder rights plan) so that none of the execution, delivery and performance of the Arrangement Agreement will cause the


68


rights to become exercisable. Our shareholder rights plan will be terminated at the effective time as part of the Plan of Arrangement and the rights will expire in their entirety at the effective time without any payment being made in respect thereof.
Further Action; Reasonable Best Efforts
Hindalco, Acquisition Sub and Novelis have agreed to use our reasonable best efforts to take, or cause to be taken, all appropriate actions and to do, or cause to be done, all things necessary or advisable to consummate and make effective the transactions contemplated by the Arrangement Agreement. Without limiting the foregoing, the parties have agreed to use reasonable best efforts to:
(a) obtain all necessary regulatory approvals as soon as practicable;
(b) seek all consents, approvals or waivers from third parties in connection with the transactions contemplated by the Arrangement Agreement;
(c) execute and deliver certain covenants and agreements related to obligations of Novelis to be specifically assumed by Hindalco;
(d) defend any lawsuits or other legal proceedings challenging the Arrangement Agreement or transactions contemplated in the Arrangement Agreement;
(e) carry out the terms of the Interim Order and the Final Order; and
(f) execute and deliver any additional instrument necessary to consummate the transactions contemplated by the Arrangement Agreement and the Plan of Arrangement.
In addition, the parties agree to cooperate and assist one another in connection with all actions to be taken as described above. The parties also agree that to the extent practicable neither party will have any communication with any governmental entity without prior consultation of the other party, and each party shall keep the other party apprised of the content and status of any communications with any governmental entity.
Directors’ and Officers’ Indemnification and Insurance
Hindalco has agreed to cause Novelis, after the completion of the Arrangement, to indemnify our officers and directors (or their equivalents) to the fullest extent permitted under our organizational documents and applicable laws. These obligations shall survive the Arrangement and shall continue in full force and effect in accordance with the terms of such organizational documents and such individual indemnity agreements from the effective date.
The Arrangement Agreement also requires us to maintain for six years from the effective date of the Arrangement our current officers’ and directors’ liability insurance providing coverage to each person currently covered by our directors’ and officers’ liability insurance. We (or our successor) or Hindalco shall not be required to pay an aggregate amount in excess of 300% of the annual premium currently paid by us. In lieu of the foregoing, we (or our successor) may purchase, prior to, on or after the effective date, a six-year “tail” prepaid officers’ and directors’ liability insurance policy in respect of acts or omissions occurring prior to the effective date of the Arrangement covering each such officer and director, provided that such policy shall not be in an amount in excess of $4.5 million without our first obtaining Hindalco’s prior written consent.
Public Announcements
We and Hindalco have agreed to obtain the approval, not to be unreasonably withheld or delayed, of the other party prior to making any public announcement or statement with respect to the transactions contemplated by the Arrangement or the Arrangement Agreement, except for such releases or announcements which may be required by law or the requirements of any applicable stock exchange. In each event, we and Hindalco will consult with each other prior to issuing any such public announcement.


69


Benefits Continuation
The Arrangement Agreement provides that for a period beginning on the effective date of the Arrangement and ending no earlier than the 24 months following such date, Hindalco shall cause Novelis and our subsidiaries, subject to collective bargaining and applicable laws, to provide a continuation of the benefits that are substantially equivalent in the aggregate to the employee benefits provided under our employee benefit plans in effect on February 10, 2007 to our employees or former employees as of the effective date of the Arrangement and their eligible dependents. We and Hindalco agree, from and after the effective date, to provide severance pay and other severance benefits to our employees or former employees as of the effective date who are terminated prior to the second anniversary of the effective date on the effective date of the Arrangement in accordance with employee benefit plans providing for such payments or our severance pay and other severance benefits as of the date of the Arrangement Agreement.
In addition, our employees or former employees as of the effective date of the Arrangement shall be given credit for all service with us and our subsidiaries and any of our predecessors under all employee benefit plans and arrangements currently maintained or established in the future by Hindalco or any of its subsidiaries in which they are or become participants for purposes of participation, eligibility, vesting and level of benefits. Hindalco and its subsidiaries shall cause any pre-existing conditions or limitations, eligibility or waiting periods or required physical examinations under any welfare benefit plans of Hindalco and its subsidiaries to be waived with respect to our employees or former employees as of the effective date and their eligible dependents to the extent waived under the existing employee benefit plan. With respect to life insurance, Hindalco and its Subsidiaries shall provide coverage up to the employee or former employees as of the effective date current level of insurability. Hindalco and its subsidiaries shall also give our employees or former employees and their eligible dependents credit for the employee benefit plan year in which the effective date of the Arrangement occurs towards applicable deductibles andout-of-pocket limits for expenses incurred prior to the effective date of the Arrangement.
Amendment and Waiver
The Arrangement Agreement and the Plan of Arrangement may be amended at any time by the parties before or after approval of the Arrangement Resolution by our shareholders. However, after approval of the Arrangement Resolution by our shareholders, no amendment can be made without first obtaining the approval of our shareholders if the amendment is otherwise required by law or the Interim Order to be approved by our shareholders.
Prior to the effective date, the parties by mutual agreement may:
(a) change the time for the performance of any of the obligations or other acts of the parties;
(b) waive any inaccuracies or modify any representation and warranty contained in the Arrangement Agreement or in any document delivered pursuant to the Arrangement Agreement; and
(c) waive compliance with or modify any of the covenants in the Arrangement Agreement and waive or modify performance of any of the obligations of the parties; and
(d) waive compliance with or modify any conditions precedent in the Arrangement Agreement provided that any such change does not decrease the consideration payable to our shareholders.
DISSENTING HOLDERS’ RIGHTS
The discussion set forth below is not a complete summary regarding your dissenting holders’ rights under Canadian law and is qualified in its entirety by reference to the text of the relevant provisions of Canadian law, which are attached to this Proxy Statement/Circular as Annex F. Shareholders intending to exercise dissenting holders’ rights should carefully review Annex F. Failure to follow precisely any of the statutory procedures set forth in Annex F may result in a termination or waiver of these rights.
Section 190 of the CBCA provides registered shareholders with the right to dissent from certain resolutions that effect extraordinary corporate transactions or fundamental corporate changes. The Interim


70


Order expressly provides registered shareholders with the right to dissent from the Arrangement Resolution pursuant to section 190 of the CBCA, with modifications to the provisions of section 190 as provided in the Plan of Arrangement and the Interim Order (“Dissenting Holders’ Rights”). Under the CBCA, if registered shareholders properly exercise Dissenting Holders’ Rights, Novelis would be required to pay the fair value of the common shares to the Dissenting Holders (the “Dissenting Holders”), whereas under the Plan of Arrangement such payment will be made by Acquisition Sub. In addition, section 190 of the CBCA provides that in order to dissent, a written objection must be received by us at or before the Meeting, whereas the Plan of Arrangement provides that a written objection must be received by us no later than 5:00 p.m. (Toronto time) on the last business day preceding the Meeting. Any registered shareholder who properly dissents from the Arrangement Resolution in compliance with section 190 of the CBCA, as modified by the Plan of Arrangement and the Interim Order, will be entitled, in the event the Arrangement becomes effective, to be paid the fair value of common shares held by such Dissenting Holder, determined as of the close of business on the day before the day the Arrangement Resolution is adopted. Shareholders are cautioned that fair value could be determined to be less than the $44.93 payable pursuant to the terms of the Arrangement.
Section 190 of the CBCA provides that a shareholder may only make a claim under that section with respect to all of the common shares of a class held by the shareholder on behalf of any one beneficial owner and registered in the shareholder’s name.One consequence of this provision is that only a registered shareholder may exercise the Dissenting Holders’ Rights in respect of common shares that are registered in that shareholder’s name.
In many cases, common shares beneficially owned by a non-registered shareholder are registered either (a) in the name of an intermediary or (b) in the name of a clearing agency (such as CDS or DTC) of which the intermediary is a participant. Accordingly, a non-registered shareholder will not be entitled to exercise its Dissenting Holders’ Rights directly (unless the common shares are re-registered in the non-registered shareholder’s name). A non-registered shareholder who wishes to exercise Dissenting Holders’ Rights should immediately contact the intermediary with whom the non-registered shareholder deals in respect of its common shares and either (i) instruct the intermediary to exercise the Dissenting Holders’ Rights on the non-registered shareholder’s behalf (which, if the common shares are registered in the name of CDS, DTC or other clearing agency, may require that such common shares first be re-registered in the name of the intermediary), or (ii) instruct the intermediary to re-register such common shares in the name of the non-registered shareholder, in which case the non-registered shareholder would be able to exercise the Dissenting Holders’ Rights directly.
A registered shareholder who wishes to dissent must provide a dissent notice to Novelis (a) at 3399 Peachtree Road NE, Suite 1500, Atlanta, Georgia, 30326 (Attention: Corporate Secretary) or (b) by facsimile transmission to(404) 814-4219 (Attention: Corporate Secretary) no later than 5:00 p.m. (Toronto time) on May 9, 2007 (or 5:00 p.m. (Toronto time) on the day which is one business day immediately preceding any adjourned or postponed Meeting.) Failure to strictly comply with these dissent procedures may result in the loss or unavailability of the right to dissent.
The filing of a Dissent Notice does not deprive a registered shareholder of the right to vote at the Meeting. However, the CBCA provides, in effect, that a registered shareholder who has submitted a Dissent Notice and who votes for the Arrangement Resolution will no longer be considered a Dissenting Holder. The CBCA does not provide, and Novelis will not assume, that a proxy submitted instructing the proxyholder to vote against the Arrangement Resolution, or a vote against the Arrangement Resolution constitutes a Dissent Notice, but a registered shareholder need not vote its common shares against the Arrangement Resolution in order to dissent. Similarly, the revocation of a proxy conferring authority on the proxyholder to vote for the Arrangement Resolution does not constitute a Dissent Notice. However, any proxy granted by a registered shareholder who intends to dissent, other than a proxy that instructs the proxyholder to vote against the Arrangement Resolution, should be validly revoked in order to prevent the proxyholder from voting such common shares in favor of the Arrangement Resolution and thereby causing the registered shareholder to forfeit its Dissenting Holders’ Rights. See “Information Concerning the Meeting and Voting”.
Novelis (or its successor) is required, within ten (10) days after the shareholders adopt the Arrangement Resolution, to notify each Dissenting Holder that the Arrangement Resolution has been adopted. Such notice


71


is not required to be sent to any shareholder who voted for the Arrangement Resolution or who has withdrawn its Dissent Notice.
A Dissenting Holder who has not withdrawn its Dissent prior to the Meeting must then, within twenty (20) days after receipt of notice that the Arrangement Resolution has been adopted, or if the Dissenting Holder does not receive such notice, within twenty (20) days after learning that the Arrangement Resolution has been adopted, send to Novelis care of our transfer agent a written notice (a “Demand for Payment”) containing its name and address, the number of common shares in respect of which he or she dissents (the “Dissenting Shares”) and a demand for payment of the fair value of such common shares. Within thirty (30) days after sending the Demand for Payment, the Dissenting Holder must send to Novelis or our transfer agent certificates representing common shares in respect of which he or she dissents. Our transfer agent will endorse on share certificates received from a Dissenting Holder a notice that the holder is a Dissenting Holder and will forthwith return the share certificates to the Dissenting Holder. A Dissenting Holder who fails to make a Demand for Payment in the time required or to send certificates representing Dissenting Shares has no right to make a claim under section 190 of the CBCA.
Under section 190 of the CBCA, as modified by the Plan of Arrangement and Interim Order, after sending a Demand for Payment, a Dissenting Holder ceases to have any rights as a shareholder in respect of its Dissenting Shares other than the right to be paid the fair value of the Dissenting Shares as determined pursuant to the Interim Order, unless (i) the Dissenting Holder withdraws its Dissent Notice before Acquisition Sub makes an offer to pay, or (ii) Acquisition Sub fails to make an offer to pay in accordance with subsection 190(12) of the CBCA and the Dissenting Holder withdraws the Demand for Payment, in which case the Dissenting Holder’s rights as a shareholder will be reinstated. Pursuant to the Plan of Arrangement, in no case shall Acquisition Sub or any other person be required to recognize any Dissenting Holder as a shareholder after the effective date, and the names of such shareholders shall be deleted from the list of registered shareholders at the effective date.
Pursuant to the Plan of Arrangement, Dissenting Holders who are ultimately determined to be entitled to be paid fair value for their Dissenting Shares shall be deemed to have transferred such Dissenting Shares to Acquisition Sub at the effective time.
Pursuant to the Plan of Arrangement, Dissenting Holders who are ultimately determined not to be entitled, for any reason, to be paid fair value for their Dissenting Shares, shall be deemed to have participated in the Arrangement on the same basis as any non-Dissenting Holder as at and from the effective date.
Acquisition Sub is required, not later than seven (7) days after the later of the effective date and the date on which a Demand for Payment is received from a Dissenting Holder, to send to each Dissenting Holder who has sent a Demand for Payment an offer to pay for its Dissenting Shares in an amount considered by the board of directors of Acquisition Sub to be the fair value of the common shares, accompanied by a statement showing the manner in which the fair value was determined. Every offer to pay must be on the same terms. Acquisition Sub must pay for the Dissenting Shares of a Dissenting Holder within ten (10) days after an offer to pay has been accepted by a Dissenting Holder, but any such offer lapses if Acquisition Sub does not receive an acceptance within thirty (30) days after the offer has been made.
If Acquisition Sub fails to make an offer to pay for a Dissenting Shares, or if a Dissenting Holder fails to accept an offer to pay that has been made, Acquisition Sub may, within fifty (50) days after the effective date or within such further period as the Court may allow, apply to a court to fix a fair value for the common shares of Dissenting Holders. If Acquisition Sub fails to apply to a court, a Dissenting Holder may apply to a court for the same purpose within a further period of twenty (20) days or within such further period as a court may allow. A Dissenting Holder is not required to give security for costs in such an application.
If Acquisition Sub or a Dissenting Holder makes an application to court, Acquisition Sub will be required to notify each affected Dissenting Holder of the date, place and consequences of the applicable and of its right to appear and be heard in person or by counsel. Upon an application to a court, all Dissenting Holders who have not accepted an offer to pay will be joined as parties and be bound by the decision of the court. Upon


72


any such application to a court, the court may determine whether any person is a Dissenting Holder who should be joined as a party, and the court will then fix a fair value for the Dissenting Shares of all Dissenting Holders. The final order of a court will be rendered against Acquisition Sub in favor of each Dissenting Holder for the amount of the fair value of its Dissenting Shares as fixed by the court. The court may, in its discretion, allow a reasonable rate of interest on the amount payable to each Dissenting Holder from the effective date until the date of payment.
Registered shareholders who are considering exercising Dissenting Holders’ Rights should be aware that there can be no assurance that the fair value of their common shares as determined under the applicable provisions of the CBCA (as modified by the Plan of Arrangement and the Interim Order) will be more than or equal to the consideration under the Arrangement. In addition, any judicial determination of fair value will result in delay of receipt by a Dissenting Holder of consideration for such Dissenting Holder’s Dissenting Shares.
The foregoing is only a summary of the dissenting holder provisions of the CBCA (as modified by the Plan of Arrangement and the Interim Order), which are technical and complex. A complete copy of section 190 of the CBCA is attached as Annex F to this Proxy Statement/Circular. It is recommended that any registered shareholder wishing to avail itself of its Dissenting Holders’ Rights under those provision seek legal advice, as failure to comply strictly with the provisions of the CBCA (as modified by the Plan of Arrangement and the Interim Order) may prejudice its Dissenting Holders’ Rights.
For a general summary of certain income tax implications to a Dissenting Holder, see “Material Tax Consequences of the Arrangement”.
PRINCIPAL LEGAL MATTERS
 
Share OwnershipCourt Approval of Certain Beneficial Ownersthe Arrangement and Completion of the Arrangement
An arrangement of a corporation under the CBCA requires court approval. Prior to the mailing of this Proxy Statement/Circular, we obtained the Interim Order. The Interim Order provides, among other things, that:
• we are authorized to call, hold and conduct the Meeting in the manner set forth in the Interim Order, at the time and place set forth in the notice of meeting, for the shareholders to consider and, if determined advisable, to pass, the Arrangement Resolution;
• this Proxy Statement/Circular, the form of proxy and the letter of transmittal must be distributed to our shareholders, the directors and auditors not later than 21 days prior to the Meeting;
• the quorum required at the Meeting is that set out in our by-laws, being 25% or more of the outstanding common shares entitled to vote, present either in person or by proxy;
• subject to the further order of the court, the vote required to pass and approve the Arrangement Resolution is the affirmative vote of at least 662/3% of the votes cast at the Meeting by shareholders entitled to vote at the Meeting, present either in person or by proxy;
• registered shareholders are entitled to exercise rights of dissent in connection with the Arrangement Resolution in accordance with section 190 of the CBCA, as modified by the Plan of Arrangement and the Interim Order; and
• upon approval of the Arrangement Resolution in the manner set forth in the Interim Order, we may apply to the court for final approval of the Arrangement and the Plan of Arrangement.
A copy of the Interim Order is attached as Annex G to this Proxy Statement/Circular.
Subject to the requisite approval of the Arrangement Resolution by shareholders entitled to vote at the Meeting, and the satisfaction of certain other conditions, the hearing in respect of the Final Order is scheduled to take place on May 14, 2007 in the Superior Court of Justice (Ontario) (Commercial List) at 330 University


73


Avenue, Toronto, Ontario, or as soon thereafter as is reasonably practicable. Any shareholder or other person who wishes to participate or to be represented or to present evidence or argument at the hearing may do so, subject to filing with the court a notice of appearance in accordance with the OntarioRules of Civil Procedure, serving that notice of appearance upon our solicitors and solicitors of Hindalco, and upon all other parties who have filed a notice of appearance, and satisfying any other requirements as provided in the Interim Order. If the hearing is postponed, adjourned or rescheduled then, subject to further order of the Court, only those persons having previously served a notice of appearance in compliance with theOntario Rules of Civil Procedure and the Interim Order will be given notice of the postponement, adjournment or rescheduled date.
At the hearing for the Final Order, the Court will consider, among other things, whether: (1) the Arrangement meets the requirements of the Interim Order and the CBCA; (2) anything has been done or purported to be done that is not authorized by the CBCA; and, (3) the Arrangement is fair and reasonable.
The Arrangement requirements of the CBCA include:
• the proposed transaction must be an arrangement within the meaning of that term in the CBCA which, with respect to a corporation, generally includes a reorganization, an amalgamation, a division of the business of the corporation, a transfer of all or substantially all of the property of the corporation, an exchange of securities of the corporation, a going-private transaction, a liquidation or dissolution, or any combination of the foregoing;
• we must not be insolvent, and it must be impracticable for us to effect the transaction proposed by the Arrangement under any other provision of the CBCA;
• the Arrangement must be approved by the requisite shareholder vote; and
• the Arrangement must be approved by the Court.
Whether an arrangement is fair and reasonable depends on procedural and substantive considerations. Considerations the Court may consider include, among others: (1) the use of independent financial advisors; (2) the provision of dissent rights; (3) the directors’ recommendation; (4) the fairness opinion(s), if any; and (5) the vote by shareholders.
The Court may approve the Arrangement either as proposed or as amended in any manner the Court may direct.
The notice of application for the Final Order is attached as Annex H to this Proxy Statement/Circular. Subject to the requisite approval of the Arrangement Resolution by shareholders entitled to vote at the Meeting, and assuming that the Final Order is granted and that the other conditions set out in the Arrangement Agreement are satisfied or waived by the party or parties for whose benefit they exist, then the articles of arrangement will be filed under the CBCA to give effect to the Arrangement and all other arrangements and documents necessary to complete the Arrangement will be delivered as soon as reasonably practicable thereafter.
Regulatory Matters
The Arrangement is conditional upon the filing of all specified notifications, the receipt of specified approvalsand/or the expiration of applicable waiting periods under applicable antitrust and competition laws and the satisfaction of other regulatory requirements, including under the HSR Act, the Competition Act (Canada), the Investment Canada Act, the EC Merger Regulation and from ANEEL (the “Regulatory Approvals”). We, Hindalco and Acquisition Sub have agreed to use our reasonable best efforts to take, or cause to be taken, all appropriate actions and to do, or cause to be done, all things necessary to obtain all necessary Regulatory Approvals. In addition, we agreed to cooperate and assist one another in connection with all actions to be taken to obtain Regulatory Approval and that, to the extent practicable, neither party will have any communication with any governmental entity without prior consultation of the other party, and each party shall keep the other party apprised of the content and status of any communications with any governmental entity. Hindalco and Acquisition Sub agree to take all steps necessary to make or enter into any necessary divestitures, licenses or other arrangements (including hold separate arrangements) of or affecting


74


their operations or business units or any part thereof, or the operations or business units of Novelis, or those of any of their subsidiaries or affiliates, and agree to any other restrictions, as may be required in order to obtain any Regulatory Approval as soon as possible, and in any event prior to the Outside Date, without any set-off or reduction or adjustment in the purchase price payable pursuant to the terms of the Arrangement Agreement or to obtain the approval of any other governmental entity that may be required following the effective time of the Arrangement.
HSR Act
The HSR Act and related rules provide that transactions such as the Arrangement may not be completed until the parties submit a Notification and Report Form to the Department of Justice and the Federal Trade Commission and certain waiting period requirements have been satisfied. On February 22, 2007, we and Hindalco each filed the required Notification and Report Form and requested early termination of the waiting period and such request was granted effective March 7, 2007.
Competition Act
The Competition Act (Canada) requires that parties to certain transactions such as the Arrangement that exceed specified size thresholds (“Notifiable Transactions”) provide to the Commissioner of Competition (the “Commissioner”) appointed under the Competition Act prior notice of, and information relating to, the Arrangement. Notification must be made either on the basis of a short-form filing (in respect of which there is a 14 day statutory waiting period from the time a complete notification is made), a long-form filing (in respect of which there is a 42 day waiting period from the time a complete notification is made) or a request for an advance ruling certificate (“ARC”).
The Commissioner’s review of a Notifiable Transaction may take longer than the statutory waiting period. Upon completion of the Commissioner’s review, the Commissioner may decide to (1) challenge the Notifiable Transaction, if the Commissioner concludes that it is likely to substantially lessen or prevent competition, (2) issue a “no action” letter stating that the Commissioner does not intend to challenge the Notifiable Transaction at that time but retains the authority to do so for three years after completion of the Notifiable Transaction, or (3) issue an ARC. Where an ARC is issued and the Notifiable Transaction to which the ARC relates is substantially completed within one year after the ARC is issued, the Commissioner cannot seek an order of the Competition Tribunal in respect of the Notifiable Transaction solely on the basis of information that is the same or substantially the same as the information on the basis on which the ARC was issued. On February 21, 2007, Hindalco filed an application for an ARC under the Competition Act (Canada). On March 6, 2007 we received a “no action” letter from the Commissioner as described in (2) above, informing us that the Commissioner is of the view that grounds do not exist at the present time to challenge the Arrangement, but that she retains the authority to do so for a period of three years after the completion of the Arrangement.
Investment Canada Act
Under the Investment Canada Act, certain transactions such as the Arrangement involving the acquisition of control of a Canadian business by a non-Canadian person that exceed prescribed monetary thresholds are subject to review and cannot be implemented unless the applicable Minister responsible for the Investment Canada Act is satisfied that the transaction is likely to be of net benefit to Canada. The transaction contemplated by the Arrangement exceeds the relevant monetary thresholds and is therefore a reviewable transaction.
The prescribed factors of assessment to be considered in the review include, among other things, the effect of the investment on the level and nature of economic activity in Canada (including the effect on employment, resource processing, utilization of Canadian products and services and exports), the degree and significance of participation by Canadians in the acquired business, the effect of the investment on productivity, industrial efficiency, technological development, product innovation and product variety in Canada, the effect of the investment on competition within any industry in Canada, the compatibility of the investment


75


with national industrial, economic and cultural policies (taking into consideration corresponding provincial policies) and the contribution of the investment to Canada’s ability to compete in world markets and may require certain commitments to be made by the applicant with respect to these matters. The Investment Canada Act contemplates an initial review period of 45 days after filing which can be extended unilaterally by the Minister by up to 30 days (or such longer period as to which the Minister and the applicant agree). On February 26, 2007 Hindalco submitted the requisite information to commence the review process.
EC Merger Regulation
The European Community merger control laws, namely Council Regulation (EC) No. 139/2004 of January 20, 2004, require that transactions, such as the Arrangement, may not be implemented until certain information has been submitted to the European Commission and it has approved the Arrangement. Because the Arrangement is significant enough to trigger filing thresholds pursuant to the antitrust regulations of several European Union member states, Hindalco filed a Form RS on March 6, 2007 with the Director General — Competition, or DG Comp, under applicable European Union regulations. A Form RS may be filed with the DG Comp at the discretion of the acquiror asking that a transaction be referred to the DG Comp in situations where multiple member state filings are required, thereby avoiding the need to obtain antitrust clearance in each such member state. The relevant European member states had 15 business days to object to Hindalco’s Form RS filing. This period expired on March 27, 2007 without objection from any member state. On March 28, 2007, Hindalco filed a Form CO with the DG Comp asking the DG Comp to review and approve the Arrangement. The initial review process for the Form CO will expire on May 8, 2007, 25 business days following the filing of the Form CO. However, the DG Comp has the discretion to unilaterally extend the review period.
Agência Nacional de Energia Elétrica
Novelis do Brasil Ltda. (“NDB”), a wholly-owned subsidiary of Novelis Inc., is a holder of power generation concessions/authorizations in Brazil, which are regulated by ANEEL. On March 12, 2007, NDB received from ANEEL a letter dated March 5, 2007, saying that ANEEL approval under article 27 of Law N.8.987, dated February 13, 1995 (as amended) was required in order for NDB’s power generation concessions/authorizations to be transferred to Hindalco in connection with the Arrangement. Upon filing, it is customary for ANEEL to review an application for 45 to 60 days prior to granting approval. We currently expect ANEEL to approve the proposed transfer to Hindalco of NDB’s power generation concessions/authorizations prior to the date of the Meeting.
Judicial Developments
Prior to the adoption of Ontario Securities Commission (“OSC”)Rule 61-501 (or its predecessor, OSC Policy 9.1) andRegulation Q-27 of the Autorité des marchés financiers du Québec, Canadian courts had in few instances granted preliminary injunctions to prohibit transactions involving going private transactions (currently referred to as business combinations in OSCRule 61-501). The trend both in legislation, including the CBCA, and in Canadian jurisprudence has been towards permitting business combinations to proceed subject to compliance with procedures designed to ensure procedural and substantive fairness to the minority shareholders. Shareholders should consult their legal advisors for a determination of their legal rights.
Stock Exchange De-Listing and Reporting Issuer Status
The common shares are expected to be de-listed from the New York Stock Exchange and the Toronto Stock Exchange following the effective date. In addition, registration of our common shares under the Exchange Act will be terminated, and we will no longer be required to file periodic reports with the SEC, except as may be required under our Senior Notes. We will also make an application to cease to be a reporting issuer (or equivalent) under the securities legislation of each of the provinces and territories in Canada.


76


SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
 
Based on filings with the SEC, the following shareholders are known by us to own more than 5% of our Sharescommon shares as of September 8, 2006:March 23, 2007:
 
         
  Shares Beneficially
    
Name and Address of Beneficial Owner
 Owned  Percentage of Class* 
 
FMR Corp.(i)  11,405,602   15.4%
82 Devonshire Street
Boston, MA 02109
        
McLean Budden Ltd.(ii)  7,270,318   9.8%
145 King Street West
Suite 2525
Toronto, ON M5H 1J8
        
Kensico Capital Management Corporation(iii)  4,633,700   6.27%
55 Railroad Avenue, 2nd Floor
Greenwich, Connecticut 06830
        
         
  Common Shares
  
  Beneficially
  
Name and Address of Beneficial Owner
 Owned Percentage of Class*
 
Noonday Asset Management, LP and  4,790,000   6.4%
Farallon Capital Management, LLC (i)        
 
 
As of September 8, 2006,March 20, 2007, we had 74,005,649 Shares75,350,963 common shares outstanding.
(i)The following information is based on the Schedule 13G, filed on February 14, 2006 with the SEC by FMR Corp. Fidelity Management & Research Company (“Fidelity”), 82 Devonshire Street, Boston, Massachusetts 02109, a wholly-owned subsidiary of FMR Corp., and an investment adviser registered under the Investment Advisers Act of 1940, is the beneficial owner of 10,830,102 Shares as a result of acting as investment adviser to various investment companies. The ownership of one investment company, FA Mid Cap Stock Fund, 82 Devonshire Street, Boston, Massachusetts 02109, amounted to 6,553,560 Shares. Edward C. Johnson 3d, FMR Corp., through its control of Fidelity, and the funds each has sole power to dispose of the 10,830,102 Shares owned by the Funds. Neither FMR Corp., nor Edward C. Johnson 3d, Chairman of FMR Corp., has the sole power to vote or direct the voting of the Shares owned directly by the Fidelity Funds, which power resides with the Funds’ Boards of Trustees. Fidelity carries out the voting of the Shares under written guidelines established by the Funds’ Boards of Trustees. Fidelity Management Trust Company, 82 Devonshire Street, Boston, Massachusetts 02109, a wholly-owned subsidiary of FMR Corp., is the beneficial owner of 129,800 Shares as a result of its serving as investment manager of the institutional account(s). Edward C. Johnson 3d and FMR Corp., through its control of Fidelity Management Trust Company, each has sole dispositive power over 129,800 Shares and sole power to vote or to direct the voting of 129,800 Shares owned by the institutional account(s). Members of the Edward C. Johnson 3d family are the predominant owners of Class B shares of common stock of FMR Corp., representing approximately 49% of the voting power of FMR Corp. The Johnson family group and all other Class B shareholders have entered into a shareholders’ voting agreement under which all Class B shares will be voted in accordance with the majority vote of Class B shares. Accordingly, through their ownership of voting common stock and the execution of the shareholders’ voting agreement, members of the Johnson family may be deemed, under the United States Investment Company Act of 1940, to form a controlling group with respect to FMR Corp. Fidelity International (“FIL”), Pembroke Hall, 42 Crowlane, Hamilton, Bermuda, and various foreign-based subsidiaries provide investment advisory and management services to a number ofnon-U.S. investment companies and certain institutional investors. FIL is the beneficial owner of 445,700 Shares and has the sole power to vote and dispose of such Shares. FMR Corp. and FIL are of the view that they are not acting as a “group” for purposes of Section 13(d) under the Exchange Act and that they are not otherwise required to attribute to each other the “beneficial ownership” of securities “beneficially owned” by the other corporation within the meaning ofRule 13d-3 under the Exchange Act. The Schedule 13G states that FMR Corp. is making the filing on a voluntary basis as if all the Shares are beneficially owned by FMR Corp. and FIL on a joint basis.
(ii)The following information is based on the Form 13F filed on August 11, 2006 with the SEC by McLean Budden Ltd. (“McLean Budden”). The Form 13F indicates that McLean Budden is the beneficial owner


28


(i)of 7,270,318 Shares. McLean Budden has sole voting power and sole dispositive power over 7,270,318 Shares.
(iii)The following informationInformation is based on the Forma Schedule 13D dated March 7, 2007 and filed on September 8, 2006 with the SECSecurities and Exchange Commission by KensicoNoonday Asset Management, LP and Farallon Capital Management, Corporation (“Kensico”).LLC on behalf of themselves and certain related parties. The Form 13D indicates that Kensicoaddress of Noonday Asset Management, LP is the beneficial owner of 4,633,700 Shares. Kensico has sole voting power and sole dispositive power over 4,633,700 Shares.227 West Trade Street, Suite 2140, Charlotte, NC 28202. The address for Farallon Capital Management, LLC is One Maritime Plaza, Suite 2100 San Francisco, California 94111.
 
Share Ownership of Directors and Executive Officers
 
The following table sets forth, as of August 10, 2006,March 23, 2007, beneficial ownership of Sharesshares of our common shares by each director and each executive officer named in the Summary Compensation Table on page 31, and all directors, nominees and executive officers as a group.
 
Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. SharesCommon shares and options, warrants and convertible securities that are currently exercisable or convertible within 60 days of August 10, 2006,March 23, 2007, into our Sharescommon shares are deemed to be outstanding and to be beneficially owned by the person holding the options, warrants or convertible securities for the purpose of computing the percentage ownership of the person, but are not treated as outstanding for the purpose of computing the percentage ownership of any other person.
 
The address for the following individuals is: c/o Novelis Inc., 3399 Peachtree Road NE; Suite 1500; Atlanta, GA 30326.
 
         
  Shares Beneficially
 Percentage
Name of Beneficial Owner
 Owned of Class**Class
 
Brian W. Sturgell, FormerEdward A. Blechschmidt, Director and Acting Chief Executive Officer(i)  222,6213,197   * 
William T. Monahan, Chairman of the Board and Interim Chief Executive Officer (ii)  8,622*
Edward Blechschmidt, Director(iii)136*
Jacques Bougie, O.C., Director(iv)10,45911,104   * 
Charles G. Cavell, Director(v)Director(iii)  5,4046,909   * 
Clarence J. Chandran, Director(vi)Director(iv)  11,25914,243   * 
C. Roberto Cordaro, Director(vii)Director(v)  5,2306,722   * 
Helmut Eschwey, Director(viii)Director(vi)  5,2306,722   * 
David J. FitzPatrick, Director(ix)Director(vii)  9,79811,339   * 
Suzanne Labarge, Director(x)Director(viii)  9,10110,842*
Patrick J. Monahan, Director0*
Sheldon Plener, Director0   * 
Rudolf Rupprecht, Director(xi)Director(ix)  5,4046,909   * 
Kevin M. Twomey, Director(xii)Director(x)  3611,892   * 
Edward V. Yang, Director(xiii)Director(xi)  5,4046,909   * 
Martha Finn Brooks, Chief Operating Officer(xiv)Officer  189,489264,021   * 
Chris Bark-Jones, FormerRick Dobson, Chief Financial Officer0*
Arnaud de Weert Senior Vice President and President — Europe(xv)Europe  1,1770   *


77


Shares Beneficially
Percentage
Name of Beneficial Owner
Ownedof Class
 
Kevin Greenawalt, Senior Vice President and President — North America(xvi)America  12,16624,304   * 
Pierre Arseneault, FormerThomas Walpole Senior Vice President Strategic Planning and Information Technology(xvii)President — Asia  22,25611,019*
Tadeau Nardocci, Senior Vice President and the President — South America18,852*
Leslie J. Parrette, Jr., General Counsel0*
Orville Lunking, Vice President and Treasurer0*
Brenda Pulley, Vice President, Corporate Affairs and Communications11,417*
Bob Patterson, Vice President and Controller0*
Steven Fisher0*
Nichole Robinson0*
David Godsell24,740   * 
Directors and executive officers as a group (28(23 persons)(xviii)  566,000441,141   * 
 
 
*Indicates less than 1% of the Shares.common shares.
**As of August 10, 2006,March 20, 2007, we had 74,005,649 Shares75,350,963 common shares outstanding.
(i)Includes 14,957 Shares held in the Savings and Retirement Plan and options to purchase approximately 188,367 Shares that are exercisable within 60 days. Mr. Sturgell was terminated as Chief Executive


29


Offer on August 29, 2006. William T. Monahan, Chairman of Novelis’s Board of Directors, is currently serving as Interim Chief Executive Officer until Mr. Sturgell’s successor has been selected and is in place.3,197 DSUs.
 
(ii)Includes 5,622 DDSUs. See “Directors’ Compensation.”8,104 DSUs.
 
(iii)Includes 136 DDSUs. See “Directors’ Compensation.”6,909 DSUs.
 
(iv)Includes 10,459 DDSUs. See “Directors’ Compensation.”13,443 DSUs.
 
(v)Includes 5,404 DDSUs. See “Directors’ Compensation.”6,722 DSUs.
 
(vi)Includes 10,459 DDSUs. See “Directors’ Compensation.”6,722 DSUs.
 
(vii)Includes 5,230 DDSUs. See “Directors’ Compensation.”6,339 DSUs.
 
(viii)Includes 5,230 DDSUs. See “Directors’ Compensation.”7,842 DSUs.
 
(ix)Includes 4,798 DDSUs. See “Directors’ Compensation.”6,909 DSUs.
 
(x)Includes 6,101 DDSUs. See “Directors’ Compensation.”1,892 DSUs.
 
(xi)Includes 5,404 DDSUs. See “Directors’ Compensation.”
(xii)Includes 361 DDSUs. See “Directors’ Compensation.”
(xiii)Includes 5,404 DDSUs. See “Directors’ Compensation.”
(xiv)Includes options to purchase 164,489 Shares that are exercisable within 60 days.
(xv)Includes options to purchase 1,157 Shares that are exercisable within 60 days.
(xvi)Includes options to purchase 12,137 Shares that are exercisable within 60 days.
(xvii)Includes options to purchase 22,256 Shares that are exercisable within 60 days.
(xviii)Our directors and executive officers as a group hold 566,000 of our Shares. Our directors and executive officers as a group hold options to purchase 426,829 of our Shares that are currently exercisable or are exercisable within 60 days. Our directors as a group hold 64,608 DDSUs.6,909 DSUs.
OTHER MATTERS
 
Section 16(a) Beneficial Ownership Reporting ComplianceOther Business at the Meeting
 
The rulesboard of directors currently knows of no other business that will be presented for consideration at the SEC requireMeeting. Nevertheless, should any business other than that set forth in the Notice of Special Meeting of Shareholders properly come before the Meeting, the enclosed proxy confers discretionary authority to vote with respect to such matters, including matters that the board of directors does not know, a reasonable time before proxy solicitation, are to be presented at the Meeting. If any of these matters are presented at the Meeting, then the persons named as proxies in the enclosed proxy card will vote in accordance with their judgment.
FUTURE SHAREHOLDER PROPOSALS
If the Arrangement is completed, we disclose late filings of reports of share ownership by Novelis directorswill no longer have public shareholders, and executive officers. Because we were a “foreign private issuer” for U.S. securities law purposes throughout the 2005 fiscal year, our directors and officers were exempt from the filing requirements of Section 16(a) of the Exchange Act. Accordingly, we have nothing to reportthere will be no public participation in respect of Section 16(a) compliance in 2005. We determined that under the rules and regulations promulgated by the SEC, as of February 27, 2006, a majorityany future meetings of our outstanding Shares are now directly or indirectly held by U.S. residentsshareholders. However, if the Arrangement is not completed, our shareholders will continue to be entitled to attend and accordingly, we ceased to qualify as a foreign private issuer. We will henceforth assume the status of a domestic issuer for purposes of the Exchange Act. Therefore,participate in our directors and officers are now required to file reports under Section 16(a) of the Exchange Act.shareholder meetings.


3078


 
EXECUTIVE OFFICERS’ COMPENSATIONShareholder Proposals
If we hold a 2007 annual meeting of shareholders in accordance with our traditional schedule, which we do not currently expect to do, any shareholder proposal intended to be presented at our 2007 annual meeting of shareholders pursuant toRule 14a-8 of the Exchange Act must have been received no later than December 15, 2006 to be considered for inclusion in the Proxy Statement/Circular for the meeting. If you have a proposal that you would like us to consider at the 2007 annual meeting of shareholders, and you do not want our proxyholders to be allowed to use their discretionary voting authority to vote against this shareholder proposal when and if raised, you must submit your proposal to us no later than March 1, 2007. Proposals should be sent to our principal executive offices located at 3399 Peachtree Road NE, Suite 1500, Atlanta, Georgia, 30326, Attention: Corporate Secretary.
Communications to Non-Management Directors
 
Summary Compensation Table
The following table sets out the compensation for our chief executive officer and the four other most highly compensated executive officers (collectively, the “Named Executive Officers”) for the years ended December 31, 2005, December 31, 2004 and December 31, 2003.
                             
              Long-Term Compensation Awards    
     Annual Compensation     Shares
    
        Bonus
        Under
    
        (Executive
        Options
  All
 
        Performance
  Other Annual
  Restricted
  Granted/
  Other
 
     Salary
  Award)
  Compensation(1)
  Share Units
  SPAUs(2)
  Compensation(3)
 
Name and Principal Position
 Year  ($)  ($)  ($)  ($)  (#)  ($) 
 
Brian W. Sturgell  2005   985,000   820,147   426,371(4)  3,876,090(5)     223,157(7)
(Former President and  2004   781,200   932,257   280,686(4)     438,751   41,301 
Chief Executive Officer)  2003   600,000   561,845   254,115(4)  347,212(6)  138,114   29,679 
Martha Finn Brooks  2005   655,000   716,252   298,669(8)  1,828,600(5)     1,889,844(9)
(Chief Operating Officer)  2004   514,400   631,538   50,723(8)     155,974   14,666 
   2003   440,000   445,608   32,661      71,438   16,440 
Christopher Bark-Jones  2005   440,611   472,667   20,289   1,440,034(5)      
(Former President —  2004   440,600   395,210   43,892      127,398    
European Operations)(12)  2003   375,000   465,972   9,659      54,769   8,348 
Kevin Greenawalt  2005   310,000   323,190   18,450   439,044(5)     11,933 
(President — North  2004   255,400   192,850   582,751(10)     29,766   15,655 
American Operations)  2003   230,800   175,440   381,849(10)     16,669   16,922 
Pierre Arseneault  2005   300,000   247,720   113,207(11)  568,108(5)     5,208 
(Former Vice President  2004   300,000   257,731   37,285      47,030   12,214 
Strategic Planning and  2003   272,000   186,045   23,145      19,646   10,880 
Information                            
Technology)(13)                            
(1)In addition to tax equalization payments and perquisites listed separately below, amounts included in this column for one or more Named Executive Officers include the following perquisites that are either in the aggregate valued at the lesser of $50,000 or 10% of the Named Executive Officer’s total salary and bonus or represent less than 25% of the perquisites reported for a given year: amounts relating to professional financial advice, club memberships, automobile allowance, education expenses, relocation allowances, housing expenses (including interest on housing-related loans transferred to third party financial institutions) and cash payments to be used for perquisites at the Named Executive Officer’s discretion.
(2)See “— Long-Term Incentives — Stock Options” above for a description of the Conversion Plan and “— Long-Term Incentives — Stock Price Appreciation Units” above for a description of the Stock Price Appreciation Unit Plan. On January 6, 2005, Alcan stock options held by employees of Alcan who became our employees following our spin-off from Alcan were replaced with options to purchase our Shares. The number of options shown for periods prior to 2005 have been recast from the number of Alcan options granted into the as-converted number of Novelis options. On January 6, 2005, all Alcan SPAUs held by our employees were replaced with Novelis SPAUs. The number of SPAUs for periods prior to 2005 have been recalculated from the number of Alcan SPAUs granted into the as-converted number of Novelis SPAUs.
(3)In addition to the other amounts stated separately below, “All Other Compensation” for each of our Named Executive Officers for 2005 includes:
• savings plan contributions; and
• amounts paid by us for term life insurance.


31


The following table shows the amount of these benefits received by each Named Executive Officer for 2005:
         
Name
 Savings Plan Contributions ($)  Life Insurance ($) 
 
Brian W. Sturgell  57,614   16,452 
Martha Finn Brooks  22,509   2,644 
Christopher Bark-Jones  0   0 
Kevin Greenawalt  10,617   1,316 
Pierre Arseneault  3,686   1,522 
(4)Amounts include $393,941 (in 2005), $254,756 (in 2004) and $219,155 (in 2003) for tax equalization payments (i.e., amounts paid such that net income after taxes was not less than it would have been in the United States).
(5)The Named Executive Officers were participants in the Alcan Total Shareholder Returns Performance Plan (“TSR Plan”) prior to the spin-off. On January 6, 2005, our employees who were Alcan employees immediately prior to the spin-off and who were eligible to participate in the Alcan TSR Plan ceased to actively participate in and accrue benefits under the TSR Plan. The accrued award amounts for each participant in the TSR Plan were converted into Novelis restricted share units. The then current three-year performance periods, namely 2002 — 2005 and 2003 — 2006, were truncated as of the date of the spin-off. At the end of each performance period, each holder of restricted share units will receive the net proceeds based on our common share price at that time, including declared dividends. The number of restricted share units granted to our Named Executive Officers and the dollar value of such restricted share units as of January 6, 2005 was as follows:
         
Name
 Restricted Share Units (#)  Value of Restricted Share Units ($) 
 
Brian W. Sturgell  166,213   3,876,090 
Martha Finn Brooks  78,413   1,828,600 
Christopher Bark-Jones  61,751   1,440,034 
Kevin Greenawalt  18,827   439,044 
Pierre Arseneault  24,361   568,108 
(6)Represents the value, at the time of the grant, of restricted share units granted prior to our spin-off from Alcan. These restricted share units vested in full and were paid in January 2005.
(7)Includes $149,092 that we were obligated to pay under an Alcan employee compensation plan as part of our spin-off from Alcan. No future payments will be required under the plan.
(8)Amounts for 2005 include reimbursement of relocation expenses of $266,245. Amounts for 2004 include $18,211 for tax equalization.
(9)Includes $1,864,691 for the cash payout of deferred share units received prior to the spin-off that were converted to Novelis deferred share units as part of the spin-off. The deferred units vested and were paid in August 2005.
(10)Amounts include $369,293 (in 2004) and $154,815 (in 2003) for tax equalization payments.
(11)Amounts for 2005 include reimbursement of relocation expenses of $84,031.
(12)Chris Bark-Jones stepped down as Senior Vice President and President — European Operations on May 1, 2006.
(13)Pierre Arseneault retired from Novelis on June 1, 2006.


32


Fiscal Year-End Option/ SPAU Table
The following table summarizes, for each of the Named Executive Officers, the total number of Shares underlying unexercised options held on December 31, 2005 and the aggregate value of unexercisedin-the-money options on December 31, 2005, which is the difference between the exercise price of the options and the market value of the Shares on December 31, 2005, which was $20.89 per share. The aggregate values indicated with respect to unexercisedin-the-money options at fiscal year-end have not been, andYou may never be, realized. These options have not been, and may never be exercised and actual gains, if any, on exercise will depend on the value of the Shares on the date of exercise. There can be no assurance that these values will be realized.
               
     Value of Unexercised
 
  Shares Underlying Unexercised
  In-the-Money
 
  Options and SPAUs
  Options and SPAUs
 
  on December 31, 2005(1)
  on December 31, 2005(1)
 
Name
 (#)  $ 
 
Brian W. Sturgell Options (E):     E:    
(Former President and Chief Executive Options (U):  753,477   U:   508,995 
Officer)              
Martha Finn Brooks Options (E):  89,960   E:    
(Chief Operating Officer) Options (U):  298,121   U:   129,679 
Christopher Bark-Jones Options (E):     E:    
(Former President — European Options (U):  4,630   U:   9,029 
Operations) SPAUs (E):     E:    
  SPAUs (U):  213,850   U:   123,926 
Kevin Greenawalt Options (E):     E:    
(President — North American Options (U):  48,550   U:   35,438 
Operations) SPAUs (E):     E:    
  SPAUs (U):  22,952   U:   31,666 
Pierre Arseneault Options (E):     E:    
(Former Vice President Strategic Options (U):  89,032   U:   68,598 
Planning and Information Technology)              
(1)E: Exercisable     U: Unexercisable


33


Long-Term Incentive Plan Table — Founders Plan
On March 24, 2005,contact our board, of directors adopted the Founders Plan to allow for an additional compensation opportunity tied to Novelis share price improvement targets for certain of our executives approved by the Human Resources Committee. Participants earn PSUs if Novelis share price improvement targets are achieved within three performance periods: March 24, 2005 to March 23, 2008; March 24, 2006 to March 23, 2008; and March 24, 2007 to March 23, 2008. The table below sets forth PSU tranches representing the number of PSUs that participants are eligible to receive for the three performance periods under the Founders Plan if share improvement targets are achieved. The share price improvement targets for these three tranches are $23.57, $25.31 and $27.28, respectively.
         
Name
 Units Granted  
Performance Period
 
 
Brian W. Sturgell(1)  0   March 24, 2005 to March 23, 2008 
(Former President and Chief  70,275   March 24, 2006 to March 23, 2008 
Executive Officer)  70,275   March 24, 2007 to March 23, 2008 
Martha Finn Brooks  23,750(2)  March 24, 2005 to March 23, 2008 
(Chief Operating Officer)  23,750   March 24, 2006 to March 23, 2008 
   23,750   March 24, 2007 to March 23, 2008 
Christopher Bark-Jones  7,200(2)  March 24, 2005 to March 23, 2008 
(Former President — European  7,200   March 24, 2006 to March 23, 2008 
Operations)  7,200   March 24, 2007 to March 23, 2008 
Kevin Greenawalt  7,200(2)  March 24, 2005 to March 23, 2008 
(President — North American  7,200   March 24, 2006 to March 23, 2008 
Operations)  7,200   March 24, 2007 to March 23, 2008 
Pierre Arseneault  6,000(2)  March 24, 2005 to March 23, 2008 
(Former Vice President Strategic  6,000   March 24, 2006 to March 23, 2008 
Planning and Information  6,000   March 24, 2007 to March 23, 2008 
Technology)        
(1)On March 14, 2006, Mr. Sturgell agreed with the board of directors’ decision that, in light of our 2005 and 2006 financial reporting delay and restatement, Mr. Sturgell would forfeit 46,850 PSUs attributable to the first tranche of the award. The board of directors also approved an increase in the size of the award opportunity for Mr. Sturgell for the second and third tranches under the Founders Plan to provide an additional incentive for reaching the share price improvement targets for those tranches. The award size for each tranche was increased by 23,425 PSUs to a potential of 70,275 PSUs. The PSUs for the second and third tranches would not have been earned unless the share price improvement targets specified in the Founders Plan ($25.31 and $27.28, respectively) were achieved. As a result of Mr. Sturgell’s termination as CEO on August 29, 2006, all of his PSUs attributable to the second and third tranches of the Founder’s Plan were forfeited.
(2)The share price improvement targets for the first tranche were satisfied in June 2005. As a result, Ms. Brooks and Messrs. Bark-Jones, Greenawalt and Arseneault received the full amount of their performance unit tranche for the performance period from March 24, 2005 to March 23, 2008. Ms. Brooks and Messrs. Bark-Jones, Greenawalt and Arseneault received cash payments for the payout of these awards in April 2006 in the amounts of $478,325, $145,008, $145,008 and $120,840, respectively, which will be reported as 2006 compensation.


34


Retirement Benefits
Novelis Pension Plan for Officers
Our Human Resources Committee determines participants in the Pension Plan for Officers (“PPO”). This plan is a supplemental executive retirement plan that provides an additional pension benefit based on combined service up to 20 years as an officer of Novelis or of Alcan and eligible earnings which consist of the excess of the average annual salary and target short-term incentive award during the 60 consecutive months when they were the greatest over eligible earnings in the U.S. Plan or the U.K. Plan, as applicable. Both the U.S. Plan and U.K. Plan are described below. Each provides for a maximum pension benefit on eligible earnings that is established with reference to the position of the officer prior to being designated a PPO participant. The following table shows the percentage of eligible earnings in the PPO, payable upon normal retirement after age 60, according to combined years of service as an officer of Novelis or of Alcan.
       
Years as Officer
5 10 15 20
 
15% 30% 40% 50%
The normal form of payment of pensions is a lifetime annuity. Pensions are not subject to any deduction for social security or other offset amounts.
Prior to their termination, Brian W. Sturgell and Christopher Bark-Jones were the only participants in the PPO. Mr. Sturgell has 9 years and 10 months of combined service and Mr. Bark-Jones has 14 years and 10 months of combined service under the PPO. Eligible earnings under the PPO for 2005 for Mr. Sturgell were $983,556 and were $282,414 for Mr. Bark-Jones.
U.S. Plan
During 2005, those of our employees previously participating in the Alcancorp Pension Plan and the Alcan Supplemental Executive Retirement Plan (collectively referred to as the “U.S. Plan”) received up to one year of additional service under each plan to the extent that such employees continued to be employed by us during the year. We paid to Alcan the normal cost (in the case of the Alcancorp Pension Plan) and the current service cost (in the case of the Alcan Supplemental Executive Retirement Plan) with respect to those employees. The U.S. Plan provides for pensions calculated based upon combined service with us or Alcan of up to 35 years. Eligible earnings consist of the average annual salary and the short-term incentive award up to its target during the 3 consecutive calendar years when they were the greatest, subject to a cap for those participating in the PPO.
Effective January 1, 2006, Novelis adopted the Novelis Pension Plan which provides benefits identical to the benefits provided under the Alcancorp Pension Plan. Executive officers who were participants in the Alcancorp Pension Plan will participate in the Novelis Plan. Executive officers who were not participants in the Alcancorp Pension Plan will not participate in the Novelis Plan. Executive officers who were hired on January 1, 2005 or later will participate in the Novelis Savings and Retirement Plan.
The following table shows estimated retirement benefits, expressed as a percentage of eligible earnings, payable upon normal retirement at age 65 according to years of combined service.
           
Years of Service
10 15 20 25 30 35
 
17% 25% 34% 42% 51% 59%
The normal form of payment of pensions is a lifetime annuity with either a guaranteed minimum of 60 monthly payments or a 50% lifetime pension to the surviving spouse.
At age 65, the estimated credited years of combined service for Martha Finn Brooks, Kevin Greenawalt and Pierre Arseneault would be approximately 22 years, 39 years and 40 years, respectively. Mr. Sturgell has 17 years and 5 months of combined service under the U.S. Plan. Eligible earnings under the plan for 2005 for


35


Mr. Sturgell, Ms. Brooks, Mr. Greenawalt and Mr. Arseneault were $938,340, $1,029,800, $443,000 and $460,380, respectively.
Individual Pension Undertakings
In addition to participation in the U.S. Plan described above, Martha Finn Brooks will receive from us a supplemental pension equal to the excess, if any, of the pension she would have received from her employer prior to joining Alcan had she been covered by her prior employer’s pension plan until her separation or retirement from Novelis, over the sum of her pension from the U.S. Plan and the pension rights actually accrued with her previous employer.
U.K. Plan.
The U.K. Plan, which was transferred to us from Alcan in connection with the spin-off, provides for pensions calculated on service of up to 40 years and eligible earnings, which consist of the average annual salary and the short-term incentive award up to its target during the last 12 months before retirement, subject to a cap for those participating in the PPO.
The following table shows estimated retirement benefits, expressed as a percentage of eligible earnings, payable upon normal retirement at age 65 according to combined years of service.
           
Years of Service
10 15 20 25 30 35
 
17% 26% 35% 43% 52% 60%
The normal form of payment of pensions is a lifetime annuity with a guaranteed minimum of 60 monthly payments and a 60% lifetime pension to the surviving spouse.
Prior to his termination, Christopher Bark-Jones was the only executive officer entitled to participate in the U.K. Plan. Mr. Bark-Jones has approximately 29 credited years of combined service under the U.K. Plan and his eligible earnings in 2005 were $480,386.
Value of the Retirement Benefits
A measure of the value of the U.S. Plan, U.K. Plan and of the Pension Plan for Officers that can be deemed to be part of the total 2005 compensation of the five aforementioned Named Executive Officers is the service cost of the plans. The service cost is the estimated present value of benefits attributable by the pension benefit formula to services rendered by the plan members during a given period. The valuation of benefits is based on actuarial assumptions in relation to future events that will vary by plan to take into account the general characteristics of its membership.
Another measure of the value of pension plans or pension benefits is the projected benefit obligation (“PBO”). The PBO is the actuarial present value of the part of the total pension payable at retirement that is attributable to service rendered up to the date of valuation.
The following table indicates the total projected annual pension of each Named Executive Officer from the plans described above, based on years of credited combined service up to the normal retirement age of 65 and eligible earnings to the end of 2005. The table also indicates 2005 service cost and the PBO as of December 31, 2005 in relation to each Named Executive Officer.
The service cost and the PBO amounts are only estimates using prevailing interest rates of the discounted value of contractual entitlements. The value of these estimated entitlements may change over time because they are based on long-term assumptions, such as the expected distribution of retirement ages, future compensation increases and life expectancy, that may not represent actual developments. Furthermore, the methods used to determine these amounts will not be the same as those used by other companies and therefore will not be directly comparable. The actuarial assumptions applied are the same as those used to determine the service cost and the benefit obligation as described in Note 15 to our combined and consolidated financial


36


statements for the year ended December 31, 2005. There is no contractual undertaking by the Company to pay benefits of equivalent amounts.
             
        Projected Benefit
 
  Projected Annual
  2005 Service
  Obligation as of
 
  Pension Payable at Age 65
  Cost
  December 31, 2005
 
Name
 ($)  ($)  ($) 
 
Brian W. Sturgell  850,068   425,124   5,261,224 
Martha Finn Brooks  306,821   109,686   396,400 
Christopher Bark-Jones  396,084   194,751   4,739,233 
Kevin Greenawalt  235,673   52,933   1,271,600 
Pierre Arseneault  270,369   65,899   1,422,000 
EMPLOYMENT AGREEMENTS AND CHANGE IN CONTROL AGREEMENTS
In connection with our spin-off from Alcan, we entered into employment agreements with Brian W. Sturgell, our former Chief Executive Officer, Martha Finn Brooks, our Chief Operating Officer, Chris Bark-Jones, our former President of our European operations, Kevin Greenawalt, President of our North American operations and Pierre Arseneault, our former Vice President of Strategic Planning and Information Technology, and other executive officers, setting out the terms and conditions of their employment. In 2005, under their respective employment agreements, Brian W. Sturgell was entitled to a base salary of $985,000, Martha Finn Brooks was entitled to a base salary of $655,000, Chris Bark-Jones was entitled to a base salary of $440,611, Kevin Greenawalt was entitled to a base salary of $310,000 and Pierre Arseneault was entitled to a base salary of $300,000. Each of these officers was also eligible for participation in programs providing short-term incentives, long-term incentives and other types of compensation that reflect the competitive level of similar positions in the compensation peer groups or as included in published survey information.
Certain of our executive officers have also entered into change in control agreements that provide for severance payments by us upon the termination of the executive officer’s employment without cause or by the executive officer for good reason. Except in the case of Brian W. Sturgell, upon the occurrence of such an event, the executive would be entitled to an amount equal to 24 months of his or her base salary and target short-term incentive award. These change in control agreements will expire on the earliest to occur of the second anniversary of the spin-off (January 6, 2007), the date of the executive’s death or retirement, or the date following the termination of the executive’s employment for any other reason.
Mr. Sturgell is entitled to an amount equal to 36 months of his base salary and target short-term incentive award (payable in 36 equal monthly instalments), plus the amount payable under provisions of the TSR Plan upon termination of his employment without cause. In addition, Mr. Sturgell’s change in control agreement provides that severance payments under such agreement will be excluded from the calculation of earnings for purposes of calculating pension benefits; however, the duration of such payments will be included for purposes of calculating years of service under the Company’s pension plans.
On July 1, 2002, Alcancorp entered into a Deferred Share Agreement with Martha Finn Brooks pursuant to which Alcancorp agreed to grant to Ms. Brooks 33,500 shares of Alcan common shares on August 1, 2005, the date of her third anniversary of employment, as compensation for the loss by Ms. Brooks of accrued benefits and unvested restricted shares at her former employer. In connection with our spin-off from Alcan, on January 6, 2005, we assumed Alcancorp’s obligations under the Deferred Share Agreement and the 33,500 shares of Alcan common stock to be granted were converted into 66,477 Shares. On July 27, 2005, the Deferred Share Agreement was amended to provide that we will, in lieu of granting Ms. Brooks 66,477 Shares, pay Ms. Brooks cash in an amount equal to the value of such Shares based on the closing price of such Shares on the New York Stock Exchange on August 1, 2005, subject to applicable withholding taxes. Ms. Brooks received a payment in the gross amount of $1,864,691.


37


DIRECTORS’ COMPENSATION
Each of our non-executive directors is entitled to receive compensation equal to $150,000 per year, payable in quarterly installments, except that the directors who are members of our Audit Committee are entitled to $155,000. The chaircommittee of our board, of directors isor an individual director by writing to receive compensation equalour Corporate Secretary — Board Communication at our head office. All communications will be compiled by the Corporate Secretary and submitted to $250,000 per year, and the chair of our Audit Committee is entitled to receive $175,000 per year. We have adopted a Deferred Share Unit Plan for Non-Executive Directors, pursuant to which 50% of our directors’ compensation is required to be paid inappropriate board member. The Corporate Secretary will reply or take other instructions from the form of DDSUs, and 50% in the form of either cash, additional DDSUs, or a combination of the two at the election of each non-executive director, unless otherwise determined by our Human Resources Committee. An employee of Novelis who is a director is not entitled to receive fees for serving on ourapplicable board of directors.contact
 
Because at least half of our non-executive directors’ compensation will be paid in DDSUs, our non-executive directors are not required to own a specific amount of our Shares. DDSUs are the economic equivalent of our Shares. A director cannot redeem the accumulated DDSUs until he or she ceases to be a member of our board of directors.
Our board of directors believes that compensation in the form of DDSUs together with the requirement that our non-executive directors retain all DDSUs until they cease to be a director helps to align the interests of our non-executive directors with those of our shareholders.
The number of DDSUs to be credited to the account of a non-executive director each quarter will be determined by dividing the quarterly amount payable in DDSUs, by the average closing prices of a common share on the Toronto and New York stock exchanges on the last five trading days of each quarter. Additional DDSUs will be credited to each non-executive director corresponding to dividends declared on our Shares. The DDSUs are redeemable only upon termination of the directorship and may be redeemed in cash, our Shares or a combination thereof, at the election of the director. The amount to be paid by us upon redemption will be calculated by multiplying the accumulated balance of DDSUs by the average closing prices of a common share on the Toronto and New York stock exchanges on the last five trading days prior to the redemption date. For services rendered by directors in 2005, 57,051 DDSUs were granted.
Our non-executive directors are entitled to reimbursement for transportation, lodging and other expenses incurred in attending meetings of our board of directors and meetings of committees of our board of directors. Our non-executive directors who are not Canadian residents are entitled to reimbursement for tax advice related to compensation.
The following table sets out the individual election of each non-executive director in relation to their compensation.
             
  Portion of Fees Paid
  Portion of Fees
  Amount of Fees
 
Name
 in the Form of DDSUs  Paid in Cash  Paid in Cash (US$) 
 
Edward A. Blechschmidt  100%   0%    
Jacques Bougie, O.C  100%   0%    
Charles G. Cavell  50%   50%   77,500 
Clarence J. Chandran  100%   0%    
C. Roberto Cordaro  50%   50%   75,000 
Helmut Eschwey  50%   50%   75,000 
David J. FitzPatrick  50%   50%   64,583 
Suzanne Labarge  50%   50%   87,500 
William T. Monahan  50%   50%   75,000 
J.E. Newall  100%   0%    
Rudolf Rupprecht  50%   50%   77,500 
Kevin M. Twomey  50%   50%    
Edward Yang  50%   50%   77,500 


38


CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Alcancorp established a real estate loan program to assist relocating employees in the United States. Under the program, an employee was permitted to obtain an interest-free loan from Alcancorp, the proceeds of which were to be used only to purchase a new principal residence. The loan is secured by a mortgage on the new principal residence. On July 1, 2003, Jo-Ann Longworth, our former Vice President and Controller, received a loan from Alcancorp in the amount of $75,000 under this program. As of January 20, 2005, the loan was transferred to a third-party bank. The largest amount outstanding under the loan in 2005 was $73,125. There was no interest paid to us for the loan prior to it being transferred to the third party bank.
DIRECTORS’ AND OFFICERS’ LIABILITY INSURANCE
Novelis carries insurance covering liability, including defense costs, of directors and officers of Novelis and its subsidiaries, incurred as a result of their acting as such, except in the case of failure to act honestly and in good faith. The policy provides coverage against certain risks in situations where Novelis may be prohibited by law from indemnifying the directors or officers. The policy also reimburses Novelis for certain indemnity payments made by Novelis to such directors or officers, subject to a $2.5 million deductible in respect of each insured loss.
The premium paid by Novelis for coverage in 2005 was $1.62 million and the limit of insurance is $125 million per occurrence and in the aggregate per year.
ADDITIONAL INFORMATION
 
NOVELIS WILL MAIL WITHOUT CHARGE, UPON WRITTEN REQUEST, A COPY OF ITS ANNUAL REPORT ONNovelis will mail without charge, upon written request, a copy of its annual report onFORMForm 10-K FOR THE YEAR ENDED DECEMBERfor the year ended December 31, 2005, INCLUDING THE CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULES. REQUESTS SHOULD BE SENT TO: NOVELIS INC.2006, including our consolidated and combined financial statements and management’s discussion and analysis. Requests should be sent to: Novelis Inc., 3399 PEACHTREE ROADPeachtree Road NE, SUITESuite 1500, ATLANTA, GAAtlanta, Georgia 30326, ATTENTION: CORPORATE SECRETARY.Attention: Corporate Secretary.
 
AdditionalWe file annual, quarterly and current reports, proxy statements and other information relatingwith the SEC. You may read and copy any reports, statements or other information that we file with the SEC at its Public Reference Room, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates. Please call the SEC at1-800-SEC-0330 for further information on the operation of the public reference room.
Our public filings are also available to Novelis may be found on our websitethe public from document retrieval services and at Internet sites maintained by the SEC atwww.novelis.comwww.sec.gov, on and SEDAR atwww.sedar.com.
If you have any questions about this Proxy Statement/Circular, the Meeting or the Arrangement or need assistance with the voting procedures, you should contact Georgeson, our proxy solicitor, toll-free at866-834-6791.
You should only rely on EDGAR atwww.sec.govinformation provided in this Proxy Statement/Circular. No persons have been authorized to give any information or to make any representations other than those contained in this Proxy Statement/Circular and, if given or made, such information or representations must not be relied upon as having been authorized by us or any other person. This Proxy Statement/Circular is dated                    . You should not assume that the information contained in this Proxy Statement/Circular is accurate as of any date other than that date, and the mailing of this Proxy Statement/Circular to shareholders shall not create any implication to the contrary.
APPROVAL OF THE BOARD OF DIRECTORSNOVELIS
 
The contents and mailing to shareholders of this Proxy Statement/Circular have been approved by our board of directors has approveddirectors.
Nichole Robinson
Corporate Secretary
Atlanta, Georgia
April 5, 2007


79


ANNEX A

ARRANGEMENT RESOLUTION


ARRANGEMENT RESOLUTION
SPECIAL RESOLUTION OF THE SHAREHOLDERS
BE IT RESOLVED THAT:
1. The arrangement (the “Arrangement”) under Section 192 of the contentsCanada Business Corporations Act (the “CBCA”) involving Novelis Inc., a corporation existing under the laws of Canada (the “Corporation”), as more particularly described and set forth in the proxy statement/circular (the “Proxy Statement/Circular”) of the Corporation accompanying the notice of this meeting (as the Arrangement may be or may have been modified or amended in accordance with its terms) is hereby authorized, approved and adopted.
2. The plan of arrangement (the “Plan of Arrangement”) involving the Corporation, the full text of which is set out asAnnex C to the Proxy Statement/Circular as contemplated by the Arrangement Agreement (the “Agreement”) made between Hindalco Industries Limited, a corporation existing under the laws of India, AV Metals Inc., a corporation existing under the laws of Canada (as assigned by its subsidiary, AV Aluminum Inc., a corporation existing under the laws of Canada) and the sendingCorporation and dated as of February 10, 2007 (as the Plan of Arrangement may be or may have been modified or amended in accordance with its terms) is hereby authorized, approved and adopted.
3. The Agreement, the actions of the directors of the Corporation in approving the Agreement and the actions of the directors and officers of the Corporation in executing and delivering and causing the Corporation to shareholders.perform its obligations under the Agreement and any amendments thereto are hereby ratified and confirmed.
4. Notwithstanding that this resolution has been passed (and the Plan of Arrangement adopted) by the shareholders of the Corporation or that the Arrangement has been approved by the Superior Court of Justice (Ontario), the directors of the Corporation are hereby authorized and empowered without further notice to or approval of the shareholders of the Corporation (i) to amend the Agreement or the Plan of Arrangement to the extent permitted by the Agreement, and (ii) subject to the terms of the Agreement, to cause the Corporation not to proceed with the Arrangement.
5. Any officer or director of the Corporation is hereby authorized and directed for and on behalf of the Corporation to execute, under the seal of the Corporation or otherwise, and to deliver articles of arrangement and such other documents as are necessary or desirable to the Director under the CBCA in accordance with the Agreement for filing.
6. Any officer or director of the Corporation is hereby authorized and directed for and on behalf of the Corporation to execute or cause to be executed, under the seal of the Corporation or otherwise, and to deliver or cause to be delivered, all such other documents and instruments and to perform or cause to be performed all such other acts and things as may be necessary or desirable to give full effect to the foregoing resolutions and the matters authorized hereby, such determination to be conclusively evidenced by the execution and delivery of such document or instrument and the doing of such act or thing.


A-1


ANNEX B

ARRANGEMENT AGREEMENT


Note: On March 30, 2007 AV Aluminum Inc. assigned its interest in the Arrangement Agreement to Acquisition Sub.
 
 
-s- Nichole RobinsonARRANGEMENT AGREEMENT
by and among
HINDALCO INDUSTRIES LIMITED,
AV ALUMINUM INC.
and
NOVELIS INC.
DATED AS OF FEBRUARY 10, 2007


B-1


TABLE OF CONTENTS
Page
ARTICLE IDEFINITIONS; PRINCIPLES OF INTERPRETATION1
Section 1.01.Definitions1
Section 1.02.Currency9
Section 1.03.Headings9
Section 1.04.Including9
Section 1.05.No Strict Construction9
Section 1.06.Number and Gender9
Section 1.07.Statutory References9
Section 1.08.Time9
Section 1.09.Time Periods9
Section 1.10.Entire Agreement9
Section 1.11.Schedules9
ARTICLE IITHE TRANSACTIONS9
Section 2.01.The Arrangement9
Section 2.02.Implementation Steps by the Company9
Section 2.03.Interim Order10
Section 2.04.Articles of Arrangement, Effective Date and Closing10
Section 2.05.The Proxy Statement/Circular and Related Materials11
Section 2.06.Securities and Corporate Compliance11
Section 2.07.Depositary12
ARTICLE IIIREPRESENTATIONS AND WARRANTIES OF THE COMPANY12
Section 3.01.Authority12
Section 3.02.Organization and Qualification12
Section 3.03.Capitalization13
Section 3.04.Consents and Approvals; No Conflicts13
Section 3.05.Financial Statements14
Section 3.06.Absence of Certain Changes; Certain Liabilities and Obligations14
Section 3.07.Litigation14
Section 3.08.Compliance with Law; Licenses and Permits15
Section 3.09.Contracts15
Section 3.10.Securities Laws Matters15
Section 3.11.Customer Relations15
Section 3.12.Foreign Corrupt Practices15
Section 3.13.Intellectual Property15
Section 3.14.Property16
Section 3.15.Labor Relations and Other Employment Matters16
Section 3.16.Employee Benefit Plans17
Section 3.17.Tax Matters17
Section 3.18.Environmental18
Section 3.19.Product Warranty Matters19
Section 3.20.Affiliate Transactions19
Section 3.21.Opinions of Financial Advisors19


Page
Section 3.22.Rights Plan19
Section 3.23.Disclaimer19
Section 3.24.Company Disclosure Schedule19
ARTICLE IVREPRESENTATIONS AND WARRANTIES OF THE PARENT AND ACQUISITION SUB19
Section 4.01.Parent Formation19
Section 4.02.Acquisition Sub Formation19
Section 4.03.Ownership20
Section 4.04.Authority20
Section 4.05.Authorization20
Section 4.06.No Governmental Consent20
Section 4.07.Availability of Funds20
Section 4.08.Common Shares21
Section 4.09.Litigation21
Section 4.10.Disclaimer21
ARTICLE VCOVENANTS21
Section 5.01.Conduct of Business During Pre-Effective Date Period21
Section 5.02.Operational Covenants21
Section 5.03.Other Covenants of the Company23
Section 5.04.Company Covenants Regarding Non-Solicitation23
Section 5.05.Access to Information; Confidentiality25
Section 5.06.Indemnification25
Section 5.07.Further Action; Reasonable Best Efforts26
Section 5.08.Resignations27
Section 5.09.Notice of Developments27
Section 5.10.Benefits Continuation27
Section 5.11.No Control of Other Party’s Business28
Section 5.12.Financing28
ARTICLE VICONDITIONS30
Section 6.01.Mutual Conditions Precedent30
Section 6.02.Additional Conditions Precedent to the Obligations of Parent30
Section 6.03.Additional Conditions Precedent to the Obligations of the Company31
Section 6.04.Satisfaction of Conditions31
ARTICLE VIIAMENDMENT AND TERMINATION31
Section 7.01.Amendment31
Section 7.02.Termination32
Section 7.03.Termination Fees33
Section 7.04.Remedies34
ARTICLE VIIIGENERAL34
Section 8.01.Advisors34
Section 8.02.Public Statements34
Section 8.03.Notices34


ii


Page
Section 8.04.Assignment35
Section 8.05.Further Assurances35
Section 8.06.Execution and Delivery35
Section 8.07.No Liability36
Section 8.08.Agent for Service of Process36
Section 8.09.Dispute Resolution36
Section 8.10.Governing Law37
Section 8.11.Severability37
Section 8.12.Binding Effect37
Section 8.13.Survival37
Section 8.14.Third Party Beneficiary37
Section 8.15.Expenses37


iii


ARRANGEMENT AGREEMENT
THIS ARRANGEMENT AGREEMENT, dated as of February 10, 2007, is made by and among Hindalco Industries Limited, a corporation existing under the laws of India (“Parent”), AV Aluminum Inc., a corporation existing under the laws of Canada and a subsidiary of Parent (“Acquisition Sub”), and Novelis Inc., a corporation existing under the laws of Canada (the “Company”).
 
Nichole RobinsonRECITALS:
Corporate Secretary
WHEREAS, subject to the terms and conditions of this Agreement, Parent, through its subsidiary, Acquisition Sub, is offering to acquire all of the outstanding Common Shares for $44.93 per Common Share in cash (the “Purchase Price”);
WHEREAS, the Company has agreed to submit to its Shareholders a statutory arrangement under Section 192 of the CBCA pursuant to which Acquisition Sub will acquire all of the Common Shares of the Company for the Purchase Price per Common Share on the terms set out in the Plan of Arrangement; and
WHEREAS, the Parties have entered this Agreement to set out their agreements in respect of the proposed statutory arrangement.
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, Parent, Acquisition Sub and the Company hereby agree as follows:
ARTICLE I
DEFINITIONS; PRINCIPLES OF INTERPRETATION
Section 1.01.  Definitions.  Unless otherwise provided in this Agreement, the following terms shall have the following meanings respectively:
2006 Incentive Plan” means the Company’s 2006 Incentive Plan approved by the Company’s Shareholders at the 2006 Annual Meeting of Shareholders;
Acquisition Proposal” means: (i) any merger, tender offer, take-over bid, amalgamation, plan of arrangement, business combination, consolidation or recapitalization that, if consummated, would result in any Person beneficially owning more than 35% of the Common Shares, or any liquidation orwinding-up in respect of the Company; (ii) any sale or acquisition of 35% or more of the fair market value of the assets of the Company on a consolidated basis; (iii) any acquisition of 35% or more of the Common Shares (or rights thereto) or any acquisition of 35% or more of the equity interests (or rights thereto) in any of the material Subsidiaries of the Company; or (iv) any proposal or offer to do, or public announcement of an intention to do, any of the foregoing or any similar transaction from any Person other than Parent or Acquisition Sub, but for greater certainty does not include the Transactions;
Affected Employees” has the meaning given to it in Section 5.11;
Affiliate” has the meaning ascribed to it underRule 12b-2 of the Exchange Act;
Agreement” means this Agreement, including all schedules, and all amendments or restatements hereof (if any), and, unless otherwise specified, references to “Article” or “Section” mean the specified Article or Section of this Agreement;
Alcan” means Alcan, Inc., a corporation existing under the laws of Canada;
Alternative Financing” has the meaning given to it in Section 5.12.
Applicable Plans” has the meaning given to it in Section 3.16;
Arrangement” means the proposed arrangement under the provisions of Section 192 of the CBCA as set out in the Plan of Arrangement, subject to any amendments or variations thereto made in


accordance with Section 7.01 of this Agreement or Article V of the Plan of Arrangement or made at the direction of the Court in the Final Order;
Arrangement Resolution” means the special resolution approving the Plan of Arrangement to be considered at the Meeting, substantially in the form ofSchedule B;
Articles of Arrangement” means the articles of arrangement of the Company in respect of the Arrangement that are required by the CBCA to be filed with the Director after the Final Order is made in order for the Arrangement to become effective;
Associate” has the meaning ascribed to it inRule 12b-2 under the Exchange Act;
Authorized Agent” has the meaning given to it in Section 8.08;
Business Day” means any day other than a Saturday or Sunday on which commercial deposit taking banks are generally open for business in Mumbai, India, Toronto, Ontario and Atlanta, Georgia;
CBCA” means the Canada Business Corporations Act, as amended from time to time;
Certificate of Arrangement” means the Certificate of Arrangement to be issued by the Director pursuant to Section 192(7) of the CBCA in respect of the Articles of Arrangement;
Claimant” has the meaning given to it in Section 8.09;
Code” means the United States Internal Revenue Code of 1986, as amended;
Collective Agreements” has the meaning given to it in Section 3.15;
Commissioner” means the Commissioner of Competition appointed under the Competition Act;
Commitment Letters” has the meaning given to it in Section 4.07;
Common Shares” means the common shares of the Company;
Company Adverse Recommendation Change” has the meaning given to it in Section 5.04;
Company Disclosure Schedule” has the meaning given to it in Article III;
Company IP” has the meaning given to it in Section 3.13;
Company Recommendation” means the recommendation of the Company’s Board of Directors that the Shareholders vote in favor of the Arrangement Resolution;
Company Shareholder Approval” means the affirmative vote of holders of not less than 662/3% of the outstanding Common Shares voting at the Meeting on the Arrangement;
Company Termination Payment” means $100,000,000;
Competition Act” means the Competition Act (Canada), as amended from time to time;
Competition Act Approval” means: (i) the issuance of an advance ruling certificate (“ARC”) pursuant to Section 102 of the Competition Act by the Commissioner to the effect that the Commissioner would not have sufficient grounds upon which to apply to the Competition Tribunal for an Order under Section 92 of the Competition Act with respect to the transactions contemplated by this Agreement; or (ii) that:
(A) the waiting period under Section 123 of the Competition Act shall have expired, or the Commissioner shall have waived the obligation to notify and supply information under Section 113(c) of the Competition Act because substantially similar information was previously supplied in relation to a request for an ARC, and
(B) Parent shall have been advised in writing by the Commissioner that the Commissioner has determined not to make an application for an Order under Section 92 or Section 100 of the Competition Act in respect of the transactions contemplated by this Agreement;


392


Consent Procedures” has the meaning given to it in Section 5.02;
Contracts” means contracts, licenses, leases, agreements, undertakings, understandings, arrangements or commitments to which the Company or any of its Subsidiaries is a party or by which any of them or their assets are bound or under which the Company or any of its Subsidiaries has any liability;
Conversion Plan” means the Company’s Conversion Plan of 2005, as amended as of October 19, 2006;
Court” means the Ontario Superior Court of Justice (Commercial List);
Credit Agreement” means the Credit Agreement, dated as of January 7, 2005, among the Company, Novelis Corporation, Novelis Deutschland GmbH, Novelis UK Limited and Novelis AG, the lenders party thereto, and Citicorp North America, Inc., as administrative agent and collateral agent.
Credit Rating” means, with respect to any Person, the rating given to such Person’s long-term unsecured debt obligations by Standard & Poor’s Ratings Group (a division of McGraw Hill, Inc.) or Moody’s Investors Service, Inc., as applicable, and any successors thereto;
Damages” means any and all costs or expenses (including reasonable attorneys’ fees and expenses), judgments, fines, losses, claims, damages, liabilities and amounts reasonably paid in any settlement;
Deferred Share Unit Plan” means the Company’s Deferred Share Unit Plan for Non-Executive Directors;
Depositary” means CIBC Mellon Trust Company;
Director” means the Director appointed pursuant to Section 260 of the CBCA;
Disclosed Publicly” means disclosed or furnished by the Company in a publicly available filing (i) on the Electronic Document Gathering, Analysis and Retrieval System (EDGAR) or (ii) with the OSC which is available for retrieval through the SEDAR system, in each case prior to the date of this Agreement;
Dissent Rights” means the rights of dissent in respect of the Arrangement as described in the Plan of Arrangement;
D&O Insurance” has the meaning given to it in Section 5.06;
DSU” means a deferred share unit granted pursuant to the Deferred Share Unit Plan;
Effective Date” means the date shown on the Certificate of Arrangement to be issued under the CBCA giving effect to the Arrangement;
Effective Time” means the date and time of the issuance of the Articles of Arrangement by the Director;
Encumbrance” means any mortgage, pledge, assignment, charge, lien, claim, security interest, adverse interest, easement, license,right-of-way, covenant, right of use, encroachment or other encumbrance of any nature or kind;
Environmental Claim” means any and all actions, suits, orders, demands, directives, claims, liens, investigations, requests for information, proceedings or notices of noncompliance, liability or violation by or from any Person alleging liability (including potential responsibility or liability for enforcement, investigatory costs, cleanup costs, response costs, removal costs, remedial costs, natural resources damages or restoration, property damages, personal injuries or penalties) based on, arising out of, resulting from, or in connection with the presence or Release of, or exposure to, any Hazardous Substances at any location; or the failure to comply with any Environmental Law;
Environmental Laws” has the meaning given to it in Section 3.18;
Environmental Permits” has the meaning given to it in Section 3.18;


3


ERISA” means the United States Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder;
ERISA Affiliate” means each business or entity which is a member of a “controlled group of corporations,” under “common control” or an “affiliated service group” with the Company within the meaning of Sections 414(b), (c) or (m) of the Code, or required to be aggregated with the Company under Section 414(o) of the Code, or is under “common control” with the Company, within the meaning of Section 4001(a)(14) of ERISA;provided that the term “ERISA Affiliate” excludes Alcan and any business or entity that is a member of a “controlled group of corporations,” under “common control” or an “affiliated service group” with Alcan within the meaning of Sections 414(b), (c) or (m) of the Code, or required to be aggregated with Alcan under Section 414(o) of the Code, or is under “common control” with Alcan, within the meaning of Section 4001(a)(14) of ERISA;
Exchange Act” means the United States Securities Exchange Act of 1934, as amended from time to time;
Financial Statements” has the meaning given to it in Section 3.05;
Financing” and “Financings” have the meanings given to them in Section 5.12;
Final Order” means the final order of the Court approving the Arrangement as such order may be amended by the Court at any time prior to the Effective Time or, if appealed, then, unless such appeal is withdrawn or denied, as affirmed or as amended on appeal;
Founders Performance Awards Plan” means the Company’s Founders Performance Awards Plan, as amended as of March 14, 2006;
Governmental Entity” means:
(i) any supranational or multinational body or organization (such as the European Union), nation, government, state, province, country, territory, municipality, quasi-government, any administrative, judicial or regulatory authority, agency, board, body, bureau, commission, or instrumentality thereof or any political subdivision thereof, or any court, tribunal or arbitral body, any central bank (or similar monetary or regulatory authority), any taxing authority, any ministry or department or agency of any of the foregoing;
(ii) any entity exercising executive, legislative, judicial, quasi-judicial, regulatory or administrative functions of or pertaining to government, or any self regulatory organization (including the TSX and the NYSE); and
(iii) any corporation or other entity owned or controlled, through stock or capital ownership or otherwise, by any of such entities or other such bodies pursuant to the foregoing;
Hazardous Substances” has the meaning given to it in Section 3.18;
HSR Act” means theHart-Scott-Rodino Antitrust Improvements Act of 1976 of the United States of America, as amended from time to time;
ICC” has the meaning given to it in Section 8.09;
Information” has the meaning given to it in Section 5.05;
Interim Order” means the interim order of the Court as contemplated by Section 2.03, providing for, among other things, the calling and holding of the Meeting, as the same may be amended by the Court;
Intellectual Property” means (a) any intellectual property in any jurisdiction and all rights therein provided under (i) patent law, (ii) copyright law, (iii) trade-mark law, (iv) design patent or industrial design law, (v) semi-conductor chip or mask work law, or (vi) any other statutory provision or common law principle, including trade secret law, which may provide a right in ideas, formulae, compositions, processes, products, algorithms, concepts, inventions or know-how; (b) any and all applications,


4


registrations, licenses,sub-licenses, franchises, agreements or any other evidence of a right in any of the foregoing; and (c) all rights to enforce the rights and obtain remedies for a violation of any of the rights set out in the foregoing;
Investment Canada Act” means the Investment Canada Act, as amended;
Investment Canada Act Approval” means approval or deemed approval pursuant to the Investment Canada Act by the applicable Minister;
Knowledge of the Company” means the actual knowledge of the executive officers of the Company listed in Schedule 1.01 of the Company Disclosure Schedule;
Laws” means any applicable laws, including supranational (including European Union), national, provincial, state, municipal and local, laws, treaties, statutes, ordinances, rules, regulations, subordinate legislation, by-laws, directives, decrees, ordinances, codes or other requirements of any Governmental Entity, and includes common law;
Material Adverse Effect” means any change, effect, event, occurrence, state of facts or development which individually or in the aggregate (i) is or would reasonably be expected to be materially adverse to the business, operations, results of operations, liabilities or obligations (whether absolute, accrued, conditional, contingent or otherwise), capitalization or financial condition of the Company and its Subsidiaries, taken as a whole; or (ii) is or would reasonably be expected to impair in any material respect the ability of the Company to consummate the transactions contemplated by this Agreement or to perform its obligations under this Agreement on a timely basis;provided that none of the following shall be deemed, either individually or in the aggregate to constitute a Material Adverse Effect: any change, effect, event, occurrence, state of facts or development (A) in the financial, banking, credit, securities, or commodities markets, the economy in general or prevailing interest rates of the United States, Canada or any other jurisdiction, where the Company or any of its Subsidiaries has operations or significant revenues, (B) in any industry in which the Company or any of its Subsidiaries operates, (C) in the Company’s stock price or trading volume (provided that this clause (C) shall not be construed as providing that any cause or factor affecting the Company’s stock price or trading volume does not constitute a Material Adverse Effect), (D) arising as a result of a change in U.S. GAAP or regulatory accounting principles or interpretations thereof after the date hereof, (E) in Law or interpretations thereof by any Governmental Entity, (F) arising or resulting from the announcement of this Agreement, the pendency of the Transactions, or compliance by any Party with the covenants and agreements herein, (G) arising or resulting from any failure by the Company to meet any internal or published projections, forecasts or revenue or earnings predictions (provided that this clause (G) shall not be construed as providing that any cause or factor giving rise to such failure does not constitute a Material Adverse Effect), (H) any continuation of an adverse trend or condition or the escalation of, or any developments with respect to, any dispute referred to on Schedule 3.07 of the Company Disclosure Schedule, (I) arising or resulting from any act of war or terrorism (or, in each case, escalation thereof) or declaration of a national emergency, or (J) arising or resulting from the acts or omissions of Parentand/or its Affiliates; except in the cases of clauses (A), (B) and (I), to the extent such change, effect, event, occurrence, state of facts or development has or would reasonably be expected to have a disproportionate effect on the Company and its Subsidiaries, taken as a whole, as compared to other Persons in the industries in which the Company and its Subsidiaries operate unless such disproportionate change, effect, event, occurrence, state of facts or development arises from any metal price ceiling in any of the Company’s customer contracts;provided that any change, effect, event, occurrence, state of facts or development that is cured prior to the termination of this Agreement in accordance with its terms shall not be considered a Material Adverse Effect;
Meeting” means the special meeting of Shareholders, including any adjournment or postponement thereof, to be called and held in accordance with the Interim Order to consider the Arrangement Resolution;
Notice” has the meaning given to it in Section 8.03;


5


Notice of Superior Proposal” has the meaning given to it in Section 5.04;
NYSE” means the New York Stock Exchange;
Optionholders” means holders of Options;
Options” means the options to acquire Common Shares granted under the 2006 Incentive Plan or converted into options to acquire Common Shares pursuant to the Conversion Plan;
OSC” means the Ontario Securities Commission;
Orders” means orders, injunctions, judgments, decrees, rulings, awards, assessments, penalties or sanctions issued, filed or imposed by any Governmental Entity;
Outside Date” has the meaning given to it in Section 7.02(a)(ii);
Party” or “Parties” means a signatory or the signatories to this Agreement, respectively;
Permitted Encumbrances” means any of the following Encumbrances in respect of a Real Property or other asset of the Company or any of its Subsidiaries, as applicable: (a) Encumbrances set forth in the Company Disclosure Schedule or relating to debt obligations reflected in the Company’s Financial Statements; (b) Encumbrances reflected in the Financial Statements, (c) Encumbrances for Taxes or other governmental charges not yet due or payable or subject to penalties for non-payment or which are being contested in good faith by appropriate proceedings, if adequate reserves with respect thereto are maintained in the appropriate financial statements; (d) Encumbrances imposed by law, such as carriers’, warehousemen’s and mechanics’ liens and other similar Encumbrances, in each case, incurred in good faith in the ordinary course of business for sums not yet due or payable, for construction in process, or being contested in good faith by appropriate proceedings or other Encumbrances arising out of judgments or awards against the Company or any of its Subsidiaries with respect to which the Company or such Subsidiary, as applicable, shall then be proceeding with an appeal or other proceedings for review, if, in each case, adequate reserves with respect thereto are maintained in the appropriate financial statements; (e) pledges or deposits by the Company or any of its Subsidiaries under worker’s compensation Laws, unemployment insurance Laws or similar legislation, good faith deposits to secure bids, tenders, contracts (other than for the payment of indebtedness for borrowed money or guarantees in respect thereof) or leases to which such Person is a party, or to secure surety or appeal bonds to which such Person is a party, or deposits as security for contested Taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business and provided in each case the same are not then enforceable; (f) leases and subleases granted to third parties in the ordinary course of business permitting occupancy of portions of any Real Property and which do not materially impair the use of the Real Property subject thereto; (g) title exceptions, imperfections or irregularities, easements,rights-of-way, covenants, licenses, rights of use, encroachments and similar Encumbrances and zoning or other restrictions as to the use of a Real Property that, in each case do not materially impair the use of the Real Property subject thereto; (h) Encumbrances disclosed in existing title policies, title reports, title opinions or plats of survey provided to Parent prior to the date hereof; and (i) Encumbrances which would not have, individually or in the aggregate, a Material Adverse Effect;
Person” includes any individual, sole proprietorship, partnership, firm, entity, limited partnership, limited liability company, unlimited liability company, unincorporated association, unincorporated syndicate, unincorporated organization, trust, body, corporation or Governmental Entity, and Persons acting jointly or in concert and where the context requires any of the foregoing when they are acting as trustee, executor, administrator or other legal representative;
Plan of Arrangement” means the plan of arrangement in the form ofSchedule C and any amendments or variations made thereto in accordance with this Agreement, the Plan of Arrangement or made at the direction of the Court in the Final Order;


6


Pre-Effective Date Period” means the period from the time of the execution and delivery of this Agreement among the Parties until the closing of the Transactions on the Effective Date, subject to the earlier termination of this Agreement in accordance with its terms;
Proxy Statement/Circular” means the notice of the Meeting and accompanying proxy statement/circular, including all appendices thereto, to be sent to Shareholders in connection with the Meeting;
PSU” means a performance share unit granted pursuant to the Founders Performance Award Plan;
Public Acquisition Proposal” has the meaning given to it in Section 7.03;
Public Disclosure Documents” means all reports, schedules, forms, statements and other documents (including exhibits and other information incorporated therein) filed by the Company with the SECand/or OSC since January 4, 2005 together with any documents filed (rather than furnished) during such period by the Company to the SEC on a voluntary basis on Current Reports onForm 8-K in each case which are available to the public on EDGAR or SEDAR;
Purchase Price” has the meaning given to it in the recitals hereto;
Regulatory Approvals” means those rulings, consents, orders, exemptions, permits, waivers, authorizations, agreements, certificates, clearances and other approvals (including the lapse, without objection, of a prescribed time under a statute or regulation that provides that a transaction may only be implemented if a prescribed time lapses following the giving of notice without an objection being made) of any Governmental Entity that are necessary in connection with the Transactions, as set out inSchedule A hereto;
Reimbursement Amount” has the meaning given to it in Section 7.03;
Release” means any release, spill, emission, leaking, dumping, injection, pouring, deposit, disposal, discharge, dispersal, leaching or migration into or through the environment (including ambient air, surface water, groundwater, land surface or subsurface strata);
Representatives” means any Person’s or such Person’s Subsidiaries’ employees, agents and representatives, including any investment banker, financial advisor, attorney, accountant or other advisor, agent, representative or controlled Affiliate;
Request” has the meaning given to it in Section 8.09;
Respondent” has the meaning given to it in Section 8.09;
Rights Plan” means the Shareholder Rights Agreement between the Company and CIBC Mellon Trust Company dated as of December 23, 2004, as amended by the First Amendment Agreement dated February 10, 2007;
SAR” means a stock appreciation right granted pursuant to the 2006 Incentive Plan;
SEC” means the United States Securities and Exchange Commission;
Securities” means Common Shares, Options, SARs, SPAUs, PSUs and DSUs;
Securities Laws” means, collectively, the federal securities laws of the United States, any applicable state securities Laws and the securities Laws of each province and territory of Canada (including the rules and policies of the Canadian Securities Administrators);
Senior Notes” means the Company’s 71/4% Senior Notes due 2015;
Shareholders” means holders of Common Shares;
Significant Metal Supply Agreement” means any metal supply agreement pursuant to which the aggregate dollar value of metal purchased under such agreement (i) represented greater than 3% of the aggregate dollar value of metal purchased by the Company and its Subsidiaries under all metal supply agreements for the year ended December 31, 2006 or (ii) is reasonably expected to represent greater than


7


3% of the aggregate dollar value of metal purchased by the Company and its Subsidiaries under all metal supply agreements during the year ending December 31, 2007;
Significant Customer Agreement” means any customer agreement pursuant to which the aggregate shipments under any such agreement (i) represented greater than 1% of the Company and its Subsidiaries’ total shipments for the year ended December 31, 2006 or (ii) are reasonably expected to represent greater than 1% of the Company and its Subsidiaries’ total shipments for the year ending December 31, 2007;
SPAU” means a stock price appreciation unit granted pursuant to the Stock Price Appreciation Unit Plan;
Stock Price Appreciation Unit Plan” means the Company’s Stock Price Appreciation Unit Plan;
Subsidiary” means, with respect to a Person, any other Person of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other Persons performing similar functions, or a majority of the outstanding voting securities of which, are at the time owned directly or indirectly by such Person;
Superior Proposal” means any bona fide written Acquisition Proposal made after the date hereof by a third party that was not solicited in breach of Section 5.04 and that if consummated would result in such Person (or its stockholders) owning, directly or indirectly, more than 50% of the Common Shares then outstanding or more than 50% of the assets of the Company on a consolidated basis, which the Board of Directors of the Company determines, acting in good faith and after consultation with its financial advisors and outside legal counsel, taking into account all financial, legal, regulatory and other aspects of such proposal (including anybreak-up fee, expense reimbursement provisions, due diligence and other conditions to consummation and financing terms, including the committed status thereof) and the Person making the proposal, to be more favorable to the Shareholders from a financial point of view than the Transactions;
Superior Proposal Agreement” has the meaning given to it in Section 5.04;
Superior Proposal Recommendation” has the meaning given to it in Section 5.04;
Tax” and “Taxes” means, with respect to any Person, all supranational, federal, state, local, provincial, branch or other taxes, including income, gross receipts, windfall profits, value added, severance, ad valorem, property, capital, net worth, production, sales, use, license, excise, franchise, employment, environmental taxes, sales taxes, use taxes, value added taxes, transfer taxes, withholding or similar taxes, payroll taxes, employment taxes, Canada and provincial pension plan premiums, severance taxes, social security premiums, workers’ compensation premiums, employment insurance or compensation premiums, stamp taxes, occupation taxes, premium taxes, alternative or add-on minimum taxes, goods and services tax, customs duties or other taxes of any kind whatsoever imposed or charged by any Governmental Entity, together with any interest, penalties, or additions with respect thereto and any interest in respect of such additions or penalties;
Tax Returns” includes all returns, reports, declarations, elections, notices, filings, forms, statements and other documents (whether in tangible, electronic or other form) and including any amendments, schedules, attachments, supplements, appendices and exhibits thereto required by Law to be filed with any taxing authority in respect of Taxes;
Tax Sharing and Disaffiliation Agreement” has the meaning given to it in Section 3.17;
Transactions” means, collectively the transactions contemplated herein and in the Plan of Arrangement;
Transfer Agent” means the registrar and transfer agent of the Common Shares;
TSX” means The Toronto Stock Exchange; and
U.S. GAAP” means generally accepted accounting principles as applied in the United States of America.


8


Section 1.02.  Currency.  Unless otherwise specified, all references to money amounts are expressed in and all payments provided for herein shall be made in lawful money of the United States of America and “$” refers to U.S. Dollars.
Section 1.03.  Headings.  Headings of Articles and Sections are inserted for convenience of reference only and shall not affect the construction or interpretation of this Agreement.
Section 1.04.  Including.  Where the word “including” or “includes” is used in this Agreement, it means “including (or includes) without limitation.”
Section 1.05.  No Strict Construction.  The language used in this Agreement is the language chosen by the Parties to express their mutual intent, and no rule of strict construction shall be applied against any Party.
Section 1.06.  Number and Gender.  Unless the context otherwise requires, words importing the singular include the plural and vice versa and words importing gender include all genders.
Section 1.07.  Statutory References.  A reference to a statute includes all rules and regulations made pursuant to such statute and, unless otherwise specified, the provisions of any statute or regulation or rule which amends, supplements or supersedes any such statute or any such regulation or rule.
Section 1.08.  Time.  Time is of the essence in the performance of the Parties’ respective obligations under this Agreement.
Section 1.09.  Time Periods.  Unless otherwise specified, time periods within or following which any payment is to be made or act is to be done shall be calculated by excluding the day on which the period commences and including the day on which the period ends and by extending the period to the next Business Day following if the last day of the period is not a Business Day.
Section 1.10.  Entire Agreement.  This Agreement, together with the Plan of Arrangement and the agreements and other documents required to be delivered pursuant to this Agreement, constitutes the entire agreement between the Parties with respect to the subject matter of this Agreement and sets out all the covenants, promises, warranties, representations, conditions, understandings and agreements between the Parties pertaining to the subject matter of this Agreement and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, relating thereto. No reliance has been made upon, and there are no covenants, promises, warranties, representations, conditions, understandings or other agreements, oral or written, between the Parties in connection with the subject matter of this Agreement except as specifically set forth in this Agreement and any document required to be delivered pursuant to this Agreement.
Section 1.11.  Schedules.  In addition to the Company Disclosure Schedule, the other schedules to this Agreement, as listed below, are an integral part of this Agreement:
ScheduleDescription
ARegulatory Approvals
BArrangement Resolution
CPlan of Arrangement
ARTICLE II
THE TRANSACTIONS
Section 2.01.  The Arrangement.  The Arrangement shall comprise substantially the events or transactions, taken in the sequence indicated, set forth inSchedule C to this Agreement.
Section 2.02.  Implementation Steps by the Company.  The Company shall:
(a) subject to the terms of this Agreement, as soon as reasonably practicable, apply in a manner (including as to form, content and procedure) acceptable to Parent, acting reasonably, under Section 192 of the CBCA for the Interim Order and thereafter proceed with and diligently pursue the obtaining of the Interim Order;


9


(b) use its reasonable best efforts to convene and hold the Meeting, in accordance with the Interim Order, as soon as reasonably practicable, for the purpose of considering the Arrangement Resolution;
(c) except as required for quorum purposes or otherwise permitted under this Agreement, not adjourn (except as required by Law or by valid Shareholder action), postpone or cancel (or propose or permit the adjournment, postponement or cancellation of) the Meeting without Parent’s prior written consent, such consent not to be unreasonably withheld or delayed;
(d) subject to Section 5.04, (i) through the Company’s Board of Directors, recommend that Shareholders vote in favor of the Arrangement Resolution and include such recommendation in the Proxy Statement/Circular; and (ii) use its reasonable best efforts to solicit from the Shareholders proxies in favor of the approval of the Arrangement Resolution;
(e) provide notice to Parent of the Meeting and allow Representatives of Parent to attend the Meeting;
(f) provide notice of the application for the Interim Order and Final Order to the Director as required by Section 192 of the CBCA;
(g) subject to obtaining the approvals as required by the Interim Order, as soon as reasonably practicable after the Meeting, apply in a manner (including as to form, content and procedure) reasonably acceptable to Parent, to the Court under Section 192 of the CBCA for the Final Order and thereafter proceed with and diligently pursue the obtaining of the Final Order;
(h) subject to obtaining the Final Order and the satisfaction or waiver of the other conditions herein contained in favor of each Party, on the date contemplated in Section 2.04 or as soon thereafter as reasonably practicable, send to the Director for endorsement and filing by the Director, the Articles of Arrangement and such other documents as may be required in connection therewith under the CBCA to give effect to the Arrangement; and
(i) without limiting the foregoing, provide Parent with all drafts, copies of the final versions of and reasonable opportunity to review and comment on all applications, filings, motions and other documents prepared by or on behalf of the Company in connection with the Arrangement, consider (acting reasonably) all of the comments on changes to such documents received from or on behalf of Parent and make such changes to such documents as are reasonably acceptable to the Company.
Section 2.03.  Interim Order.  The application referred to in Section 2.02(a) shall request that the Interim Order provide:
(a) for the class of Persons to whom notice is to be provided in respect of the Arrangement and the Meeting and for the manner in which such notice is to be provided;
(b) that, subject to the approval of the Court, the requisite approval for the Arrangement Resolution shall be 662/3% of the votes cast on the Arrangement Resolution by Shareholders present in person or by proxy at the Meeting, voting together as a single class, each Common Share entitling the holder thereof to one vote on the Arrangement Resolution;
(c) that, in all other respects, the terms, restrictions and conditions of the Company’s articles of incorporation and by-laws each as amended prior to the date of this Agreement, including quorum requirements and all other matters, shall apply in respect of the Meeting;
(d) for the grant of the Dissent Rights; and
(e) for the notice requirements with respect to the application to the Court for the Final Order.
Section 2.04.  Articles of Arrangement, Effective Date and Closing.  The Articles of Arrangement shall implement the Plan of Arrangement. On the second Business Day after the satisfaction or waiver (subject to applicable Laws) of the conditions (excluding conditions that, by their terms, cannot be satisfied until the Effective Date, but subject to the satisfaction or, where permitted, waiver of those conditions as of the Effective Date) set forth in Article VI, unless another time or date is agreed to in writing by the Parties, the


10


Articles of Arrangement (in form and substance reasonably satisfactory to Parent) shall be filed by the Company with the Director. From and after the Effective Time, the Plan of Arrangement will have all of the effects provided by applicable Laws, including the CBCA. The closing of the Transactions will take place at the offices of King & Spalding LLP located at 1180 Peachtree Street, N.E., Atlanta, Georgia 30309 on the Effective Date, or at such other location as may be agreed upon by the Parties.
Section 2.05.  The Proxy Statement/Circular and Related Materials.  As promptly as reasonably practicable after the execution of this Agreement, the Company shall prepare the Proxy Statement/Circular together with any other documents required by the applicable Securities Laws, the CBCA and other applicable Laws in connection with the Meeting and the Arrangement and cause a preliminary copy of the Proxy Statement/Circular to be filed with the SEC. The Company shall use its reasonable best efforts to determine as soon as practicable whether the SEC intends to review the Proxy Statement/Circular and to the extent the SEC does conduct such review, to respond to any comments by the SEC or its staff on such Proxy Statement/Circular as promptly as reasonably practicable after such filing. Parent and Acquisition Sub shall furnish all information as may be reasonably requested by the Company in connection with any such action and the preparation, filing and distribution of the Proxy Statement/Circular. As promptly as reasonably practicable after (i) the SEC or its staff advises the Company that it either does not intend to review the Proxy Statement/Circular or has no further comments on the Proxy Statement/Circular, as applicable, and (ii) receipt of the Interim Order, the Company shall use its reasonable best efforts to cause the final version of the Proxy Statement/Circular to be (A) sent to the Shareholders as of the record date for the Meeting and any other Person required by the Interim Order and applicable Laws and (B) filed as required by the Interim Order and applicable Laws. Parent and its counsel shall be given a reasonable opportunity to review all drafts of the Proxy Statement/Circular and all other documentation contemplated by this Section 2.05 (including the Proxy Statement/Circular prior to its filing with the SEC and its being sent to Shareholders and the form of proxy and any correspondence with the SEC) and comment thereon and the Company shall consider (acting reasonably) all of the Parent’s comments and Parent shall be provided a final copy thereof promptly following its completion, recognizing in the case of the Proxy Statement/Circular that the content, preparation and delivery of the Proxy Statement/Circular is primarily the responsibility of the Company.
Notwithstanding the preceding sentence, all information concerning Parent and Acquisition Sub in the Proxy Statement/Circular or such other documents shall be in form and substance reasonably satisfactory to the Parent.
Section 2.06.  Securities and Corporate Compliance.
(a) Each of Parent, Acquisition Sub and the Company shall furnish to the other all such information concerning it, its respective Affiliates and its respective shareholders and, in the case of the Company, the Optionholders, as may be reasonably required to effect the actions described in Section 2.02, Section 2.04 and Section 2.05 and this Section 2.06, and each covenants that no information furnished by it in connection with such actions will contain any untrue statement of a material fact or omit to state a material fact required to be stated in any such document or necessary in order to make any information so furnished for use in any such document not misleading in the light of the circumstances in which it is furnished or to be used.
(b) Each of Parent, Acquisition Sub and the Company shall promptly notify the other Parties if at any time before the Effective Time it becomes aware that the Proxy Statement/Circular or any application for an Order hereunder contains any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements contained therein not misleading in light of the circumstances in which they are made, or that otherwise requires an amendment or supplement to the Proxy Statement/Circular or such application. In any such event, Parent, Acquisition Sub and the Company shall cooperate in the preparation of a supplement or amendment to the Proxy Statement/Circular or such other document, as required and as the case may be, and, if required by applicable Law or the Court, shall cause the same to be distributed to the Shareholders and filed with the SEC, the OSC and any applicable securities regulatory authorities of the other provinces and territories of Canada.
(c) The Company shall ensure that the Proxy Statement/Circular and the manner in which it is sent to Shareholders complies in all material respects with all applicable Laws and, without limiting the generality of


11


the foregoing, that the Proxy Statement/Circular does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements contained therein not misleading in light of the circumstances in which they are made (other than with respect to any information relating to and provided by Parent or Acquisition Sub). Without limiting the generality of the foregoing, the Company shall ensure that the Proxy Statement/Circular provides Shareholders with information in sufficient detail to permit them to form a reasoned judgment concerning the matters to be placed before them at the Meeting.
Section 2.07.  Depositary.  The Company shall permit the Transfer Agent for Common Shares to act as Depositary in connection with the Transactions and instruct the Transfer Agent to furnish to Parent (and such Persons as it may designate) at such times as it may reasonably request such information and provide to Parent (and such Persons as it may designate) such other assistance as it may reasonably request in connection with the implementation and completion of the Transactions.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except as Disclosed Publicly prior to the date hereof (other than in the case of the matters covered in Sections 3.01, 3.02, 3.03, 3.21 and 3.22 which shall not be subject to such qualification), or as set forth in the disclosure schedule of the Company dated the date hereof (the “Company Disclosure Schedule”), the Company hereby represents and warrants to Parent and Acquisition Sub as follows:
Section 3.01.  Authority.  The Company has the corporate power and authority to enter into this Agreement and to perform its obligations hereunder. The execution and delivery of this Agreement by the Company and the consummation by the Company of the Arrangement and the Transactions have been duly authorized by its Board of Directors and, except for Shareholder approval of the Arrangement Resolution, the Interim Order and the Final Order and the approval by the Company’s Board of Directors of the Proxy Statement/Circular, no other corporate proceedings on its part are necessary to authorize this Agreement or the Arrangement or the Transactions. This Agreement has been duly executed and delivered by the Company and constitutes a valid and binding obligation of the Company, enforceable against it in accordance with its terms, subject to the qualification that such enforceability is subject to bankruptcy, insolvency and other applicable Laws affecting creditors’ rights generally, and to general principles of equity. As of the date hereof, the Company’s Board of Directors has adopted resolutions: (i) authorizing and approving this Agreement and the Arrangement and the Transactions; (ii) authorizing the Company to execute and deliver this Agreement; (iii) authorizing the Company to consummate the Transactions on the terms set forth herein and in the Plan of Arrangement; (iv) determining that the Plan of Arrangement is fair to the Shareholders and is in the best interests of the Company; (v) directing that the Arrangement Resolution be submitted to a vote at a meeting of Shareholders; and (vi) recommending that Shareholders approve the Arrangement Resolution.
Section 3.02.  Organization and Qualification.  The Company and each of its Subsidiaries has been duly incorporated or formed under all applicable Laws of its jurisdiction of incorporation or formation, is validly existing and has all necessary corporate or organizational power and authority to own its property and assets and to carry on its business as currently owned and conducted, except as would not have, individually or in the aggregate, a Material Adverse Effect. The Company and each of its Subsidiaries is duly registered, qualified or otherwise authorized to do business and each is in good standing in each jurisdiction in which the character of its properties, owned, leased, licensed or otherwise held, or the nature of its activities makes such registration, qualification or authorization necessary, except where the failure to be so registered, qualified or in good standing or otherwise authorized to do business would not have, individually or in the aggregate, a Material Adverse Effect. The Company and each of its Subsidiaries is not subject to any liquidation, administrative, bankruptcy or similar proceedings and has not entered into any composition or arrangement, within the meaning of applicable Laws, with its creditors. The Company and its Subsidiaries do not hold or own any securities or have any equity interest in any other Person (other than a Subsidiary) that is material to the Company. All of the Company’s Subsidiaries are wholly owned by the Company. All of the outstanding shares or other equity interests of the Company’s Subsidiaries which are held directly or indirectly by the


12


Company are validly issued, fully paid and non-assessable and are owned directly or indirectly by the Company free and clear of all Encumbrances held by third parties. There are no options, warrants, conversion privileges or other rights, agreements, arrangements, entitlements, understandings or commitments (pre-emptive, contingent or otherwise) regarding the right to acquire any shares, other ownership interests or other securities in any of the Company’s Subsidiaries.
Section 3.03.  Capitalization.
(a) The authorized capital of the Company consists of an unlimited number of Common Shares, an unlimited number of first preferred shares (issuable in series) and an unlimited number of second preferred shares (issuable in series). At the close of business on February 9, 2007, 75,191,430 Common Shares were issued and outstanding, and there were no preferred shares outstanding.
(b) The Company Disclosure Schedule sets forth a listing of all Options, SARs, DSUs, SPAUs and PSUs outstanding as of the date hereof, and if applicable, the exercise price, vested status and expiration dates therefor.
(c) Except as set forth above in Section 3.03(a) and Section 3.03(b), as of the date hereof, there were no other options, warrants, conversion privileges or other rights, agreements, arrangements or commitments (pre-emptive, contingent or otherwise) obligating the Company or any Subsidiary to issue, transfer or sell any shares of the capital stock or ownership interests in the Company or any of its Subsidiaries or any securities or obligations of any kind convertible into or exchangeable for any shares of the Company or any of its Subsidiaries. All outstanding Common Shares and the Common Shares to be issued on exercise of the Options have been duly authorized. The outstanding Common Shares are, and the Common Shares to be issued on exercise of the Options, will be when issued, validly issued and outstanding as fully paid and non-assessable shares, free of pre-emptive rights. Other than the Common Shares, there are no securities of the Company or of any of its Subsidiaries outstanding which have the right to vote generally (or are exercisable, convertible into or exchangeable for securities having the right to vote generally) or with the Shareholders on any matter. There are no outstanding contractual or other obligations of the Company to repurchase, redeem or otherwise acquire any of their respective securities or with respect to the voting or disposition of any of their respective securities.
Section 3.04.  Consents and Approvals; No Conflicts.  No consent, approval, order or authorization of, or declaration or filing with, any Governmental Entity is required to be obtained by the Company or any Subsidiary in connection with the execution and delivery by the Company of this Agreement and the performance by it of its obligations under this Agreement, and the consummation by the Company of the Arrangement and other Transactions, other than those which are referred to in this Agreement and except for those that would not have, individually or in the aggregate, a Material Adverse Effect. The authorization of this Agreement, the execution and delivery by the Company of this Agreement and the performance by it of its obligations under this Agreement, and the consummation of the Arrangement and other Transactions will not:
(a) result (with or without notice or the passage of time) in a violation or breach of or otherwise accelerate any rights, obligations or liabilities under, constitute a default under, or require any consent to be obtained under, any provision of:
(i) its or any of its Subsidiaries’ certificate of incorporation, articles, by-laws or other charter documents;
(ii) any applicable Laws (subject to obtaining the Regulatory Approvals), except to the extent that the violation or breach of, or failure to obtain any consent under, any applicable Laws, would not have, individually or in the aggregate, a Material Adverse Effect; or
(iii) any Contract or Order to which the Company or any of its Subsidiaries is party or by which it is bound, except (A) as would not have, individually or in the aggregate, a Material Adverse Effect, or (B) for any violation, breach, acceleration, default or consent obligation caused as a result of the status, business or activities of Parent or Acquisition Sub; or


13


(b) give rise to any event of default under, right of termination under, or acceleration or cancellation of, any Contract or indebtedness of the Company or any Subsidiary, or cause any such Contract to terminate or such indebtedness to come due before its stated maturity or cause any available credit of the Company or any Subsidiary to cease to be available, in each case except as would not have, individually or in the aggregate, a Material Adverse Effect.
Section 3.05.  Financial Statements.
(a) The audited consolidated financial statements of the Company (including any related notes thereto) as of and for the fiscal year ended December 31, 2005 and the unaudited consolidated financial statements of the Company as of and for the nine months ended September 30, 2006 (such audited and unaudited consolidated financial statements referred to collectively as the “Financial Statements”) have been prepared in accordance with U.S. GAAP applied on a consistent basis and present fairly, in all material respects, the financial condition, cash flows and results of operation of the Company and its Subsidiaries on a consolidated and combined basis as of the respective dates thereof and for the respective periods covered thereby (except as may be indicated expressly in the notes thereto) and, in the case of unaudited statements, subject to normal year-end adjustments. Since September 30, 2006 through the date of this Agreement, there has been no material change in the Company’s accounting policies.
(b) The Company maintains a system of disclosure controls and procedures designed to ensure that information required to be disclosed by the Company under applicable Securities Laws is recorded, processed, summarized and reported within the time periods specified in the applicable Securities Laws. Such disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports and other filings under applicable Securities Laws is accumulated and communicated to the Company’s management, including its principal executive and principal financial officers, or Persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company maintains internal control over financial reporting. Such internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP.
(c) Neither the Company nor any of its Subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off balance sheet partnership or any similar agreement (including any agreement or arrangement relating to any transaction or relationship between or among the Company and any of its Subsidiaries, on the one hand, and any unconsolidated entity, including any structured finance, special purpose, or limited purpose entity or person, on the other hand) or any “off balance sheet arrangements” (as defined in Item 303(a) ofRegulation S-K of the SEC and Section 1.8 and the instructions thereto ofForm 51-102F1 of National Instrument51-102 — Continuous Disclosure Obligations) where the result, purpose or effect of such agreement or arrangement is to avoid disclosure of any material transaction involving, or material liabilities of, the Company or any of its Subsidiaries in the Company’s or such Subsidiary’s financial statements or any other documents filed by the Company under applicable Securities Laws.
Section 3.06.  Absence of Certain Changes; Certain Liabilities and Obligations.  Since September 30, 2006 and through the date hereof, (i) each of the Company and its Subsidiaries has conducted its business in all material respects in the ordinary course of business consistent with past practice; and (ii) there have not occurred any circumstances or events which would have, individually or in the aggregate, a Material Adverse Effect. Except as disclosed or referred to in the Financial Statements, and except for liabilities and obligations incurred in the ordinary course of business consistent with past practice since September 30, 2006, as of the date hereof, none of the Company or any of its Subsidiaries has any liabilities or obligations required by U.S. GAAP to be reflected or reserved against on the Financial Statements, except for those that would not have, individually or in the aggregate, a Material Adverse Effect.
Section 3.07.  Litigation.  As of the date hereof, there is no claim, action, proceeding or investigation that has been commenced or, to the Knowledge of the Company, threatened against the Company or any Subsidiary, as the case may be, before any Governmental Entity which would have, individually or in the


14


aggregate, a Material Adverse Effect. As of the date hereof, none of the Company or its Subsidiaries is subject to any outstanding judgment, order, writ, injunction or decree which would have a Material Adverse Effect.
Section 3.08.  Compliance with Law; Licenses and Permits.
(a) As of the date hereof, the Company and its Subsidiaries are in compliance with all applicable Laws, other than non-compliance which would not have, individually or in the aggregate, a Material Adverse Effect; provided, however, that this Section 3.08 does not address securities laws, labor and employment laws, tax laws, environmental laws and product warranty laws, which are exclusively addressed by Section 3.10, Section 3.15, Section 3.17, Section 3.18 and Section 3.19, respectively.
(b) As of the date hereof, the Company and its Subsidiaries own, possess, or have obtained and are in compliance with, all licenses, permits, certificates, orders, grants and other authorizations of or from any Governmental Entity necessary to conduct its businesses substantially as now conducted or as proposed to be conducted, except for where the failure to do so would not have, individually or in the aggregate, a Material Adverse Effect.
Section 3.09.  Contracts.  Except for any default which would not have, individually or in the aggregate, a Material Adverse Effect, none of the Company or any of its Subsidiaries, or, to the Knowledge of the Company, any other party thereto, is in default under, and there exists no event, condition or occurrence which, after notice or lapse of time or both, would constitute such a default under: (i) any note, bond, mortgage, indenture or other instrument evidencing any indebtedness to which the Company or any of its Subsidiaries is a party; or (ii) any other Contract.
Section 3.10.  Securities Laws Matters.  The Company has filed under applicable Securities Laws and the applicable listing standards and rules of the NYSE and the TSX true and complete copies of all forms, reports, schedules, statements and other documents required to be filed by it since January 6, 2005, and all such documents complied in all material respects at the time filed with such securities Laws, listing standards and rules. Except to the extent the information contained in any Public Disclosure Document has been amended, supplemented or superseded by a later-filed Public Disclosure Document, none of the Public Disclosure Documents contains any untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary in order to make the statements therein in light of the circumstances under which they were made not misleading, which individually or in the aggregate would require an amendment, supplement or correction to such Public Disclosure Documents.
Section 3.11.  Customer Relations.  As of the date hereof, the Company has not received any written notice that any customer, supplier, distributor or sales representative intends to cancel, terminate or otherwise modify or not renew its relationship with the Company or its Subsidiaries, which, individually or in the aggregate, would have a Material Adverse Effect.
Section 3.12.  Foreign Corrupt Practices.  To the Knowledge of the Company, neither the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee or other Person acting on behalf of the Company or any of its Subsidiaries has violated or is in violation of the U.S. Foreign Corrupt Practices Act of 1977 or similar Laws in any applicable jurisdiction, or made any bribe, rebate, payoff, influence payment, kickback or unlawful payment to any foreign or domestic Governmental Entity or political party, official, employee, appointee or candidate.
Section 3.13.  Intellectual Property.  Except, in each case, as would not have, individually or in the aggregate, a Material Adverse Effect: (a) the Company and its Subsidiaries own or otherwise have the right to use all Intellectual Property used in the conduct of their business (the “Company IP”), in each case free and clear of all Encumbrances (other than Permitted Encumbrances); (b) to the Knowledge of the Company, the use of all licensed Company IP is in accordance with the terms of the applicable licenses; (c) other than matters that have been settled or otherwise resolved, to the Knowledge of the Company, the conduct of the business of the Company and its Subsidiaries, including the manufacture, use or sale of products, processes and technology, has not infringed upon, misappropriated or violated, and does not infringe upon, misappropriate or violate, the rights or Intellectual Property of any other Person; (d) to the Knowledge of the Company, no other Person is challenging, infringing upon or misappropriating any Intellectual Property owned by the


15


Company or its Subsidiaries or has or is claiming an interest in any Intellectual Property owned by the Company or its Subsidiaries; (e) the Company and its Subsidiaries have taken reasonable steps (in accordance with industry standards) to protect the Company IP owned by the Company and its Subsidiaries, including reasonable steps to prevent unauthorized use or disclosure of any trade secrets, confidential information and know how possessed by the Company and its Subsidiaries; and (f) the information and communications technologies systems used by the Company and its Subsidiaries are in effective working order, and the Company and its Subsidiaries have in place appropriate (in accordance with industry standards) virus and intrusion protections andback-up and disaster recover plans, procedures and facilities to ensure the continuing availability and operation of such systems and the data contained therein.
Section 3.14.  Property.
(a) The Company and each of its Subsidiaries has good and, in the case of real property, marketable title to, or, in the case of leased properties and assets, valid leasehold or other possessory interests in, all of its real property and tangible property, except where the failure to have such title or leasehold or other possessory interests would not have, individually or in the aggregate, a Material Adverse Effect, in each case subject to no Encumbrances except Permitted Encumbrances.
(b) Except as would not have, individually or in the aggregate, a Material Adverse Effect, each material lease of tangible property is in full force and effect and is valid, binding and enforceable against the Company and each of its Subsidiaries party thereto, and to the Knowledge of the Company, each other party thereto. Neither the Company nor any Subsidiary is currently party to any Contract to sell, transfer or otherwise dispose of any material real property or to acquire or lease any other material real property or interest therein. As of the date of this Agreement, neither the Company nor any of its Subsidiaries has received a written notice of default under any material leases of real and tangible property to which they are a party, except for (i) defaults for which the grace or cure period has not expired and which are reasonably capable of cure during the cure period, (ii) defaults which have been cured or (iii) defaults which would not have, individually or in the aggregate, a Material Adverse Effect.
(c) Except as would not have, individually or in the aggregate, a Material Adverse Effect, neither the Company nor any of its Subsidiaries has received any written notice that any condemnation, expropriation, nationalization, forced sale or eminent domain proceedings are pending or threatened with respect to any material real property owned by the Company or its Subsidiaries.
Section 3.15.  Labor Relations and Other Employment Matters.
(a) Except as disclosed in Schedule 3.15 of the Company Disclosure Schedule, none of the Company or any of its Subsidiaries is a party to any Contract or has made any commitment providing for severance or termination payments to, or any employment or incentive Contract or other arrangement in respect of the Transaction with, any executive listed as a “Named Executive Officer” in the Company’s Proxy Statement for the 2006 Annual Meeting of Shareholders, as amended.
(b) Except as would not have, individually or in the aggregate, a Material Adverse Effect, the Company and its Subsidiaries are in compliance with all applicable Laws with respect to employment and labor, including employment and labor standards, occupational health and safety, employment equity, pay equity, workers’ compensation, social security, human rights and labor relations, and there are no current, pending or, to the Knowledge of the Company, threatened proceedings before any Governmental Entity with respect to any of the areas listed herein.
(c) Parent has been provided with access to true and complete copies of all collective bargaining agreements and other agreements with trade unions, work councils and other employee representatives to which the Company or its Subsidiaries is a party (the “Collective Agreements”). Schedule 3.15 of the Company Disclosure Schedule lists the jurisdictions where employees of the Company or its Subsidiaries are represented by a works’ council or similar labor organization. To the Knowledge of the Company, there are no overtly threatened union organizing activities involving employees of the Company or any of its Subsidiaries not already covered by the Collective Agreements that would have, individually or in the aggregate, a Material Adverse Effect. None of the Company or any of its Subsidiaries, is in violation of any material provision


16


under any Collective Agreement. There is no strike or lock out occurring or, to the Knowledge of the Company, threatened affecting the Company or any of its Subsidiaries.
Section 3.16.  Employee Benefit Plans.
(a) Except as would not have, individually or in the aggregate, a Material Adverse Effect, the Company and each of its ERISA Affiliates has complied with the terms of all agreements and all applicable Laws relating to each of the pension or retirement income plans or other employee compensation or benefit plans, agreements, policies, programs, arrangements or practices, whether written or oral, with respect to which the Company or any of its ERISA Affiliates sponsors, administers or has any liability to make contributions or provide benefits (collectively referred to as “Applicable Plans”).
(b) No step has been taken, no event has occurred and no condition or circumstance exists that has resulted in or could reasonably be expected to result in any Applicable Plan under applicable Laws being ordered or required to be terminated or wound up in whole or in part or having its registration, qualification or tax exemption under applicable Law refused or revoked, or being placed under the administration of any trustee or receiver or regulatory authority or being required to pay any material taxes, fees, penalties or levies under applicable Laws. There are no actions, suits, claims (other than routine claims for payment of benefits in the ordinary course), trials, demands, investigations, arbitrations or other proceedings which are pending or, to the Knowledge of the Company, threatened in respect of any of the Applicable Plans or their assets which would have, individually or in the aggregate, a Material Adverse Effect.
(c) Except as would not have, individually or in the aggregate, a Material Adverse Effect (i) neither the execution and delivery of this Agreement nor the consummation of the Transactions will (either alone or in conjunction with any other event, including termination of employment) result in, cause the accelerated vesting or delivery of, or increase the amount or value of, any payment or benefit to any employee, officer or director of the Company or any of its ERISA Affiliates; (ii) the Company and each ERISA Affiliate has made all contributions required under applicable Law to fund their liabilities in respect of any Applicable Plan including going concern unfunded liabilities, solvency deficiencies orwind-up deficiencies, where applicable; and (iii) none of the Applicable Plans provide post-retirement health care continuation coverageand/or other benefits beyond retirement or other termination of service to employees or former employees or to the beneficiaries or dependents of such employees (except with respect to beneficiaries and dependents to the extent required under applicable Law).
Section 3.17.  Tax Matters.  Except as would not have, individually or in the aggregate, a Material Adverse Effect:
(a) All Tax Returns required to be filed by the Company and its Subsidiaries have been filed in the prescribed form and within the prescribed time and all such Tax Returns are true, complete and correct;
(b) Each of the Company and its Subsidiaries has duly and timely paid all Taxes due and payable whether or not shown on any Tax Return, including all installments on account of Taxes for the current year;
(c) There are no Encumbrances for Taxes against the Company or any of its Subsidiaries, other than Permitted Encumbrances;
(d) Neither the Company nor any of its Subsidiaries has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency;
(e) Other than the Tax Sharing and Disaffiliation Agreement between Alcan Inc., Novelis Inc., ArcusTarget Inc., Alcan Corporation and Novelis Corporation, dated January 5, 2005 (the “Tax Sharing and Disaffiliation Agreement”), there are no Tax sharing agreements (or similar agreements) under which the Company or any of its Subsidiaries could be liable for the Tax liability of an entity that is none of the Company or its Subsidiaries;
(f) Neither the Company nor any of its Subsidiaries has knowingly taken any action (or has knowingly omitted taking any action) that would reasonably be expected to result in: (i) a liability for


17


Taxes of the Company or any of its Subsidiaries in connection with the transactions described in the advance income tax ruling received by Alcan from the Canada Revenue Agency on December 15, 2004; (ii) a liability for Taxes or an obligation for the Company or any of its Subsidiaries to indemnify Alcan for Taxes under the Tax Sharing and Disaffiliation Agreement; or (iii) Tax consequences to the Company and its Subsidiaries different from those described in the tax ruling referred to in clause (i) above;
(g) To the Knowledge of the Company, neither the Company nor any of its Subsidiaries has entered into any transaction that would result in a liability for Taxes or an adjustment resulting in a liability for Taxes to the Company or such Subsidiaries pursuant to a transfer pricing or similar provision of any applicable Law of any jurisdiction that requires the value of the consideration paid or received for the acquisition, sale, transfer or other disposition of property (including intangibles) or services (including financial transactions) to be the fair value of such property or services in the case of transactions with (i) in the case of Income Tax Act (Canada), Persons not resident in Canada dealing at non-arm’s length; (ii) in the case of the Code, related Persons; or (iii) in any case, Persons who have a relationship similar to (i) or (ii) based on the criteria imposed by applicable Law;
(h) No deficiencies exist or, to the Knowledge of the Company, have been asserted with respect to Taxes of the Company or any of its Subsidiaries; and none of the Company or any of its Subsidiaries is a party to any action or proceeding for assessment or collection of Taxes, nor, to the Knowledge of the Company, has such an event been asserted or threatened against the Company or any of its Subsidiaries, or any of their respective assets;
(i) Each of the Company and its Subsidiaries has duly and timely withheld all Taxes required by Law to be withheld by it (including Taxes required to be withheld by it in respect of any amount paid or credited or deemed to be paid or credited by it to or for the account of any Person, including any employees, officers or directors and any non-resident Person) and has duly and timely remitted to the appropriate tax authority such Taxes and other amounts required by Law to be remitted by it; and
(j) The Company and its Subsidiaries have duly and timely collected all amounts on account of any sales or transfer taxes, including goods and services, harmonized sales and provincial or territorial sales taxes, required by Law to be collected by them and have duly and timely remitted to the appropriate authority any such amounts required by Law to be remitted by them.
Section 3.18.  Environmental.  Except as would not have, individually or in the aggregate, a Material Adverse Effect:
(a) All operations of the Company and its Subsidiaries are in compliance with all applicable Laws relating to the protection of the environment, health or safety (collectively “Environmental Laws”);
(b) None of the Company or any of its Subsidiaries: (i) is subject to any proceeding or order which relates to environmental, health or safety matters, and which would require any material work, repairs, construction or expenditures; (ii) has received any demand, notice, request for information or written communication alleging the breach of or liability under any Environmental Law, including with respect to any regulations respecting the use, storage, treatment, transportation, Release or disposition of any pollutant, contaminant, waste of any nature, hazardous substance, hazardous material, toxic substance, dangerous substance or dangerous good as defined, judicially interpreted or identified in any Environmental Law (“Hazardous Substances”); or (iii) has received written notice, or to the Knowledge of the Company is aware, of any requirement that is proposed for adoption or implementation under any Environmental Law that would be applicable to the operations of the Company or any of its Subsidiaries and which may require any material expenditure;
(c) (i) The Company and each of its Subsidiaries have obtained and are in compliance with all permits, licenses, emissions credits or allowances and any other authorizations of any Governmental Entity pursuant to Environmental Law (collectively, “Environmental Permits”) necessary for their operations as currently conducted, (ii) all such Environmental Permits are valid and in good standing, and (iii) none of the Company or any Subsidiary is aware of or has been advised by any Governmental Entity of any actual or potential change in the status or terms and conditions of any Environmental Permit;


18


(d) There are no Environmental Claims pending or, to the Knowledge of the Company, threatened, against the Company or any of its Subsidiaries or against any property or operations that the Company or any of its Subsidiaries owns, leases, or operates, in whole or in part, or, to the Knowledge of the Company, formerly owned, leased or operated, in whole or in part; and
(e) There have been no Releases of any Hazardous Substances that would reasonably be expected to form the basis of any Environmental Claim against the Company or any of its Subsidiaries or against any Person whose liabilities for such Environmental Claims the Company or any of its Subsidiaries has or may have, retained or assumed, either contractually or by operation of Law.
Section 3.19.  Product Warranty Matters.  To the Knowledge of the Company, except as would not have, individually or in the aggregate, a Material Adverse Effect (a) all products sold by the Company and its Subsidiaries since January 6, 2005, have been in conformity with all applicable contractual commitments and all express and implied warranties, and none of the Company or its Subsidiaries has any liability for replacement thereof or other damages in connection therewith and (b) there is no pending or threatened recall or investigation of any product manufactured, sold, leased or delivered by any of the Company or its Subsidiaries since January 6, 2005.
Section 3.20.  Affiliate Transactions.  There are no material contracts or other material transactions between the Company or any of its Subsidiaries, on the one hand, and (i) any officer or director of the Company or any of its Subsidiaries, or (ii) to the Knowledge of the Company, any Affiliate or Associate, other than the Company or any of its Subsidiaries, of any such officer or director on the other hand.
Section 3.21.  Opinions of Financial Advisors.  The Board of Directors of the Company has received from each of its financial advisors, Morgan Stanley & Co. Incorporated and Evercore Partners, an opinion, dated the date of this Agreement, to the effect that, as of such date, the Purchase Price to be received pursuant to this Agreement is fair to the Shareholders from a financial point of view and as of the date hereof such opinions have not been withdrawn, amended or modified.
Section 3.22.  Rights Plan.  The Board of Directors of the Company has resolved to defer the “Separation Time” (as defined in the Rights Plan) so that neither the execution, delivery or performance of this Agreement nor the consummation of the Transactions will cause the Rights (as defined in the Rights Plan) to become exercisable.
Section 3.23.  Disclaimer.  Notwithstanding anything in this Agreement to the contrary, the Company makes no (and shall not be deemed to make any) representation or warranty to Parent or Acquisition Sub other than as set forth in this Article III and Section 8.01.
Section 3.24.  Company Disclosure Schedule.  The Company Disclosure Schedule is arranged in sections and subsections corresponding to the numbered and lettered sections and subsections contained in this Article III with the disclosures in any section or subsection of such schedule qualifying the corresponding section or subsection in Article III, as well as any other section or subsection of Article III if the relevance of the disclosed item to such other section or subsection is reasonably apparent;provided that notwithstanding any other provision hereof, only the disclosures specifically set forth in Schedule 3.03 of the Company Disclosure Schedule shall qualify the representations and warranties contained in Section 3.03.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF
THE PARENT AND ACQUISITION SUB
Parent and Acquisition Sub jointly and severally represent and warrant to the Company as follows:
Section 4.01.  Parent Formation.  Parent has been duly incorporated or formed under the laws of India and is validly existing and has the corporate power and authority to own its assets and conduct its business.
Section 4.02.  Acquisition Sub Formation.  Acquisition Sub has been duly incorporated under the laws of Canada, is validly existing, and has the corporate power and authority to own its assets and conduct its


19


business, was formed solely for the purpose of engaging in the Transactions, has engaged in no other business activities and has conducted its operations solely as contemplated hereby.
Section 4.03.  Ownership.  All of the outstanding shares of Acquisition Sub are held directly or indirectly by Parent and its Affiliates.
Section 4.04.  Authority.  Each of Parent and Acquisition Sub has the necessary corporate power, authority and capacity to enter into this Agreement and to perform its respective obligations hereunder. The execution and delivery of this Agreement by Parent and Acquisition Sub and the consummation of the Arrangement and the Transactions have been duly authorized by the boards of directors of Parent and Acquisition Sub, respectively, and no other corporate proceedings on the part of Parent or Acquisition Sub are necessary to authorize this Agreement or the Arrangement. This Agreement has been duly executed and delivered by Parent and Acquisition Sub and constitutes a valid and binding obligation of each of them, enforceable against each in accordance with its terms, subject to applicable bankruptcy, insolvency and other Laws affecting creditors’ rights generally, and to general principles of equity.
Section 4.05.  Authorization.  The authorization of this Agreement, the execution and delivery by Parent and Acquisition Sub of this Agreement and the performance by Parent and Acquisition Sub of their respective obligations hereunder and the consummation of the Arrangement and the Transactions, will not result (with or without notice or the passage of time) in violation or breach of, or constitute a default under any provision of: (i) the organizational documents of Parent or Acquisition Sub; (ii) subject to obtaining any necessary consent to the Arrangement and the Regulatory Approvals listed in Schedule A, any approval, order or authorization of a Governmental Entity, or any other applicable Law or Order; or (iii) any material contract or agreement to which Parent or any Subsidiary is a party or by which either of them is bound, except as would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the business or financial condition of Parent and its Subsidiaries taken as a whole or on the ability of Parent or Acquisition Sub to perform its obligations under this Agreement.
Section 4.06.  No Governmental Consent.  No material consent, approval, order or authorization of, or declaration or filing with, any Governmental Entity is required to be obtained by Parent or any Subsidiary in connection with the execution and delivery of this Agreement and the performance by it of its obligations under this Agreement, and the consummation by it of the Arrangement, other than those which are contemplated by this Agreement and the Regulatory Approvals listed in Schedule A.
Section 4.07.  Availability of Funds.  Parent has delivered to the Company true, correct and complete copies of executed commitment letters (as the same may be amended or replaced pursuant to Section 5.12, the “Commitment Letters”), pursuant to which the lender parties thereto have agreed, subject to the terms and conditions thereof, to provide or cause to be provided the debt amounts set forth therein. As of the date hereof, none of the Commitment Letters has been amended or modified, and none of the respective commitments contained in the Commitment Letters have been withdrawn, terminated or rescinded in whole or in part. As of the date hereof, the Commitment Letters are in full force and effect. As of the date hereof, there are no conditions precedent or other contingencies related to the funding of the full amount of the financing provided for in the Commitment Letters other than as specified in the Commitment Letters. As of the date hereof, neither Parent nor Acquisition Sub has any expectation that any of the conditions set forth in the Commitment Letters will not be satisfied. Parent has furnished to the Company and its Representatives prior to the date hereof, documentation and evidence of the availability of additional funds, which together with the financing provided for in the Commitment Letters, are necessary to make the payments referenced in the following sentence. Parent and Acquisition Sub will have available funds at the time required in the Plan of Arrangement sufficient to (a) pay the Purchase Price and the fees and expenses of Parent and Acquisition Sub related to the Transactions, (b) if the Credit Agreement is not amended in accordance with the requirements set forth in the Commitment Letters, prepay all outstanding indebtedness and all other amounts then due and owing under the Credit Agreement, (c) if required under the terms thereof, repay, retire or redeem the Senior Notes, (d) redeem, retire or prepay any other indebtedness required to be redeemed, retired or prepaid under the Commitment Letters, (e) pay fees and expenses related to the financings provided for in the Commitment Letters and (f) pay any other fees, expenses, redemption premiums, penalties, charges or other required amounts in connection


20


with the redemption, retirement or prepayment of the Company’s outstanding indebtedness in connection with the Transactions. As of the date hereof, Parent and Acquisition Sub know of no circumstance or condition that could be reasonably expected to prevent the availability at the time required in the Plan of Arrangement of such funds, including, without limitation, (i) the compliance with all applicable Laws and regulations of India and (ii) any and all requirements under applicable Law with respect to shareholder or lender consents, the due filing of all reports and returns with the Reserve Bank of India or authorized dealers, as applicable, and the giving of all applicable notifications.
Section 4.08.  Common Shares.  The Parent does not own, or have control or direction over, any Common Shares and is not a party to any agreement, arrangement or understanding (other than this Agreement) for the purpose of acquiring, holding, voting or disposing of any Common Shares.
Section 4.09.  Litigation.  As of the date of this Agreement, there is no claim, action, suit, proceeding, arbitration, mediation or governmental investigation pending or, to the knowledge of Parent or Acquisition Sub, threatened against or relating to Parent or Acquisition Sub or any of their respective Subsidiaries or any properties or assets of Parent or Acquisition Sub or any of their respective Subsidiaries, other than any such claim, action, suit, proceeding, arbitration, mediation or governmental investigation that would not reasonably be expected to prevent or materially delay the consummation of the Transactions. As of the date of this Agreement, none of Parent, Acquisition Sub or any of their respective Subsidiaries nor any of their respective properties or assets is subject to any outstanding order, writ, injunction or decree except for those that would not reasonably be expected to prevent or materially delay the consummation of the Transactions.
Section 4.10.  Disclaimer   Notwithstanding anything in this Agreement to the contrary, neither Parent nor the Acquisition Sub makes (and shall not be deemed to make) any representation or warranty to the Company, except as set forth in this Article IV.
ARTICLE V
COVENANTS
Section 5.01.  Conduct of Business During Pre-Effective Date Period.  During the Pre-Effective Date Period, without the consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed) or as otherwise expressly contemplated or specifically permitted by this Agreement, the Company shall cause the business of the Company and its Subsidiaries to be conducted substantially in the ordinary course of business and consistent with past practice, and the Company shall use its reasonable best efforts to preserve the goodwill of such entities, including preserving the current relationships of the Company and its Subsidiaries with customers, suppliers, distributors, joint venture partners, licensors, employees and other Persons with which the Company or any Subsidiary has significant business relations.
Section 5.02.  Operational Covenants.  Without limiting the generality of the foregoing, except in each case (i) as expressly set forth in Schedule 5.02 of the Company Disclosure Schedule, (ii) as expressly contemplated, permitted or required by this Agreement, (iii) as required by Law or (iv) as consented to by Parent (which consent shall not be unreasonably withheld, conditioned or delayed), the Company agrees that during the Pre-Effective Date Period, the Company shall and shall cause each of the Company’s Subsidiaries to:
(a) not split, consolidate or reclassify any of the outstanding securities of the Company or any of its Subsidiaries nor undertake any other capital reorganization, nor declare, set aside or pay any dividends on, reduce capital or make any other distributions on or in respect of the outstanding securities of the Company or any of its Subsidiaries other than quarterly cash dividends or distributions on the Common Shares or DSUs in accordance with the Company’s past practice and dividend policy, or dividends or other distributions by a direct or indirect wholly-owned Subsidiary to the Company or another wholly-owned Subsidiary;
(b) not amend or modify the articles of incorporation or by-laws or other organizational documents of the Company or any of its Subsidiaries, as the case may be, the terms of any of the outstanding


21


securities (or rights to acquire them), or any outstanding indebtedness and credit facilities of the Company or any of its Subsidiaries;
(c) subject to (i) below, not issue any securities (other than the issuance of Common Shares upon the exercise of currently outstanding rights to acquire Common Shares set forth on Schedule 3.03 of the Company Disclosure Schedule) or new options to acquire the capital stock of the Company, or redeem, offer to purchase or purchase any of its outstanding securities, other than pursuant to any existing Contract set forth on Schedule 3.03 of the Company Disclosure Schedule;
(d) subject to (g) below and except for the Transactions, not enter into, adopt or consummate any liquidation, dissolution, merger, amalgamation, arrangement, consolidation or reorganization of the Company or any of its Subsidiaries;
(e) subject to applicable Laws, (i) not enter into, terminate, amend, or waive any material term of any material Contract other than in the ordinary course of business, (ii) not enter into or extend the term or scope of any Contract that purports to restrict the Company or any of its Subsidiaries or Affiliates, from engaging in any line of business or in any geographic area, and (iii) not enter into any material Contract that would be breached by, or require the consent of any third party in order to continue in full force following, the consummation of the Transactions;provided that the Company shall advise Parent prior to entering into, amending, terminating or waiving any material term of any Significant Metal Supply Agreement or Significant Customer Contract;
(f) not enter into, adopt, amend, vary, modify or take any other action with respect to any bonus, profit sharing, incentive, salary or other compensation, equity based award, pension, retirement, deferred compensation, severance, change in control, employment or other employee benefit plan, agreement, trust, fund, or arrangement for the benefit or welfare of any employee, except, in each case, (i) for any increases in the compensation or benefits (A) in the ordinary course of business and consistent with past practice, (B) in accordance with annual merit salary or bonus increases, or (C) as required by Contract (provided that in the case of the Company’s directors and executive officers, such Contracts are set forth on Schedule 5.10 of the Company Disclosure Schedule), or (ii) for any new hires where annual base salary does not exceed $350,000, with respect to employees located in North America, or $400,000, with respect to employees located outside of North America;
(g) subject to Section 5.04, not sell, lease, encumber or otherwise dispose of any capital assets or group of related capital assets other than obsolete equipment (through one or more related or unrelated transactions) having a value in excess of $20,000,000 in the aggregate for all such transactions;
(h) other than borrowings under existing lines of credit and revolving credit facilities in the ordinary course of business (or any refinancing of such existing lines not to exceed their current limits) or indebtedness owing to, or guarantees of indebtedness owing to, the Company or any Subsidiary, not incur or commit to incur any indebtedness for borrowed money or issue any debt securities, incur or commit to incur, or guarantee, endorse or otherwise become responsible for any other material liability, obligation or indemnity or the obligations of any other Person or other business organization, or make any loans or advances except to the Company or wholly-owned Subsidiaries;
(i) not grant or amend the terms of any Options, SARs, DSUs, PSUs, SPAUs or similar incentives except, in each case, as specifically required by Contracts set forth on Schedule 3.03 of the Company Disclosure Schedule;
(j) except in the ordinary course of business and consistent with past practice, not waive, release, assign, settle or compromise any material claims, litigation or arbitration or other material legal rights, not satisfy any material liabilities substantially prior to the same being due, and other than in the ordinary course of business, not enter into any interest rate, currency or commodity swaps, hedges, or similar financial instruments;
(k) not incur, or commit to, capital expenditures: (i) other than capital expenditures contemplated by the Company’s budget or capital plan for 2007, or (ii) otherwise not in excess of $35,000,000 in the


22


aggregate (provided that the Company shall advise Parent in advance of incurring or committing to any capital expenditures in excess of $15,000,000 in the aggregate);
(l) not make any changes to existing accounting policies unless required by U.S. GAAP, or as recommended by the Company’s independently registered public accountants, or pursuant to written instructions, comments or orders from the SEC, the OSC or any applicable securities regulatory authority of the other provinces and territories of Canada;
(m) subject to Section 5.04, not acquire or agree to acquire (by merger, amalgamation, acquisition of stock or assets or otherwise) any Person or other business organization or division other than (i) acquisitions for consideration that is individually not in excess of $5,000,000, or in the aggregate, not in excess of $10,000,000 and (ii) capital expenditures to the extent otherwise permitted by this Agreement;
(n) not make, rescind or change any material election with respect to Taxes or file any material amended Tax Return, settle any material Tax claim or dispute or waive or extend the statute of limitations relating to any Taxes of the Company or any Subsidiary, or other than in the ordinary course of business and consistent with past practice, enter into any closing agreement regarding Taxes, surrender any right to claim a material tax refund or amend any of its transfer pricing policies;
(o) not amend the Rights Plan or adopt, approve or implement any other shareholder rights plan or similar poison pill arrangement, other than in connection with a Superior Proposal;
(p) not take any materially adverse employment actions outside the ordinary course of business, including mass redundancies, and including with respect to the employees of the Company and its Subsidiaries employed in Europe, except in consultation with the applicable works councils of the European Community member nations, the European works council, and the United Kingdom works council; or
(q) not authorize or enter into any agreement or commitment to do any of the things prohibited by any of the foregoing subparagraphs.
In the event that the Company proposes to take an action not otherwise permitted by Section 5.02 of this Agreement, or proposes to decline to take an action otherwise required by Section 5.01 of this Agreement, the Company will request the consent of Parent to such action, or inaction, as the case may be, in accordance with the procedures set forth in the Company Disclosure Schedule (the “Consent Procedures”). Each of the Company and Parent agree to comply in good faith with the Consent Procedures.
Section 5.03.  Other Covenants of the Company.  During the Pre-Effective Date Period, the Company shall:
(a) carry out the terms of the Interim Order and the Final Order applicable to it;
(b) provide Parent with a copy of any purported exercise of the Dissent Rights and written communications with any holders exercising or purporting to exercise Dissent Rights; and not settle or compromise any Dissent Rights claim brought by any holder of any of its securities in connection with the Transactions; and
(c) advise Parent as reasonably requested prior to the Meeting as to the aggregate tally of the proxies and votes received in respect of the Meeting and all matters to be considered at such meeting.
Section 5.04.  Company Covenants Regarding Non-Solicitation.
(a) The Company agrees that neither it nor any of its Subsidiaries nor any of its and their respective directors or officers shall, and the Company and its Subsidiaries shall use its reasonable best efforts to cause their respective Representatives not to, (i) directly or indirectly solicit, initiate or knowingly encourage or knowingly facilitate any Acquisition Proposal or the making or consummation thereof, or (ii) enter into, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any Person any information in connection with, any Acquisition Proposal. The Company shall, and shall cause its Subsidiaries


23


to, and shall use its reasonable best efforts to cause its and their Representatives to, immediately cease and cause to be terminated all existing discussions or negotiations with any Person conducted heretofore with respect to any Acquisition Proposal. The Company agrees not to release any third party from, waive or otherwise forbear in the enforcement of any confidentiality, non-solicitation or standstill agreement to which the Company and such third party are parties,provided that the foregoing shall not prevent the Board of Directors of the Company from considering and accepting any Superior Proposal that might be made by any such third party if the provisions of this Agreement are complied with. The Company shall immediately cease to provide any other Person with access to information concerning the Company and its Subsidiaries and shall immediately request the returnand/or destruction of all information provided to any third parties that have entered into a confidentiality agreement with the Company relating to any potential Acquisition Proposal and shall use all reasonable efforts to ensure that such requests are honored. Notwithstanding the foregoing, at any time prior to obtaining the Company Shareholder Approval, in response to an Acquisition Proposal made without violation of this Section 5.04 that the Board of Directors of the Company or any committee thereof determines in good faith (after consultation with its legal advisors and its financial advisors) constitutes or is reasonably likely to lead to a Superior Proposal, the Company may, subject to compliance with this Section 5.04, (A) provide access to its properties, books, records and personnel and furnish information with respect to the Company and its Subsidiaries to the Person making such Acquisition Proposal (and its Representatives),provided that prior to any such access or furnishing of information the Company shall enter into a customary confidentiality and standstill agreement with such person which is no more favorable to such person than the confidentiality agreement between the Company and the Parent dated September 26, 2006, and (B) participate in discussions or negotiations with the Person making such Acquisition Proposal (and its Representatives) regarding such Acquisition Proposal.
(b) Neither the Board of Directors of the Company nor any committee thereof shall (i) withdraw, modify or qualify in any manner adverse to Parent or Acquisition Sub the Company Recommendation (any action described in this clause (i) being referred to as a “Company Adverse Recommendation Change”); (ii) approve, adopt or recommend an Acquisition Proposal (any action described in this clause (ii) relating to a Superior Proposal being referred to as a “Superior Proposal Recommendation”); or (iii) allow the Company or any of its Subsidiaries to enter into any binding agreement effecting or in connection with an Acquisition Proposal (other than a confidentiality agreement referred to in Section 5.04(a)) (any agreement described in this clause (iii) relating to a Superior Proposal being referred to as a “Superior Proposal Agreement”). Notwithstanding the foregoing, at any time prior to obtaining the Company Shareholder Approval and subject to Section 5.04(c):
(i) the Board of Directors of the Company may effect a Company Adverse Recommendation Change if the Board has determined in good faith (after consultation with its legal advisors and its financial advisors) that the failure to effect a Company Adverse Recommendation Change (regardless of the existence of a Superior Proposal) would not be in the best interests of the Company;provided that the Company shall not be relieved of its obligations to proceed to call and hold the Meeting and to hold the vote on the Arrangement Resolution except in circumstances where this Agreement has been terminated in accordance with its terms;
(ii) if the Board of Directors of the Company or such committee, as the case may be, determines that the failure to do so would not be in the best interests of the Company, the Board of Directors of the Company may, in response to an Acquisition Proposal that the Board of Directors of the Company determines in good faith (after consultation with its legal advisors and its financial advisors) constitutes or is reasonably likely to lead to a Superior Proposal and that did not otherwise result from a breach of this Section 5.04, make a Company Adverse Recommendation Change,and/or a Superior Proposal Recommendationand/or cause the Company to enter into a Superior Proposal Agreement; provided, however, that the Board of Directors shall not be entitled to exercise its right to make a Company Adverse Recommendation Change, or a Superior Proposal Recommendation or cause the Company to enter into a Superior Proposal Agreement as provided under this clause (ii) unless: (A) the Company has complied in all material respects with this Section 5.04, (B) the Company has provided to Parent three Business Days’ prior written notice (such notice, a “Notice of Superior Proposal”) advising Parent that the Board of


24


Directors of the Company intends to take such action and specifying the reasons therefor, including the terms and conditions of any Superior Proposal that is the basis of the proposed action by the Board of Directors of the Company (it being understood and agreed that any material amendment to the financial terms or any other material term of any such Superior Proposal shall require a new Notice of Superior Proposal and a new three Business Day period), (C) the Company has, during such three Business Day period, if requested by Parent, afforded the Parent a reasonable opportunity (but not obligation) to amend this Agreement in such a manner that any Acquisition Proposal which was determined to constitute a Superior Proposal no longer is a Superior Proposal, (D) if the Parent has agreed to amend this Agreement, the Board of Directors of the Company shall have considered the terms of the amendment to determine whether such Acquisition Proposal continues to constitute a Superior Proposal and (E) at the end of such three Business Day period, such Acquisition Proposal has not been withdrawn and continues to constitute a Superior Proposal (taking into account any changes to the financial and other terms of this Agreement agreed to by Parent following a Notice of Superior Proposal, as a result of the opportunity afforded by clause (C)); and
(iii) if the three Business Day period referred to in clause (ii) above would not terminate before the date fixed for the Meeting, the Company shall adjourn the Meeting to a date that is at least one Business Day after the expiration of the three Business Day period.
(c) In addition to the obligations of the Company set forth in paragraphs (a) and (b) of this Section 5.04, the Company shall as promptly as practicable (and in any event within one (1) Business Day after receipt) advise Parent orally and in writing of any Acquisition Proposal and the material terms and conditions of any such Acquisition Proposal and the identity of the Person making such proposal.
(d) Nothing contained in this Section 5.04 shall prohibit the Company from taking and disclosing to its Shareholders a position contemplated byRule 14e-2(a) (2) or (3) under the Exchange Act or making a statement required underRule 14d-9 under the Exchange Act.
Section 5.05.  Access to Information; Confidentiality.
(a) Subject to applicable Law and the terms of any Contracts, upon reasonable notice, the Company agrees to provide Parent and its Representatives with reasonable access (without disruption to the conduct of the Company’s business) during normal business hours to all books, records, information and files in its possession and control and access to its personnel on an as reasonably requested basis as well as reasonable access to the properties of the Company and its Subsidiaries in order to allow Parent to conduct such investigations as Parent may consider necessary for strategic and transition planning. Any investigation by a Party and its advisors shall not mitigate, diminish or affect the representations and warranties of the other Party contained in this Agreement or any document or certificate given pursuant hereto. In the case of any Contracts which restrict the provision of information to the Parent, the Company shall at the request of Parent use its reasonable best efforts to obtain the consent of the applicable third party to the disclosure of any information requested by the Parent.
(b) Parent acknowledges that certain information provided to it prior to the execution of this Agreement or under Section 5.05(a) may be confidentialand/or proprietary in nature (the “Information”) and except as permitted by the confidentiality agreement entered into by the Parent and the Company, Parent shall keep the Information confidential and shall not, without the prior consent of the Company, disclose it and shall not use it for any purpose other than those contemplated herein.
Section 5.06.  Indemnification.
(a) From and after the Effective Date, Parent shall, and shall cause the Company (or its successor) to, indemnify the directors and officers (or their equivalents) of the Company and its Subsidiaries to the fullest extent to which Parent and the Company and the Subsidiaries are permitted to indemnify such officers and directors (or their equivalents) under their respective organizational documents and applicable Laws and such obligations shall survive the Arrangement and shall continue in full force and effect in accordance with the terms of such organizational documents from the Effective Date.


25


(b) From and after the Effective Date, Parent shall cause the Company to, and the Company shall, maintain in effect for six years from the Effective Date, the Company’s current directors’ and officers’ liability insurance policies covering acts or omissions occurring at or prior to the Effective Date (“D&O Insurance”) with respect to those Persons who are currently (and any additional Persons who prior to the Effective Date become) directors and officers of the Company that is no less favorable to such directors and officers than the current policy or, if substantially equivalent insurance coverage is unavailable, the best available coverage, provided however that the Parent and the Company shall not be required to pay an annual premium for such insurance in excess of 300% of the annual amounts currently paid by the Company to maintain the existing policies (which amount has been disclosed to Parent), provided further that if the annual premium for such insurance coverage exceeds such amount, the Parent and the Company shall be obligated to obtain a policy with the greatest coverage available for a cost not exceeding such amount. In lieu of the foregoing, the Company may purchase, prior to, on or after the Effective Date, a six-year “tail” prepaid officers’ and directors’ liability insurance policy in respect of acts or omissions occurring prior to the Effective Date covering each such director and officer;provided that the Company shall not purchase any such policy for an amount in excess of $4,500,000 without the prior written consent of the Parent.
(c) In the event the Company or any of its successors or assigns, after the Effective Date, (i) consolidates with or merges or winds up into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that such successors and assigns of the Company or, at Parent’s option, Parent, shall assume the obligations set forth in this Section 5.06.
(d) The Company shall not amend the by-laws of the Company after the Effective Date if such action would adversely affect the rights of individuals who, on or prior to the Effective Date, were entitled to advances, indemnification or exculpation thereunder for actions or omissions by such individuals at any time at or prior to the Effective Date. The individuals referred to in the preceding sentence shall include any individuals who served at any time as directors or officers of any Subsidiary of the Company at the Company’s request, it being acknowledged by the Parties that each director or officer of a Subsidiary of the Company is or was doing so at such request of the Company.
(e) The provisions of this Section 5.06 are intended for the benefit of, and shall be enforceable by, each insured or indemnified Person, his or her heirs and his or her legal representatives and, for such purpose, the Company confirms that it is acting as agent and trustee on their behalf. The provisions of this Section 5.06 are in addition to, and not in substitution for, any other rights to indemnification or contribution that any such Person may have by contract or otherwise.
Section 5.07.  Further Action; Reasonable Best Efforts.
(a) Upon the terms and subject to the conditions set forth in this Agreement, each of the Parties shall use all reasonable best efforts to take, or cause its Subsidiaries and Representatives to take, all actions (and to refrain from taking, or to cause its Subsidiaries and Representatives to refrain from taking, any inconsistent actions), and to do, or cause to be done, and to assist and cooperate with the other Parties in doing, all things (and to refrain from doing, or to cause its Subsidiaries and Representatives to refrain from doing, any inconsistent things) necessary, proper or advisable to consummate and make effective, in a timely manner, the Arrangement and the Transactions, including (i) the seeking of all necessary Regulatory Approvals and using all reasonable best efforts to obtain any Regulatory Approval as soon as practicable and as required and within the timeframes set forth under applicable Laws, (ii) seeking all consents, approvals or waivers from third parties in connection with the Transactions, including those of which the failure to obtain would result in any breach of, or constitute a default (or an event which, with notice or lapse of time or both, would become a default) under, or give to others any right of termination, amendment, acceleration or cancellation of, or create, give rise to or change any rights or obligations of any Person under, or result in the creation of an Encumbrance on any property or asset of the Parties pursuant to any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation, (iii) the execution and delivery of the covenants and agreements related to obligations of the Company to be specifically assumed at the Effective Time as set forth in Schedule 5.07 of the Company Disclosure Schedule, (iv) the defending of any


26


lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Transactions, including seeking to have any stay or temporary restraining or interim order entered by any court or other Governmental Entity lifted, mitigated, rescinded, vacated or reversed, (v) the carrying out of the terms of the Interim Order and Final Order applicable to it and (vi) the execution and delivery of any additional instrument necessary to consummate the Transactions and to fully carry out the purposes of this Agreement and the Plan of Arrangement. In addition to, and not in limitation of the foregoing, (x) the Parties agree to take all steps to and to incur any costs that are necessary to defend any lawsuits or other legal proceedings, whether judicial or administrative, challenging this Agreement or the consummation of the Transactions, including seeking to have any stay or temporary restraining or interim order entered by any court or other Governmental Entity vacated or reversed, and (y) Parent and Acquisition Sub agree to take all steps necessary to make or enter into any necessary divestitures, licenses or other arrangements (including hold separate arrangements) of or affecting their operations or business units or any part thereof, or the operations or business units of the Company, or those of any of their Subsidiaries or Affiliates, and agree to any other restrictions, as may be required in order to obtain any Regulatory Approval as soon as possible, and in any event prior to the Outside Date, without any set-off or reduction or adjustment in the Purchase Price or to obtain the approval of any other Governmental Entity that may be required following the Effective Time.
(b) The Parties agree to use reasonable best efforts to cooperate and assist one another in connection with all actions to be taken pursuant to Section 5.07(a), including the preparation and making of the filings referred to therein and, if requested, amending and furnishing additional information hereunder, including providing all drafts and final copies of all related documents to the non-filing Partyand/or its advisors (if necessary, on an external counsel basis redacted as may be necessary) prior to filing and to consider in good faith the views and comments of the other party, and, to the extent practicable (unless prohibited by applicable Laws), none of the Parties will file any such document or have any communication with any Governmental Entity without prior consultation with the other Party. Each Party shall keep the others apprised of the content and status of any communications in whatever form with, and communications from, any Governmental Entity with respect to the Arrangement and other Transactions. During the period from the date of this Agreement to the Effective Date, none of the Parties will take any action that would materially delay or adversely affect the ability of the Company and any of the other Parties to obtain any approvals of a Governmental Entity required to permit consummation of the Arrangement and the Transactions. Each of the Parties shall provide to the other Parties or, if competitively sensitive, such Party’s external counsel, all information it reasonably requests for purposes of obtaining any required approval under the Investment Canada Act, Competition Act Approval, the expiration or termination of the waiting period under the HSR Act, and all other required competition, foreign investment or antitrust consents and approvals.
Section 5.08.  Resignations.  The Company shall use its reasonable best efforts to obtain and deliver to Parent evidence reasonably satisfactory to Parent of the resignation, effective as of the Effective Date, of each director of the Company and its Subsidiaries other than those whom Parent shall have specified in writing at least (10) Business Days prior to the Effective Date.
Section 5.09.  Notice of Developments.  The Company shall give prompt notice to Parent, and Parent or Acquisition Sub shall give prompt notice to the Company, of (i) any representation or warranty made by it contained in this Agreement becoming untrue or inaccurate such that the condition set forth in Section 6.02(b) or Section 6.03(b), as applicable, would not be satisfied or (ii) the failure by it to comply with or satisfy in any material respect any covenant, condition or agreement to be complied with or satisfied by it under this Agreement;providedhowever, that no such notification shall affect the representations, warranties, covenants or agreements of the Parties or the conditions to the obligations of the Parties under this Agreement.
Section 5.10.  Benefits Continuation.
(a) For the period beginning on the Effective Date and ending no earlier than the 24 months following the Effective Date, Parent shall cause the Company and its Subsidiaries (or any successors to the Company or any of it Subsidiaries), subject to collective bargaining and applicable Laws, to provide a continuation of the benefits that are substantially equivalent in the aggregate to those provided under the Applicable Plans as in effect on the date hereof to those individuals who are employees or former employees of the Company and its


27


Subsidiaries as of the Effective Date (“Affected Employees”) and their eligible dependents. From and after the Effective Date, Parent shall cause the Company and its Subsidiaries (or any successors to the Company or any of its Subsidiaries) to comply with the terms of all Applicable Plans in effect on the date hereof, subject to any reserved right to amend or terminate any Applicable Plan;provided,however, no such amendment or termination may be inconsistent with the obligations pursuant to the first sentence of this Section 5.10(a). Without limiting the generality of the foregoing, Parent shall cause the Company and its Subsidiaries (or any successors to the Company or any of its Subsidiaries), from and after the Effective Date, to provide severance pay and other severance benefits to Affected Employees who are terminated prior to the second anniversary of the Effective Date in accordance with any Applicable Plans providing for such payments and benefits or the Company’s severance pay and other severance benefits as of the date hereof and under any severance agreements in existence as of the date hereof.
(b) Affected Employees shall be given credit, to the extent not prohibited by applicable Laws, for all service with the Company and its Subsidiaries and any predecessors of the Company and its Subsidiaries (or service credited by the Company or its Subsidiaries or any predecessors of the Company and its Subsidiaries) under all employee benefit plans and arrangements currently maintained or established in the future by Parent or any of its Subsidiaries (including the Company) in which they are or become participants for purposes of participation, eligibility, vesting and level of benefits. Parent and its Subsidiaries (including the Company) shall cause, to the extent not prohibited by applicable Laws, any pre-existing conditions or limitations, eligibility waiting periods or required physical examinations under any welfare benefit plans of Parent and its Subsidiaries (including the Company) to be waived with respect to Affected Employees and their eligible dependents to the extent waived under the corresponding Applicable Plan in which the applicable Affected Employee participated prior to the Effective Date or to the extent they arose while the Affected Employee was employed prior to the Effective Date by the Company or any Subsidiary (or any predecessor of the Company or any Subsidiary) and, with respect to life insurance coverage, up to the Affected Employee’s current level of insurability. Parent and its Subsidiaries (including the Company) shall give Affected Employees and their eligible dependents credit for the plan year in which the Effective Date (or, if later, the commencement of participation in any benefit plan) occurs toward applicable deductibles and annualout-of-pocket limits for expenses incurred prior to the Effective Date (or, if later, the date of commencement of participation in such benefit plan).
(c) Parent shall cause the Company or its applicable Subsidiary (or any successors to the Company or any of its Subsidiaries) to honor, on and after the Effective Time all of the obligations of the Company and of any Subsidiary under the employment and other agreements with executives who are Affected Employees or former employees which are identified in Section 5.10(c) of the Company Disclosure Schedule. Notwithstanding anything in this Agreement to the contrary, nothing in this Section 5.10 shall impose or limit the Company or any of its Subsidiaries from terminating any of their employees at any time for any reason or no reason, subject to the provisions of applicable Law and any Contract.
(d) Nothing in this Section 5.10 (other than the provisions of Section 5.10(c), which may be enforced directly by the applicable Affected Employees or by the Affected Employees as third party beneficiaries to this Agreement) shall confer any third party beneficiary rights or remedies upon any Person, individual or whomsoever other than the Company, Parent and Acquisition Sub.
Section 5.11.  No Control of Other Party’s Business.  Nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct the Company’s or its Subsidiaries’ operations prior to the Effective Date, and nothing contained in this Agreement shall give the Company, directly or indirectly, the right to control or direct Parent’s or its Subsidiaries’ operations prior to the Effective Date. Prior to the Effective Date, each of the Company and Parent shall exercise, consistent with the terms and conditions of this Agreement, complete control over its and its Subsidiaries’ respective operations.
Section 5.12.  Financing.  (a) From the date hereof until the earlier of (i) the Effective Date, and (ii) the termination of this Agreement pursuant to Article VII hereof, the Company shall provide Parent and Acquisition Sub such cooperation as may be reasonably requested in an effort to implement and make effective, as of the Effective Date, the financing provided for in the Commitment Lettersand/or any


28


Alternative Financing (as defined below)and/or any other financing proposed by Parent and Acquisition Sub in connection with the Transactions (individually, a “Financing”, and collectively, the “Financings”), including using reasonable efforts to assist Parent and Acquisition Sub with:
(i) the preparation by Parent and Acquisition Sub of an information package (including a version that does not contain material non-public information);
(ii) participating in the presentation by Parent and Acquisition Sub of such information package and related matters to prospective lenders, including by facilitating direct contact between the Company’s senior management and prospective lenders;
(iii) paying and discharging on the Effective Date any Encumbrances under existing indebtedness, as may be reasonably requested by Parent;
(iv) giving timely redemption and pre-payment notices, as applicable, in connection with the refinancing of the Company’s existing indebtedness, as may be reasonably requested by Parent;
(v) providing Parent at least three (3) days prior to the Effective Date, with estimated outstanding balances, penalties, fees, per diems and related costs as may be required by Parent to effect the payment or prepayment of any outstanding indebtedness and related amounts on the Effective Date;
(vi) the preparation by Parent and Acquisition Sub of an offering memorandum or private placement memorandum suitable for use in a customary “road show” for an offering of high-yield debt securities by the Company and the participation of the senior management of the Company and its Subsidiaries and representatives of the Parent in any such road show;
(vii) the rating agency process, as reasonably requested by Parent;
(viii) the execution and delivery of a customary purchase agreement and related documentation in connection with any offering of high-yield debt securities; and
(ix) any tender offer by or on behalf of Parent or Acquisition Sub of the Company’s Senior Notes in connection with the refinancing of the Company’s existing indebtedness.
(b) Notwithstanding the foregoing, nothing contained in this Section 5.12 shall require cooperation with Parent and Acquisition Sub to the extent it would interfere unreasonably with the business or operations of the Company or its Subsidiaries. Parent also covenants and agrees that if the closing of the Transactions does not occur (other than in a circumstance where the Company Termination Payment or Reimbursement Amount is payable by the Company), Parent shall reimburse the Company for allout-of-pocket travel expenses and the fees and expenses of attorneys, accountants and financial and other advisors to the Company in connection with participation in any “road shows” or other meetings or otherwise in connection with any Financing and shall indemnify Company with respect to any liabilities arising out of any agreements, arrangements, understandings or documentation entered into in connection with any Financing.
(c) Subject to the following sentence, Parent shall use its reasonable best efforts to arrange the financing provided for in the Commitment Letters on the terms and conditions described in the Commitment Letters, including using reasonable best efforts to (i) maintain the effectiveness of the Commitment Letters in accordance with their respective terms, (ii) negotiate and enter into definitive Contracts with respect to the financing provided for in the Commitment Letters, (iii) satisfy on a timely basis all conditions applicable to Parent in such definitive agreements with respect to the financing provided for in the Commitment Letters (including, without limitation, (A) the compliance with all applicable Laws and regulations of India and (B) any and all requirements under applicable Law with respect to shareholder or lender consents, the due filing of all reports and returns with the Reserve Bank of India or authorized dealers, as applicable, and the giving of all applicable notifications) and (iv) consummate the financing provided for in the Commitment Letters at or prior to the closing of the Transactions. In the event any portion of the financing provided for in the Commitment Letters becomes unavailable on the terms and conditions contemplated in the Commitment Letters or if Parent elects to obtain alternative financing, Parent shall arrange to obtain such alternative financing from alternative sources (“Alternative Financing”) in an aggregate principal amount equal to the


29


amounts set forth in, and on terms substantially equivalent to or better than the terms of, the Commitment Letters. Parent shall keep the Company reasonably apprised as to the status of, and any material developments relating to, any Financing. Parent shall promptly notify the Company of any proposal by any of the institutions party to the Commitment Letters to withdraw, terminate or make any material change in the amount or terms of the Commitment Letters. Parent shall not consent to any amendment, modification or early termination of the Commitment Letters that could reasonably be expected to adversely affect the ability of Parent and Acquisition Sub to consummate the Transactions.
ARTICLE VI
CONDITIONS
Section 6.01.  Mutual Conditions Precedent.  The respective obligations of the Parties to complete the Arrangement shall be subject to the satisfaction or waiver, on or before the Effective Time, of the following conditions precedent, each of which may only be waived by the mutual consent of Parent and the Company:
(a) the Arrangement Resolution shall have been approved and adopted at the Meeting by the Shareholders in accordance with the Interim Order;
(b) the Interim Order and the Final Order shall each have been obtained on terms consistent with this Agreement and in a form satisfactory to each of the Company and Parent, acting reasonably, and shall not have been set aside or modified in a manner unacceptable to such Parties, acting reasonably, on appeal or otherwise;
(c) no Governmental Entity shall have enacted, issued, enforced or entered any Law which is then in effect that makes the Arrangement illegal or otherwise prevents, prohibits or enjoins the consummation of the Arrangement; and
(d) the Regulatory Approvals shall have been obtained or satisfied and shall not have been revoked and reasonably satisfactory evidence of the receipt of such Regulatory Approvals shall have been delivered to each Party.
Section 6.02.  Additional Conditions Precedent to the Obligations of Parent.  The obligations of Parent to complete the Arrangement shall also be subject to the fulfillment of each of the following conditions precedent (each of which is for Parent’s exclusive benefit and may be waived in writing by Parent in its sole discretion):
(a) all covenants of the Company under this Agreement to be performed on or before the Effective Time shall have been performed by the Company in all material respects, and Parent shall have received a certificate of the Company addressed to Parent and dated the Effective Date, signed on behalf of the Company by a senior executive officer of the Company (on the Company’s behalf and without personal liability), confirming the same as at the Effective Date;
(b) all representations and warranties of the Company under this Agreement shall have been true and correct (without giving effect to any materiality qualifiers set forth therein) as of the Effective Date as if made on and as of such date (except (i) to the extent such representations and warranties that speak solely as of an earlier date, in which event such representations and warranties shall be true and correct to such extent as of such earlier date, (ii) other than in the case of the representations and warranties specifically referred to in clause (iii) below, to the extent that facts or matters as to which such representations and warranties are not so true and correct as of such dates, individually or in the aggregate, have not had and would not have a Material Adverse Effect, and (iii) in the case of the representations and warranties set forth in Section 3.03, such representations and warranties shall be true and correct in all material respects) and Parent shall have received a certificate of the Company addressed to Parent and dated the Effective Date, signed on behalf of the Company by a senior executive officer of the Company (on the Company’s behalf and without personal liability), confirming the same as at the Effective Date;


30


(c) during the Pre-Effective Date Period, there shall not have occurred and be continuing a Material Adverse Effect; and
(d) there shall be no action, investigation, proceeding or litigation instituted or commenced by any Governmental Entity that is reasonably likely to (i) set aside, appeal or challenge the validity of the Interim Order or the Final Order, (ii) restrain, enjoin, prevent, prohibit or make illegal the consummation of the Arrangement or the Transactions, or (iii) result in a Material Adverse Effect.
Section 6.03.  Additional Conditions Precedent to the Obligations of the Company.  The obligations of the Company to complete the Arrangement shall also be subject to fulfillment of each of the following conditions precedent (each of which is for the exclusive benefit of the Company and may be waived by the Company):
(a) all covenants of Parent and Acquisition Sub under this Agreement to be performed on or before the Effective Date shall have been performed by Parent and Acquisition Sub in all material respects, and the Company shall have received a certificate of Parent addressed to the Company and dated the Effective Date, signed on behalf of Parent by a senior executive officer of Parent (on Parent’s behalf and without personal liability), confirming the same as at the Effective Date;
(b) all representations and warranties of Parent and Acquisition Sub under this Agreement shall have been true and correct (without giving effect to any materiality qualifiers contained therein) as of the Effective Date as if made on and as of such time (except to the extent that such failures to be true and correct would not have a material adverse effect on the ability of the Parent and Acquisition Sub to close the Transactions and perform their obligations hereunder and except such representations and warranties that speak solely as of an earlier date, in which event such representations and warranties shall be true and correct (subject to the exception in the first parenthetical of this Section 6.03(b)) to such extent as of such earlier date) and the Company shall have received a certificate of Parent addressed to the Company and dated the Effective Date, signed on behalf of Parent by a senior executive officer of Parent (on Parent’s behalf and without personal liability), confirming the same as at the Effective Date; and
(c) Acquisition Sub shall have deposited with the Depositary in escrow at or prior to the time of filing of the Articles of Arrangement the funds required to effect payment in full for all of the Securities to be acquired pursuant to the Arrangement and the Depositary shall have confirmed to the Company receipt of these funds. Such funds may be invested by the Depositary as directed by Acquisition Sub or, after the Effective Time, the Company;provided that (i) no such investment or losses thereon shall affect the Purchase Price per Common Share and following any losses Parent shall promptly provide additional funds to the Depositary in the amount of such losses and (ii) such investments shall be in short-term obligations of the United States of America with maturities of no more than 30 days or guaranteed by the United States of America and backed by the full faith and credit of the United States of America or in commercial paper obligations with a Credit Rating of“P-1” or“A-1” or better by Standard & Poor’s Ratings Group or Moody’s Investors Service, Inc., respectively. Any interest or income produced by such investments will be payable to the Company or Acquisition Sub, as Parent directs.
Section 6.04.  Satisfaction of Conditions.  The conditions precedent set out in Section 6.01, Section 6.02 and Section 6.03 shall be conclusively deemed to have been satisfied, waived or released when a Certificate of Arrangement in respect of the Arrangement is issued by the Director.
ARTICLE VII
AMENDMENT AND TERMINATION
Section 7.01.  Amendment.  This Agreement and the Plan of Arrangement may, at any time and from time to time before or after the holding of the Meeting but not later than the Effective Date, be amended by mutual written agreement of the Parties, and any such amendment may without further Shareholder approvals, subject to applicable Laws, the Interim Order and the Final Order, without limitation:
(a) change the time for performance of any of the obligations or acts of the Parties;


31


(b) waive any inaccuracies or modify any representation or warranty contained herein or in any document delivered pursuant hereto;
(c) waive compliance with or modify any of the covenants herein contained and waive or modify performance of any of the obligations of the Parties; and/or
(d) waive compliance with or modify any conditions precedent herein contained provided that any such change does not decrease the consideration payable to the Shareholders.
Section 7.02.  Termination.
(a) This Agreement may be terminated and the Arrangement may be abandoned at any time prior to the filing of the Articles of Arrangement, notwithstanding any requisite approval and authorization of this Agreement by Shareholders:
(i) by mutual written consent of Parent and the Company duly authorized by the boards of directors of Parent and the Company;
(ii) by either Parent or the Company if the Effective Time shall not have occurred on or before July 7, 2007, or at the option of Parent, July 31, 2007, if the expiration date of the Commitment Letters is extended to or beyond such date (as applicable, the “Outside Date”);provided,however, that the right to terminate this Agreement under this Section 7.02(a)(ii) shall not be available to any Party whose failure to fulfill any representation, warranty or obligation under this Agreement or other action has been the cause of, or resulted in, the failure of the Effective Time to occur on or before such date;
(iii) by either Parent or the Company if any Governmental Entity shall have enacted, issued, promulgated, enforced or entered any Law or Order which has become final and nonappealable and has the effect of making the Arrangement illegal or otherwise preventing or prohibiting consummation of the Arrangement;
(iv) by either Parent or the Company if the Arrangement Resolution shall have failed to receive the requisite vote for approval at the Meeting or at any adjournment or postponement thereof in accordance with the Interim Order;
(v) by Parent, if: (i) the Company’s Board of Directors effects a Company Adverse Recommendation Change; or (ii) the Company’s Board of Directors makes a Superior Proposal Recommendation or (iii) the Company enters into a Superior Proposal Agreement;
(vi) by the Company, if the Company enters into a Superior Proposal Agreement in compliance with the provisions of Section 5.04;
(vii) by Parent, if there has been a breach of or failure to perform any representation, warranty, covenant or agreement on the part of the Company set forth in this Agreement, which breach or failure to perform would cause the conditions set forth in Section 6.02(a) or (b) not to be satisfied;provided that if such breach or failure to perform is capable of being cured through the exercise of reasonable best efforts, Parent may not terminate this Agreement under this Section 7.02(a)(vii) for a period equal to the lesser of 30 days after giving notice of such breach or failure to perform and the period between the giving of such notice until the day prior to the Outside Date, in each case so long as the Company continues to exercise such reasonable best efforts; and
(viii) by the Company, if there has been a breach of or failure to perform any representation, warranty, covenant or agreement on the part of Parent or Acquisition Sub set forth in this Agreement, which breach or failure to perform would cause the conditions set forth in Section 6.03(a) or (b) not to be satisfied;provided that if such breach or failure to perform is capable of being cured through the exercise of reasonable best efforts, the Company may not terminate this Agreement under this Section 7.02(a)(viii) for a period equal to the lesser of 30 days after giving notice of such breach or failure to perform and the period between the giving of such notice until the day prior to the Outside Date, in each case so long as Parent or Acquisition Sub continues to exercise such reasonable best efforts.


32


(b) If this Agreement is terminated in accordance with the foregoing provisions of this Section 7.02, no Party shall have further liability under this Agreement except as provided in Section 7.02 or Section 7.03, and provided that neither the termination of this Agreement nor anything contained in this Section 7.02 shall relieve any Party from any liability for any willful and material breach by it of this Agreement.
(c) If this Agreement is terminated pursuant to Section 7.02(a)(ii) (unless the Company does not have the right to terminate this Agreement under Section 7.02(a)(ii) due to its failure to fulfill any obligation under this Agreement or breach of any representation or warranty which failure or breach has been the cause of, or resulted in, the failure of the Effective Time to occur on or before the Outside Date), Section 7.02(a)(iii) or Section 7.02(a)(viii), in any such case Parent and Acquisition Sub agree, jointly and severally, to indemnify the Company and its Affiliates against any Damages which are incurred or suffered by the Company and its Affiliates or the Shareholders resulting from or arising out of any breach by either of them of Section 4.07, any failure to pay or deposit or be able to pay or deposit the Purchase Price when due in accordance with the terms of this Agreement, or any breach or failure to perform any of their obligations pursuant to Section 5.07.
Section 7.03.  Termination Fees.
(a) The Company shall pay the Company Termination Payment to Acquisition Sub, by way of a wire transfer in immediately available funds to an account specified by Parent, if:
(i) this Agreement is terminated in the circumstances set out in Section 7.02(a)(v) or Section 7.02(a)(vi); or
(ii) (A) prior to the Meeting an Acquisition Proposal is publicly announced (a “Public Acquisition Proposal”); (B) the Shareholders fail to approve this Agreement and the Transactions; and (C) during the period commencing on the date hereof and ending twelve (12) months following the termination of this Agreement (X) an Acquisition Proposal is consummated by the Person who publicly announced the Public Acquisition Proposal, or (Y) the Company enters into a definitive agreement with respect to such Public Acquisition Proposal and that Acquisition Proposal is subsequently consummated at any time thereafter (provided that for purposes of this Section 7.03(a)(ii), references to “35% or more” in the definition of “Acquisition Proposal” shall be deemed references to “50% or more”).
Such payment shall be made by wire transfer of immediately available funds to an account designated by Parent and shall be due: (A) in the case of a termination specified in clause (i) above, within five (5) Business Days following the termination of this Agreement but prior to or concurrently with termination in the case of a termination pursuant to Section 7.02(a)(vi); and (B) in the case of the circumstances specified in clause (ii) above, prior to or concurrently with the consummation of the Acquisition Proposal.
(b) If this Agreement is terminated by Parent in the circumstances set out in Section 7.02(a)(vii), then the Company shall pay to Parent by wire transfer of immediately available funds within five (5) Business Days following such termination of this Agreement an amount equal to the aggregate of all reasonable out of pocket costs and expenses incurred by Parent and its Affiliates in connection with the Transactions (including all reasonable fees and expenses of financial, legal, accounting and other advisors and of potential lenders) up to a maximum of $15,000,000 (the “Reimbursement Amount”). If after the payment of the Reimbursement Amount, the events set forth in Section 7.03(a)(ii) occur, the Company shall pay an amount equal to the difference between the Company Termination Payment and the Reimbursement Amount to the Parent in the manner provided for in the last paragraph of Section 7.03(a).
(c) The Company irrevocably waives any right it may have to raise as a defense that the Company Termination Payment or the Reimbursement Amount is excessive or punitive. In no event shall more than one Company Termination Payment by the Company be payable. Parent and Acquisition Sub hereby agree that, upon any termination of this Agreement under circumstances where Parent is entitled to the Company Termination Payment or the Reimbursement Amount and such Company Termination Payment or the Reimbursement Amount is paid in full to Acquisition Sub, Parent and Acquisition Sub shall be precluded from any other remedy against the Company, at law or in equity or otherwise, and neither Parent nor Acquisition Sub shall seek to obtain any recovery, judgment, or damages of any kind, including consequential, indirect, or punitive damages, against the Company or any of the Company’s Subsidiaries or any of their respective


33


directors, officers, employees, partners, managers, members, shareholders or Affiliates in connection with this Agreement or the transactions contemplated hereby.
Section 7.04.  Remedies.  Subject to Section 7.03, the Parties acknowledge and agree that an award of money damages would be inadequate for any breach of this Agreement by any Party or its Representatives and any such breach would cause the non-breaching Party or a third party beneficiary of this Agreement irreparable harm. Accordingly, the Parties (on behalf of themselves and the third party beneficiaries of this Agreement) agree that, in the event of any breach or threatened breach of this Agreement by one of the Parties, the non-breaching Party will also be entitled, without the requirement of posting a bond or other security, to equitable relief, including injunctive relief and specific performance, and the Parties shall not object to the granting of injunctive or other equitable relief on the basis that there exists an adequate remedy at law. Subject to Section 7.03, such remedies will not be the exclusive remedies for any breach of this Agreement but will be in addition to all other remedies available at law or equity to each of the Parties.
ARTICLE VIII
GENERAL
Section 8.01.  Advisors.  Parent and the Company represent and warrant to each other that, with the exception of UBS Securities LLC, for whose fees and expenses Parent shall be solely liable, and Morgan Stanley & Co. Incorporated and Evercore Partners, for whose fees and expenses the Company shall be solely liable, no securityholder, director, officer, employee, consultant, broker, finder or investment banker is entitled to any brokerage, finder’s or other fee or commission (other than professional fees), or to the reimbursement of any of its expenses, in connection with the Transactions or any similar transaction based upon arrangements made by or on behalf of Parent or the Company, as the case may be.
Section 8.02.  Public Statements.  Except as required by applicable Law or applicable stock exchange requirements, neither Parent (including its Representatives) nor the Company (including its Representatives) shall make any public announcement or statement with respect to the Transactions or this Agreement without the approval of the Company or Parent, respectively, such approval not to be unreasonably withheld or delayed. Moreover, in any event, each Party agrees to give prior notice to the other of any public announcement relating to the Transactions or this Agreement and agrees to consult with each other prior to issuing each such public announcement. Each of Parent and the Company agrees that, promptly after the entering into of this Agreement, it shall issue a press release announcing the entering into of this Agreement, which press release shall, in each case, be satisfactory in form and substance to the other party acting reasonably.
Section 8.03.  Notices.  Any notice, consent or approval required or permitted to be given in connection with this Agreement (in this Section referred to as a “Notice”) shall be in writing and shall be sufficiently given if delivered (whether in person, by courier service or other personal method of delivery), or if transmitted by facsimile or email:
(a) If to Parent or Acquisition Sub, at:
Hindalco Industries Limited
Aditya Birla Centre, B-Wing, 3rd Floor
S.K. Ahire Marg, Worli, Mumbai-400 030 India
Attn: Mr. D. Bhattacharya, Managing Director
Fax:91-22-6652 5841
Email: dbhattacharya@adityabirla.com


34


with a copy to:
Torys LLP
Suite 3000
79 Wellington St. W
Toronto ON
M5K 1N2
Attn: Patricia Koval
Fax:(416) 865-7380
Email: pkoval@torys.com
(b) If to the Company at:
Novelis Inc.
3399 Peachtree Road
Suite 1500
Atlanta, Georgia 30326
Attn: Leslie J. Parrette, Jr.
Fax:(404) 814-4282
Email: les.parrette@novelis.com
with a copy to:
King & Spalding LLP
1180 Peachtree Street, NE
Atlanta, Georgia 30309
Attn: John J. Kelley III
Fax:(404) 572-5133
Email: jkelley@kslaw.com
Any Notice delivered or transmitted to a Party as provided above shall be deemed to have been given and received on the day it is delivered or transmitted,provided that it is delivered or transmitted on a Business Day prior to 5:00 p.m. local time in the place of delivery or receipt. However, if the Notice is delivered or transmitted after 5:00 p.m. local time or if such day is not a Business Day then the Notice shall be deemed to have been given and received on the next Business Day.
Any Party may, from time to time, change its address by giving Notice to the other Parties in accordance with the provisions of this Section.
Section 8.04.  Assignment.  Neither this Agreement nor any rights or obligations under this Agreement shall be assignable by operation of law or otherwise by any Party, in whole or in part, without the prior written consent of each of the other Parties, except that Parent may assign in its sole discretion any or all of its rights, interestsand/or obligations under this Agreement to any direct or indirect Subsidiary of Parent,provided that Parent shall remain liable for any breach of this Agreement by such Subsidiaries. Any assignment in violation of the preceding sentence shall be void. This Agreement shall inure to the benefit of and be binding upon the Parties and their respective successors (including any successor by reason of amalgamation of any Party) and permitted assigns.
Section 8.05.  Further Assurances.  The Parties shall with reasonable diligence do all such reasonable things and provide all such reasonable assurances as may be required to consummate the Transactions, and each Party shall provide such further documents or instruments required by any other Party as may be reasonably necessary or desirable to effect the purpose of this Agreement and carry out its provisions.
Section 8.06.  Execution and Delivery.  This Agreement may be executed by the Parties in counterparts and may be executed and delivered by facsimile and all such counterparts and facsimiles shall together constitute one and the same agreement.


35


Section 8.07.  No Liability.
(a) No director or officer of the Parent or Acquisition Sub shall have any personal liability whatsoever to the Company under this Agreement, or any other document delivered in connection with the Transactions on behalf of the Parent or Acquisition Sub.
(b) No director or officer of the Company shall have any personal liability whatsoever to the Parent or Acquisition Sub under this Agreement, or any other document delivered in connection with the Transactions on behalf of the Company.
Section 8.08.  Agent for Service of Process.  Parent and Acquisition Sub hereby appoint Joshua Goldstein, Torys LLP, 237 Park Avenue, New York, New York10017-3147, as their authorized agent (the “Authorized Agent”) upon whom process may be served in any suit, action or proceeding arising under or in relation to this Agreement and agree that service of process upon the Authorized Agent shall be deemed in every respect effective service of process upon Parent or Acquisition Sub, as applicable, in any such suit or proceeding. Parent and Acquisition Sub hereby represent and warrant that the Authorized Agent has accepted such appointment and has agreed to act as such agent for service of process, and Parent and Acquisition Sub agree to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Any service of process to be made in such action or proceeding may be made by delivery of process in accordance with the notice provisions contained in Section 8.03.
Section 8.09.  Dispute Resolution.
(a) Any dispute, controversy or claim arising out of, relating to, or in connection with this Agreement, or the breach, termination or validity hereof, shall be finally settled exclusively by arbitration. The arbitration shall be conducted in accordance with the rules of the International Chamber of Commerce (the “ICC”) in effect at the time of the arbitration, except as they may be modified by mutual agreement of the Parties. The seat of the arbitration shall be New York City, New York, and the substantive law governing the arbitration shall be the law of the State of New York. The arbitration shall be conducted in the English language.
(b) The arbitration shall be conducted by three arbitrators. The Party (or the Parties, acting jointly, if there are more than one) initiating arbitration (the “Claimant”) shall appoint an arbitrator in its request for arbitration (the “Request”). The other Party (or the other parties, acting jointly, if there are more than one) to the arbitration (the “Respondent”) shall appoint an arbitrator within 30 days of receipt of the Request and shall notify the Claimant of such appointment in writing. If within 30 days of receipt of the Request by the Respondent, the Respondent has not appointed an arbitrator, then such arbitrator shall be appointed by the ICC. The first two arbitrators appointed in accordance with this provision shall appoint a third arbitrator within 30 days after the Respondent has notified Claimant of the appointment of the Respondent’s arbitrator or, in the event of a failure by a Party to appoint, within 30 days after the ICC has notified the Parties and any arbitrator already appointed of the appointment of an arbitrator on behalf of the Party failing to appoint. When the third arbitrator has accepted the appointment, the two arbitrators making the appointment shall promptly notify the Parties of the appointment. If the first two arbitrators appointed fail to appoint a third arbitrator or so to notify the Parties within the time period prescribed above, then the ICC shall appoint the third arbitrator and shall promptly notify the Parties of the appointment. The third arbitrator shall act as chair of the tribunal.
(c) The arbitral award shall be in writing, state the reasons for the award, and be final and binding on the Parties. The award shall include an award of costs, including reasonable attorneys’ fees and disbursements. The arbitral tribunal shall be authorized in its discretion to grant pre-award and post-award interest at commercial rates. Any costs, fees or taxes incident to enforcing the award shall, to the maximum extent permitted by Law, be charged against the party resisting such enforcement. Judgment upon the award may be entered by any court having jurisdiction thereof or having jurisdiction over the relevant Party or its assets.
(d) The Parties agree that the arbitration shall be kept confidential and that the existence of the proceeding and any element of it (including but not limited to any pleadings, briefs or other documents submitted or exchanged, any testimony or other oral submissions, and any awards) shall not be disclosed beyond the tribunal, the ICC, the Parties, their counsel and any Person necessary to the conduct of the


36


proceeding, except as may be lawfully required in judicial proceedings relating to the arbitration or otherwise, or as required by applicable stock exchange requirements or the rules of any other quotation system or exchange on which the disclosing Party’s securities are listed or applicable Law.
(e) All payments made pursuant to the arbitration decision or award and any judgment entered thereon shall be made in United States dollars, free from any deduction, offset or withholding for Taxes.
Section 8.10.  Governing Law.  This Agreement is a contract made under and shall be governed by and construed in accordance with the laws of the State of New York (except for the matters subject to the CBCA (including the duties of the Board of Directors of the Company and the Plan of Arrangement) which shall be governed by and in accordance with the CBCA).
Section 8.11.  Severability.  If, in any jurisdiction, any provision of this Agreement or its application to any Party or circumstance is restricted, prohibited or unenforceable, such provision shall, as to such jurisdiction, be ineffective only to the extent of such restriction, prohibition or unenforceability without invalidating the remaining provisions of this Agreement and without affecting the validity or enforceability of such provision in any other jurisdiction or without affecting its application to other Parties or circumstances.
Section 8.12.  Binding Effect.  This Agreement shall be binding upon and inure to the benefit of and be enforceable by the Parties and their respective successors and permitted assigns.
Section 8.13.  Survival.  The representations and warranties of the Parties contained herein shall survive the execution and delivery of this Agreement but shall terminate on the earlier of the termination of this Agreement in accordance with its terms and immediately following the filing of the Articles of Arrangement. Any investigation by a Party and its advisors shall not mitigate, diminish or affect the representations and warranties of another Party.
Section 8.14.  Third Party Beneficiary.  Nothing in this Agreement, express or implied, is intended to or shall confer upon any other person any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement other than (i) as specifically provided in Section 5.06 and 5.10; (ii) the rights of the Company to pursue claims for Damages and other relief on behalf of Shareholders, including equitable relief, pursuant to Section 7.02 for Parent or Acquisition Sub’s breach of this Agreement; and (iii) after the Effective Date, the rights of Shareholders to receive the Purchase Price per share;provided,however, that the rights granted pursuant to clause (ii) shall be enforceable on behalf of such Shareholders only by the Company in its sole and absolute discretion, it being understood and agreed that any and all interest in such claims shall attach to such Common Shares and subsequently trade and transfer therewith and, consequently, Damages recovered or received by the Company with respect to such claims (net of expenses incurred by the Company in connection therewith) may, in the Company’s sole and absolute discretion, be (A) distributed, in whole or in part, by the Company to the Shareholders as of any date determined by the Company of record as of any date determined by the Company or (B) retained by the Company for use and benefit of the Company on behalf of its Shareholders in any manner the Company deems fit.
Section 8.15.  Expenses.  Each Party shall pay all fees, costs and expenses incurred by such Party in connection with this Agreement and the Transactions, except Parent shall be responsible for paying all filing fees in connection with obtaining the Regulatory Approvals, and each Party shall share equally all fees, costs and expenses incurred in connection with the preparation, filing and mailing of the Proxy Statement/Circular.
[remainder of page intentionally left blank]


37


IN WITNESS WHEREOFthe Parties hereto have executed this Agreement as of the date first written above.
HINDALCO INDUSTRIES LIMITED
By: /s/ D. Bhattacharya

Name: D. Bhattacharya
Title: Managing Director
AV ALUMINUM INC.
By: /s/ M.R. Prasanna

Name: M.R. Prasanna
Title: Director
NOVELIS INC.
By: /s/ Edward A. Blechschmidt

Name: Edward A. Blechschmidt
Title: Acting Chief Executive Officer


38


SCHEDULE A
 
• Competition Act Approval.
• Investment Canada Act Approval.
• The antitrust filings and approvals under the HSR Act or the expiration or earlier termination of the applicable waiting period under the HSR Act.
• The antitrust approvals of the European Commission pursuant to the EC Merger Regulation or of the competent antitrust authorities in the applicable European Union Member States.
• Approval by Agência Nacional de Energia Elétrica (ANEEL) under article 27 of Law N.8.987, dated February 13, 1995 (as amended), if required by Law.




ANNEX C
PLAN OF ARRANGEMENT


PLAN OF ARRANGEMENT
UNDER SECTION 192
OF THE CANADA BUSINESS CORPORATIONS ACT
ARTICLE I
INTERPRETATION
(Section 1.01.  Definitions.  In this Plan of Arrangement, unless there is something in the subject matter or context inconsistent therewith, the following terms shall have the respective meanings set out below and grammatical variations of such terms shall have corresponding meanings:
(a) “2006 Incentive Plan”means the Company’s 2006 Incentive Plan approved by the Company’s Shareholders at the 2006 Annual Meeting of Shareholders;
(b) “Acquisition Sub”means AV Metals Inc., a corporation existing under the CBCA and being a subsidiary of Parent;
(c) “Affiliate”means, with respect to any specified Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person, unless otherwise expressly stated herein;
(d) “Arrangement”means the arrangement under Section 192 of the CBCA on the terms and subject to the conditions set out in this Plan of Arrangement, subject to any amendments or variations thereto made in accordance with Section 7.01 of the Arrangement Agreement or Article V hereof;
(e) “Arrangement Agreement”means the Arrangement Agreement, dated February 10, 2007, among Parent, AV Aluminum Inc. Sub and the Company, as amended in accordance with Section 7.01 thereof providing for, among other things, the Arrangement;
(f) “Arrangement Resolution”means the special resolution in respect of the Arrangement, put forth at the Special Meeting for vote by the Shareholders;
(g) “Articles of Arrangement”means the articles of arrangement of the Company in respect of the Arrangement that are required by the CBCA to be sent to the Director after the Final Order is made in order for the arrangement to become effective;
(h) “Business Day”means any day other than a Saturday or Sunday on which commercial deposit taking banks are generally open for business in Mumbai, India, Toronto, Ontario and Atlanta, Georgia;
(i) “CBCA”means the Canada Business Corporations Act, as amended from time to time;
(j) “Certificate of Arrangement”means the certificate of arrangement to be issued by the Director pursuant to subsection 192(7) of the CBCA in respect of the Articles of Arrangement;
(k) “Common Shares”means the common shares of the Company;
(1) “Company”means Novelis Inc., a corporation existing under the CBCA;
(m) “Company Stock Plans”means the 2006 Incentive Plan, the Conversion Plan, the Deferred Share Unit Plan, the Founders Performance Awards Plan and the Stock Price Appreciation Unit Plan;
(n) “Conversion Plan”means the Company’s Conversion Plan of 2005, as amended as of October 19, 2006;
(o) “Court”means the Ontario Superior Court of Justice (Commercial List);
(p) “Deferred Share Unit Plan”means the Company’s Deferred Share Unit Plan for Non-Executive Directors;
(q) “Depositary”means CIBC Mellon Trust Company at its offices set out in the Letter of Transmittal;
(r) “Director”means the Director appointed pursuant to Section 260 of the CBCA;
(s) “Dissent Rights”means the rights of dissent in respect of the Arrangement described in Section 3.01;


C-1


(t) “Dissenting Holder”means any Shareholder who has duly exercised its Dissent Rights and has not withdrawn or been deemed to have withdrawn such Dissent Rights;
(u) “DSU”means a deferred share unit granted pursuant to the Deferred Share Unit Plan;
(v) “Effective Date”means the date shown on the Certificate of Arrangement giving effect to the Arrangement;
(w) “Effective Time”means the date and time of issuance of the Articles of Arrangement by the Director;
(x) “Final Order”means the order of the Court approving the Arrangement as such order may be amended at any time prior to the Effective Time or, if appealed, then, unless such appeal is withdrawn or denied, as affirmed or as amended on appeal;
(y) “Founders Performance Awards Plan”means the Company’s Founders Performance Award Plan, as amended as of March 14, 2006;
(z) “Interim Order”means the interim order of the Court providing for, among other things, the calling and holding of the Special Meeting, as such order may be amended, as contemplated by Section 2.03 of the Arrangement Agreement;
(aa) “ITA” means the Income Tax Act (Canada), as amended;
(bb) “Letter of Transmittal”means the letter of transmittal forwarded by the Company to Shareholders in connection with the Arrangement, in form accompanying the Proxy Statement/Circular;
(cc) “Options”means any option to purchase a Common Share granted under the 2006 Incentive Plan or converted into an option to acquire a Common Share pursuant to the Conversion Plan;
(dd) “Optionholders”means the holders of Options;
(ee) “Parent”means Hindalco Industries Limited, a corporation existing under the laws of India;
(ff) “Person”includes any individual, sole proprietorship, partnership, firm, entity, limited partnership, limited liability company, unlimited liability company, unincorporated association, unincorporated syndicate, unincorporated organization, trust, body, corporation or Governmental Entity, and persons acting jointly or in concert and where the context requires any of the foregoing when they are acting as trustee, executor, administrator or other legal representative;
(gg) “Proxy Statement/Circular”means the notice of the Special Meeting and accompanying proxy statement/circular, including all appendices thereto, to be sent to Shareholders in connection with the Special Meeting;
(hh) “PSU” means a performance share unit granted pursuant to the Founders Performance Award Plan;
(ii) “Purchase Price”means the Purchase Price as defined in the Arrangement Agreement;
(jj) “SAR” means a stock appreciation right granted pursuant to the 2006 Incentive Plan;
(kk) “Rights Plan”means the Shareholder Rights Agreement between the Company and CIBC Mellon Trust company dated as of December 23, 2004, as amended by the First Amendment Agreement dated February 10, 2007;
(11) “Shareholders”means the holders of Common Shares whose names appear in the register of holders of Common Shares maintained by or on behalf of the Company and, where the context so provides, includes joint holders of such Common Shares;
(mm) “Sixth Anniversary”means the sixth anniversary of the Effective Date;
(nn) “SPAU”means a stock price appreciation unit granted pursuant to the Stock Price Appreciation Unit Plan;


C-2


(oo) “Special Meeting”means the special meeting of Shareholders to be held to consider the Arrangement Resolution, including any and all meetings held thereafter as a result of an adjournment or postponement thereof, to be called and held in accordance with the Interim Order; and
(pp) “Stock Price Appreciation Unit Plan”means the Company’s Stock Price Appreciation Unit Plan.
Section 1.02.  Interpretation Not Affected by Headings, Etc.  The division of this Plan of Arrangement into articles, sections and other portions and the insertion of headings are for reference purposes only and shall not affect the interpretation of this Plan of Arrangement. Unless otherwise indicated, any reference in this Plan of Arrangement to“Article”or“section”followed by a number refers to the specified Article or section of this Plan of Arrangement. The terms“this Plan of Arrangement”, “hereof”, “herein”, “hereunder”and similar expressions refer to this Plan of Arrangement, including any appendices hereto, and any amendments, variations or supplements hereto made in accordance with the terms hereof or the Arrangement Agreement or made at the direction of the Court in the Final Order and do not refer to any particular Article, section or other portion of this Plan of Arrangement.
Section 1.03.  Rules of Construction.  In this Plan of Arrangement, unless the context otherwise requires, (a) words importing the singular number include the plural and vice versa, (b) words importing any gender include all genders, and (c) “include”, “includes”and“including”shall be deemed to be followed by the words “without limitation”.
Section 1.04.  Date of Any Action.  In the event that any date on which any action is required to be taken hereunder by any of the parties hereto is not a Business Day, such action shall be required to be taken on the next succeeding day which is a Business Day.
Section 1.05.  Time.  Time shall be of the essence in every matter or action contemplated hereunder. All times expressed herein or in the Letter of Transmittal are local time (Toronto, Ontario) unless otherwise stipulated herein or therein.
Section 1.06.  Currency.  Unless otherwise stated, all references in this Plan of Arrangement to sums of money and payments to be made hereunder are expressed in lawful money of the United States of America.
Section 1.07.  Statutes.  Any reference to a statute includes all rules and regulations made pursuant to such statute and, unless otherwise specified, the provisions of any statute or regulation or rule which amends, supplements or supersedes any such statute, regulation or rule.
ARTICLE II
ARRANGEMENT
Section 2.01.  Arrangement Agreement.  This Plan of Arrangement is made pursuant to, is subject to the provisions of and forms part of the Arrangement Agreement.
Section 2.02.  Binding Effect.  This Plan of Arrangement, upon the filing of the Articles of Arrangement and the issuance of the Certificate of Arrangement, will become effective at, and be binding at and after, the Effective Time on (i) the Company, (ii) Parent and Acquisition Sub, (iii) all Shareholders and beneficial owners of Common Shares, and (iv) all Optionholders and holders of SARs, SPAUs, PSUs and DSUs.
Section 2.03.  Arrangement.  Commencing at the Effective Time, the following shall occur and shall be deemed to occur in the following order without any further act or formality, in each case, effective at the Effective Time:
(a) the Rights Plan shall be terminated;


C-3


(b) each outstanding Option, SAR and SPAU (whether vested or unvested), notwithstanding the terms of the applicable Company Stock Plan, shall be deemed to be unconditionally vested and exercisable, and such Option, SAR or SPAU:
(i) shall, without any further action by or on behalf of the holder thereof, be transferred by such holder to the Company in exchange for a cash payment from the Company equal to the amount (if any) by which the Purchase Price exceeds the exercise price thereof, less applicable withholdings; and
(ii) shall immediately be cancelled and all agreements related thereto shall be terminated and the holder thereof shall thereafter have only the right to receive the consideration to which such holder is entitled pursuant to this Section 2.03(b) at the time and in the manner specified in Article IV; and
(c) each outstanding PSU and DSU will be cancelled by the Company in exchange for a cash payment by the Company in the amount of the Purchase Price per PSU or DSU, as applicable, less applicable withholdings;
(d) each Common Share outstanding at the Effective Time other than a Common Share held by (i) a Dissenting Holder who is ultimately entitled to be paid the fair value of the Common Shares held by such Dissenting Holder, or (ii) Parent, Acquisition Sub or any Affiliate thereof (which shall not be exchanged under the Arrangement and shall remain outstanding as a Common Share held by Parent, Acquisition Sub or any Affiliate thereof), shall be transferred to Acquisition Sub in exchange for the Purchase Price per Common Share in cash;
(e) the names of the holders of the Common Shares transferred to Acquisition Sub shall be removed from the applicable registers of holders of Common Shares and Acquisition Sub shall be recorded as the registered holder of the Common Shares so acquired and shall be deemed the legal and beneficial owner thereof free and clear of any liens or encumbrances;
(f) the Company shall pay any short-term incentive compensation payable under the 2006 Incentive Plan in connection with a change in control; and
(g) the Company Stock Plans shall be terminated.
ARTICLE III
RIGHTS OF DISSENT
Section 3.01.  Rights of Dissent.
(a) Shareholders may exercise pursuant to and in the manner set forth in Section 190 of the CBCA, as modified by this Section 3.01, the right of dissent in connection with the Arrangement, as the same may be modified by the Interim Order or the Final Order (the“Dissent Rights”);provided that notwithstanding Section 190(5) of the CBCA, the written objection to the Arrangement Resolution referred to in Section 190(5) of the CBCA must be received by the Company not later than 5:00 p.m. (Toronto time) on the Business Day preceding the Special Meeting. Holders who duly exercise such Dissent Rights and who:
(i) are ultimately entitled to be paid by Acquisition Sub the fair value for their Common Shares shall be deemed to have transferred such Common Shares to Acquisition Sub free and clear of any liens or encumbrances on the Effective Date contemporaneously with the event described in Section 2.03(d) in exchange for a debt claim in an amount equal to the fair value of such Common Shares; or
(ii) are ultimately not entitled, for any reason, to be paid fair value for their Common Shares shall be deemed to have participated in the Arrangement on the same basis as a non-dissenting Shareholder.
(b) In no circumstances shall the Company, Acquisition Sub or any other Person be required to recognize a Person exercising Dissent Rights unless such Person is a registered holder of those Common Shares in respect of which such rights are sought to be exercised.


C-4


(c) For greater certainty, in no case shall Parent, Acquisition Sub, the Company or any other Person be required to recognize Dissenting Holders as holders of Common Shares after the Effective Time, and the names of such Dissenting Holders shall be deleted from the register of Shareholders on the Effective Date at the same time as the event described in Section 2.03(d) occurs. In addition to any other restrictions under Section 190 of the CBCA, none of the following shall be entitled to exercise Dissent Rights: (i) holders of Options, SARs, SPAU, PSUs and DSUs and (ii) Shareholders who vote or are deemed to have instructed a proxyholder to vote, in favor of the Arrangement Resolution.
ARTICLE IV
CERTIFICATES AND PAYMENTS
12-monthSection 4.01.  Exchange of Certificates for Cash.
(a) At or before the time of filing of the Articles of Arrangement, Acquisition Sub shall deposit with the Depositary in escrow for the benefit of Shareholders, cash in the aggregate amount equal to the payments contemplated by Section 2.03(d). Upon surrender to the Depositary for cancellation of a certificate which immediately prior to the Effective Time represented outstanding Common Shares that were exchanged for cash, together with a duly completed and executed Letter of Transmittal and such additional documents and instruments as the Depositary may reasonably require, the Shareholder of such surrendered certificate shall be entitled to receive in exchange therefor, and the Parent shall cause the Depositary to deliver to such Shareholder, a check (or other form of immediately available funds) representing the cash which such Shareholder has the right to receive under the Arrangement for such Common Shares, less any amounts withheld pursuant to Section 4.03 and any certificate so surrendered shall forthwith be cancelled. The cash deposited with the Depositary shall be held in an interest-bearing account, and any interest earned on such funds shall be for the account of Acquisition Sub.
(b) Until surrendered as contemplated by this Section 4.01, each certificate which immediately prior to the Effective Time represented Common Shares shall be deemed after the Effective Time to represent only the right to receive upon such surrender a cash payment in lieu of such certificate as contemplated in this Section 4.01, less any amounts withheld pursuant to Section 4.03. Any such certificate formerly representing Common Shares not duly surrendered on or before the Sixth Anniversary shall cease to represent a claim by or interest of any former Shareholder of any kind or nature against or in the Company, Parent or Acquisition Sub. On the Sixth Anniversary, all cash to which such former holder was entitled shall be deemed to have been surrendered to Parent.
(c) At or before the Effective Time, the Company shall deposit with the Depositary the amount of cash required to satisfy the payment obligations of the Company pursuant to Sections 2.03(b) and 2.03(c), such amount to be held for purposes of such obligations. The cash shall be held in a separate interest-bearing account and any interest earned on such funds shall be for the account of the Company. On or as soon as practicable after the Effective Date, the Depositary shall deliver on behalf of the Company to each holder who immediately before the Effective Time was an Optionholder, or a holder of SARs, SPAUs, DSUsand/or PSUs, as reflected on the books and records of the Company, a check (or other form of immediately available funds) representing the cash which such holder is entitled in accordance with Sections 2.03(b)and/or 2.03(c) against receipt of such documentation as Parent or the Company may reasonably require acknowledging the transferand/or termination of the Options, SARs, SPAUs, DSUs or PSUs, as the case may be, held by such holder.
(d) Any payment made by way of check by the Depositary on behalf of Acquisition Sub or the Company that has not been deposited or has been returned to the Depositary or that otherwise remains unclaimed, in each case, on or before the Sixth Anniversary, and any right or claim to payment hereunder that remains outstanding on the Sixth Anniversary shall cease to represent a right or claim of any kind or nature and the right of the holder to receive the consideration for Common Shares, Options, SARs, SPAUs, DSUs or PSUs, as the case may be, pursuant to this Plan of Arrangement shall terminate and be deemed to be surrendered and forfeited to Acquisition Sub or the Company, as applicable, for no consideration.


C-5


Section 4.02.  Lost Certificates.  In the event any certificate which immediately prior to the Effective Time represented one or more outstanding Common Shares that were exchanged pursuant to Section 2.03 shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such certificate to be lost, stolen or destroyed, the Depositary will issue in exchange for such lost, stolen or destroyed certificate, cash deliverable in accordance with such holder’s Letter of Transmittal. When authorizing such payment in exchange for any lost, stolen or destroyed certificate, the Person to whom such cash is to be delivered shall as a condition precedent to the delivery of such cash, give a bond satisfactory to Acquisition Sub and the Depositary in such sum as Acquisition Sub may direct, or otherwise indemnify Acquisition Sub and the Company in a manner satisfactory to Acquisition Sub and the Company, against any claim that may be made against Acquisition Sub and the Company with respect to the certificate alleged to have been lost, stolen or destroyed.
Section 4.03.  Withholding Rights.  The Company, Acquisition Sub, Parent and the Depositary shall be entitled to deduct and withhold from any consideration otherwise payable to any Shareholder, Optionholder, or holder of SARs, SPAUs, DSUsand/or PSUs such amounts as the Company, Acquisition Sub, Parent or the Depositary determines, acting reasonably, are required or permitted to be deducted and withheld with respect to such payment under the ITA, the United States Internal Revenue Code of 1986, or any provision of federal, provincial, territorial, state, local or foreign tax law, in each case, as amended. To the extent that amounts are so withheld, such withheld amounts shall be treated for all purposes hereof as having been paid to the holder of the Common Shares, Optionholder, or holder of SARs, SPAUs, DSUsand/or PSUs, as the case may be, in respect of which such deduction and withholding was made,provided that such withheld amounts are actually remitted to the appropriate taxing authority.
ARTICLE V
AMENDMENTS
Section 5.01.  Amendments to Plan of Arrangement.
(a) The Company may amend, modifyand/or supplement this Plan of Arrangement at any time and from time to time prior to the Effective Time;provided that each such amendment, modificationand/or supplement must be (i) set out in writing, (ii) approved by Parent, (iii) filed with the Court and, if made following the Special Meeting, approved by the Court, and (iv) communicated to Shareholders if and as required by the Court.
(b) Any amendment, modification or supplement to this Plan of Arrangement may be proposed by the Company at any time prior to the Special Meeting (provided that Parent and Acquisition Sub shall have consented thereto) with or without any other prior notice or communication, and if so proposed and accepted by the Persons voting at the Special Meeting (other than as may be required under the Interim Order), shall become part of this Plan of Arrangement for all purposes.
(c) Any amendment, modification or supplement to this Plan of Arrangement that is approved or directed by the Court following the Special Meeting shall be effective only if (i) it is consented to by each of the Company and Parent (in each case, acting reasonably) and (ii) if required by the Court, it is consented to by Shareholders voting in the manner directed by the Court.
(d) Any amendment, modification or supplement to this Plan of Arrangement may be made following the Effective Time unilaterally by Parent,provided that it concerns a matter which, in the reasonable opinion of Parent, is of an administrative nature required to better give effect to the implementation of this Plan of Arrangement and is not adverse to the economic interest of any former Shareholder.
(e) This Plan of Arrangement may be withdrawn prior to the occurrence of any of the events in Section 2.03 in accordance with the terms of the Arrangement Agreement.


C-6


ARTICLE VI
FURTHER ASSURANCES
Section 6.01.  Further Assurances.  Notwithstanding that the transactions and events set out herein shall occur and be deemed to occur in the order set out in this Plan of Arrangement without any further act or formality, each of the parties to the Arrangement Agreement shall make, do and execute, or cause to be made, done and executed, all such further acts, deeds, agreements, transfers, assurances, instruments or documents as may reasonably be required by any of them in order further to document or evidence any of the transactions or events set out herein.


C-7


ANNEX D
OPINION OF MORGAN STANLEY & CO.


1585 Broadway
New York, NY 10036
MORGANSTANLEY LOGO
February 10, 2007
Board of Directors
Novelis Inc.
3399 Peachtree Road
Suite 1500
Atlanta, GA 30326
Members of the Board:
We understand that Novelis Inc. (“Novelis” or the “Company”), Hindalco Industries Ltd. (“Hindalco”) and AV Aluminum Inc., a wholly owned subsidiary of Hindalco (“Acquisition Sub”), propose to enter into an Arrangement Agreement, substantially in the form of the draft dated February 9, 2007 (the “Arrangement Agreement”), which provides, among other things, for the acquisition of all the outstanding common shares of the Company (the “Company Common Stock”) by Acquisition Sub pursuant to a Plan of Arrangement, whereby each outstanding share of the Company Common Stock, other than shares held in treasury or held by Hindalco, Acquisition Sub or any of their respective affiliates or as to which dissenters’ rights have been perfected, will be exchanged for $44.93 per share in cash (the “Transaction”). The terms and conditions of the Transaction are more fully set forth in the Arrangement Agreement.
You have asked for our opinion as to whether the consideration to be received by the holders of shares of the Company Common Stock pursuant to the Arrangement Agreement is fair from a financial point of view to such holders.
For purposes of the opinion set forth herein, we have:
i) reviewed certain publicly available financial statements and other business and financial information of the Company;
ii) reviewed certain internal financial statements and other financial and operating data concerning the Company prepared by the management of the Company;
iii) reviewed certain financial projections prepared by the management of the Company;
iv) discussed the past and current operations and financial condition and the prospects of the Company with senior executives of the Company;
v) reviewed the reported prices and trading activity for the Company Common Stock;
vi) compared the financial performance of the Company and the prices and trading activity of the Company Common Stock with that of certain other comparable publicly-traded companies and their securities;
vii) reviewed the financial terms, to the extent publicly available, of certain comparable acquisition transactions;
viii) participated in discussions and negotiations among representatives of the Company, Hindalco and certain other parties and their financial and legal advisors;


D-1


MORGANSTANLEY LOGO

ix) reviewed the Arrangement Agreement, the draft commitment letters relating to the debt and equity financing to be obtained by Hindalco, substantially in the form of the drafts dated February 9, 2007 (the “Financing Commitments”) and certain related documents; and
x) performed such other analyses and considered such other factors as we have deemed appropriate.
We have assumed and relied upon without independent verification the accuracy and completeness of the information supplied or otherwise made available to us by the Company for the purposes of this opinion. With respect to the financial projections, we have assumed that they have been reasonably prepared on bases reflecting the best currently available estimates and judgments of the future financial performance of the Company. In addition, we have assumed that the Transaction will be consummated in accordance with the terms set forth in the Arrangement Agreement without any waiver, amendment or delay of any terms or conditions including, among other things, that Hindalco will obtain financing for the Transaction in accordance with the terms set forth in the Financing Commitments. We have assumed that in connection with the receipt of all the necessary governmental, regulatory or other approvals and consents required for the proposed Transaction, no delays, limitations, conditions or restrictions will be imposed that would have a material adverse effect on the contemplated benefits expected to be derived in the proposed Transaction. We are not legal, tax or regulatory advisors and have relied upon, without independent verification, the assessment of the Company and its legal, tax or regulatory advisors with respect to legal, tax or regulatory matters. We express no opinion on any impact of the Transaction on the tax treatments of any prior corporate restructuring involving the Company or otherwise. We have not made any independent valuation or appraisal of the assets or liabilities of the Company, nor have we been furnished with any such appraisals. Our opinion is necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to us as of, the date hereof. Events occurring after the date hereof may effect this opinion and the assumptions used in preparing it, and we do not assume any obligation to update, revise or reaffirm this opinion.
We have acted as financial advisor to the Board of Directors of the Company in connection with this Transaction and will receive a fee for our services, a substantial portion of which is contingent upon the closing of the Transaction. In the past we have provided financial advisory and financing services for the Company and have received fees in connection with such services. In the ordinary course of our trading, brokerage, investment management and financing activities, Morgan Stanley or its affiliates may at any time hold long or short positions, and may trade or otherwise effect transactions, for our own account or the accounts of customers, in debt or equity securities or senior loans of Hindalco, the Company or any other company, or currency or commodity, that may be involved in this Transaction.
It is understood that this letter is for the information of the Board of Directors and may not be used for any other purpose without our prior written consent, except that a copy of this opinion may be included in its entirety in any filing the Company is required to make with the Securities and Exchange Commission in connection with the Transaction if such inclusion is required by applicable law. In addition, we express no opinion or recommendation as to how the shareholders of the Company should vote at the shareholders’ meeting to be held in connection with the Transaction.


D-2


MORGANSTANLEY LOGO

Based on the foregoing, we are of the opinion on the date hereof that the consideration to be received by the holders of shares of the Company Common Stock pursuant to the Arrangement Agreement is fair from a financial point of view to such holders.
Very truly yours,
MORGAN STANLEY & CO. INCORPORATED
By: -s- Brian Healy
Brian Healy
Executive Director


D-3


ANNEX E
OPINION OF EVERCORE


(EVERCORE GROUP L.L.C. LOGO)
February 10, 2007
Board of Directors
Novelis Inc.
3399 Peachtree Road
Suite 1500
Atlanta, GA 30326
Members of the Board of Directors:
We understand that Novelis Inc., a corporation existing under the laws of Canada (“Novelis” or the “Company”), is considering a transaction pursuant to an Arrangement Agreement, dated as of February 10, 2007 (the “Arrangement Agreement”), among the Company, Hindalco Industries Limited, a corporation existing under the laws of India (“Parent”), and AV Aluminum Inc., a corporation existing under the laws of Canada and a subsidiary of Parent (“Acquisition Sub”), which provides for, among other things, the acquisition of all of the outstanding common shares of the Company (the “Company Common Shares”) by Acquisition Sub (the “Transaction”) pursuant to a Plan of Arrangement (the “Plan of Arrangement”) whereby each Company Common Share outstanding at the effective time of the Transaction, other than a Company Common Share held by (i) a Dissenting Holder (as defined in the Plan of Arrangement) who is ultimately entitled to be paid the fair value of the Company Common Shares held by such Dissenting Holder, or (ii) Parent, Acquisition Sub or any Affiliate (as defined in the Plan of Arrangement) of Parent or Acquisition Sub (the shares referenced in the preceding clauses (i) and (ii) being referred to herein as “Excluded Shares”), will be transferred to Acquisition Sub in exchange for $44.93 per Company Common Share in cash (the “Common Share Consideration”). The terms and conditions of the Transaction are more fully set forth in the Arrangement Agreement.
You have asked us whether, in our opinion, the Common Share Consideration to be received pursuant to the Arrangement Agreement by the holders of Company Common Shares, other than holders of Excluded Shares, is fair, from a financial point of view as of the date hereof, to the holders of such Company Common Shares.
In connection with rendering our opinion, we have, among other things:
(i) reviewed certain publicly available audited and unaudited financial statements of the Company;
(ii) reviewed certain internal financial statements and other financial statements and other non-public operating data relating to the Company prepared by and furnished to us by the management of the Company;
(iii) reviewed certain financial projections relating to the Company prepared by and furnished to us by the management of the Company;
(iv) discussed the past and current operations, financial projections and current financial condition of the Company with the management of the Company;
(v) reviewed the reported prices and trading activity of the Company Common Shares;
(vi) reviewed the transaction process conducted on behalf of the Company;
(vii) compared certain financial information for the Company with that of certain publicly-traded companies that we deemed relevant;
Evercore Group L.L.C. 55 East 52nd Street New York, NY 10055 Tel: 212.857.3100 Fax: 212.857.3101


E-1


February 10, 2007

(viii) reviewed the financial terms of certain business combinations and other transactions that we deemed relevant and compared the valuation multiples in those transactions to those contemplated by the Transaction;
(ix) reviewed the Arrangement Agreement; and
(x) performed such other analyses and examinations and considered such other factors as we have in our sole judgment deemed appropriate.
For purposes of our analysis and opinion, we have not assumed any responsibility for independently verifying the accuracy and completeness of the information reviewed by us or reviewed for us. With respect to the financial projections of the Company which were furnished to us, we have assumed that such financial projections have been reasonably prepared by the Company, on bases reflecting the best currently available estimates and good faith judgments of the future competitive, operating and regulatory environments and related financial performance of the Company. We express no view as to any such financial projections or the assumptions on which they are based. We have not made nor assumed any responsibility for making any independent valuation or appraisal of the assets or liabilities of the Company, nor have we been furnished with any such appraisals. We are not legal, regulatory, accounting or tax experts and have assumed the accuracy and completeness of assessments by the Company’s advisors with respect to such issues. We express no opinion on any impact of the Transaction on the tax treatments of any prior corporate restructuring involving the Company. We have assumed that the Transaction will be consummated in accordance with the terms set forth in the Arrangement Agreement without any waiver, amendment or delay of any term, condition or agreement set forth therein. We have further assumed that all required governmental, regulatory or other consents and approvals necessary for the consummation of the Transaction will be obtained without any material adverse effect on the Company.
Our opinion is necessarily based on economic, market and other conditions as in effect on, and the information and the Arrangement Agreement and related exhibits and schedules thereto made available to us as of the date hereof. It should be understood that subsequent developments may affect this opinion and that we do not have any obligation to update, revise or reaffirm this opinion. Our opinion does not address the Company’s underlying business decision to effect the Transaction and we express no opinion or recommendation as to how the shareholders of the Company should vote at the shareholders’ meeting to be held in connection with the Transaction.
In addition, we were not requested to and did not provide advice concerning the structure, the specific amount of the consideration, or any other aspects of the Transaction contemplated by the Arrangement Agreement, nor were we requested to provide services other than the delivery of this opinion. We were not authorized to solicit, and did not solicit, interest from any party with respect to an acquisition of, business combination with, or other extraordinary transaction involving, the Company. We did not participate in the transaction process conducted on behalf of the Company or in the negotiations with respect to the terms of the Transaction.
We have not been asked to pass upon, and express no opinion with respect to, any matter other than the fairness from a financial point of view of the Common Share Consideration to be received by the holders of the Company Common Shares, other than holders of Excluded Shares, pursuant to the Arrangement Agreement.
We have acted as financial advisor to the Board of Directors of the Company and will receive a fee for rendering this opinion. The Company has also agreed to reimburse our expenses and to indemnify us against certain liabilities arising out of our engagement. In the ordinary course of business, the affiliates of Evercore Group L.L.C. may actively trade in the debt and equity securities, or options on securities, of the Company or Parent, for its own account and for the accounts of its customers and, accordingly, may at any time hold a long or short position in such securities.


E-2


February 10, 2007

It is understood that this letter is for the information and benefit of the Board of Directors of the Company in connection with its consideration of the Transaction and may not be used for any other purpose without our prior written consent, except that a copy of this opinion may be included in its entirety in any filing the Company is required to make with the Securities and Exchange Commission in connection with this transaction if such inclusion is required by applicable law.
Based upon and subject to the foregoing, it is our opinion that the Common Share Consideration to be received pursuant to the Arrangement Agreement by the holders of Company Common Shares, other than holders of Excluded Shares, is fair, from a financial point of view as of the date hereof, to the holders of such Company Common Shares.
Very truly yours,
Evercore Group L.L.C.
By: 
Name: William O. Hiltz
Title:   Senior Managing Director


E-3


ANNEX F
DISSENTING HOLDER’S RIGHTS


SECTION 190 OF THE CANADA BUSINESS CORPORATIONS ACT
190.  (1)  Right to dissent — Subject to sections 191 and 241, a holder of shares of any class of a corporation may dissent if the corporation is subject to an order under paragraph 192(4)(d) that affects the holder or if the corporation resolves to
(a) amend its articles under section 173 or 174 to add, change or remove any provisions restricting or constraining the issue, transfer or ownership of shares of that class;
(b) amend its articles under section 173 to add, change or remove any restriction on the business or businesses that the corporation may carry on;
(c) amalgamate otherwise than under section 184;
(d) be continued under section 188;
(e) sell, lease or exchange all or substantially all its property under subsection 189(3); or
(f) carry out a going-private transaction or a squeeze-out transaction.
(2)  Further right — A holder of shares of any class or series of shares entitled to vote under section 176 may dissent if the corporation resolves to amend its articles in a manner described in that section.
(2.1)  If one class of shares — The right to dissent described in subsection (2) applies even if there is only one class of shares.
(3)  Payment for shares — In addition to any other right the shareholder may have, but subject to subsection (26), a shareholder who complies with this section is entitled, when the action approved by the resolution from which the shareholder dissents or an order made under subsection 192(4) becomes effective, to be paid by the corporation the fair value of the shares in respect of which the shareholder dissents, determined as of the close of business on the day before the resolution was adopted or the order was made.
(4)  No partial dissent — A Dissenting Holder may only claim under this section with respect to all the shares of a class held on behalf of any one beneficial owner and registered in the name of the Dissenting Holder.
(5)  Objection — A Dissenting Holder shall send to the corporation, at or before any meeting of shareholders at which a resolution referred to in subsection (1) or (2) is to be voted on, a written objection to the resolution, unless the corporation did not give notice to the shareholder of the purpose of the meeting and of their right to dissent.
(6)  Notice of resolution — The corporation shall, within ten days after the shareholders adopt the resolution, send to each shareholder who has filed the objection referred to in subsection (5) notice that the resolution has been adopted, but such notice is not required to be sent to any shareholder who voted for the resolution or who has withdrawn their objection.
(7)  Demand for payment — A Dissenting Holder shall, within twenty days after receiving a notice under subsection (6) or, if the shareholder does not receive such notice, within twenty days after learning that the resolution has been adopted, send to the corporation a written notice containing
(a) the shareholder’s name and address;
(b) the number and class of shares in respect of which the shareholder dissents; and
(c) a demand for payment of the fair value of such shares.
(8)  Common Share certificate — A Dissenting Holder shall, within thirty days after sending a notice under subsection (7), send the certificates representing the shares in respect of which the shareholder dissents to the corporation or its transfer agent.
(9)  Forfeiture — A Dissenting Holder who fails to comply with subsection (8) has no right to make a claim under this section.


F-1


(10)  Endorsing certificate — A corporation or its transfer agent shall endorse on any share certificate received under subsection (8) a notice that the holder is a Dissenting Holder under this section and shall forthwith return the share certificates to the Dissenting Holder.
(11)  Suspension of rights — On sending a notice under subsection (7), a Dissenting Holder ceases to have any rights as a shareholder other than to be paid the fair value of their shares as determined under this section except where
(a) the shareholder withdraws that notice before the corporation makes an offer under subsection (12),
(b) the corporation fails to make an offer in accordance with subsection (12) and the shareholder withdraws the notice, or
(c) the directors revoke a resolution to amend the articles under subsection 173(2) or 174(5), terminate an amalgamation agreement under subsection 183(6) or an application for continuance under subsection 188(6), or abandon a sale, lease or exchange under subsection 189(9),
in which case the shareholder’s rights are reinstated as of the date the notice was sent.
(12)  Offer to pay — A corporation shall, not later than seven days after the later of the day on which the action approved by the resolution is effective or the day the corporation received the notice referred to in subsection (7), send to each Dissenting Holder who has sent such notice
(a) a written offer to pay for their shares in an amount considered by the directors of the corporation to be the fair value, accompanied by a statement showing how the fair value was determined; or
(b) if subsection (26) applies, a notification that it is unable lawfully to pay Dissenting Holders for their shares.
(13)  Same terms — Every offer made under subsection (12) for shares of the same class or series shall be on the same terms.
(14)  Payment — Subject to subsection (26), a corporation shall pay for the shares of a Dissenting Holder within ten days after an offer made under subsection (12) has been accepted, but any such offer lapses if the corporation does not receive an acceptance thereof within thirty days after the offer has been made.
(15)  Corporation may apply to court — Where a corporation fails to make an offer under subsection (12), or if a Dissenting Holder fails to accept an offer, the corporation may, within fifty days after the action approved by the resolution is effective or within such further period ended December 31, 2005)as a court may allow, apply to a court to fix a fair value for the shares of any Dissenting Holder.
(16)  Shareholder application to court — If a corporation fails to apply to a court under subsection (15), a Dissenting Holder may apply to a court for the same purpose within a further period of twenty days or within such further period as a court may allow.
(17)  Venue — An application under subsection (15) or (16) shall be made to a court having jurisdiction in the place where the corporation has its registered office or in the province where the Dissenting Holder resides if the corporation carries on business in that province.
(18)  No security for costs — A Dissenting Holder is not required to give security for costs in an application made under subsection (15) or (16).
(19)  Parties —On an application to a court under subsection (15) or (16),
(a) all Dissenting Holders whose shares have not been purchased by the corporation shall be joined as parties and are bound by the decision of the court; and
(b) the corporation shall notify each affected Dissenting Holder of the date, place and consequences of the application and of their right to appear and be heard in person or by counsel.


F-2


(20)  Powers of court — On an application to a court under subsection (15) or (16), the court may determine whether any other person is a Dissenting Holder who should be joined as a party, and the court shall then fix a fair value for the shares of all Dissenting Holders.
(21)  Appraisers — A court may in its discretion appoint one or more appraisers to assist the court to fix a fair value for the shares of the Dissenting Holders.
(22)  Final order — The final order of a court shall be rendered against the corporation in favour of each Dissenting Holder and for the amount of his shares as fixed by the court.
(23)  Interest — A court may in its discretion allow a reasonable rate of interest on the amount payable to each Dissenting Holder from the date the action approved by the resolution is effective until the date of payment.
(24)  Notice that subsection (26) applies — If subsection (26) applies, the corporation shall, within ten days after the pronouncement of an order under subsection (22), notify each Dissenting Holder that it is unable lawfully to pay Dissenting Holders for their shares.
(25)  Effect where subsection (26) applies — If subsection (26) applies, a Dissenting Holder, by written notice delivered to the corporation within thirty days after receiving a notice under subsection (24), may (a) withdraw their notice of dissent, in which case the corporation is deemed to consent to the withdrawal and the shareholder is reinstated to their full rights as a shareholder, or (b) retain a status as a claimant against the corporation, to be paid as soon as the corporation is lawfully able to do so or, in a liquidation, to be ranked subordinate to the rights of creditors of the corporation but in priority to its shareholders.
(26)  Limitation — A corporation shall not make a payment to a Dissenting Holder under this section if there are reasonable grounds for believing that (a) the corporation is or would after the payment be unable to pay its liabilities as they become due; or (b) the realizable value of the corporation’s assets would thereby be less than the aggregate of its liabilities.


F-3


ANNEX G
INTERIM ORDER


Coua FileNo. 07-CL-6916
ONTARIO
SUPERIOR COURT OF JUSTICE
(COMMERCIAL LIST)
 
         
Number of Meetings Attended
DirectorTHE HONOURABLE MR
Board  Committees)THURSDAY, THE 5TH 
 
Jacques Bougie, O.C.   7 of 8)   8 of 9 
Charles G. Cavell
JUSTICE SPENCE
  8 of 8)DAY OF APRIL, 2007
   22 of 24
Clarence J. Chandran7 of 8)   13 of 14
C. Roberto Cordaro8 of 812 of 14
Helmut Eschwey8 of 817 of 17
David J. FitzPatrick6 of 6*11 of 12
Suzanne Labarge6 of 820 of 21
William T. Monahan7 of 816 of 17
J.E. Newall, O.C. 8 of 825 of 25
Rudolf Rupprecht7 of 817 of 21
Brian W. Sturgell8 of 8**
Edward V. Yang8 of 818 of 21 
 
IN THE MATTER OF AN APPLICATION UNDER SECTION 192 OF THECANADA BUSINESS CORPORATIONS ACT, R.S.C. 1985, c. C-44, AS AMENDED, AND RULES 14.05(2) AND 14.05(3) OF THE RULES OF CIVIL PROCEDURE
AND IN THE MATTER OF A PROPOSED PLAN OF ARRANGEMENT OF NOVELIS INC.
NOVELIS INC.
(SUPERIOR COURT SEAL)
Applicant
ORDER
THIS MOTIONmade by the Applicant, Novelis Inc. (“Novelis”), pursuant to section 192(4) of theCanada Business Corporations Act, R.S.C. 1985, c. C-44, as amended (the “CBCA”), for an interim order for advice and directions in connection with the within application (the “Application”), was heard this day at 330 University Avenue, Toronto, Ontario.
ON READINGthe Notice of Application, Notice of Motion and the Affidavit of Leslie J. Parrette Jr., sworn March 30, 2007 (the “Parrette Affidavit”), and the exhibits thereto, and on hearing the submissions of counsel for Novelis and counsel for AV Metals Inc. (“Acquisition Sub”), and on being advised of the letter of non-appearance delivered by the Director appointed under the CBCA.


G-1


Definitions
 
*1.THIS COURT ORDERSthat all capitalized terms not otherwise defined in this Order shall have the meanings ascribed thereto in the proxy statement/management information circular (the “Circular”) attached as Exhibit “A” to the Parrette Affidavit.
The Meeting
Not appointed
2.THIS COURT ORDERSthat Novelis shall be permitted to call, hold and conduct the special meeting (the “Meeting”) of the holders of common shares of Novelis (the “Shareholders”), at which Shareholders will be asked to, among other things, consider and, if deemed advisable, pass, with or without variation, the Arrangement Resolution, a copy of which is attached as Annex A to the boardCircular, to, among other things, authorize, adopt and approve the Arrangement and Plan of directors until March 24, 2005.Arrangement.
 
**3.THIS COURT ORDERSthat the Meeting shall be called, held and conducted in accordance with the notice of the Meeting forming part of the Circular (the “Notice”), the CBCA, the articles and by-laws of Novelis (including the quorum requirements thereof) and the terms of this Order and any further Order of this Honourable Court.
4.THIS COURT ORDERSthat the only persons entitled to attend or speak at the Meeting shall be:
(a) the Shareholders or their respective proxy holders;
(b) the officers, directors, auditors and advisors of Novelis;
(c) representatives and advisors of Acquisition Sub;
(d) the Director; and
(e) other persons who may receive the permission of the Chair of the Meeting.
Amendments to the Arrangement and Plan of Arrangement
5. THIS COURT ORDERSthat Novelis is authorized, subject to the terms of the Arrangement Agreement and without additional notice to the Shareholders, to make such amendments, revisions and/or supplements to the Arrangement and to the Plan of Arrangement as it may determine, and the Arrangement and the Plan of Arrangement, as so amended, revised and/or supplemented, shall be the Arrangement and the Plan of Arrangement to be submitted to the Shareholders at the Meeting and shall be the subject of the Arrangement Resolution.
Adjournments and Postponements
Mr. Sturgell attended 25
6.THIS COURT ORDERSthat Novelis, if it deems advisable and subject to the terms of 25 committee meetings, although hethe Arrangement Agreement, is not an appointed memberspecifically authorized to adjourn or postpone the Meeting on one or more occasions, without the necessity of first convening the Meeting or first obtaining any vote of Shareholders respecting the adjournment or postponement. Notice of any board committee. Mr. Sturgell did not attend any meetingsuch adjournment or postponement shall be given by such method as Novelis may determine is appropriate in the circumstances.
Record Date for Notice
7.THIS COURT ORDERSthat the record date (the “Record Date”) for determining Shareholders entitled to receive the Notice, the Circular (including the forms of proxy for use by such Shareholders) shall be the close of business on March 20, 2007.
Notice of the Meeting
8.THIS COURT ORDERSthat Novelis shall give notice of the NominatingSub-Committee.Meeting, substantially in the form of the Notice, subject to Novelis’ ability to change dates and other relevant information in the final form


G-2


of Notice. The Notice shall be mailed or delivered in accordance with paragraph 11 of this Order. Failure or omission to give notice in accordance with paragraph 11 of this Order, as a result of mistake or of events beyond the control of Novelis, shall not constitute a breach of this Order or a defect in the calling of the Meeting and shall not invalidate any resolution passed or proceedings taken at the Meeting, but if any such failure or omission is brought to the attention of Novelis, then Novelis shall use its best efforts to rectify it by the method and in the time most reasonably practicable in the circumstances.
Solicitation of Proxies
9. THIS COURT ORDERSthat Novelis is authorized to use proxies at the Meeting, substantially in the form accompanying the Circular, subject to Novelis’ ability to insert dates and other relevant information in the final form of proxy. Novelis is authorized, at its expense, to solicit proxies, directly and through its officers, directors and employees, and through such agents or representatives as it may retain for that purpose, and by mail or such other forms of personal or electronic communication as it may determine. Novelis may waive, in its discretion, the time limits for the deposit of proxies by Shareholders if Novelis deems it advisable to do so.
10. THIS COURT ORDERSthat Shareholders shall be entitled to revoke their proxies in accordance with section 148(4) of the CBCA (except as the procedures of that section are varied by this paragraph and the Plan of Arrangement) provided that any instruments in writing delivered pursuant to s. l48(4)(a)(i) of the CBCA: (a) may be deposited at the registered office of Novelis or with the authorized agent of Novelis as set out in the Circular and that (b) any such instruments must be received by Novelis not later than 5:00 p.m. (Eastern Daylight Time) on the Business Day immediately preceding the Meeting (or any adjournment or postponement thereof).
Method of Distribution of Meeting Materials and Court Materials
11. THIS COURT ORDERSthat Novelis is hereby authorized to distribute the Notice of Application, this Order, the Notice, the Circular, the form of proxy, the letter of transmittal and any other communications or documents determined by Novelis to be necessary or desirable (collectively, the “Meeting Materials”), as follows:
(a) to registered Shareholders, to the directors of Novelis and to the auditor of Novelis, respectively, by mailing same by pre-paid ordinary mail (or, alternatively, by delivery, in person, by courier or inter-office mail), not later than twenty-one (21) days prior to the date established for the Meeting in the Notice. Distribution to such persons shall be to their addresses as they appear on the books and records of Novelis as of the Record Date (March 20, 2007), or such later date as Novelis may determine in accordance with the CBCA; and
(b) to non-registered Shareholders by Novelis, by providing multiple copies of the Meeting Materials to intermediaries and registered nominees in a timely manner, in accordance with National InstrumentNo. 54-101 of the Canadian Securities Administrators.
12. THIS COURT ORDERSthat Novelis is hereby authorized to distribute the Notice of Application, this Order, the Circular, and any other communications or documents determined by Novelis to be necessary or desirable (collectively, the “Court Materials”) to the holders of Novelis options (“Options”), stock appreciation rights (“SARs”), stock price appreciation units (“SPAUs”), performance share units (“PSUs”), and deferred share units (“DSUs”) by mailing same by pre-paid ordinary mail (or, alternatively, by delivery, in person, by courier or inter-office mail), concurrently with the distribution described in paragraph 11 of this Order. Distribution to such persons shall be to their addresses as they appear on the books and records of Novelis as of the Record Date. The holders of such Options, SARs, SPAUs, PSUs and DSUs are hereby made parties to this proceeding.
13. THIS COURT ORDERSthat Novelis is hereby authorized to make such amendments, revisions or supplements to the Meeting Materials and Court Materials, as Novelis may determine in accordance with the


G-3


terms of the Arrangement Agreement (“Additional Information”), and that notice of such Additional Information may be communicated to Shareholders and holders of Options, SARs, SPAUs, PSUs and DSUs by press release, newspaper advertisement or one of the methods by which the Meeting Materials and Court Materials will be distributed (e.g. by direct mailing or through intermediaries).
Deemed Receipt of Notice
14. THIS COURT ORDERS that the Meeting Materials and Court Materials shall be deemed for the purposes of this Interim Order to have been received,
(a) in the case of mailing, three (3) days after delivery thereof to the post office; and
(b) in the case of delivery in person, upon receipt thereof at the intended recipient’s address, or, in the case of delivery by courier or by inter-office mail, one (1) Business Day after receipt by the courier or inter-office system.
15. THIS COURT ORDERSthat distribution of the Meeting Materials and Court Materials pursuant to paragraphs 11 and 12 of this Order shall constitute good and sufficient service and notice thereof upon all such persons of the Meeting and the within Application. Further, no other form of service of the Meeting Materials or the Court Materials or any portion thereof need be made, or notice given or other material served in respect of these proceedings and/or the Meeting to the persons described in paragraphs 11 and 12 of this Order or to any other persons.
16. THIS COURT ORDERSthat a failure or omission to distribute the Meeting Materials and Court Materials in accordance with paragraphs 11 and 12 of this Order as a result of mistake or of events beyond the control of Novelis shall not constitute a breach of this Order and shall not invalidate any resolution passed or proceedings taken at the Meeting, but if any such failure or omission is brought to the attention of Novelis, then Novelis shall use its best efforts to rectify it by the method and in the time most reasonably practicable in the circumstances.
Voting
17. THIS COURT ORDERSthat the only persons entitled to vote in person or by proxy on the Arrangement Resolution shall be the Shareholders as at the close of business on the Record Date.
18. THIS COURT ORDERSthat, subject to further Order of this Honourable Court, the Arrangement Resolution must be passed at the Meeting by the affirmative vote of at least two-thirds of the votes cast in respect of the Arrangement Resolution by the Shareholders present in person or represented by proxy at the Meeting. Such vote shall be sufficient to authorize and direct Novelis to do all such acts and things as may be necessary or desirable to give effect to the Arrangement and the Plan of Arrangement on a basis consistent with what is provided for in the Circular without the necessity of any further approval by the Shareholders, subject only to final approval of the Arrangement by this Honourable Court.
19. THIS COURT ORDERSthat in respect of the vote on the Arrangement Resolution, each Shareholder is entitled to one vote for each Share held. Illegible votes, spoiled votes, defective votes and abstentions shall be deemed not to be votes cast. Proxies that are properly signed and dated but which do not contain voting instructions shall be voted in favour of the Arrangement Resolution.
20. THIS COURT ORDERSthat in respect of matters properly brought before the Meeting pertaining to items of business affecting Novelis (other than in respect of the Arrangement Resolution), each Shareholder is entitled to one vote for each Share held. Illegible votes, spoiled votes, defective votes and abstentions shall be deemed not to be votes cast.
Dissent Rights
21. THIS COURT ORDERSthat each registered holder of Shares shall be entitled to exercise Dissent Rights in connection with the Arrangement Resolution in accordance with section 190 of the CBCA (except as


G-4


the procedures of that section are varied by this Order and the Plan of Arrangement) provided that, notwithstanding subsection 190(5) of the CBCA, any registered holder of Novelis Shares who wishes to dissent must, as a condition precedent thereto, provide written objection to the Arrangement Resolution to Novelis in the form required by section 190 of the CBCA and the Arrangement Agreement, which written objection must be received by Novelis not later than 5:00 p.m. (Eastern Daylight Time) on the Business Day immediately preceding the Meeting (or any adjournment or postponement thereof), and must otherwise strictly comply with the requirements of the CBCA. For purposes of these proceedings, the “court” referred to in section 190 of the CBCA means this Honourable Court.
22.THIS COURT ORDERSthat, notwithstanding section 190(3) of the CBCA, Acquisition Sub, not Novelis, shall be required to offer to pay fair value, as of the day prior to approval of the Arrangement Resolution, for Novelis Shares held by registered holders who duly exercise Dissent Rights, and to pay the amount to which such registered holders may be entitled pursuant to the terms of the Arrangement Agreement.
23.THIS COURT ORDERSthat registered Shareholders who duly exercise such Dissent Rights set out in paragraph 21 above and who:
 
(a) are ultimately entitled to be paid fair value for their Novelis Shares, shall be deemed to have transferred such Novelis Shares as of the Effective Time, without any further act or formality and free and clear of all liens, claims and encumbrances, to Acquisition Sub for cancellation in consideration for a payment of cash from Acquisition Sub equal to such fair value; or
(b) are ultimately not to be entitled, for any reason, to be paid fair value for their Novelis Shares, shall be deemed to have participated in the Arrangement as of the Effective Time, on the same basis as a non-dissenting holder of Novelis Shares;
but in no case shall Novelis, Acquisition Sub or any other person or entity be required to recognize such dissenting shareholders as holders of Novelis Shares after the Effective Time, and the names of such dissenting shareholders shall be deleted from the registers of the holders of Novelis Shares at the Effective Time.
Hearing of Application for Approval of the Arrangement
24.THIS COURT ORDERSthat, upon the passing of the Arrangement Resolution pursuant to the provisions of paragraph 18 hereof, Novelis shall be permitted to apply to this Honourable Court for final approval of the Arrangement pursuant to the within Notice of Application.
25.THIS COURT ORDERSthat the only persons entitled to appear and be heard at the hearing of the within Application shall be:
(a) Novelis;
(b) Acquisition Sub;
(c) the Director; and
(d) any person who has filed a Notice of Appearance herein in accordance with the provisions of the Notice of Application, this Order and theRules of Civil Procedure.
26.THIS COURT ORDERSthat any Notice of Appearance served in response to the Notice of Application shall be served on counsel for Novelis at the following address: Osler, Hoskin & Harcourt LLP, Box 50, 1 First Canadian Place, Suite 6100, Toronto, Ontario, M5X 1B8, Attention: Laura Fric / Craig Lockwood, with a copy to counsel for Acquisition Sub at the following address: Torys LLP, Suite 3000, Box 270, TD Centre, 79 Wellington Street West, Toronto, Ontario, M5K 1N2, Attention: Andrew Gray.
27.THIS COURT ORDERSthat in the event the within Application for final approval does not proceed on the date set forth in the Notice of Application, and is adjourned, only those persons who served


G-5


and filed a Notice of Appearance in accordance with paragraphs 25 and 26 shall be entitled to be given notice of the adjourned date.
28.THIS COURT ORDERSthat any materials to be filed by Novelis in support of the within Application for final approval of the Arrangement may be filed up to two days prior to the hearing of the Application without further order of this Honourable Court.
Precedence
29.THIS COURT ORDERSthat, to the extent of any inconsistency or discrepancy with respect to the matters provided for in this Interim Order, between this Interim Order and the terms of any instrument creating, governing or collateral to the Novelis Shares, Options, SARs, SPAUs, PSUs, DSUs, or the articles or by-laws of Novelis, this Interim Order shall govern.
Extra-Territorial Assistance
30.THIS COURTseeks and requests the aid and recognition of any court or any judicial, regulatory or administrative body in any Province of Canada and any judicial, regulatory or administrative tribunal or other court constituted pursuant to the Parliament of Canada or the legislature of any province and any court or any judicial, regulatory or administrative body of the United States to act in aid of and to assist this Court in carrying out the terms of this Interim Order.
Variance
31.THIS COURT ORDERSthat Novelis shall be entitled to seek leave to vary this order upon such terms and upon the giving of such notice as this Honourable Court may direct.
SIGNATURE


G-6


IN THE MATTER OF AN APPLICATION UNDER SECTION 192 OF THECANADA BUSINESS CORPORATIONS ACT,R.S.C. 1985, c. C-44, AS AMENDED, AND RULES 14.05(2) AND 14.05(3) OF THE RULES OF CIVIL PROCEDURECourt File No: 07-CL-6916
AND IN THE MATTER OF A PROPOSED PLAN OF ARRANGEMENT OF NOVELIS INC.
NOVELIS INC.
Applicant
Ontario
SUPERIOR COURT OF JUSTICE
COMMERCIAL LIST
Proceeding commenced at Toronto
ORDER
  OSLER, HOSKIN & HARCOURT LLP
  Barristers & Solicitors
  Box 50, 1 First Canadian Place
  Toronto, Canada M5X 1B8
  Laura K. Fric (LSUC #: 36545Q)
  Craig T. Lockwood (LSUC#: 46668M)
  Tel:(416) 362-2111
  Fax:(416) 862-6666
  Solicitors for the Applicant,
  Novelis Inc.
F.1098595


G-7


ANNEX H
NOTICE OF APPLICATION FOR THE FINAL ORDER


Court FileNo. 07-CL-6916
ONTARIO
SUPERIOR COURT OF JUSTICE
(COMMERCIAL LIST)
IN THE MATTER OF AN APPLICATION UNDER SECTION 192 OF THECANADA BUSINESS CORPORATIONS ACT,R.S.C. 1985, c. C-44, AS AMENDED, AND RULES 14.05(2) AND 14.05(3) OF THE RULES OF CIVIL PROCEDURE AND IN THE MATTER OF A PROPOSED PLAN OF ARRANGEMENT OF NOVELIS INC.
NOVELIS INC.
(SUPERIOR COURT SEAL)
Applicant
NOTICE OF APPLICATION
TO THE RESPONDENTS:
A LEGAL PROCEEDING HAS BEEN COMMENCEDby the Applicant. The claim made by the applicant appears on the following page.
THIS APPLICATIONwill come on for a hearing before a Judge presiding over the Commercial List on May 14, 2007, at 9:30 a.m., or as soon after that time as the application may be heard, at 330 University Avenue, Toronto, Ontario.
IF YOU WISH TO OPPOSE THIS APPLICATION,to receive notice of any step in the application or to be served with any documents in the application, you or an Ontario lawyer acting for you must forthwith prepare a notice of appearance in Form 38A prescribed by the Rules of Civil Procedure, serve it on the applicant’s lawyer or, where the applicant does not have a lawyer, serve it on the applicant, and file it, with proof of service, in this court office, and you or your lawyer must appear at the hearing.
IF YOU WISH TO PRESENT AFFIDAVIT OR OTHER DOCUMENTARY EVIDENCE TO THE COURT OR TO EXAMINE OR CROSS-EXAMINE WITNESSES ON THE APPLICATION,you or your lawyer must, in addition to serving your notice of appearance, serve a copy of the evidence on the applicant’s lawyer or, where the applicant does not have a lawyer, serve it on the applicant, and file it, with proof of service, in the court office where the application is to be heard as soon as possible, but not later than 2 p.m. on the day before the hearing.


H-1


IF YOU FAIL TO APPEAR AT THE HEARING, JUDGMENT MAY BE GIVEN IN YOUR ABSENCE AND WITHOUT FURTHER NOTICE TO YOU. IF YOU WISH TO OPPOSE THIS APPLICATION BUT ARE UNABLE TO PAY LEGAL FEES, LEGAL AID MAY BE AVAILABLE TO YOU BY CONTACTING A LOCAL LEGAL AID OFFICE.
Date  March 29, 2007
Issued by-s- Tara Stead
Local registrar
     
  393 University Avenue
Toronto, Ontario M5G 1E6
TO:ALL HOLDERS OF COMMON SHARES OF NOVELIS INC.
AND TO:ALL HOLDERS OF OPTIONS OF NOVELIS INC.
AND TO:ALL HOLDERS OF STOCK APPRECIATION RIGHTS OF NOVELIS INC.
AND TO:ALL HOLDERS OF STOCK PRICE APPRECIATION UNITS OF NOVELIS INC.
AND TO:ALL HOLDERS OF PERFORMANCE SHARE UNITS OF NOVELIS INC.
AND TO:Number ofALL HOLDERS OF DEFERRED SHARE UNITS OFNOVELIS INC.
AND TO:ALL DIRECTORS OF NOVELIS INC.
AND TO:PRICEWATERHOUSE COOPERS LLP
Royal Trust Tower, Suite 3000
Toronto-Dominion Centre
77 King Street West
Toronto, Ontario M5K 1G8
Auditors for Novelis Inc.
AND TO:THE DIRECTOR
Compliance & Policy Directorate
Corporations Canada, Industry Canada
9th Floor, Jean Edmonds Tower South
365 Laurier Avenue West
Ottawa, Ontario, K1A 0C8


H-2


AND TO:TORYS LLP
Suite 3000
Box 270, TD Centre
79 Wellington Street West
Toronto, Ontario
M5K 1N2
Andrew Gray
Tel:(416) 865-7630
Fax:(416) 865-7380

Solicitors for AV Aluminum Inc. and
Hindalco Industries Limited


H-3


APPLICATION
1.  THE APPLICANT MAKES APPLICATION FOR:
a) an interim order for advice and directions pursuant to section 192(4) of theCanada Business Corporations Act,R.S.C. 1985, c. C-44, as amended (the “CBCA”) with respect to a proposed arrangement (the “Arrangement”) of Novelis Inc. (“Novelis”), concerning the acquisition by AV Aluminum Inc. of all of the shares of Novelis and the cancellation of Novelis’ options, Stock Appreciation Rights, Stock Price Appreciation Units, Performance Share Units and Deferred Share Units, and the termination of all agreements related thereto;
b) an order approving the Arrangement pursuant to sections 192(3) and 192(4) of the CBCA; and
c) such further and other relief as this Honourable Court may deem just.
2.  THE GROUNDS FOR THE APPLICATION ARE:
a) Novelis is a corporation organized under the laws of Canada and governed by the CBCA, with its common shares listed and traded on the TSX and the NYSE;
b) section 192 of the CBCA;
c) all statutory requirements under the CBCA have been fulfilled or will be fulfilled by the date of the return of this Application;
d) Novelis is not insolvent;
e) it is not practicable for Novelis to effect the Arrangement under any other provision of the CBCA;
f) the Arrangement is in the best interests of Novelis, and is put forward in good faith;


H-4


g) the Arrangement is fair and reasonable to the parties affected;
h) the directions set out, and shareholder approvals required pursuant to, any interim order this Court may grant have been followed and obtained, or will be followed and obtained, by the date of the return of this Application;
i) certain of the holders of common shares of Novelis are resident outside of Ontario and will be served at their addresses as they appear on the books and records of Novelis as at March 13, 2007, pursuant to rules 17.02(n)and 17.02(o) of theRules of Civil Procedure and the terms of any interim Order for advice and directions granted by this Honourable Court;
j) National InstrumentNo. 54-101 of the Canadian Securities Administrators;
k) rules 14.05(2), 14.05(3) and 38 of theRules of Civil Procedure;and
l) such further and other grounds as counsel may advise and this Honourable Court may permit.
3.  THE FOLLOWING DOCUMENTARY EVIDENCE WILL BE USED AT THE HEARING OF THE APPLICATION:
a) an Affidavit of Leslie J. Parrette Jr., to be sworn on behalf of Novelis, with exhibits thereto, outlining the basis for the within application and for an interim Order for advice and directions;
b) a further Affidavit(s), to be sworn on behalf of Novelis, with exhibits thereto, including an Affidavit outlining the basis for the final order approving the Arrangement, and reporting as to compliance with any interim order and the results of any meeting conducted pursuant to such interim order; and
c) such further and other material as counsel may advise and this Honourable Court may permit.


H-5


March 29, 2007OSLER, HOSKIN & HARCOURT LLP
Barristers & Solicitors
Box 50, 1 First Canadian Place
Toronto, Canada M5X 1B8
Laura K. Fric (LSUC #: 36545Q)
Craig T. Lockwood (LSUC#: 46668M)
Tel:(416) 362-2111
Fax:(416) 862-6666
Solicitors for the Applicant,
Novelis Inc.


H-6


IN THE MATTER OF AN APPLICATION UNDER SECTION 192 OF THECANADA BUSINESS CORPORATIONS ACT,R.S.C. 1985, c. C-44, AS AMENDED, AND RULES 14.05(2) AND 14.05(3) OF THE RULES OF CIVIL PROCEDURECourt File No: 07-CL-6916
AND IN THE MATTER OF A PROPOSED PLAN OF ARRANGEMENT OF NOVELIS INC.
NOVELIS INC.
 
Board and Board Committee MeetingsApplicant
 Meetings Held 
 
Board
  8
Audit Committee11
Nominating and Corporate Governance Committee3
Human Resources Committee7
Customer Relations Committee4
NominatingSub-Committee
2
During 2005, all directors attended at least 75% of the meetings of the board of directors and the committees on which they served.


A-1


SCHEDULE B
STATEMENT OF CORPORATE GOVERNANCE PRACTICES
In January 2004, the Canadian Securities Administrators (the “CSAs”) adopted Multilateral Instrument 52-110 — Audit Committees. Certain amendments to such instrument were subsequently adopted and are effective since June 30, 2005 (such instrument, as amended, the “Audit Committee Rules”). The Audit Committee Rules include requirements regarding audit committee composition and responsibilities, as well as reporting obligations with respect to audit related matters. The Company complies with these rules and appropriate disclosure is made, where applicable, in the following table.
The CSAs also adopted, effective on June 30, 2005, National Instrument 58-101 — Disclosure of Corporate Governance Practices (the “Disclosure Instrument”) and National Policy 58-201 — Effective Corporate Governance (the “Governance Policy”). The Governance Policy provides guidance on governance practices to Canadian issuers, while the Disclosure Instrument requires issuers to make the prescribed disclosure regarding their governance practices. The disclosure made hereunder refers to the items of the Disclosure Instrument as well as to the Governance Policy, where appropriate. We believe that our corporate governance practices meet and exceed the requirements of the Disclosure Instrument and the Governance Policy, as reflected in the disclosure made hereunder.
Please also refer to our Charter of the Board of Directors and Corporate Governance Guidelines (the “Board of Directors Charter”) and our Code of Business Conduct and Ethics available on the Company’s website atwww.novelis.com. The other charters, codes and guidelines referred to in the table below are also available on our website. All of these documents are available in print to any shareholder who requests copies by contacting our Corporate Secretary. The Company is dedicated to amending its corporate governance practices on an ongoing basis in order to respond to the evolution of best practices that are appropriate for the Company.
   
  Corporate Governance PracticesOntario
SUPERIOR COURT OF JUSTICE
(COMMERCIAL LIST)
Guidelines
at the Company
 Proceeding commenced at Toronto
1.  Board of Directors
  
 (a)  Disclose the identity of directors who are independent. Of the 13 current directors, our board (the ‘‘board”) has determined that 12 are ‘‘independent”, and 1 (our Chairman and Interim Chief Executive Officer, Mr.  Monahan) is ‘‘not independent”.
 (b)  Disclose the identity of directors who are not independent, and describe the basis for that determination. Please see above.
 (c)  Disclose whether or not a majority of directors are independent. If a majority of directors are not independent, describe what the board does to facilitate its exercise of independent judgement in carrying out its responsibilities.Please see above. See also our Guidelines on the Independence of the Board of Directors available on the Company’s website atwww.novelis.com.
 (d)  If a director is presently a director of any other issuer that is a reporting issuer (or the equivalent) in a jurisdiction or a foreign jurisdiction, identify both the director and the other issuer.Please see director biographies in this Circular.
 (e)  Disclose whether or not the independent directors hold regularly scheduled meetings at which non- independent directors and members of management are not in attendance. If the independent directors hold such meetings, disclose the number of meetings held since the beginning of the issuer’s most recently completed financial year. If the independent directors do not hold such meetings, describeEvery meeting of our board is followed by anin- camerasession at which members of management are not present, to ensure free and open discussion and communication among the non-executive directors. Please see ‘‘Board of Directors and Corporate Governance Matters” in this Circular.


B-1


   
  Corporate Governance Practices
NOTICE OF APPLICATION
Guidelines
at the Company
what the board does to facilitate open and candid discussion among its independent directors.  
 (f)  Disclose whether or not the chair of the board is an independent director. If the board has a chair or lead director who is an independent director, disclose the identity of the independent chair or lead director, and describe his or her role and responsibilities. If the board has neither a chair that is independent nor a lead director that is independent, describe what the board does to provide leadership for its independent directors. Our Board of Directors Charter states that in the event that the Chairman is a director who is an executive of the Company, the board must also appoint a lead director from among the non-executive directors to chair the board at all meetings where management is absent and to assume other appropriate functions. Mr.  Newall, is the independent board chair. The Chairman’s responsibilities include the following: (i)  presiding at meetings of shareholders and the board; (ii)  providing leadership to enhance board effectiveness and focus; (iii)  acting as liaison between the board and management; (iv)  assisting in representing the Company to external groups; and (v)  ensuring good corporate governance.
 (g)  Disclose the procedure for shareholders to communicate with the presiding director or non-management directors as a group.You may contact our board, a committee of our board, or an individual director by writing to our Corporate Secretary  — Board Communication at our head office. All communications will be compiled by the Corporate Secretary and submitted to the appropriate board member. The Corporate Secretary will reply or take other instructions from the applicable board contact. Please see ‘‘Board of Directors and Corporate Governance Matters” in this Circular.
 (h)  Disclose the attendance record of each director for all board meetings held during the issuer’s most recently completed financial year.Please see Schedule A to this Circular.
2.  Board Mandate  — Disclose the text of the board’s written mandate. If the board does not have a written mandate, describe how the board delineates its role and responsibilities.
On February  23, 2006, the board approved a revised charter which is included as Schedule D to this Circular and which states that the prime stewardship responsibility of the board is to ensure the viability of the Company and to ensure that it is managed in the interest of shareholders as a whole, while taking into account the interests of other stakeholders.
3.  Position Descriptions
  
 (a)  Disclose whether or not the board has developed written position descriptions for the chair and the chair of each board committee. If the board has not developed written position descriptions for the chairand/or the chair of each board committee, briefly describe how the board delineates the role and responsibilities of each such position.
Our Board of Directors Charter includes position descriptions for the board chair. Our Audit Committee Charter includes a position description for the Audit Committee chair. Our other committee charters do not have specific descriptions for the committee chairs.
 (b)  Disclose whether or not the board and CEO have developed a written position description for the CEO. If the board and CEO have not developed such a position description, briefly describe how the board delineates the role and responsibilities of the CEO.We do not have a CEO job position description. The CEO’s role is tied to the achievement of annual objectives and responsibilities outlined in various policies.

B-2


   
  Corporate Governance Practices  OSLER, HOSKIN & HARCOURT LLP
Guidelines
at the Company
4.  Orientation and Continuing Education
 (a)  Briefly describe what measures the board takes to orient new directors regarding  Barristers & Solicitors
  Box 50, 1 First Canadian Place
(i)  the role of the board, its committees and its directors, and  Toronto, Canada M5X 1B8

(ii)  the nature and operation of the issuer’s business.
Our Corporate Secretary maintains material on Company policies and director responsibilities and liabilities, which is updated as necessary, and provides this material to directors. Detailed current information on the Company and its business, operations and finances are sent on a monthly basis to the directors. Particularly important items and information requiring urgent attention is conveyed immediately. In addition, new directors spend time with members of senior management, including those involved in our business operations, so that they become rapidly familiar with the Company, its issues, business and operations. On site plant tours and meetings are also made available. Care is taken to ensure that new directors understand the roles and responsibilities of the board of directors and its committees, as well at the commitment level that we expect from our directors. The Company also encourages directors to attend seminars and other educational programs and to report back to the board on the quality of such programs.
 (b)  Briefly describe what measures, if any, the board takes to provide continuing education for its directors. If the board does not provide continuing education, describe how the board ensures that its directors maintain the skill and knowledge necessary to meet their obligations as directors.Please see above.
5.  Ethical Business Conduct
 (a)  Disclose whether or not the board has adopted a written code for the directors, officers and employees. If the board has adopted a written code:

(i)  disclose how a person or company may obtain a copy of the code;

(ii)  describe how the board monitors compliance with its code, or if the board does not monitor compliance, explain whether and how the board satisfies itself regarding compliance with its code; and

(iii)  provide a cross-reference to any material change report filed since the beginning of the issuer’s most recently completed financial year that pertains to any conduct of a director or executive officer that constitutes a departure from the code.
The board adopted, on March  24, 2005, the Code of Business Conduct and Ethics. This Code, which was amended on July  27, 2005, is available the Company’s website atwww.novelis.com and is available in print to any shareholder who requests copies by contacting our Corporate Secretary. The board, through its Audit Committee, reviews, monitors and oversees the Code. Each year, management reports to such committee on the implementation of the Code within the organization and on any material contravention by employees of the Company to the provisions of the Code. No material change report has ever been filed or required to be filed pertaining to any conduct of a director or executive officer constituting a departure from the Code. During 2005, the Company granted no waivers from the provisions of the Code.
 (b)  Describe any steps the board takes to ensure directors exercise independent judgement in considering transactions and agreements inThe Code of Business Conduct and Ethics states that any material transaction or relationship that could reasonably be expected to give rise to a conflict of

B-3


   
  Corporate Governance Practices  Laura K. Fric (LSUC #: 36545Q)
  Craig T. Lockwood (LSUC#: 46668M)
Guidelines
at the Company
respect of which a director or executive officer has a material interest.interest should be discussed with the person responsible for the application of the Code. In practice, a questionnaire is sent annually to each director to make sure that the director is in no such conflict that has not been disclosed. Should there be a discussion or decision relating to an organization, business or association in which a director has an interest, the board would request such director not to participate in any such discussion or decision.
 (c)  Describe any other steps the board takes to encourage and promote a culture of ethical business conduct.The Company takes ethical business conduct very seriously. Hence, the Board of Directors Charter states that board members are expected to demonstrate high ethical standards and integrity in their personal and professional dealings; as part of the Code of Business Conduct and Ethics, the directors, officers and employees owe a duty to the Company to act with integrity. The Code also prescribes that service to the Company should never be subordinated to personal gain and advantage. Conflicts of interest should be avoided. Additionally, a code of ethics has been adopted for the Company’s senior financial officers.
6.  Nomination of Directors
 (a)  Describe the process by which the board identifies new candidates for board nomination.The Nominating and Corporate Governance Committee has, as stated in its charter, the responsibility to review candidates for nomination as directors and recommend candidates for election to our board. When reviewing candidates, the committee takes into consideration factors such as judgment, independence, skill, diversity and business experience of the individual candidates and their expected contribution to the skill set of our board as a whole. The committee is allowed to employ third party search firms for identifying and evaluating nominees. Pursuant to our governing statute, one or more shareholders holding 5% or more of our Shares may, in certain circumstances, propose nominees for election to our board.
 (b)  Disclose whether or not the board has a nominating committee composed entirely of independent directors. If the board does not have a nominating committee composed entirely of independent directors, describe what steps the board takes to encourage an objective nomination process.Our Corporate Governance Guidelines state that the members of the Nominating and Corporate Governance Committee shall each have no material relationship with the Company and each member shall be otherwise unrelated and independent under the laws, regulations and listing requirements to which the Company is subject and in accordance with the Guidelines on the Independence of the Directors. As of August  31, 2006, all members of the Nominating and Corporate Governance Committee are ‘‘independent”.
 (c)  If the board has a nominating committee, describe the responsibilities, powers and operation of the nominating committee.The Nominating and Corporate Governance Committee reviews the Company’s corporate governance practices. The committee also assesses and ensures annually the effectiveness of our board as a whole, of each committee of the board and the

B-4


   
  Corporate Governance Practices  Tel:(416) 362-2111
Guidelines
at the Company
contribution of individual directors. It reviews candidates for nominations as directors and recommends candidates for election to our board. The responsibilities, powers and operation of the Nominating and Corporate Governance Committee are further described in the charter of such committee.
  Fax:7. Compensation(416) 862-6666
 (a)  Describe the process by which the board determines the compensation for the issuer’s directors and officers.The Human Resources Committee Charter provides that the committee recommends levels of compensation for our directors.
The Human Resources Committee has the responsibility to make recommendations with respect to human resources policy and employee relations. The Human Resources Committee establishes our general compensation philosophy and oversees the development and implementation of compensation policies and programs. It also reviews and approves the level of,and/or changes to, the compensation of individual executive officers, taking into consideration individual performance and competitive compensation practices.
The Human Resources Committee reviews corporate goals and objectives relevant to the President and CEO and the COO, evaluates the President and CEO’s and the COO’s performance based on those goals and objectives and such other factors as the Human Resources Committee deems appropriate and in the best interest of the Company, and either alone or together with other independent directors (as directed by the board) determines and approves CEO and COO compensation based on this evaluation of performance and competitive compensation in the relevant competitor group.
 (b)  Disclose whether or not the board has a compensation committee composed entirely of independent directors. If the board does not have a compensation committee composed entirely of independent directors, describe what steps the board takes to ensure an objective process for determining such compensation.Our Corporate Governance Guidelines state that the members of the Human Resources Committee shall each have no material relationship with the Company and each member shall be otherwise unrelated and independent under the laws, regulations and listing requirements to which the Company is subject and in accordance with Guidelines on the Independence of the Board of Directors. All members of the Human Resources Committee are ‘‘independent”.
 (c)  If the board has a compensation committee, describe the responsibilities, powers and operation of the compensation committee.The Human Resources Committee has the broad responsibility to review human resources policy and employee relations matters and make recommendations with respect to such matters to our board or our chief executive officer, as appropriate. It reviews the effectiveness of our overall management organization structure and succession planning and reviews the recommendations for the appointment of executive officers. It oversees the development and implementation of compensation policies and approves the compensation of individual executive

B-5


   
  Corporate Governance Practices
Guidelines
at the Company
officers. It also reviews our policy, management practices and performance in environment, health and safety matters. The responsibilities, powers and operation of the Human Resources Committee are further described in the charter of such committee which is included on our website atwww.novelis.com.
 (d)  If a compensation consultant or advisor has, at any time since the beginning of the issuer’s most recently completed financial year, been retained to assist in determining compensation for any of the issuer’s directors and officers, disclose the identity of the consultant or advisor and briefly summarize the mandate for which they have been retained. If the consultant or advisor has been retained to perform any other work  Solicitors for the issuer, state that fact and briefly describe the nature of the work.The Human Resources Committee hired James F. Reda and Associates as a compensation consultant to assist it in 2005. The primary role for the consultant was to assist the Human Resources Committee and the board in determining the compensation of the Company’s directors and officers.Applicant,
  Novelis Inc.
8.  Other Board Committees  — If the board has standing committees other than the audit, compensation and nominating committees, identify the committees and describe their function.
In addition to the committees referred to above, the board has also established a Customer Relations Committee. The Customer Relations Committee focuses on customer relationships, competitive dynamics and market segment analysis, among other things. For more information on the mandate of the Customer Relations Committee, please see its charter which is available on the Company’s website atwww.novelis.com.
9.  Assessments  — Disclose whether or not the board, its committees and individual directors are regularly assessed with respect to their effectiveness and contribution. If assessments are regularly conducted, describe the process used for the assessments. If assessments are not regularly conducted, describe how the board satisfies itself that the board, its committees, and its individual directors are performing effectively.
Our Corporate Governance Guidelines state that formal assessments of the board, its committees and the individual directors are carried-out at least annually in order to determine whether they are functioning effectively and to enhance their performance. As part of the board performance assessment, questionnaires are approved by the Nominating and Corporate Governance Committee in order to assess the performance of the board and its committees, the board chair and committee chairs. Each questionnaire is sent and completed by each director. Full reports are then made by the chair of the Nominating and Corporate Governance Committee to the board with suggestions to improve the effectiveness of the board, board committees, board and committee chairs.
The CSA Audit Committee Rules state that the audit committee must be composed of a minimum of three  (3)  members, who must be “independent” directors (as defined in those rules).
Our Corporate Governance Guidelines state that the members of the Audit Committee shall each have no material relationship with the Company and each member shall be otherwise unrelated and independent under the laws, regulations and listing requirements to which the Company is subject and in accordance with the Guidelines on the Independence of the Board of Directors. In addition, all members of the Audit Committee are ‘‘independent” directors, as required under the CSA Audit Committee Rules. No member

B-6


   
  Corporate Governance PracticesF.1098595
Guidelines
at the Company
of the Audit Committee receives, other than in his or her capacity as a director or member of a board committee, directly or indirectly, any fee from the Company or any subsidiary of the Company, nor is an affiliated person of the Company, or any subsidiary of the Company.
The CSA Audit Committee Rules state that each audit committee member must be financially literate.
All members of the Audit Committee are ‘‘financially literate” and all members of the committee meet the criteria to be designated as ‘‘audit committee financial expert” under the rules of the United States Securities and Exchange Commission.

In determining whether or not a director is ‘‘financially literate”, the board considers if the director has ‘‘the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Company’s financial statements.

In determining if a director is an ‘‘audit committee financial expert”, the board considers if the director is a person who has: (a)  an understanding of generally accepted accounting principles and financial statements; (b)  the ability to assess the general application of such accounting principles in connection with the accounting for estimates, accruals and reserves; (c) experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experience actively supervising one or more persons engaged in such activities; (d)  an understanding of internal controls and procedures for financial reporting; and (e)  an understanding of audit committee functions.
The CSA Audit Committee Rules state that the audit committee must have a written charter that sets out its mandate and responsibilities.
See Schedule E to this Circular. The Audit Committee Charter is also available on the Company’s website atwww.novelis.com.
   

The CSA Audit Committee Rules state that the audit committee must recommend to the board of directors:  (a)  the external auditor to be nominated for the purposes of preparing or issuing an auditors’ report or performing other audit, review or attest services for the issuer; and  (b)  the compensation of the external auditor.
The charter of the Audit Committee states that the committee is responsible for recommending the retention and, if appropriate, the termination of external auditors, evaluating and remunerating them, and monitoring their qualifications, performance and independence.
The CSA Audit Committee Rules state that the audit committee must be directly responsible for overseeing the work of the external auditor engaged for the purpose of preparing or issuing an auditors report or performing other audit, review
The charter of the Audit Committee provides that the committee is responsible for overseeing the external auditors and discussing with them the quality and not just the acceptability of the Company’s accounting principles, including any material written

B-7


Corporate Governance Practices
Guidelines
at the Company
or attest services for the issuer, including the resolution of disagreements between management and the external auditor regarding financial reporting.communications between the Company and the external auditors.
The CSA Audit Committee Rules state that the audit committee must pre-approve all non-audit services to be provided to the issuer or its subsidiary entities by the issuer’s external auditor.
The charter of the Audit Committee provides that the Audit Committee approves all audit engagement, compensation and terms, as well as all significant non-audit compensation and terms, subject to any requirement under Canadian law for shareholder approval.
The CSA Audit Committee Rules state that the audit committee must review the issuer’s financial statements, MD&A and annual and interim earnings press releases before the issuer publicly discloses this information. These rules also mention that the audit committee must be satisfied that adequate procedures are in place for the review of the issuer’s public disclosure of financial information extracted or derived from the issuer’s financial statements, other than the public disclosure referred to in the preceding sentence, and must periodically assess the adequacy of those procedures.
The charter of the Audit Committee provides that the Audit Committee should review and discuss with management and the external auditors the Company’s annual audited financial statements and quarterly financial statements prior to public disclosure thereof, including reviewing the Company’s disclosure under management’s discussion and analysis of financial condition and results of operation. It also states that the Audit Committee should ensure that adequate procedures are in place for the review of the Company’s public disclosure of financial information extracted or derived from the Company’s financial statements and to periodically review the adequacy of those procedures.
The CSA Audit Committee Rules state that the audit committee must establish procedures for:  (a)  the receipt, retention and treatment of complaints received by the issuer regarding accounting, internal accounting controls, or auditing matters; and  (b)  the confidential, anonymous submission by employees of the issuer of concerns regarding questionable accounting or auditing matters.
The charter of the Audit Committee states that the Audit Committee is responsible for establishing procedures for: (a)  the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls, or auditing matters; and (b)  the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters. We have adopted such procedures. Please refer to the Company’s website atwww.novelis.com for more details on these procedures.
The CSA Audit Committee Rules and state that the audit committee must review and approve the issuer’s hiring policies regarding partners, employees and former partners and employees of the present and former external auditor of the issuer.
The charter of the Audit Committee provides that the Audit Committee should set policies on the hiring of employees or former employees of the auditors, with a view to preserving the auditors’ independence, which policies shall include the restrictions set forth in the applicable rules promulgated by the United  States Securities and Exchange Commission.
The CSA Audit Committee Rules state that the audit committee must have the authority:  (a)  to engage independent counsel and other advisors as it determines necessary to carry out its duties;  (b)  to set and pay the compensation for any advisors employed by the audit committee; and  (c)  to communicate directly with the internal and external auditors.
The charter of the Audit Committee states that the committee is empowered to retain independent counsel, advisors, accountants or other experts, as it deems appropriate, without seeking approval of the board or management. The Company provides appropriate funding to compensate any such persons. In accordance with its charter, the Committee must insist on maintaining free and open communication between the Committee, the auditors, the internal auditors and management of the Company.

B-8


SCHEDULE C
NOVELIS INC. (THE “CORPORATION”)
As stated in the Corporation’s Board of Directors’ Charter, a majority of the Board shall be composed of Directors who have been determined to have no material relationship with the Corporation and who, in the reasonable opinion of the Board, must be unrelated and independent.
The following Guidelines have been established by the Board to assist it in determining Director independence for this purpose:
1. A Director of the Corporation shall be considered to be an “Independent Director” if he or she (i) is free from any interest and any business or other relationship which could, or could reasonably be perceived to, materially interfere with the Director’s ability to act without bias and with a view to the best interests of the Corporation, and (ii) has no relationship with the Corporation or any of its employees that is likely to, or is likely to be perceived to, interfere with the exercise of his or her judgement in a manner that is independent from management.
Without affecting the general application of the foregoing:
(a) A Director will not be an Independent Director if, within the preceding three years:
(i) the Director was employed by the Corporation;
(ii) an immediate family member of the Director was employed by the Corporation as an officer;
(iii) the Director was employed by or affiliated with the Corporation’s internal or external auditor;
(iv) an immediate family member of the Director was employed by the Corporation’s internal or external auditor as a partner, principal, manager or general employee;
(v) a senior Officer of the Corporation was on the board of directors of a company which employed the Director, or which employed an immediate family member of the Director as an officer;
(vi) the Director has received, or has an immediately family member who has received, during any twelve-month period within such previous three years, more than $100,000 in direct compensation from the Corporation, other than director and committee fees and pension or other forms of deferred compensation for prior service (provided such compensation is not contingent in any way on continued service);provided, that compensation received by the Director for former service as an interim Chairman or CEO or other executive officer need not be considered in determining independence and compensation received by an immediately family member for service as an employee (other than executive officer) of the Corporation need not be considered; or
(vii) the Director is a current employee, or an immediate family member is a current executive officer, of a company that has made payments to, or received payments from, the Corporation for property or services in an amount which, in any of such previous three years, exceeds the greater of $1 million, or 2% of such other company’s consolidated gross revenues
(b) The following relationships will be considered not to be material relationships that would impair a Director’s independence:
(i) if a Director is an officer, partner or significant shareholder in an entity that does business with the Corporation and the annual sales or purchases, for goods or services, to or from the Corporation are less than two percent of the consolidated gross annual revenues of that entity;


C-1H-7


(ii) if a Director is a limited partner, a non-managing member or occupies a similar position in an entity that does business with the Corporation, or has a shareholding in such entity which is not significant, and who, in each case, has no active role in sales to or in providing services to the Corporation and derives no direct material personal benefit from same; and
(iii) if a Director serves as an officer, director or trustee of a charitable organization, and the Corporation’s charitable contributions to the organization are less than two percent of that organization’s total consolidated gross annual revenues.
2. All Members of the Audit and Human Resources Committees of the Board and of the Nominating and Corporate Governance Committee must be Independent Directors, who must also meet additional criteria whereby he or she must not, directly or indirectly, accept any consulting, advisory or other compensatory fee from the Corporation, other than fixed amounts of compensation under a retirement plan (including deferred compensation) for prior service with the Corporation, and provided that such compensation is not contingent in any way on continued service. “Indirect” acceptance includes acceptance of such a fee by a spouse, minor child or stepchild or a child or stepchild sharing a home with the Director or by an entity in which such member is a partner, member, an officer such as a managing director occupying a comparable position or senior officer, or occupies a similar position (except limited partners, non-managing members and those occupying similar positions who, in each case, have no active role in providing services to the entity and derive no direct material personal benefit from compensation paid in respect of same) and which provides accounting, consulting, legal, investment banking or financial advisory services to the Corporation.
In addition, the Director must not be an affiliated person of the Corporation within the U.S. Securities and Exchange Commission’s rules relating to audit committee listing standards.
3. In the case where the Corporation enters into a business relationship with a corporation or entity with which a Director is affiliated as a director, officer, partner or significant shareholder, the following guidelines will apply:
(a) the relationship must not cause the Director to lose his status as an Independent Director; and
(b) the relationship must not cause the Director to fail to meet the additional criteria set out in paragraph 2 of these Guidelines if the Director is a Member of the Audit or Human Resources Committees or the Nominating and Corporate Governance Committee; and
(c) either:
(i) the relationship was already in existence and fully disclosed to the Corporation prior to the Director joining the Board; or
(ii) the relationship was initiated at the request of the Corporation because of the particular competence or products of the entity in question and not by the Director; and
(d) any proposed new relationship must be brought to the attention of the Chairman in advance and, where such relationship is not one covered by paragraph 1 of these Guidelines, be subject to the determination of the Corporate Governance Committee as to its materiality and the consequent effect on the independence of the Director; and
(e) the relationship will be disclosed in the Corporation’s public disclosure documents in accordance with applicable regulations and the Corporation’s policy.


C-2


4. While service by the Corporation’s Directors together on the boards of other companies does not, as such, affect their independence, no more than two Directors may serve together on the board of another publicly-traded company.
For the purposes of these Guidelines; (i), a “significant shareholding” means direct or indirect beneficial ownership of five percent or more of the outstanding equity or voting rights of the relevant entity; and (ii) “immediate family member” includes a person’s spouse, parents, children, siblings, mothers andfathers-in-law, sons anddaughters-in-law, brothers andsisters-in-law, and anyone (other than domestic employees) who shares such person’s home; and (iii) unless the context otherwise requires, the “Corporation” includes Novelis Inc. or any of its subsidiaries or any other member of the Novelis consolidated group.
Any questions relating to these Guidelines or to the interpretation of specific circumstances may be addressed to the Chairman who will consult the Corporation’s Chief Legal Officer or Corporate Secretary. The matter may, as appropriate, be brought to the attention of the Corporate Governance Committee for a decision.


C-3


SCHEDULE D
I.  Statement of Policy
The Board of Directors of Novelis Inc. (the “Company”) is elected by the Company’s Shareholders to supervise the management of the business and affairs of the Company. The prime stewardship responsibility of Novelis Inc.’s Board is to to ensure the viability of the Company and to ensure that it is managed in the interest of the Shareholders as a whole while taking into account the interests of other stakeholders.
The Board sets policy for the Company and advises the Chief Executive Officer and senior executives who manage the Company’s business and affairs.
II.  Composition and Organization of the Board
  1.  Selection of Members
The Nominating and Corporate Governance Committee of the Board oversees the desired size of the Board, the need for recruitment and the expected experience of the new candidates. The Nominating and Corporate Governance Committee reviews and recommends to the Board the candidates for nomination as Directors. The Board approves the final choice of candidates for nomination and election by the Shareholders.
  2.  Membership Criteria
Board members must have an appropriate mix of skills, knowledge and experience in business and an understanding of the regions in which the Company operates. Directors selected should be able to commit the requisite time for all the Board’s business.
  3.  Independent Directors
A majority of the Board shall be composed of Directors who the Board has determined to have no material relationship with the Company and who, in the reasonable opinion of the Board, are unrelated and independent under the laws, regulations and listing requirements to which the Company is subject. The Board has approvedGuidelines on the Independence of Directors of Novelis Inc. which contain specific criteria for determining Director independence.
  4.  Chairman
The Board shall appoint its Chairman and Vice-Chairman (if one is to be appointed) from among the Company’s Directors. In the event that the Chairman is a Director who is an executive of the Company, the Board shall also appoint a Lead Director from among the non-executive Directors to chair the Board at all meetings where Management is absent and to assume other appropriate functions.
The Chairman’s responsibilities include the following:
(a) presiding at meetings of Shareholders and the Board;
(b) providing leadership to enhance Board effectiveness and focus;
(c) acting as liaison between the Board and Management;
(d) assisting in representing the Company to external groups; and
(e) ensuring good corporate governance.
  5.  No Retirement Age
There is no mandatory retirement age for Directors.


D-1


  6.  Term of Directors
The Directors are elected by the Shareholders at every Annual Meeting. The term of office of each Director shall expire at the close of the Annual Meeting of Shareholders following that at which he or she was elected or until his or her successor shall be elected.
III.  Meetings of the Board
  1.  Board Agenda
The Chairman of the Board, in consultation with the appropriate members of Management, develops the agenda for Board Meetings.
  2.  Board Material Distribution
Information and materials that are important to the Board’s understanding of the agenda items and related topics are distributed in advance of the meeting. The Company will deliver information on the business, operations and finances of the Company to the Board on a monthly basis and on an as-required basis.
  3.  Board Meeting Frequency and Schedule
A minimum of five regularly-scheduled Board meetings shall be held each year. Additional meetings may be held when required. The Chairman of the Board, in consultation with the Directors and Management, will set the frequency and length of Board meetings. Board members may participate in meetings by means of conference calls or similar communications equipment by means of which all persons participating in the meeting can communicate with each other.
  4.  Management at Meetings
Management shall participate in meetings and make presentations to allow Directors to gain additional understanding and insight into the Company’s businesses.
  5.  In-camera Meetings
Every meeting of the Board shall be followed by an in-camera session at which management Directors and other members of Management are not present, to ensure free and open discussion and communication among the non-executive Directors.
IV.  Duties and Responsibilities of the Board
In addition to its statutory responsibilities, the Board has the following duties and responsibilities:
(a) ensuring that Novelis Inc. is operated so as to preserve its financial integrity and in accordance with policies approved by the Board;
(b) appointing its Chief Executive Officer, developing his or her position description and ensuring succession preparedness with the recommendations of the Human Resources Committee and the Nominating and Corporate Governance Committee, which recommendations will address the policies and principles for selecting a successor to the Chief Executive Officer, both in an emergency situation and in the ordinary course of business;
(c) adopting a strategic planning process and thereafter reviewing and approving the overall business strategy for the Company, all of which are originally developed by Management;
(d) identifying the principal risks of the Company’s businesses and ensuring the implementation of appropriate systems to manage these risks;
(e) ensuring that appropriate structures and procedures are in place so that the Board and its committees can function independently of Management;


D-2


(f) providing a source of advice and counsel to Management on critical and sensitive matters;
(g) reviewing and approving key policy statements developed by Management on various issues such as ethics, compliance, communications, environment and public disclosures;
(h) ensuring that its expectations of Management are understood, that the appropriate matters come before the Board and that the Board is kept informed of Shareholder feedback;
(i) ensuring that members of senior Management are of the calibre required for their roles, are adequately trained and monitored and that planning for their succession is ongoing;
(j) conducting, through the Nominating and Corporate Governance Committee, an annual review of Board practices and Board, Chairman and Committee performance (including Directors’ individual contributions);
(k) reviewing the recommendations of the Human Resources Committee that have been approved and recommended by the Nominating and Corporate Governance Committee with respect to the adequacy and form of the compensation of non-executive Directors and ensuring their compensation adequately reflects the responsibilities and risks involved in being an effective Director;
(l) evaluating, through the Human Resources Committee, the performance and reviewing the compensation of the Chief Executive Officer and ensuring that such compensation is competitive and measured according to benchmarks which reward contribution to shareholder value;
(m) selecting, upon the recommendation of the Nominating and Corporate Governance Committee, nominees for election as Directors;
(n) selecting the Chairman of the Board;
(o) evaluating with the Nominating and Corporate Governance Committee whether the Board as a whole, the Committees of the Board and the Directors are capable of carrying out and do carry out their roles effectively;
(p) ensuring that new Directors are provided with an adequate orientation on their roles and responsibilities and the Company’s operations;
(q) encouraging all Directors to attend at least one continuing education program for directors endorsed by Institutional Shareholder Services (ISS) or other internationally recognized corporate governance organization;
(r) overseeing the quality and integrity of the Company’s accounting and financial reporting systems, disclosure controls and procedures and internal controls;
(s) approving projects requiring an investment or disposition that is material and acquisitions where environmental or other liabilities exist and which could result in significant exposure to the Company are also subject to Board approval, irrespective of amounts;
(t) reviewing alternate strategies in response to any possible takeover bid in order to maximize value for shareholders;
(u) discussing and developing the Company’s approach to corporate governance in general, with the involvement of the Nominating and Corporate Governance Committee.
V.  Expected Qualities of Board Members
Board members are expected to possess the following characteristics and traits:
(a) demonstrate high ethical standards and integrity in their personal and professional dealings;
(b) act honestly and in good faith with a view to the best interest of the Company;


D-3


(c) devote sufficient time to the affairs of the Company and exercise care, diligence and skill in fulfilling their responsibilities both as Board members and as a Committee members;
(d) provide independent judgment on a broad range of issues;
(e) understand and challenge the key business plans of the Company;
(f) be willing to work in a team and be open to opinions of others;
(g) raise appropriate and difficult questions and issues to facilitate active and effective participation in the deliberation of the Board and of each Committee on which he or she serves;
(h) make all reasonable efforts to attend all Board and Committee meetings;
(i) review the materials provided by Management in advance of the Board and Committee meetings;
(j) inform the Chairman and Vice-Chairman (if applicable) of the Board before accepting membership on any other board of directors or audit committee and also inform of any change in the Director’s interests that could affect his or her relationship to the Company.
VI.  Board Committees
  1.  Number, Structure and Jurisdiction of Committees
The Board delegates certain of its functions to Committees, each of which has a written charter. There are four standing Committees of the Board: the Human Resources, the Audit, the Nominating and Corporate Governance and the Customer Relations Committees. Other Committees or sub-committees may be established from time to time by Board resolution. The roles and responsibilities of each Committee are described in the respective Committee charters. “Task Force” Committees may be established on anad hocbasis to deal with specific subjects.
  2.  Independent Committee Members
Members of the Audit Committee, Human Resources Committee and the Nominating and Corporate Governance Committee shall each have no material relationship with the Company and each Member shall be otherwise unrelated and independent under the laws, regulations and listing requirements to which the Company is subject and in accordance with theGuidelines on the Independence of Directors of Novelis Inc.  The Nominating and Corporate Governance Committee reviews and recommends the memberships of the various Committees to the Board.
  3.  Committee Agendas
The Chairman of each Committee, in consultation with the appropriate members of Management, develops the agenda for Committee meetings.
  4.  Committee Report to Board
At the next Board meeting following each meeting of a Committee, the Committee Chairmen will report to the Board on the Committees’ activities. Minutes of Committee meetings are provided to all Directors.
  5.  Assignment and Rotation of Committee Members
The responsibility for the assignment and rotation of Committee Members rests with the Chairman of the Board, who acts in consultation with and at the recommendation of the Nominating and Corporate Governance Committee. Rotation is not required but changes are made occasionally to accommodate the Board’s needs and individual interest and skills.


D-4


  6.  Frequency and Length of Committee Meetings
The Chairman of a Committee, in consultation with Committee Members and Management, will set the frequency and length of meetings of such Committee.
VII.  Administrative Matters
  1.  Board Performance Assessment
The Board will ensure that formal assessments of the Board, its Committees and the individual Directors are carried out at least annually in order to determine whether they are functioning effectively and to enhance their performance.
  2.  Board Compensation
On a regular basis and at least every three years, the Human Resources Committee will review Director compensation (including components and amounts) and propose any recommendations with respect to Directors’ compensation to the Nominating and Corporate Governance Committee for its review based on market practices and the particular demands made on Directors. The Nominating and Corporate Governance Committee will then make recommendations on Director compensation to the Board. Any change to the compensation of Directors must be formally approved by the full Board.
  3.  Director Share Ownership
In order to ensure alignment of the interests of Directors with those of the Shareholders, at least one-half of Directors’ fees are paid to non-executive Directors in Deferred Share Units, being the economic equivalent of the Common Shares of the Company.
  4.  Board Confidentiality
Directors will maintain the absolute confidentiality of the deliberations and decisions of the Board of Directors and information received at meetings, except as may be specified by the Chairman or if the information is publicly disclosed by the Company.
  5.  Board Interaction with Third Parties
If a third party approaches a Director on a matter of interest to the Company, the Director should bring the matter to the attention of the Chairman who shall determine whether this matter should be reviewed with Management or should more appropriately be dealt with by the Board in anin camerasession.
  6.  Communication with the Board
Shareholders and other constituencies may communicate with our Board, a committee of our Board, or an individual director by writing to our Corporate Secretary — Board Communication at our head office. All communications will be compiled by the Secretary and submitted to the appropriate Board member. The Secretary will reply or take other actions in accordance with instructions from the applicable Board contact.
  7.  Code of Conduct
The Company has a comprehensive code of business conduct and ethics that governs all employees of Novelis Inc. as well as the Directors.
  8.  Board Visits
Directors are expected to visit from time to time the Company’s plant and business locations in different parts of the world to meet local personnel and gain insight into the Company’s business and operations.


D-5


  9.  Orientation and Information
The Company Secretary will prepare aDirectors’ Manualcontaining information on Company policies and Director responsibilities and liabilities, which shall be updated as necessary. Detailed current information on the Company and its business, operations and finances are sent on a monthly basis to the Directors. Particularly important items and information requiring urgent attention is conveyed immediately. In addition, new Directors are expected to spend time with members of senior Management, including those involved in Novelis Inc.’s business operations, so that they can become familiar with the Company, its issues, business and operations. Care is taken to ensure that new Directors understand the roles and responsibilities of the Board and its Committees, as well as the commitment level that Novelis Inc. expects of its Directors.
VIII.  Resources and Authority of the Board
The Board shall have the resources and authority appropriate to discharge its duties and responsibilities, including the authority to retain counsel or other experts, as it deems appropriate, without seeking approval of Management. All directors are invited to contact the Chief Executive Officer at any time to discuss any aspect of the Company’s business. Directors also have complete access to other members of management.


D-6


SCHEDULE E
I.  Statement of Purpose
The primary purpose of the Audit Committee (the “Committee”) of the Board of Directors of Novelis Inc. (the “Company”) is to assist the Board of Directors (the “Board”) in fulfilling the Board’s oversight responsibilities for (i) the integrity of the Company’s financial statements, (ii) the Company’s compliance with legal and regulatory requirements, (iii) the qualifications and independence of the independent auditors (the “Auditors”) and (iv) the performance of the Company’s internal audit function and the Auditors. The Committee is also responsible for preparation of the Committee’s report that the Securities and Exchange Commission (“SEC”) rules require be included in the Company’s annual proxy statement (the “Audit Committee Report”). The Committee shall also carry out the other functions set out in this Charter. In so doing, the Committee shall insist on maintaining free and open communication between the Committee, the Auditors, the internal auditors and Management of the Company. In discharging its oversight role, the Committee is empowered to investigate any matter brought to its attention with full access to all books, records, facilities, and personnel of the Company and to retain independent counsel, advisors, accountants or other experts, as it deems appropriate, without seeking approval of the Board or Management.
II.  Composition and Organization of the Audit Committee
The Committee shall consist of at least three Directors, each of whom the Board of Directors has determined to be independent in respect of the Company as contemplated by the laws, regulations and listing requirements to which the Company is subject and in accordance with theGuidelines on the Independence of the Directors of Novelis Inc. Each Member shall be “financially literate,” as such qualification is interpreted by the Board of Directors in its business judgment, or must become financially literate within a reasonable period of time after his or her appointment to the Committee. At least one Member shall be qualified as an “audit committee financial expert” as defined by applicable regulations.
Members shall be appointed by the Board based on nominations recommended by the Company’s Corporate Governance Committee or a sub-committee thereof, and shall serve for such term as the Board may determine.
The Committee shall designate one Member of the Committee to act as its Chair. The Secretary or an Assistant Secretary of the Company shall act as secretary to the Committee.
If a Committee Member simultaneously serves on the audit committee of more than three public companies (including the Company), the Board of Directors must determine that such simultaneous service would not impair the ability of such Member to effectively serve on the Committee. The Company shall disclose any such determination in its annual proxy statement.
III.  Meetings of the Audit Committee
The Committee shall meet regularly at least four times a year, or more frequently if circumstances so dictate. In addition, the Members of the Committee shall meet quarterly to review the Company’s annual and quarterly releases of financial results and Management’s Discussion and Analysis of Financial Condition and Results of Operation prior to public disclosure.
At each regular meeting, the Committee shall meet separately with senior Management, the Chief Internal Auditor and the Auditors to discuss any matters that the Committee or any of these parties believe should be discussed privately. The Committee may request any officer or employee of the Company or the Auditors to attend a meeting of the Committee or to meet with any Members of the Committee. In addition, the members of senior Management, the Chief Internal Auditor and the Auditors shall have access to the Committee to bring forward matters requiring urgent attention.


E-1


The Chair of the Committee shall, in consultation with the other Members of the Committee, the Auditors and the appropriate officers of the Company, be responsible for calling meetings of the Committee, establishing agenda therefor and supervising the conduct thereof. The Committee may also take any action permitted hereunder by unanimous written consent.
The Committee shall meet in executive session, as necessary.
Subject to the laws governing the Committee, any Member may, if all Members consent, participate at any meeting of the Committee, by means of telephonic, electronic or other communication facility that permits all participants to communicate with each other during the meeting.
IV.  Division of Responsibilities of the Audit Committee, the Auditors and Management
The primary responsibility of the Committee is to oversee the Company’s accounting and financial reporting processes and audits of the Company’s financial statements on behalf of the Board and report the results of the Committee’s activities to the Board. The Management of the Company is responsible for the preparation, presentation and integrity of the Company’s financial statements and for the effectiveness of internal control over financial reporting. Management and the internal audit department are responsible for maintaining appropriate accounting and financial reporting principles and policies as well as internal controls and procedures that provide for compliance with accounting standards and applicable laws and regulations. The Auditors are responsible for planning and carrying out audits of the Company’s annual financial statements in accordance with generally accepted auditing standards, reviewing the Company’s quarterly financial statements prior to the filing of each quarterly report, annually auditing management’s assessment of the effectiveness of internal control over financial reporting and other auditing procedures.
The Committee shall have a clear understanding with Management and the Auditors that the Auditors are accountable to the Committee, as the representative of the Company’s shareholders. The Committee shall recommend the appointment of the Auditors to the Board for ultimate approval by the shareholders. The Auditors’ audit engagement letter shall be signed by the Chair of the Committee on behalf of the Company, having been previously approved by the Committee.
V.  Duties and Powers of the Audit Committee
To carry out its responsibilities, the Committee shall have the following duties and powers in respect of which it shall be entitled to full support and cooperation from Management:
  1.  In respect of the Auditors:
(i) to recommend to the Board the retention or termination of the Auditors, having evaluated their performance;
(ii) to oversee the work of the Auditors (including the resolution of any disagreement between Management and the Auditors regarding financial reporting) who shall report to the Committee;
(iii) to approve all audit engagement compensation and terms, as well as all significant non-audit compensation and terms, subject to any requirement under Canadian law for Shareholder approval;
(iv) to require the Auditors to submit annually, and to review, a formal written statement describing the Auditors’ internal quality control procedures; any material issues raised by the most recent internal quality control review, or peer review, of the Auditors, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years, respecting one or more independent audits carried out by the Auditors, and any steps taken to deal with any such issues; and all relationships between the Auditors and the Company;
(v) to consider any reports or communications (and Management’s responses thereto) submitted to the Committee by the Auditors as required by or referred to in applicable auditing standards, including Independence Standards Board Standard No. 1;


E-2


(vi) to require the Auditors to submit a report relating to the Company’s annual audited financial statements describing all critical accounting policies and practices as required by relevant regulations;
(vii) to discuss with the Auditors the independence of the Auditors and any relationships or services that may impact the quality of audit services or the objectivity and independence of the Auditors;
(viii) to discuss with the Auditors the matters required to be discussed by the Statement on Auditing Standards No. 61, as well as any significant matters or difficulties encountered in the course of the audit work, including any significant disagreements with Management, and Management’s response thereto; the discussion should include the responsibilities, budget and staffing of the Company’s internal audit function;
(ix) to review the annual Auditors’ Report;
(x) to review and pre-approve the Auditors’ provision of audit and any non-audit services to the Company;
(xi) to review at each scheduled Committee meeting the decisions of any Member(s) of the Committee to whom authority to grant pre-approvals of audit and non-audit services is delegated;
(xii) to review and discuss with the Auditors the scope and plan of the annual audit;
(xiii) to review and evaluate the qualifications, performance and independence of the Auditors, including a review and evaluation of the lead partner of the Auditors, taking into account the opinions of Management and internal audit personnel;
(xiv) to ensure the rotation of the lead (or coordinating) audit partner, or the audit partner responsible for reviewing the audit, in accordance with applicable law and regulations;
(xv) to consider whether, in order to assure continuing auditor independence, there should be regular rotation of the Auditors;
(xvi) to set policies on the hiring of employees or former employees of the Auditors, with a view to preserving the Auditors’ independence, which policies shall include the restrictions set forth in Section 706 of the Sarbanes-Oxley Act of 2002 and any rules promulgated thereunder by the SEC;
(xvii) to obtain from the Auditors assurance that the audit was conducted in a manner consistent with applicable laws and regulations and that in the course of conducting the audit, there were no acts detected or that otherwise came to the attention of the Auditors that require disclosure to the Committee under Section 10A(b) of the Securities Exchange Act of 1934, as amended;
(xviii) to discuss with the Auditors the quality, not just acceptability, of the Company’s accounting principles, including all critical accounting policies and practices used, any alternative treatments of financial information that have been discussed with Management, the ramifications of the use of such alternative disclosures and treatments, and the treatment preferred by the Auditors, as well as any other material written communications between the Auditors and Management;
(xix) to remind the Auditors that they are accountable to the Committee, as the representative of the Company’s shareholders, and that the Committee expects to be advised on any areas that require its attention;
(xx) to present all conclusions of the Committee with respect to the Auditors to the full Board of Directors.
  2.  In respect to the Internal Audit Function:
(i) to review and approve the appointment of the Chief Internal Auditor;
(ii) to advise the Chief Internal Auditor that he or she is expected to provide to the Committee summaries of the significant issues and practices relating to accounting principles and policies, financial reporting and internal control over financial reporting prepared by the internal audit department for Management and Management’s responses thereto;


E-3


(iii) to review and discuss with the Chief Internal Auditor reports on the activities of the internal audit function;
(iv) to review the Company’s internal audit plan;
(v) to review the degree of independence of the internal audit function and the adequacy of staffing and compensation;
(vi) to review senior employee expenses and perquisites on an annual basis.
  3.  In respect of Disclosure and Internal Controls:
(i) to advise Management, the internal audit function and the Auditors that they are expected to provide the Committee with a timely disclosure and analysis of transactions and other events that would materially impact the Company’s financial statements;
(ii) to discuss guidelines and policies governing the process by which Management assesses and manages the Company’s exposure to risk (including insurance coverage), and to discuss the Company’s major financial risk exposures and the steps Management has taken to monitor and control such exposures;
(iii) on a regular basis to review policies and practices of the Company, including those related to pension governance, funding and investments, metal and other commodity hedging activities, insurance and foreign exchange, and to receive updates as to current status;
(iv) to annually prepare, with the assistance of Management and the Auditors, and issue an Audit Committee Report;
(v) to meet, review and discuss with Management and the Auditors the Company’s annual audited financial statements and quarterly financial statements prior to public disclosure and filing with securities authorities, including reviewing the Company’s disclosure under Management’s Discussion and Analysis of Financial Condition and Results of Operation;
(vi) to ensure that the Company’s disclosure policy and practices meet applicable regulatory requirements and the needs of the Company;
(vii) to ensure that adequate procedures are in place for the review of the Company’s public disclosure of financial information extracted or derived from the Company’s financial statements, other than the information referred to in paragraph (v) above, and to periodically review the adequacy of these procedures;
(viii) to review and discuss with Management and the Auditors the Company’s earnings press releases, as well as financial information and earnings guidance provided to analysts and rating agencies; these discussions may be general, covering types of information to be disclosed and the type of presentation to be made and need not take place in advance;
(ix) to review on an annual basis the Legal Proceedings Report prepared by Management with a view to ensuring that all potential material claims against the Company have been properly evaluated, accounted for and disclosed;
(x) to discuss with the Company’s Chief Legal Officer any significant legal, compliance or regulatory matters that may have a material effect on the financial statements or the Company’s business;
(xi) to review the Company’s policies and processes for monitoring compliance with applicable laws and regulations and theWorldwide Code of Employee and Business Conduct(including any annexes) and theCode of Ethics for Senior Financial Officers;
(xii) to review the adequacy of the Company’s disaster recovery plan to ensure the ability to resume operations as rapidly and efficiently as possible in the event of a disaster;
(xiii) to review significant tax exposures and tax planning initiatives with a view to ensuring full compliance while minimizing tax costs;


E-4


(xiv) to review the results of the Company’s joint ventures and investments;
(xv) to review major issues regarding accounting principles and financial statement presentations, including any significant changes in the Company’s selection or application of accounting standards or principles, and major issues as to the adequacy of the Company’s internal controls and any special audit steps adopted in light of material control deficiencies;
(xvi) to review analyses prepared by Managementand/or the Auditors setting forth significant financial reporting issues and judgments made in connection with the preparation of the Company’s financial statements;
(xvii) to review the effect of regulatory and accounting initiatives, as well as off-balance sheet structures, on the Company’s financial statements;
(xviii) to review Management’s determination of goodwill impairment, if any, as required by accounting standards or principles;
(xix) to review any use of pro forma or non-generally accepted accounting principles information by the Company in any documents other than the financial statements;
(xx) to inquire of the Company’s Chief Executive Officer and Chief Financial Officer as to the Company’s internal controls and procedures and as to the existence of any significant deficiencies or material weakness in the design or operation of internal controls and any fraud that involves Management or other employees who have a significant role in the Company’s internal controls; and review any disclosure with respect thereto.
  4.  In respect of Financial Matters and Securities:
(i) to review any proposed material financial and capital transactions;
(ii) to review the impact of the Company’s financing plan on capital structure and credit rating;
(iii) to review proposals from the Company’s Chief Financial Officer in respect of any issue of securities previously approved by the Board;
(iv) to review the text of any registration or offering document that may be required to be provided and to make recommendations to the Board with respect to such documents;
(v) to review Management’s recommendations regarding the Company’s dividend policy and make recommendations thereon to the Board.
  5.  In respect of Corporate Governance:
(i) to prepare any report or other disclosures of the Committee, including any recommendation of the Committee, required by applicable laws and regulations to be included in the Company’s reports to shareholders or regulatory filings;
(ii) to review periodically the content and application of the Code of Ethics for Senior Financial Officersof the Company;
(iii) to deal with internal Company complaints referred to it by the Corporate Compliance Officer or otherwise in respect of theWorldwide Code of Employees and Business Conduct(including any annexes) and theCode of Ethics for Senior Financial Officers;
(iv) to deal with any reports of material violations of securities laws or breaches of fiduciary duties brought to its attention by Company lawyers or others;
(v) to review the activities of the Disclosure Committee of Management assigned to review the functioning of the Company’s disclosure controls and procedures;


E-5


(vi) to establish procedures for (A) the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls, or auditing matters; and (B) the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters; and
(vii) to review and discuss such other matters that relate to the accounting, auditing and financial reporting practices and procedures of the Company as the Committee may, in its own discretion, deem desirable in connection with the review functions described above;
(viii) to report its activities to the Board on a regular basis and to make such recommendations with respect to the above and other matters as the Committee may deem necessary or appropriate;
(ix) to prepare and review with the Board an annual performance evaluation of the Committee and its Members; the performance evaluation by the Committee shall be conducted in such manner as the Committee deems appropriate;
(x) to review and recommend to the Board the appointment of senior financial officers;
(xi) to review the adequacy and competence of the Company’s finance personnel;
(xii) to regularly review the independence, financial literacy and financial expertise of the Committee Members;
(xiii) to review this Charter at least annually and recommend any changes to the Board; the Committee may conduct its review in such manner as the Committee deems appropriate.
VI.  Delegation to Subcommittee
The Committee may, in its discretion and as appropriate, delegate duties and responsibilities to a Member or to a subcommittee of the Committee, subject to compliance with any applicable legal, regulatory or listing requirements.
VII.  Resources, Authority and Function of the Committee
The Committee shall have the resources and authority appropriate to discharge its duties and responsibilities, including the authority to retain independent counsel, advisors, accountants or other experts, as it deems appropriate, without seeking approval of the Board or Management. The Company shall provide appropriate funding, as determined by the Committee, to compensate any and all of such persons and to satisfy all ordinary administrative expenses of the Committee that are necessary or appropriate in carrying out its duties.
The function of the Committee is oversight. It is not the duty or responsibility of the Committee or its Members (i) to plan or conduct audits, (ii) to determine that the Company’s financial statements are complete and accurate and are in accordance with generally accepted accounting principles or (iii) to conduct other types of auditing or accounting reviews or similar procedures or investigations. The Committee, its Chair and its financial expert Member(s) are Members of the Board, appointed to the Committee to provide broad oversight of the accounting and financial reporting processes and audits of the Company’s financial statements, and are specifically not accountable or responsible for the day to day operation or performance of such activities. In particular, the Member or Members identified as financial experts shall not be accountable for giving professional opinions on the internal or external audit of the Company’s financial information, but shall provide expertise in the Committee’s oversight thereof.
Absent actual knowledge to the contrary (which shall be promptly reported to the Board), each Member of the Committee shall be entitled to rely on (i) the presumed integrity of those persons or organizations within and outside the Company from which it receives information, (ii) the accuracy and completeness of the financial and other information provided to the Committee by such persons or organizations and (iii) representations made by Management and the Auditors as to any non-audit services provided by the Auditors to the Company and its subsidiaries.


E-6


SCHEDULE F
2006 INCENTIVE PLAN
ARTICLE I
ESTABLISHMENT
1.1  Purpose.  The purpose of Novelis Inc. 2006 Incentive Plan (the “Plan”) is to enhance Company performance by motivating, attracting, and retaining key employees and directors through the issuance of equity and cash awards. This Plan is intended to supersede the Novelis Conversion Plan of 2005 and the Novelis Inc. Stock Price Appreciation Unit Plan and no new awards will be made under such prior plans after the effective date of this Plan.
1.2  Effective Date.  The Plan shall be effective as of the date the stockholders of the Company approve the Plan.
ARTICLE II
DEFINITIONS
As used in this Plan, the following terms shall be defined as set forth below:
2.1  “Award”means any Short-Term Incentive, Option, SAR, Restricted Share, Restricted Share Unit, or Performance Award granted or payable under the Plan.
2.2  “Award Agreement”means an agreement, certificate, resolution or other form of writing or other evidence approved by the Committee which sets forth the terms and conditions of an Award. An Award Agreement may be in an electronic medium, may be limited to a notation on the Company’s books and records and, if approved by the Committee, need not be signed by a representative of the Company or a Participant.
2.3  “Board”means the Board of Directors of the Company.
2.4  “Cause”means (a) a Participant’s conviction of any crime (whether or not involving the Company) constituting a felony in the jurisdiction involved; (b) conduct of a Participant related to the Participant’s employment for which either criminal or civil penalties against the Participant or the Company may be sought; (c) material violation of the Company’s policies, including, but not limited to those relating to sexual harassment, the disclosure or misuse of confidential information, or those set forth in Company manuals or statements of policy; or (d) serious neglect or misconduct in the performance of a Participant’s duties for the Company or willful or repeated failure or refusal to perform such duties.
Any rights the Company may have in respect of the events giving rise to Cause shall be in addition to the rights the Company may have under any other agreement with a Participant or at law or in equity. Any determination of whether a Participant’s employment is (or is deemed to have been) terminated for Cause shall be made by the Committee in its sole discretion, which determination shall be final and binding on all parties. If, subsequent to a Participant’s termination of employment (whether voluntary or involuntary) without Cause, it is discovered that the Participant’s employment could have been terminated for Cause, such Participant’s employment shall be deemed to have been terminated for Cause. A Participant’s termination of employment for Cause shall be effective as of the date of the occurrence of the event giving rise to Cause, regardless of when the determination of Cause is made.
2.5  “Change in Control”means the first to occur of any of the following events:
(i) any person is or becomes the beneficial owner, directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such person any securities acquired directly from the Company or its affiliates, other than in connection with the acquisition by the Company


F-1


or its affiliates of a business) representing 35% or more of either the then outstanding shares of common stock of the Company or the combined voting power of the Company’s then outstanding securities; or
(ii) the majority of the members of the Board is replaced during any12-month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election; or
(iii) the consummation of a merger or consolidation of the Company with any other entity, other than (a) a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or any parent thereof), in combination with the ownership of any trustee or other fiduciary holding securities under an employee benefit plan of the Company, 50% or more of the combined voting power of the voting securities of the Company or such surviving entity or any parent thereof outstanding immediately after such merger or consolidation, or (b) a merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which no person is or becomes the beneficial owner, directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such person any securities acquired directly from the Company or its affiliates, other than in connection with the acquisition by the Company or its affiliates of a business) representing 50% or more of either the then outstanding shares of common stock of the Company or the combined voting power of the Company’s then outstanding securities; or
(iv) the stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than a sale or disposition by the Company of all or substantially all of the Company’s assets to an entity, 50% or more of the combined voting power of the voting securities of which is owned by persons in substantially the same proportions as their ownership of the Company immediately prior to such sale.
Notwithstanding the foregoing, no “Change in Control” shall be deemed to have occurred if there is consummated any transaction or series of integrated transactions immediately following which the record holders of the common stock of the Company immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions.
For purposes of this Section, “beneficial ownership” shall be determined in accordance withRule 13d-3 under the Securities Exchange Act of 1934, as amended.
2.6  “Code”means the U.S. Internal Revenue Code of 1986, as amended from time to time.
2.7  “Committee”means the committee of the Board described in Section 4.1.
2.8  “Company”means Novelis Inc., a corporation organized under the laws of Canada, or any successor corporation.
2.9  “Covered Employee”shall have the meaning as set forth in Code Section 162(m).
2.10  “Disability”means that a Participant is permanently and totally disabled and unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of twelve months. The existence of a Disability shall be determined by the Committee in its sole discretion.
2.11  “Employee”means any person, including an officer, employed by the Company or a Subsidiary as an employee. The Company’s employment classification of an individual shall be binding and controlling for all purposes of the Plan and shall apply irrespective of any contrary employment classification of such individual by the Internal Revenue Service, a court of competent jurisdiction or any other person or entity.
2.12  “Fair Market Value”means the fair market value of the Shares as determined by the Committee from time to time. Unless otherwise determined by the Committee, the fair market value shall be the closing


F-2


price for the Shares reported on the New York Stock Exchange on the relevant date or, if there were no sales on such date, the closing price on the nearest preceding date on which sales occurred.
2.13  “Grant Date”means the date specified by the Committee on which a grant of an Award shall become effective, which date shall not be earlier than the date on which the Committee takes action with respect thereto.
2.14  “Incentive Stock Option”means any Option that is intended to qualify as an “incentive stock option” under Code Section 422 or any successor provision. Only Participants who are employees of the Company or a Subsidiary may receive Incentive Stock Options.
2.15  “Non-Employee Director”means a director of the Company who is not an active employee of the Company.
2.16  “Nonqualified Stock Option”means an Option that is not intended to qualify as an Incentive Stock Option.
2.17  “Option”means any option to purchase Shares granted under Article VI.
2.18  “Participant”means an Employee or Non-Employee Director who is selected by the Committee to receive benefits under this Plan.
2.19  “Performance Award”means an Award of “Performance Shares” or “Performance Units” granted pursuant to Article V that is contingent upon the satisfaction of one or more Performance Objectives. Each Performance Share or Performance Unit shall have an initial value equal to the Fair Market Value of one Share.
2.20  “Performance Objectives”has the meaning set for in Article XI.
2.21  “Performance Period”means a period of time established by the Committee during which the attainment of Performance Objectives relating to an Award are to be achieved.
2.22  “Qualified Performance-Based Award” means an Award or portion of an Award that is intended to satisfy the requirements for “qualified performance-based compensation” under Code Section 162(m). The Committee shall designate any Qualified Performance-Based Award as such at the time of grant.
2.23  “Restricted Shares”means an award of Shares granted pursuant to Article VII that are subject to a substantial risk of forfeiture.
2.24  “Restricted Share Units”means an award of a contractual right granted pursuant to Article VII to receive a specified number of Shares or cash at the end of a specified deferral period. Each Restricted Share Unit shall have an initial value equal to the Fair Market Value of one Share.
2.25  “Retirement”means a Participant’s termination of employment on or after (i) attaining age 65 or (ii) attaining age 55 and completing 10 years of service with the Company or Alcan Inc.
2.26  “Shares”means shares of the Common Stock of the Company, no par value.
2.27  “Short Term Incentive”means an incentive payment described in Section 8.1.
2.28  “SAR”means an award of a contractual right granted pursuant to Article VI to receive an amount equal to the appreciation in the Company’s Shares over a specified period.
2.29  “Subsidiary”means a corporation or other entity in which the Company owns or controls directly or indirectly more than 50% of the total combined voting power represented by all classes of stock issued by such corporation at the time of such grant.


F-3


ARTICLE III
SHARES AVAILABLE UNDER THE PLAN
3.1  Reserved Shares.  Subject to adjustment as provided in Section 3.4, the maximum number of Shares that may be issued or transferred pursuant to this Plan shall not exceed 7,000,000 Shares. Such Shares may be Shares of original issuance, Shares held in treasury, or Shares that have been reacquired by the Company. Any shares of Common Stock that are subject to Awards other than Options or SARs shall be counted against such overall Plan limit as 1.75 Shares for every Share granted.
3.2  Stock Option Maximum.  In no event shall the number of Shares issued upon the exercise of Incentive Stock Options exceed 3,000,000 Shares, subject to adjustment as provided in Section 3.4.
3.3  Maximum Calendar Year Award.  No Employee may receive Awards representing more than 750,000 Shares or $20,000,000 in any one calendar year, subject to adjustment as provided in Section 3.4. The maximum number of Shares that may be granted to a Non-Employee Director shall not exceed 7,500 Shares in any one calendar year, subject to adjustment as provided in Section 3.4.
3.4  Adjustments.  The Committee shall make such adjustments in (a) the number of Shares covered by outstanding Awards granted hereunder, (b) prices per share applicable to outstanding Options and SARs, and (c) the kind of shares covered thereby (including shares of another issuer), as the Committee determines to be equitable in order to prevent dilution or enlargement of the rights of Participants that otherwise would result from any stock dividend, stock split, combination or exchange of Shares, reorganization, partial or complete liquidation or other distribution of assets (other than a normal cash dividend), recapitalization or other change in the capital structure of the Company, or other corporate transaction or event having an effect similar to any of the foregoing. Adjustments under this Section 3.4 shall be made by the Committee, whose determinations with regard thereto shall be final and binding upon all persons.
3.5  Fractional Shares.  The Company shall not be required to issue any fractional Shares pursuant to this Plan. The Committee may provide for the elimination of fractions or for the settlement thereof in cash.
3.6  Unused and Forfeited Shares.  Shares related to Awards that are forfeited, terminated, expire unexercised, tendered by a Participant in connection with the exercise of an Award, withheld from issuance in connection with a Participant’s payment of tax withholding liability, settled in cash in lieu of Shares, or settled in such other manner so that a portion or all of the Shares included in an Award are not issued to a Participant shall become automatically available for other Awards. Notwithstanding the foregoing, any Shares used for full or partial payment of the purchase price of the Shares with respect to which an Option is exercised and any Shares retained by the Company pursuant to Section 12.1 that were originally Incentive Stock Option Shares shall be considered as having been granted for purposes of determining whether the Share limitation provided for in Section 3.2 has been reached for purposes of Incentive Stock Option grants.
ARTICLE IV
PLAN ADMINISTRATION
4.1  Board Committee Administration.  This Plan shall be administered by the Human Resource Committee of the Board (or such other Committee appointed by the Board from among its Non-Employee Directors), provided that the full Board may act at any time as the Committee. Notwithstanding the foregoing, the full Board shall be responsible for the administration of Awards to Non-Employee Directors.
4.2  Duties and Powers.  The Committee shall have the full power and discretion to administer, construe, and apply the provisions of the Plan and any Award.
4.3  Committee Delegation.  The Committee may delegate to one or more officers of the Company the authority to grant Awards to Participants who are not Covered Employees of the Company, provided that the Committee shall have fixed the total number of shares of Stock subject to such grants.


F-4


4.4  Determinations Binding.  All actions taken or determinations made by the Committee, in good faith, with respect to the Plan, an Award or any Award Agreement shall not be subject to review by anyone, but shall be final, binding and conclusive upon all persons interested in the Plan or any Award. No member of the Committee shall be liable to any person for any such action taken or determination made in good faith.
ARTICLE V
PERFORMANCE AWARDS
5.1  General.  The Committee may from time to time authorize grants to Participants of Performance Awards upon such terms and conditions as the Committee may determine in accordance with provisions of this Article V. Performance Awards shall be evidenced by an Award Agreement containing such terms and provisions as the Committee may determine consistent with this Plan.
5.2  Incentive Opportunity.  Prior to the beginning of each Performance Period, the Committee shall specify the value of the opportunity subject to the number of Performance Shares or Performance Units to which the Performance Award pertains.
5.3  Performance Period.  The Performance Period with respect to each Performance Award shall commence and end as of the dates determined by the Committee under the terms of the applicable Award Agreement.
5.4  Performance Objectives.  Each Performance Award shall specify the Performance Objectives that must be achieved before such Award shall become vested and payable. The Committee may adjust such Performance Objectives if, in the sole judgment of the Committee, events or transactions have occurred after the grant that are unrelated to the performance of the Companyand/or Participant and result in distortion of the Performance Objectives. The Committee also may specify a minimum acceptable level of achievement below which no payment will be made and may set forth a formula for determining the amount of any payment to be made if performance is at or above such minimum acceptable level but falls short of the maximum achievement of the specified Performance Objectives.
5.5  Payment in Cash or Shares.  The amount payable upon the completion of the Performance Period and the achievement of the Performance Objectives with respect to any Performance Award may be paid by the Company in cash, Shares or any combination thereof and may either grant to the Participant or reserve to the Committee the right to elect among those alternatives. The determination of the payment in cash or Shares will be made at the beginning of the Performance Period, unless otherwise specified by the Committee.
5.6  Dividend Equivalents.  Prior to the expiration of a Performance Period and payment of any Shares or cash earned with respect to a Performance Award, no dividend equivalents shall be paid or payable with respect to such Award.
5.7  Effect of Termination of Employment.
(i) Unless otherwise specified by the Committee, in the event that the employment of a Participant shall terminate for any reason other than Retirement, Cause, Disability or death prior to the payment of any Performance Award granted to such Participant, all Performance Awards that have not paid as of the date of such termination shall be forfeited.
(ii) Unless otherwise specified by the Committee, in the event that the employment of a Participant with the Company shall terminate on account of the Retirement, death, or Disability of the Participant prior to the payment of any Performance Award granted to such Participant, a pro rata portion of such Performance Award shall be payable to such Participant following the end of the applicable Performance Period. The amount payable pursuant to the preceding sentence shall be determined by assuming that 100% of such Performance Award was earned at the time of such termination of employment, and by multiplying the earned amount by a fraction, the numerator of which shall be the number of days that have elapsed in the applicable Performance Period prior to the Participant’s termination of employment and the denominator of which shall be the total number of days in the Performance Period.


F-5


(iii) In the event of the termination of a Participant’s employment for Cause, all outstanding Performance Awards granted to such Participant shall be forfeited.
5.8  Effect of Change in Control.  Unless otherwise specified by the Committee, a pro rata portion of a Participant’s Performance Awards shall be payable to such Participant within ten days following a Change in Control. The amount payable pursuant to the preceding sentence shall be determined by assuming that 100% of such Performance Awards were earned at the time of such Change in Control, and by multiplying the earned amount by a fraction, the numerator of which shall be the number of days that have elapsed in the applicable Performance Period prior to the Change in Control and the denominator of which shall be the total number of days in the Performance Period.
ARTICLE VI
OPTIONS AND SARS
6.1  General.  The Committee may from time to time authorize grants to Participants of Optionsand/or SARs upon such terms and conditions as the Committee may determine in accordance with provisions of this Article VI. Options and SARs shall be evidenced by an Award Agreement containing such terms and provisions as the Committee may determine consistent with this Plan.
6.2  Number of Options or SARs.  Each grant shall specify the number of Shares subject to the Option.
6.3  Exercise Price.  Each grant shall specify an exercise price per Option Share or SAR, provided that in no event shall the exercise price be less than the Fair Market Value per Share on the Grant Date.
6.4  Consideration for Options.  The form of consideration to be paid in satisfaction of the exercise price of an Option and the manner of payment of such consideration include (i) cash in the form of currency or check or other cash equivalent acceptable to the Company, (ii) nonforfeitable, unrestricted Shares owned by the Participant which have a value at the time of exercise that is equal to the option price, (iii) any other legal consideration that the Committee may deem appropriate, on such basis as the Committee shall determine in accordance with this Plan, or (iv) any combination of the foregoing. Notwithstanding the foregoing, to the extent permitted by applicable law, any grant may provide for payment of the exercise price of an Option from the proceeds of sale through a bank or broker on the date of exercise of some or all of the Shares to which the exercise relates.
6.5  Payment for SARs.  Upon exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by multiplying (i) the difference between the Fair Market Value of a Share on the date of exercise over the exercise price, times (ii) the number of Shares with respect to which the SAR is exercised. Any grant may specify that the amount payable upon the exercise of a SAR may be paid by the Company in cash, Shares or any combination thereof and may either grant to the Participant or reserve to the Committee the right to elect among those alternatives.
6.6  Performance-Based Options and SARs.  Any grant of an Option or SAR may specify Performance Objectives that must be achieved as a condition to vestingand/or exercise of the Option or SAR.
6.7  Vesting.  Each Option or SAR grant may specify the conditions that must be satisfied before the Options or SARs (or installments thereof) shall become vested and exercisable.
6.8  ISO Dollar Limitation.  Options granted under this Plan may be Incentive Stock Options, Nonqualified Stock Options or a combination of the foregoing. Each grant shall specify whether (or the extent to which) the Option is an Incentive Stock Option or a Nonqualified Stock Option. Notwithstanding any such designation, to the extent that the aggregate Fair Market Value of the Shares with respect to which Options designated as Incentive Stock Options are exercisable for the first time by a Participant during any calendar year (under all plans of the Company) exceeds $100,000, such Options shall be treated as Nonqualified Stock Options.
6.9  Exercise Period.  Any grant may specify (i) a waiting period or periods before Options or SARs shall become exercisable and (ii) permissible dates or periods on or during which Options or SARs shall be


F-6


exercisable. No Option or SAR granted under this Plan may be exercised more than seven years from the Grant Date. In addition, the exercise period for any Incentive Stock Option for a Participant possessing more than 10% of the voting power of all classes of stock of the Company shall not exceed five years. The Committee may not extend the exercise period of an outstanding Option or SAR beyond the time originally prescribed in the Award Agreement, except to the extent permitted under Code Section 409A and U.S. Department of Treasury regulations or other guidance issued thereunder.
6.10  Repricing and Backdating Prohibited.  The Committee shall not reprice any outstanding Option or SAR including the cancellation of an existing Option or SAR and substitution of a new Option or SAR with a lower exercise price, directly or indirectly, without the approval of the stockholders of the Company, provided that nothing herein shall prevent the Committee from taking any action provided for in Section 3.4. In no event shall the Grant Date of any Option or SAR be earlier than the date on which the Committee takes action with respect thereto.
6.11  Notification of Disqualifying Disposition.  If any Participant shall make any disposition of Shares issued pursuant to the exercise of an Incentive Stock Option under the circumstances described in Section 421(b) of the Code (relating to certain disqualifying dispositions), such Participant shall notify the Company of such disposition within ten (10) days thereof.
6.12  Effect of Termination of Employment.
(i) Unless otherwise provided in an applicable Award Agreement, in the event that the employment of a Participant shall terminate for any reason other than Retirement, Cause, Disability or death, (a) Options and SARs granted to such Participant, to the extent that they were exercisable at the time of such termination, shall remain exercisable until the expiration of 90 days after such termination, on which date they shall expire, and (b) Options and SARs granted to such Participant, to the extent that they were not exercisable at the time of such termination, shall expire at the close of business on the date of such termination;provided however, no Option or SAR shall be exercisable after the expiration of its term.
(ii) Unless otherwise provided in an applicable Award Agreement, in the event that the employment of a Participant shall terminate on account of the Retirement, death, or Disability of the Participant, (a) Options and SARs granted to such Participant, to the extent that they were exercisable at the time of such termination, shall remain exercisable until the expiration of one year after such termination, on which date they shall expire, and (b) Options and SARs granted to such Participant, to the extent that they were not exercisable at the time of such termination, shall expire at the close of business on the date of such termination;provided however, no Option or SAR shall be exercisable after the expiration of its term.
(iii) In the event of the termination of a Participant’s employment for Cause, all outstanding Options and SARs granted to such Participant (regardless of whether or not exercisable at the time of such termination) shall expire at the commencement of business on the effective date of such termination (or deemed termination).
6.13  Effect of Change in Control.  Unless otherwise provided in an applicable Award Agreement, all Options and SARs granted to Participants who are employed by the Company or a Subsidiary at the time of such Change in Control shall become fully vested and exercisable.
ARTICLE VII
RESTRICTED SHARES AND RESTRICTED SHARE UNITS
7.1  General.  The Committee may from time to time authorize grants to Participants of Restricted Sharesand/or Restricted Share Units upon such terms and conditions as the Committee may determine in accordance with provisions of this Article VII. Each grant of Restricted Share and Restricted Share Units shall be evidenced by an Award Agreement containing such terms and provisions as the Committee may determine consistent with this Plan.


F-7


7.2  Number of Restricted Shares or Units.  Each grant shall specify the number of Restricted Shares or Restricted Share Units to which it pertains.
7.3  Transfer of Shares.  Each grant of Restricted Shares shall constitute an immediate transfer of the ownership of Shares to the Participant in consideration of the performance of services, subject to the restrictions on transfer hereinafter referred to. Each grant of Restricted Stock Units shall constitute the agreement by the Company to issue or transfer Shares, cash or a combination thereof to the Participant in the future subject to the fulfillment of such conditions as the Committee may specify.
7.4  Consideration.  Each grant of Restricted Shares or Restricted Share Units may be made without additional consideration from the Participant or in consideration of a payment by the Participant that is less than the Fair Market Value per share or unit on the Grant Date.
7.5  Substantial Risk of Forfeiture.  Each grant of Restricted Shares shall provide that the Restricted Shares covered thereby shall be subject to a “substantial risk of forfeiture” within the meaning of Code Section 83 for a period to be determined by the Committee on the Grant Date. If any Participant makes an election under Code Section 83(b) with respect to any Restricted Shares granted hereunder, such Participant shall notify the Company with ten days of such election.
7.6  Dividends, Voting and Other Ownership Rights.  Unless otherwise provided in an applicable Award Agreement, an Award of Restricted Shares shall entitle the Participant to dividend, voting and other ownership rights during the period for which such substantial risk of forfeiture is to continue. Any Award of Restricted Shares may require that any or all dividends or other distributions paid on the Restricted Shares during the period of such restrictions be automatically sequestered and reinvested on an immediate or deferred basis in additional Shares, which may be subject to the same restrictions as the underlying Award or such other restrictions as the Committee may determine. To the extent set forth in a Participant’s Award Agreement with respect to Restricted Stock Units, a Participant shall be entitled to receive dividend equivalents payable in cash or additional Shares on a current, deferred or contingent basis.
7.7  Performance-Based Restricted Shares and Restricted Stock Units.  Any grant of Restricted Shares or Restricted Stock Units may specify Performance Objectives that must be achieved as a condition of vestingand/or payment of such Restricted Shares or Restricted Stock Units.
7.8  Effect of Termination of Employment.
(i) Unless otherwise provided in an applicable Award Agreement, in the event that the employment of a Participant shall terminate for any reason other than Retirement, Cause, Disability or death prior to the vesting of Restricted Shares or Restricted Stock Units granted to such Participant, all Restricted Shares and Restricted Stock Units that have not vested as of the date of such termination shall be forfeited.
(ii) Unless otherwise provided in an applicable Award Agreement, in the event that the employment of a Participant shall terminate on account of the Retirement, death or Disability of the Participant prior to the vesting of Restricted Shares or Restricted Stock Units granted to such Participant, a proportion of such Restricted Shares and Restricted Stock Units, to the extent not forfeited or canceled on or prior to such termination pursuant to any provision hereof, shall vest on the date of such termination. The proportion referred to in the preceding sentence shall be determined by multiplying the Participant’s non-vested Restricted Shares or Restricted Stock Units by a fraction, the numerator of which shall be the number of days that have elapsed in the applicable vesting period prior to the Participant’s termination of employment and the denominator of which shall be the total number of days in such vesting period.
(iii) In the event a Participant’s employment is or is deemed to have been terminated for Cause, all Restricted Shares and Restricted Stock Units granted to such Participant that have not vested as of the effective date of such termination shall be forfeited.
7.9  Effect of Change in Control.  Unless otherwise provided in an applicable Award Agreement, all Restricted Shares and Restricted Stock Units granted to Participants who are employed by the Company or a Subsidiary at the time of such Change in Control shall become fully vested and non-forfeitable.


F-8


ARTICLE VIII
SHORT-TERM INCENTIVES AND OTHER AWARDS
8.1  Short-Term Incentives.  For each fiscal year of the Company, the Committee may establish an incentive pool or other incentive structure or policy with respect to Participants who are not Non-Employee Directors. Any such incentive pool, structure or policy shall be subject to such terms, restrictions and conditions determined by the Committee and consistent with the terms of this Plan. Short-Term Incentives may be paid in the form of cash, Shares or a combination thereof as determined by the Committee in it discretion. Payment of such Short-Term Incentives shall be subject to the following:
(i) Unless otherwise specified by the Committee, in the event that the employment of a Participant shall terminate for any reason other than Retirement, Cause, Disability or death prior to the payment date of any Short-Term Incentive, such incentive opportunity shall be forfeited in its entirety.
(ii) Unless otherwise specified by the Committee, in the event that the employment of a Participant with the Company shall terminate on account of the Retirement, death, or Disability of the Participant prior to the payment date of any Short-Term Incentive, a pro rata portion of such Short-Term Incentive shall be payable to such Participant following the end of the applicable Performance Period. The amount payable pursuant to the preceding sentence shall be determined by assuming that 100% of such Short-Term Incentive was earned at the time of such termination of employment, and by multiplying the earned amount by a fraction, the numerator of which shall be the number of days that have elapsed in the applicable Performance Period prior to the Participant’s termination of employment and the denominator of which shall be the total number of days in the Performance Period.
(iii) In the event of the termination of a Participant’s employment for Cause, such Participant’s incentive opportunity shall be forfeited in its entirety.
(iv) Unless otherwise specified by the Committee, a pro rata portion of a Participant’s Short-Term Incentive shall be payable to such Participant within ten days following a Change in Control. The amount payable pursuant to the preceding sentence shall be determined by assuming that 100% of such Short-Term Incentive was earned at the time of such Change in Control, and by multiplying the earned amount by a fraction, the numerator of which shall be the number of days that have elapsed in the applicable Performance Period prior to the Change in Control and the denominator of which shall be the total number of days in the Performance Period.
8.2  Other Stock Awards.  The Committee may, subject to limitations under applicable law, grant to any Participant such other awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares or factors that may influence the value of such Shares, including, without limitation, convertible or exchangeable debt securities, other rights convertible or exchangeable into Shares, purchase rights for Shares, awards with value and payment contingent upon performance of the Company or specified Subsidiaries, affiliates or other business units thereof or any other factors designated by the Committee, and awards valued by reference to the book value of Shares or the value of securities of, or the performance of specified Subsidiaries or affiliates or other business units of the Company. The Committee shall determine the terms and conditions of such awards. Shares delivered pursuant to an award in the nature of a purchase right granted under this Article VIII shall be purchased for such consideration, paid for at such time, by such methods, and in such forms, including, without limitation, cash, Shares, other awards, notes or other property, as the Committee shall determine.
8.3  Payment In Lieu of Other Obligations.  The Committee may grant Shares as a bonus, or may grant other awards in lieu of obligations of the Company or a Subsidiary to pay cash or deliver other property under this Plan or under other plans or compensatory arrangements, subject to such terms as shall be determined by the Committee.


F-9


ARTICLE IX
TRANSFERABILITY
9.1  Transfer Restrictions.  No Award granted under this Plan shall be transferable by a Participant other than by will or the laws of descent and distribution, and Options and SARs shall be exercisable during a Participant’s lifetime only by the Participant or, in the event of the Participant’s legal incapacity, by his guardian or legal representative acting in a fiduciary capacity on behalf of the Participant under state law. Any attempt to transfer an Award in violation of this Plan shall render such Award null and void.
9.2  Restrictions on Transfer.  Any Award made under this Plan may provide that all or any part of the Shares that are (i) to be issued or transferred by the Company upon the exercise of Options or SARs, upon the termination of any deferral period applicable to Restricted Share Units or upon payment of any Short-Term Incentives or Performance Awards, or (ii) no longer subject to the substantial risk of forfeiture and restrictions on transfer referred to in Article VII, shall be subject to further restrictions upon transfer.
ARTICLE X
DEFERRAL OF AWARDS
10.1  General.  The Committee may permit Participants to elect to defer the issuance of Shares or the settlement of Awards in cash under the Plan pursuant to such rules, procedures or programs as it may establish for purposes of this Plan. In the case of an Award of Restricted Shares, the deferral may be effected by the Participant’s agreement to forego or exchange his or her Award of Restricted Shares and to receive an Award of Restricted Share Units. The Committee also may provide that deferred settlements include the payment or crediting of interest on the deferral amounts, or the payment or crediting of dividend equivalents where the deferral amounts are denominated in Shares.
10.2  Compliance with Code Section 409A.  To the extent any Award (or portion thereof) provides for the deferral of compensation and is subject to Code Section 409A, such deferred compensation shall be subject to the following limitations and conditions:
(i) In no event shall any deferred compensation be distributed earlier than separation from service, death, disability, a time (or pursuant to a fixed schedule) specified at the date of the deferral of such compensation, a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company, or the occurrence of an unforeseeable emergency.
(ii) In the case of a Participant who is a key employee, as defined in Code Section 416(i), distribution due to separation from service may not be made before the date which is six months after the date of separation from service (or, if earlier, the date of death of such Participant).
(iii) Except to the extent provided in U.S. Department of Treasury regulations or other guidance, any deferred compensation payable to a Participant may not be accelerated.
(iv) To the extent a Participant is offered an opportunity to defer receipt of compensation for services performed during a taxable year, such Participant’s deferral election must be made not later than the close of the preceding taxable year (or within 30 days of eligibility in the case of a newly eligible individuals) or at such other time as provided in U.S. Department of Treasury regulations or other guidance. Notwithstanding the foregoing, in the case of any performance-based compensation based on services performed over a period of at twelve months, such election may be made no later than six months before the end of such performance period.
(v) To the extent a Participant is offered an opportunity to delay the payment date of any deferred compensation or to change the form in which such deferred compensation shall be paid, (a) the Participant’s new election may not take effect for at least twelve months after the date on which the election is made, (b) except in the case of an election related to a payment due to disability, death or a change in ownership or effective control of the Company, the first payment with respect to which a new election is made must provide for a deferral period of not less than five years from the date such payment


F-10


would otherwise have been made, and (c) any election relating to a specified time (or pursuant to a fixed schedule) may not be made less than twelve months prior to the date of the first scheduled payment.
To the extent applicable, the Plan and Award Agreements shall be interpreted in accordance with Code Section 409A and U.S. Department of Treasury regulations and other interpretative guidance issued thereunder, including without limitation any regulations or other guidance that may be issued after the effective date of this Plan. Notwithstanding any provision of the Plan to the contrary, in the event that following the effective date of this Plan any Award is subject to Code Section 409A and related U.S. Department of Treasury guidance (including such U.S. Department of Treasury guidance as may be issued after the effective date of the Plan), the Committee may adopt such amendments to the Plan and applicable Award Agreements or adopt other policies and procedures (including amendments, policies and procedures retroactive effect), or take any other actions, that the Committee determines are necessary or appropriate to exempt the Award from Code Section 409Aand/or preserve the intended tax treatment of the benefits provided with respect to the Award, or comply with the requirements of Code Section 409A and related U.S. Department of Treasury guidance.
ARTICLE XI
PERFORMANCE OBJECTIVES
11.1  General.  Performance Objectives means the performance objectives established pursuant to this Plan for Participants who have received Awards. Performance Objectives may be described in terms of Company-wide objectives or objectives that are related to the performance of an individual Participant or the Subsidiary, division, department or function within the Company or Subsidiary in which the Participant is employed. Performance Objectives may be measured on an absolute or relative basis. Relative performance may be measured by comparison to a group of peer companies or to a financial market index. Any Performance Objectives applicable to a Qualified Performance-Based Award are intended to be “performance-based” under Code Section 162(m) and shall be limited to specified levels of or increases in one or more of the following Performance Objectives: return on equity, regional income, diluted earnings per share, net earnings, total earnings, earnings growth, return on capital, working capital turnover, return on assets, earnings before interest and taxes, sales, sales growth, gross margin return on investment, increase in the fair market value of the Shares, share price (including but not limited to, growth measures and total stockholder return), operating profit, cash flow (including, but not limited to, operating cash flow and free cash flow), cash flow return on investment (which equals net cash flow divided by total capital), inventory turns, financial return ratios, total return to stockholders, market share, earnings measures/ratios, economic value added, balance sheet measurements such as receivable turnover, internal rate of return, increase in net present value or expense targets, productivity and satisfaction of environment, health and safety targets.
11.2  Adjustments of Performance Objectives.  Subject to any limitation under Code Section 162(m) with respect to Covered Employees, the Committee shall adjust Performance Objectives and the related minimum acceptable level of achievement if, in the sole judgment of the Committee, events or transactions have occurred after the Grant Date that are unrelated to the performance of the Companyand/or Participant and result in distortion of the Performance Objectives or the related minimum acceptable level of achievement. Potential transactions or events giving rise to adjustment include but are not limited to (i) restructurings, discontinued operations, extraordinary items or events, and other unusual or non-recurring charges; (ii) an event either not directly related to the operations of the Company or not within the reasonable control of the Company’s management; or (iii) a change in tax law or accounting standards required by generally accepted accounting principles.
ARTICLE XII
MISCELLANEOUS
12.1  Withholding Taxes.  To the extent that the Company is required to withhold federal, state, local or foreign taxes in connection with any payment made or benefit realized by a Participant or other person under this Plan, the Committee may withhold any amounts necessary to collect any withholding taxes upon any


F-11


taxable event relating to an Award. At the discretion of the Committee, such arrangements may include relinquishment of a portion of such benefit payable in cash or Shares.
12.2  Change in Control.  Notwithstanding any provision in this Plan or an Award Agreement to the contrary, in the event that the Company undergoes a Change in Control, or in the event the Company shall become a party to any corporate merger, consolidation, major acquisition of property for stock, separation, reorganization or liquidation, the Committee (or the board of directors of any corporation assuming the obligations of the Company) shall have the sole and absolute power and discretion to prescribe and amend the terms and conditions for the exercise, or modification, of any outstanding Awards granted hereunder. Such power and discretion shall include, but shall not be limited to, the power and authority to remove restrictions on Restricted Shares, to modify the performance requirements for any Awards, and to provide that Options or SARs granted hereunder must be exercised in connection with the closing of such transaction and that if not so exercised such Options and SARs will expire. Any such determinations by the Committee may be made generally with respect to all Participants, or may be made on acase-by-case basis with respect to particular Participants. Notwithstanding the foregoing, any transaction undertaken for the purpose of reincorporating the Company under the laws of another jurisdiction, if such transaction does not materially affect the beneficial ownership of the Company’s capital, shall not constitute a merger, consolidation, major acquisition of property for stock, separation, reorganization, liquidation, or Change in Control.
12.3  Certain Terminations of Employment, Hardship and Approved Leaves of Absence.  Notwithstanding any other provision of this Plan to the contrary, in the event of termination of employment by reason of death, Disability, Retirement or leave of absence approved by the Company, or in the event of hardship or other special circumstances, of a Participant who holds an Option or SAR that is not immediately and fully exercisable, any Restricted Shares as to which the substantial risk of forfeiture or the prohibition or restriction on transfer has not lapsed, any Restricted Share Units as to which any deferral period is not complete, any Performance Awards that have not been fully earned, or any Shares that are subject to any transfer restriction, the Committee may in its sole discretion take any action that it deems to be equitable under the circumstances or in the best interests of the Company, including, without limitation, waiving or modifying any limitation or requirement with respect to any Award under this Plan.
12.4  Right of Recapture.  If, at any time within one year after the date on which a Participant exercises an Option or SAR or on which Restricted Shares or Restricted Share Units vest or on which income is realized by a Participant in connection with any other Award (each of which events shall be a “realization event”), the Committee determines in its discretion that the Company has been materially harmed by the Participant, whether such harm (a) results in the Participant’s termination or deemed termination of employment for Cause or (b) results from any activity of the Participant determined by the Committee to be in competition with any activity of the Company, or otherwise prejudicial, contrary or harmful to the interests of the Company (including, but not limited to, accepting employment with or serving as a consultant, adviser or in any other capacity to an entity that is in competition with or acting against the interests of the Company), then any gain realized by the Participant from the realization event shall be paid by the Participant to the Company upon notice from the Company. Such gain shall be determined as of the date of the realization event, without regard to any subsequent change in the Fair Market Value of the Company’s Shares. The Company shall have the right to offset such gain against any amounts otherwise owed to the Participant by the Company (whether as wages, vacation pay, or pursuant to any benefit plan or other compensatory arrangement).
12.5  Foreign Participants.  To facilitate the making of any Award or combination of Awards under this Plan, the Committee may provide for such special terms for Awards to Participants who are foreign nationals, or who are employed by or perform services for the Company or any Subsidiary outside of the United States of America, as the Committee may consider necessary or appropriate to accommodate differences in local law, tax policy or custom. Moreover, the Committee may approve such supplements to, or amendments, restatements or alternative versions of, this Plan as it may consider necessary or appropriate for such purposes without thereby affecting the terms of this Plan as in effect for any other purpose, provided that no such supplements, amendments, restatements or alternative versions shall include any provisions that are inconsistent with the terms of this Plan, as then in effect, unless this Plan could have been amended to eliminate such inconsistency without further approval by the stockholders of the Company.


F-12


12.6  Amendment or Termination.  This Plan may be amended or terminated at any time by action of the Board; provided that (i) no amendment may increase any of the limitations specified in Article III, other than to reflect an adjustment made in accordance with Section 3.4, without the further approval of the stockholders of the Company, and (ii) subject to Section 12.2, no amendment or termination may in any manner adversely affect any Awards theretofore granted under the Plan without the consent of the Participants holding such Awards. The Board may condition any amendment or termination on the approval of the stockholders of the Company if such approval is necessary or deemed advisable with respect to the applicable listing or other requirements of a national securities exchange or other applicable laws, policies or regulations.
12.7  Conditional Awards.  The Committee may condition the grant of any Award or combination of Awards under the Plan on the surrender or deferral by the Participant of his or her right to receive a cash bonus or other compensation otherwise payable by the Company or any Subsidiary to the Participant.
12.8  No Employment Right.  This Plan shall not confer upon any Participant any right with respect to continuance of employment or other service with the Company or any Subsidiary and shall not interfere in any way with any right that the Company or any Subsidiary would otherwise have to terminate any Participant’s employment or other service at any time.
12.9  Tax Qualification.  To the extent that any provision of this Plan would prevent any Option that was intended to qualify under particular provisions of the Code from so qualifying, such provision of this Plan shall be null and void with respect to such Option, provided that such provision shall remain in effect with respect to other Options, and there shall be no further effect on any provision of this Plan.
12.10  Duration of the Plan.  Unless sooner terminated in accordance with Section 12.6, this Plan shall automatically terminate on the fifth anniversary of the date upon which it is approved by the stockholders of the Company, and no Award shall be granted after such fifth anniversary.
12.11  Limitations Period.  Any person who believes he or she is being denied any benefit or right under the Plan may file a written claim with the Committee. Any claim must be delivered to the Committee within forty-five (45) days of the specific event giving rise to the claim. Untimely claims will not be processed and shall be deemed denied. The Committee, or its designated agent, will notify the Participant of its decision in writing as soon as administratively practicable. Claims not responded to by the Committee in writing within ninety (90) days of the date the written claim is delivered to the Committee shall be deemed denied. The Committee’s decision shall be final and conclusive and binding on all persons. No lawsuit relating to the Plan may be filed before a written claim is filed with the Committee and is denied or deemed denied and any lawsuit must be filed within one year of such denial or deemed denial or be forever barred.
12.12  Governing Law.  The validity, construction and effect of this Plan and any Award hereunder will be determined in accordance the laws of state of Georgia.
12.13  Investment Representations.  As a condition to the exercise or granting of an Award, the Committee may require the person exercising or receiving such Award to represent and warrant that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required.
12.14  Uncertificated Shares.  To the extent that the Plan provides for issuance of certificates to reflect the transfer of Shares, the transfer of such Shares may be effected on a non-certificated basis, to the extent not prohibited by applicable law or the rules of any stock exchange.
12.15  Unfunded Plan.  Participants shall have no right, title, or interest whatsoever in or to any investments that the Company may make to aid it in meeting its obligations under the Plan. Nothing contained in the Plan, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative or any other person. To the extent that any person acquires a right to receive payments from the Company under the Plan, such right shall be no greater than the right of an unsecured general creditor of the Company. All payments to be made hereunder shall be paid from the general funds of the Company and no special or


F-13


separate fund shall be established and no segregation of assets shall be made to assure payment of such amounts except as expressly set forth in the Plan.
12.16  Beneficiary Designation.  Each Participant under the Plan may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the same Participant, shall be in a form prescribed by the Committee, and will be effective only when filed by the Participant in writing with the Committee during the Participant’s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant’s death shall be paid to the Participant’s estate.


F-14


   
Proxy (NOVELIS INC. LOGO)(NOVELIS INC. LOGO)

This Proxyproxy issolicited by the Boardmanagement of Directors and ManagementNovelis Inc. (“Novelis”) for the Annuala Special Meeting of Shareholders (the “Meeting”) to be held on October 26, 2006May 10, 2007 at The Westin Buckheadthe offices of King & Spalding LLP located at 1180 Peachtree Street, N.E., Atlanta, 3391 Peachtree Road, Atlanta, GA 30326.Georgia 30309, beginning at 8:30 a.m., Eastern time for the following purposes:
1.  to consider, pursuant to an interim order of the Ontario Superior Court of Justice dated April 5, 2007 and, if deemed advisable, to pass, with or without variation, a special resolution (the “Arrangement Resolution”) in the form attached as Appendix A to the accompanying Proxy Statement/Management Information Circular to approve an arrangement (the “Arrangement”) under section 192 of theCanada Business Corporations Act(“CBCA”) involving Novelis, its shareholders and other securityholders, Hindalco Industries Limited (“Hindalco”) and AV Aluminum Inc. (“Acquisition Sub”), a subsidiary of Hindalco, involving, among other things, the acquisition by Acquisition Sub of all of the outstanding common shares of Novelis for US $44.93 in cash for each common share; and
2.  to transact such other matters that may properly come before the Meeting or any adjournment or postponement thereof.
 
The undersigned holder of common sharesshareholder of Novelis Inc. (“Shares”), Inc. hereby appoints William T. Monahan,Edward A. Blechschmidt, or failing him, Nichole A. Robinson, or instead of the foregoing,                                       , as the proxy of the undersigned, with full power of substitution, to attend, vote and otherwise act for and on behalf of the undersigned in respect of all matters that may come before the Meeting or any postponement or adjournment thereof to the same extent and with the same power as if the undersigned were personally present, and hereby revokes any proxy previously given.
 
VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES
Without limiting the general authorization and powers hereby given, the proxyholder is specifically directed to vote as follows:
 
     
1.  Election of Directors2.  Appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm and authorize directors to fix remuneration
   
o  FOR all nominees listed below
(except as marked)
o FOR                                            o WITHHOLD
o  WITHHOLD vote for all nominees listed
below
3.  Approval of the Novelis Inc. 2006 Incentive Plan
01. William T. Monahan
02. Edward A. Blechschmidt
03. Jacques Bougie, O.C.
04. Charles G. Cavell
05. Clarence J. Chandran
06. C. Roberto Cordaro
07. Helmut Eschwey
08. David J. Fitzpatrick
09. Suzanne Labarge
10. Rudolf Rupprecht
11. Kevin M. Twomey
12. John D. Watson
13. Edward V. Yang
o FOR          o AGAINST          o WITHHOLD

4.  To vote at the discretion of the proxyholder on any amendments or variations to the foregoing and on any other matters which may properly come before the meeting or any postponement or adjournment thereof.
(Instructions: To withhold authority for any
individual nominee, strike through the nominee’s name in
the list above)
     
 1.  
Signature of ShareholderArrangement Resolution
FOR   AGAINST 
    
SignatureThe Arrangement Resolution to approve the Arrangement under section 192 of Co-ownerthe CBCA involving Novelis, its shareholders and other securityholders, Hindalco and Acquisition Sub.
o    
o   Dated this_ _ day of_ _ 2006
This proxy confers discretionary authority on the proxyholder to vote on amendments or variations of the matter above or on such other matters that may properly come before the Meeting or any adjournment(s) thereof.
The common shares represented by this proxy will be voted in accordance with the instructions of the shareholder on any ballot that may be called for and, if the shareholder specifies a choice with respect to any matter to be acted upon, the common shares will be voted accordingly.
Please be sure to sign and date this proxy.
Signature of shareholder
Signature of Co-Owner
_ _, 2007
 
See notes on reverse side


NOTES:
 
1.  If common shares are jointly held by two or more persons, any one of them present or represented by proxy at the SharesMeeting may, in the absence of the other or others, vote the common shares, but if two or more of them are present or represented by proxy, they shall vote as one on the shares jointly held.
2.  To be valid, this proxy must be signed by the shareholder or his or her attorney duly authorized in writing, or if the shareholder is a corporation, by the proper officers or directors under corporate seal, or by an officer or attorney thereof duly authorized. If the common shares are registered in the name of more than one owner (for example joint ownership, trustees executors, etc.), then all those registered should sign this Proxy.proxy. When signing as attorney, executor, administrator, trustee, guardian or corporate officer, please give your full title after your name.
 
2.3.  If this Proxyproxy is not dated, it will be deemed to bear the date on which it is mailed by management of Novelis.
 
3.4.  If you appoint the persons whose names are printed above to act as your proxyholders, the Sharescommon shares represented by this Proxyproxy will be voted as directed.If no direction is given on any matter, the Sharesyou sign and return your proxy but do not indicate how you want to vote, your proxy will be voted FOR Proposals 1, 2“FOR” the approval of the Arrangement Resolution and 3 and atin accordance with the discretion of the proxyholder on any amendments or variationspersons named as proxies as to the foregoing and on any other matters which may properly comebrought before the meeting or any postponement or adjournment thereof.Meeting for a vote.
 
4. 5.  You have the right to appoint person(s), other than those whose names are printed above, as your proxyholder(s), to attend and act on your behalf at the Meeting.Such other person need not be a shareholder of Novelis. You may use the space provided above (or another appropriate form of proxy) for that purpose. You are advised that it is in your own interest to specify a choice for voting in respect of each of the matters to be acted upon at the Meeting.
6.  In many cases, the common shares are beneficially owned by a holder and are registered in the name of a broker, nominee or other intermediary or a depositary (such as CDS). Non-registered shareholders should contact their broker or other nominee for further instructions on how to vote.
7.  Registered holders of common shares are entitled to dissent in respect of the Arrangement in accordance with the dissent procedures described in the accompanying Proxy Statement/Management Information Circular. A shareholder may only exercise the right of dissent in respect of common shares registered in that holder’s name. Shareholders who wish to dissent, including non-registered shareholders, should carefully review the section “The Arrangement - Dissenting Holders’ Rights” in the Proxy Statement/Management Information Circular. Failure to comply strictly with the dissent procedures may result in the loss or unavailability of the right to dissent.
 
Voting Options and Instructions:VOTING OPTIONS AND INSTRUCTIONS
 
Options available to convey your voting instructions are further described in the Proxy Statement/Management Information Circular.
 
Registered shareholders may vote:
 
1.  By mail;
2.  On the Internet; or
3.  By telephone.telephone; or
4.  In person at the Meeting.
 
1.  To vote by mail:
 n  Complete, sign and date the Proxy;proxy;
 n  Return the Proxyproxy by mail in the prepaid envelope provided or return it to Novelis Inc., c/o CIBC Mellon Trust Company, 320 Bay Street, Banking Hall, Toronto, Ontario, Canada M5H 4A6PO BOX 66297 STN BRM B TORONTO, ON M7Y 4K1on or beforeOctober 25th, 2006 May 9, 2007 or if the Meeting is adjourned or postponed at least one business day before the date of the reconvened Meeting, in each case, by 5:00 pm (EDT)(Eastern time) otherwise it shall be invalid.
2.  
To vote on the Internet:
 n  Use the Internet to transmit your voting instructions up until noon (EDT) on October 25, 2006;before May 9, 2007, or if the Meeting is adjourned or postponed at least one business day before the reconvened Meeting, in each case by 5:00 pm (Eastern time) otherwise such voting instructions shall be invalid;
 n  Have the Proxy in hand;
 n  Go to the following website: http://www.eproxyvoting.com/novelis;novelis; and
n  Enter your Control Number located on the front of your proxyat the bottom right hand sideand follow the instructions.
3.  To vote by telephone:
n  Use any touch-tone phone to transmit your voting instructions up until noon (EDT) on October 25, 2006;
Have the Proxy in hand;
n  Call 1-866-271-1207 in Canada and the U.S. only and;
 n  Enter your Control Number located on the front of your proxyat the bottom right hand sideand follow the instructions.
 
Unregistered shareholdersTo vote by telephone:
n  Use any touch-tone phone to transmit your voting instructionsbefore May 9, 2007, or if the Meeting is adjourned or postponed at least one business day before the reconvened Meeting, in each case by 5:00 pm (Eastern time) otherwise such voting instructions shall be invalid;
n  Have the proxy in hand;
n  Call 1-866-271-1207 in Canada and the U.S. only; and
n  Enter your Control Number located on the front of your proxyat the bottom right hand sideand follow the instructions.


LETTER OF TRANSMITTAL
WITH RESPECT TO THE COMMON SHARES OF
NOVELIS INC.
This Letter of Transmittal is for use by registered holders (“Shareholders”) of common shares (the “Common Shares”) of Novelis Inc. (“Novelis) in connection with the proposed statutory arrangement pursuant to section 192 of the Canada Business Corporations Act (the “Arrangement”) involving Novelis and AV Metals Inc. (“Acquisition Sub”), a subsidiary of Hindalco Industries Limited (“Hindalco), that is being submitted for approval at the special meeting of Shareholders to be held on May 10, 2007 (the “Meeting”). Shareholders are referred to the Notice of Special Meeting and Proxy Statement/Management Information Circular dated April 5, 2007 (the “Proxy Statement/Circular”) that accompanies this Letter of Transmittal. Capitalized terms used but not defined in this Letter of Transmittal that are defined in the Proxy Statement/Circular have the meanings set out in the Proxy Statement/Circular. All currency amounts are in U.S. dollars.
CIBC MELLON TRUST COMPANY (THE “DEPOSITARY”)
THE ARRANGEMENT IS ANTICIPATED TO CLOSE ON OR ABOUT MAY 15, 2007. AT THE EFFECTIVE TIME OF THE ARRANGEMENT (THE “EFFECTIVE TIME”), SHAREHOLDERS (OTHER THAN DISSENTING HOLDERS) WILL BE ENTITLED TO RECEIVE, IN EXCHANGE FOR EACH COMMON SHARE, $44.93 IN CASH, WITHOUT INTEREST AND LESS ANY APPLICABLE WITHHOLDING TAXES.
In order for Shareholders to receive payment for their Common Shares, Shareholders are required to deposit the certificates representing the Common Shares held by them with the Depositary. This Letter of Transmittal, properly completed and duly executed, together with all other required documents, must accompany all certificates for Common Shares deposited for payment pursuant to the Arrangement.
Please read the Proxy Statement/Circular and the instructions set out below carefully before completing this Letter of Transmittal. Delivery of this Letter of Transmittal to an address other than as set forth herein will not constitute a valid delivery. If shares are registered in different names, a separate Letter of Transmittal must be submitted for each different registered owner. See Instruction 2.
DEPOSIT
In connection with the Arrangement being considered for approval at the Meeting, the undersigned hereby deposits with the Depositary for transfer upon the Arrangement becoming effective the enclosed certificate(s) representing Common Shares, details of which are as follows: (Please print or type).
Name and Address of Registered HolderCertificate Number(s)Number of Common Shares
NOTE:  If the space provided is insufficient, details may be listed on a separate schedule to this Letter of Transmittal.
It is understood that, upon receipt of this Letter of Transmittal and of the certificate(s) representing the Common Shares deposited herewith (the “Deposited Shares”) and following the Effective Time of the Arrangement, the Depositary will deliver to the undersigned a check issued by the Depositary representing the amount of cash the undersigned is entitled to receive, or hold such check forpick-up in accordance with the instructions set out below, and the certificate(s) representing the Deposited Shares shall forthwith be cancelled.
The undersigned holder of Common Shares represents and warrants in favor of Acquisition Sub that: (i) the undersigned is the registered holder of the Deposited Shares; (ii) such shares are owned by the undersigned free and clear of all mortgages, liens, charges, encumbrances, security interests and adverse claims; (iii) the undersigned has full power


1


and authority to execute and deliver this Letter of Transmittal and to deposit, sell, assign, transfer and deliver the Deposited Shares and that, when the acquisition consideration is paid, none of Acquisition Sub, Novelis or any successor thereto will be subject to any adverse claim in respect of such Deposited Shares; (iv) the Deposited Shares have not been sold, assigned or transferred, nor has any agreement been entered into to sell, assign or transfer any such Deposited Shares, to any other person; (v) the surrender of the Deposited Shares complies with applicable laws; (vi) all information inserted by the undersigned into this Letter of Transmittal is accurate; and (vii) unless the undersigned shall have revoked this Letter of Transmittal by notice in writing given to the Depositary by no later than 5:00 p.m. (Eastern time) on the business day preceding the date of the Meeting or, if the Meeting is adjourned or postponed, no later than 5:00 p.m. (Eastern time) on the business day preceding the date of the reconvened Meeting, the undersigned will not, prior to such time, transfer or permit to be transferred any of such Deposited Shares. These representations and warranties shall survive the completion of the Arrangement.
Except for any proxy deposited with respect to the vote on the Arrangement Resolution in connection with the Meeting, the undersigned revokes any and all authority, other than as granted in this Letter of Transmittal, whether as agent,attorney-in-fact, proxy or otherwise, previously conferred or agreed to be conferred by the undersigned at any time with respect to the Deposited Shares and no subsequent authority, whether as agent,attorney-in-fact, proxy or otherwise, will be granted with respect to the Deposited Shares.
The undersigned hereby acknowledges that the delivery of the Deposited Shares shall be effected and the risk of loss and title to such Deposited Shares shall pass only upon proper receipt thereof by the Depositary. The undersigned will, upon request, execute any signature guarantees or additional documents deemed by the Depositary to be reasonably necessary or desirable to complete the transfer of the Deposited Shares.
The undersigned surrenders to Acquisition Sub, effective at the Effective Time, all right, title and interest in and to the Deposited Shares and irrevocably appoints and constitutes the Depositary lawful attorney of the undersigned, with full power of substitution to deliver the certificates representing the Deposited Shares pursuant to the Arrangement and to effect the transfer of the Deposited Shares on the books of Novelis.
Each authority conferred or agreed to be conferred by the undersigned in this Letter of Transmittal shall survive the death or incapacity of the undersigned and any obligation of the undersigned hereunder shall be binding upon the heirs, personal representatives, successors and assigns of the undersigned.
The authority herein conferred, coupled with an interest, is not intended to be a continuing power of attorney within the meaning of and governed by theSubstitute Decisions Act (Ontario), or any similar power of attorney under equivalent legislation in any of the provinces or territories of Canada (a “CPOA”). The execution of this Letter of Transmittal shall not terminate any such CPOA granted by the undersigned previously and shall not be terminated by the execution by the undersigned in the future of the CPOA, and the undersigned hereby agrees not to take any action in future which results in the termination of the authority herein conferred.
The undersigned instructs the Depositary to mail the check representing payment for the Deposited Shares promptly after the Effective Time, by first-class insured mail, postage prepaid, to the undersigned, or to hold such check forpick-up, in accordance with the instructions given below.
If the Arrangement is not completed or proceeded with, the enclosed certificate(s) and all other ancillary documents will be returned forthwith to the undersigned at the address set out below in Box D or, failing such address being specified, to the undersigned at the last address of the undersigned as it appears on the securities register of Novelis.
It is understood that the undersigned will not receive payment in respect of the Deposited Shares until the certificate(s) representing the Deposited Shares, if applicable, owned by the undersigned are received by the Depositary at the address set forth below, together with such additional documents as the Depositary may require, and until the same are processed for payment by the Depositary. It is further understood that no interest will accrue on the purchase price payable in respect of the Deposited Shares in connection with the Arrangement. The undersigned further represents and warrants that the payment of the purchase price in respect of the Deposited Shares will completely discharge any obligations of Acquisition Sub and the Depositary with respect to the matters contemplated by this Letter of Transmittal.


2


By reason of the use of the undersigned of an English language form of Letter of Transmittal, the undersigned shall be deemed to have required that any contract evidenced by the Arrangement as entered into through this Letter of Transmittal, as well as any documents related thereto, be drawn exclusively in the English language. En raison de l’utilisation d’une version anglaise de la présente lettre d’envoi, le soussingé, ce dernier et les destinataires sont réputés avoir demandé que tout contrat attesté par l’arrangement, telle qu’il est accepté au moyen de cette lettre d’envoi, de méme que tous les documents qui s’y rapportant, soient rédigés exclusivement en anglais.


3


PLEASE COMPLETE EITHER BOX A OR BOX B. SEE INSTRUCTION 5 BELOW.
BOX A
PAYMENT AND DELIVERY INSTRUCTIONS
o
ISSUE A CHECK in the name of the undersigned and SEND THE CHECK to the following address:
(Please Print or Type)
(Name)
(Street Address and Number)
(City and Province or State)
(County and Postal or Zip Code)
(Telephone — Business Hours)
(Tax Identification, Social
Insurance or Social Security Number)
BOX B
PICK-UP INSTRUCTIONS
o
HOLD CHECK FORPICK-UP AT THE OFFICE
OF THE DEPOSITARY AT
CIBC MELLON TRUST COMPANY
199 Bay Street
Commerce Court West, Securities Level
Toronto, Ontario, Canada M5L 1G9
BOX C
TO BE COMPLETED BY ALL
SHAREHOLDERS BY SELECTING ONE BOX
BELOW.
Indicate whether you are a resident of Canada for tax purposes.
The owner signing below represents that it is a resident of Canada for tax purposes;
OR
The owner signing below represents that it is not a resident of Canada for tax purposes.


4


BOX D
DELIVERY INSTRUCTIONS
(in the event that the Arrangement is not completed)
TO BE COMPLETED BY ALL SHAREHOLDERS BY SELECTING ONE BOX BELOW. SEE INSTRUCTION 8 BELOW.
o Return certificate(s) to the address from which certificate(s) were mailed.
o Mail certificate(s) to (please fill in address or mailing):
OR
o Hold certificate(s) forpick-up at the office of the Depositary listed in Box B.
BOX E
TO BE COMPLETED BY ALL SHAREHOLDERS BY SELECTING ONE BOX BELOW.
Indicate whether you are a U.S. Shareholder or are acting on behalf of a U.S. Shareholder.
The owner signing below represents that it is not a U.S. Shareholder and is not acting on behalf of a U.S. Shareholder;
OR
The owner signing below represents that it is a U.S. Shareholder or is acting on behalf of a U.S. Shareholder;
A U.S. Shareholder is any Shareholder that is either (A) providing an address in Box “A” that is located within the United States or any territory or possession thereof or (B) a U.S. person for United States federal income tax purposes.
If you are a U.S. Shareholder or are acting on behalf of a U.S. Shareholder, then in order to avoid backup withholding you must complete the SubstituteForm W-9 included below or otherwise provide certification that you are exempt from backup withholding, as provided in the instructions. If you require aForm W-8, please contact the Depositary. You can find more information on page 13 (see Instruction 9, “Important Tax Information for U.S. Shareholders”).


5


BOX F
TO BE COMPLETED BY ALL SHAREHOLDERS
Signature guaranteed by
(if required under Instruction 3):
Authorized Signature of Guarantor
Name of Guarantor (please print or type)
Address of Guarantor (please print or type)

Date: _ _, 2007
Signature of Shareholder or Authorized Representative —
See Instruction 4
Name of Shareholder
(please print or type)
Taxpayer Identification, Social Insurance or
Social Security Number (“SSN”) of Shareholder
(please print or type)
Name of Authorized Representative, if applicable
(please print or type)
Daytime telephone number of Shareholder
or Authorized Representative
Daytime facsimile number of Shareholder
or Authorized Representative


6


IF YOU ARE A U.S. PERSON, PLEASE COMPLETE THE SUBSTITUTEFORM W-9 BELOW
TO PROVIDE YOUR TAX IDENTIFICATION NUMBER AND A CERTIFICATION
AS TO YOUR EXEMPTION FROM BACKUP WITHHOLDING

SUBSTITUTE
FORM W-9
Department of the
Treasury Internal
Revenue Service
Part I — Taxpayer Identification Number — For all accounts enter your taxpayer identification number (“TIN”) on the appropriate line at right (For most individuals, this is your SSN). If you do not have a TIN, or for further instructions, see the enclosedGuidelines for Certification of Taxpayer Identification Number on SubstituteForm W-9 (“Guidelines”).Certify by signing and dating below.


SSN
(If awaiting TIN, write “Applied For”)

OR
Employer Identification Number
(If awaiting TIN, write
“Applied For”)
Payor’s Request for
Taxpayer Identification
Number (“TIN”) and
Certification
Part II — For Payees exempt from backup withholding, check the Exempt box below. See the enclosedGuidelines.

Exempt  o
Name (as shown on your income tax return):_ _
Business Name (if different from above):_ _
Please check appropriate box

o  Individual/Sole Proprietor     o  Corporation     o  Partnership     o  Other
Address: _ _
City: _ _  State: _ _  Zip Code: _ _
Part III — Certificate — Under penalties of perjury, I certify that:
(1) The number shown on this form is my correct TIN (or I am waiting for a number to be issued to me); and
(2) I am not subject to backup withholding because: (a) I am exempt from backup withholding; or (b) I have not been notified by the Internal Revenue Service (“IRS”) that I am subject to backup withholding as a result of a failure to report all interest or dividends; or(c) the IRS has notified me that I am no longer subject to backup withholding; and
(3) I am a U.S. person (including a U.S. resident alien)
Certification Instructions — You must cross out item (2) above if you have been notified by the IRS that you are currently subject to backup withholding because of underreporting interest or dividends on your tax return. However, if after notified by the IRS that you were subject to backup withholding you received another notification from the IRS that you are no longer subject to backup withholding, do not cross out item (2). (Also see instructions in the enclosedGuidelines).

Signature: _ _  Date: _ _, 2007
YOU MUST COMPLETE THE FOLLOWING CERTIFICATE IF YOU
WROTE “APPLIED FOR” IN PART 1 OF THIS SUBSTITUTEFORM W-9
CERTIFICATION OF AWAITING TAXPAYER IDENTIFICATION NUMBER
I certify under penalties of perjury that a taxpayer identification number has not been issued to me, and either (a) I have mailed or delivered an application to receive a taxpayer identification number to the appropriate IRS Center or Social Security Administration Office or (b) I intend to mail or deliver an application in the near future. I understand that, notwithstanding the information I provided in Part III of the SubstituteForm W-9 (and the fact that I have completed this Certificate of Awaiting Taxpayer Identification Number), all payments made to me before I provide a properly certified taxpayer identification number will be subject to backup withholding tax of 28% of the gross proceeds.
Signature: _ _  Date: _ _, 2007
Note:  Failure to properly complete and return this SubstituteForm W-9 may subject you to backup withholding tax of 28% of the gross proceeds on any payments made to you in exchange for your Common Shares. Failure to furnish your correct TIN may result in a US$50 penalty for each such failure imposed by the IRS, unless such failure is due to reasonable cause and not willful neglect. Please review the enclosedGuidelines for additional details.


7


GUIDELINES FOR CERTIFICATION OF TAXPAYER IDENTIFICATION
NUMBER ON SUBSTITUTEFORM W-9
Specific Instructions
All “Section” references are to the Internal Revenue Code of 1986, as amended, unless otherwise specified.
Name.  If you are an individual, you must generally enter the name shown on your income tax return. However, if you have changed your last name, for instance, due to marriage without informing the Social Security Administration of the name change, enter your first name, the last name shown on your social security card, and your new last name.
If the account is in joint names, list first and then circle the name of the person or entity whose number you enter in Part I of the Substitute Form W-9.
Sole proprietor.  Enter yourindividualname as shown on your income tax return on the “Name” line. You may enter your business, trade, or “doing business as (DBA)” name on the “Business name” line.
Limited liability company (LLC).  If you are a single-member LLC (including a foreign LLC with a domestic owner) that is disregarded as an entity separate from its owner under Treasury regulationssection 301.7701-3,enter the owner’s name on the “Name” line.  Enter the LLC’s name on the “Business name” line. Check the appropriate box for your filing status (sole proprietor, corporation, etc.), then check the box for “Other” and enter “LLC” in the space provided.
Caution:  A disregarded domestic entity that has a foreign owner must use the appropriateForm W-8.
Other entities.  Enter your business name as shown on required federal tax documents on the “Name” line. This name should contact their brokermatch the name shown on the charter or other legal document creating the entity. You may enter any business, trade, or DBA name on the “Business name” line.
Note.  You are requested to check the appropriate box for your status (individual/sole proprietor, corporation, etc.).
Exempt From Backup Withholding
If you are exempt, enter your name as described above and check the appropriate box for your status, then check the ”Exempt” box in Part II of the Substitute Form W-9, sign and date the form.
Generally, individuals (including sole proprietors) are not exempt from backup withholding. Corporations generally are exempt from backup withholding.
Note.  If you are exempt from backup withholding, you should complete and return the Substitute Form W-9 as described above to avoid possible erroneous backup withholding.
Exempt payees.  Backup withholding is not required on any payments made to the following payees:
1. An organization exempt from tax under section 501(a), any IRA, or a custodial account under section 403(b)(7) if the account satisfies the requirements of section 401(f)(2),
2. The United States or any of its agencies or instrumentalities,
3. A state, the District of Columbia, a possession of the United States, or any of their political subdivisions or instrumentalities,
4. A foreign government or any of its political subdivisions, agencies, or instrumentalities,
5. An international organization or any of its agencies or instrumentalities.
Other payees that may be exempt from backup withholding include:
6. A corporation,
7. A foreign central bank of issue,


8


8. A dealer in securities or commodities required to register in the United States, the District of Columbia, or a possession of the United States,
9. A futures commission merchant registered with the Commodity Futures Trading Commission,
10. A real estate investment trust,
11. An entity registered at all times during the tax year under the Investment Company Act of 1940,
12. A common trust fund operated by a bank under section 584(a),
13. A financial institution,
14. A middleman known in the investment community as a nominee or custodian, and
15. A trust exempt from tax under section 664 or described in section 4947.
Part I — Taxpayer Identification Number (TIN)
Enter your TIN on the appropriate line.
If you are aresident alienand you do not have and are not eligible to get an SSN, your TIN is your IRS individual taxpayer identification number (“ITIN”). Enter it on the social security number line. If you do not have an ITIN, seeHow to get a TIN below.
If you are asole proprietorand you have an employee identification number (“EIN”), you may enter either your SSN or EIN. However, the IRS prefers that you use your SSN.
If you are a single-owner LLC that isdisregarded as an entityseparate from its owner (seeLimited liability company(LLC) above), and are owned by an individual, enter the owner’s SSN (or EIN, if the owner has one). If the owner of a disregarded LLC is a corporation, partnership, etc., enter the owner’s EIN.
Note:  See the chart on the next page for further clarification of name and TIN combinations.
How to get a TIN.  If you do not have a TIN, apply for one immediately. To apply for an SSN, getForm SS-5, Application for a Social Security Card, from your local Social Security Administration office or get this form online at www.socialsecurity.gov/online/ss-5.pdf. You may also get this form by calling1-800-772-1213. UseForm W-7, Application for IRS Individual Taxpayer Identification Number, to apply for an ITIN, orForm SS-4, Application for Employer Identification Number, to apply for an EIN. You can apply for an EIN online by accessing the IRS website at www.irs.gov/businesses and clicking on Employer ID Numbers under Related Topics. You may getForms W-7 and SS-4 from the IRS by calling1-800-TAX-FORM(1-800-829-3676) or from the IRS’s Internet Web Site atwww.irs.gov.
If you do not have a TIN, write ”Applied For” in the space for the TIN, sign and date the form, and give it to the requester. For interest and dividend payments, and certain payments made with respect to readily tradable instruments, generally you will have 60 days to get a TIN and give it to the requester before you are subject to backup withholding on payments. The60-day rule does not apply to other types of payments. You will be subject to backup withholding on all such payments until you provide your TIN to the requester.
Note:  Writing ”Applied For” means that you have already applied for a TIN or that you intend to apply for one soon.
Part III — Certification
To certify to the withholding agent that you are a U.S. person, or resident alien, signForm W-9.
For a joint account, only the person whose TIN is shown in Part I should sign (when required).
Privacy Act Notice
Section 6109 of the Internal Revenue Code requires you to give your correct TIN to persons who must file information returns with the IRS to report interest, dividend, and certain other payments to you, mortgage interest you paid, the acquisition or abandonment of secured property, cancellation of debt, or contributions you made to an IRA, or Archer MSA or HSA. The IRS uses the numbers for identification purposes and to help verify the accuracy of your tax


9


return. The IRS may also provide this information to the Department of Justice for civil and criminal litigation, and to cities, states, the District of Columbia and U.S. possessions to carry out their tax laws. The IRS may also disclose this information to other countries under a tax treaty, or to federal and state agencies to enforce federal non-tax criminal laws or to federal law enforcement or intelligence agencies to combat terrorism.
You must provide your TIN whether or not you are required to file a tax return. Taxable interest, dividend, and certain other payments to a payee who does not give a TIN to a payer generally are subject to backup withholding tax of 28% of the gross proceeds. Certain penalties may also apply.
What Name and Number To Give the Requestor
For this type of account:Give name and SSN of:
1.IndividualThe individual
2.Two or more individuals (joint account)The actual owner of the account or, if combined funds, the first individual on the account(1)
3.Custodian account of a minor (Uniform Gift to Minors Act)The minor(2)
4.a. The usual revocable savings trust (grantor is also trustee)The grantor-trustee(1)
b. So-called trust account that is not a legal or valid trust under state lawThe actual owner(1)
5.Sole proprietorship or single-owner LLCThe owner(3)
For this type of account:Give name and EIN of:
1.A valid trust, estate, or pension trustLegal entity(4)
2.Corporate or LLC electing corporate status on Form 8832The corporation
3.Association, club, religious, charitable, educational, or other tax-exempt organizationThe organization
4.Partnership (including a multi-member LLC treated as a partnership)The partnership
5.A broker or registered nomineeThe broker or nominee
6.Account with the Department of Agriculture in the name of a public entity (such as a state or local government, school district, or prison) that receives agricultural program paymentsThe public entity
(1)List first and circle the name of the person whose number you furnish. If only one person on a joint account has an SSN, that person’s number must be furnished.
(2)Circle the minor’s name and furnish the minor’s SSN.
(3)If you are an individual, you must show your individual name, but you may also enter your business or “DBA” name on the business name line. You may use either your SSN or EIN (if you have one). If you are a sole proprietor, the IRS encourages you to use your SSN.
(4)List first and circle the name of the legal trust, estate or pension trust. (Do not furnish the TIN of the personal representative or trustee unless the legal entity itself is not designated in the account title.) NOTE: If no name is circled and more than one name is listed, the numbers will be considered to be those of the first name listed.


10


INSTRUCTIONS
1.  Use of Letter of Transmittal
(a) In order to permit the timely receipt of the cash proceeds payable in connection with the Arrangement, it is recommended that this Letter of Transmittal (or manually signed facsimile thereof) together with accompanying certificate(s) representing Common Shares be received by the Depositary at the office specified on the last page of this Letter of Transmittal before 5:00 p.m. (Eastern time) on May 9, 2007 or, in the case of any adjournment or postponement of the Meeting, no later than 5:00 p.m. (Eastern time) on the business day before the reconvened Meeting. Do not send the certificates or this Letter of Transmittal to Novelis or Acquisition Sub.
(b) The method used to deliver this Letter of Transmittal and any accompanying certificates representing Common Shares is at the option and risk of the holder surrendering them, and delivery will be deemed effective only when such documents are actually received. Novelis recommends that the necessary documentation be hand delivered to the Depositary at the address specified below, and a receipt obtained therefor; otherwise the use of registered mail with return receipt requested, and with proper insurance obtained, is recommended. Shareholders whose Common Shares are registered in the name of a broker, investment dealer, bank, trust company or other nominee should contact that nominee for assistance in delivering those Common Shares.
2.  Signatures
This Letter of Transmittal must be completed, dated and signed by the holder of Common Shares or by such holder’s duly authorized representative (in accordance with Instruction 4).
(a) If this Letter of Transmittal is signed by the registered owner(s) of the accompanying certificate(s), such signature(s) on this Letter of Transmittal must correspond with the name(s) as registered or as written on the face of such certificate(s) without any change whatsoever, and the certificate(s) need not be endorsed. If such transmitted certificate(s) are owned of record by two or more joint owners, all such owners must sign this Letter of Transmittal.
(b) If this Letter of Transmittal is signed by a person other than the registered owner(s) of the accompanying certificate(s), or if the payment is to be issued to a person other than the registered owners:
(i) such deposited certificate(s) must be endorsed or be accompanied by appropriate share transfer power(s) of attorney properly completed by the registered owner(s); and
(ii) the signature(s) on such endorsement or power(s) of attorney must correspond exactly to the name(s) of the registered owner(s) as registered or as appearing on the certificate(s) and must be guaranteed as noted in Instruction 3.
(c) If any of the surrendered Common Shares are registered in different names on several certificates, it will be necessary to complete, sign and submit as many separate Letters of Transmittal as there are different registrations of Common Shares.
3.  Guarantee of Signatures
No signature guarantee is required on this Letter of Transmittal if this Letter of Transmittal is signed by the registered holder(s) of Common Shares surrendered herewith and payment is sent to the registered holder(s). If this Letter of Transmittal is signed by a person other than the registered owner(s) of the Common Shares or if payment is to be sent to a person other than the registered owner(s) of the Common Shares, such signature must be guaranteed by an Eligible Institution, or in some other manner satisfactory to the Depositary (except that no guarantee is required if the signature is that of an Eligible Institution).
An “Eligible Institution” means a Canadian Schedule I chartered bank, a major trust company in Canada, a member of the Securities Transfer Agents Medallion Program (“STAMP”), a member of the Stock Exchanges Medallion Program (“SEMP”) or a member of the New York Stock Exchange Inc. Medallion Signature Program (“MSP”).


11


4.  Fiduciaries, Representatives and Authorizations
Where this Letter of Transmittal is executed by a person as an executor, administrator, trustee or guardian, on behalf of a corporation, partnership or association or by any other person acting in a representative capacity, such person should so indicate when signing and this Letter of Transmittal must be accompanied by satisfactory evidence of authority to act. Any of Novelis, Acquisition Sub or the Depositary, at its discretion, may require additional evidence of authority or additional documentation.
5.  Payment and Delivery Instructions
In all cases, either Box “A” or Box “B” should be completed and Box “D” entitled “Delivery Instructions” should be completed. If those boxes are not completed, the check for the Common Shares or the certificate(s) in respect of the Common Shares (if the Arrangement is not completed) will be mailed to the depositing Shareholder at the address of the Shareholder as it appears on the securities register of Novelis.
6.  Miscellaneous
(a) If the space on this Letter of Transmittal is insufficient to list all certificates for Common Shares, additional certificate numbers and numbers of shares may be included on a separate signed list affixed to this Letter of Transmittal.
(b) If Common Shares are registered in different forms (e.g. “John Doe” and “J. Doe”), a separate Letter of Transmittal should be signed for each different registration.
(c) No alternative, conditional or contingent deposits of Common Shares will be accepted.
(d) Additional copies of this Letter of Transmittal may be obtained from the Depositary at the office specified on the last page of this Letter of Transmittal. The Letter of Transmittal is also available at www.sec.gov and www.sedar.com.
(e) It is strongly recommended that, prior to completing this Letter of Transmittal, the undersigned read the accompanying Proxy Statement/Circular.
(f) Novelis and Acquisition Sub reserve the right, if either so elects in its absolute discretion, to instruct the Depositary to waive any defect or irregularity contained in any Letter of Transmittal received by it.
(g) This Letter of Transmittal will be construed in accordance with and governed by the laws of the Province of Ontario and the federal laws of Canada applicable therein.
7.  Lost Certificates
If a certificate representing Common Shares has been lost, stolen or destroyed, this Letter of Transmittal should be completed as fully as possible and forwarded, together with an explanation of the relevant circumstances, to the Depositary. The Depositaryand/or the registrar and transfer agent for the Common Shares will respond with the replacement requirements in order for you to receive your entitlement, which may include a requirement to provide an affidavit and such other requirements as the Depositary may determine in its sole discretion, including a bond and indemnification against any claim that may be made against Acquisition Sub with respect to the certificate alleged to have been lost, stolen or destroyed.
8.  Return of Certificates
If the Arrangement does not proceed for any reason, any certificate(s) for Common Shares received by the Depositary will be returned to you forthwith in accordance with your delivery instructions in Box “D”. If no instructions are provided in Box “D”, the certificate(s) for Common Shares will be returned to the address from which they were mailed to the Depositary.


12


9.  Important Tax Information for U.S. Shareholders
To prevent backup withholding, each U.S. person (as defined below), or person acting on behalf of a U.S. person, must furnish a correct U.S. TIN or EIN by properly completing the SubstituteForm W-9 as described more fully below.
If the SubstituteForm W-9 is not applicable to a Shareholder because such holder is not a U.S. person for United States federal income tax purposes but provided a mailing address in the United States, such holder will instead need to submit an appropriate and properly completed IRSForm W-8 Certificate of Foreign Status, signed under penalty of perjury. An appropriate IRSForm W-8(W-8BEN,W-8EXP,W-8ECI or substitute form) may be obtained from the Depositary.
You are a U.S. person if you are, for U.S. federal income tax purposes, a citizen or a resident of the United States (including a U.S. resident alien), a corporation or partnership (or other entity treated as a corporation or partnership for U.S. federal income tax purposes) created or organized in the United States or under the laws of the United States or any state or the District of Columbia, an estate whose income is subject to U.S. federal income tax regardless of its source, or a trust if a U.S. court can exercise primary supervision over the trust’s administration and one or more U.S. persons are authorized to control all substantial decisions of the trust (or certain electing trusts).
Each Shareholder of Common Shares is urged to consult his, her or its own tax advisor to determine whether such holder is required to furnish a SubstituteForm W-9, is exempt from backup withholding and information reporting, or is required to furnish an IRSForm W-8.
Each U.S. person is required to provide the Depositary with a correct TIN and with certain other information on a SubstituteForm W-9, which is attached above, and to certify that the TIN provided is correct (or that such U.S. person is awaiting a TIN) and that (a) the U.S. person has not been notified by the Internal Revenue Service that the U.S. person is subject to backup withholding as a result of a failure to report all interest or dividends or (b) the Internal Revenue Service has notified the U.S. person that the U.S. person is no longer subject to backup withholding.
Exempt holders (including, among others, all corporations) are not subject to backup withholding requirements. To prevent possible erroneous backup withholding, an exempt holder that is a U.S. person must enter its correct TIN or EIN in Part I or SubstituteForm W-9, check the “Exempt” box in Part II of such form, and sign and date the form. See theGuidelines.
If Common Shares are held in more than one name or are not in the name of the actual owner, consult theGuidelines for information on which TIN or EIN to report.
If a U.S. person does not have a TIN or EIN, such holder should: (i) consult theGuidelines for instructions on howapplying for a TIN or EIN; (ii) write “Applied For” in the space for the TIN in Part I of the SubstituteForm W-9; and (iii) sign and date the SubstituteForm W-9 and the Certificate of Awaiting Taxpayer Identification Number set out in this document.
In such case, the Depositary may withhold 28% of the gross proceeds of any payment made to vote.such holder prior to the time a properly certified TIN or EIN is provided to the Depositary, and, if the Depositary is not provided with a TIN or EIN within sixty (60) days, such amounts will be paid over to the Internal Revenue Service.
Failure to provide the required information on the SubstituteForm W-9 may subject the U.S. person to a US$50 penalty imposed by the IRS and backup withholding of a portion of any payment received in exchange for Common Shares. More serious penalties may be imposed for providing false information which, if willfully done, may result in finesand/or imprisonment.
A SHAREHOLDER WHO FAILS TO PROPERLY COMPLETE THE SUBSTITUTEFORM W-9 SET OUT IN THIS LETTER OF TRANSMITTAL OR, IF APPLICABLE, THE APPROPRIATE IRSFORM W-8 MAY BE SUBJECT TO BACKUP WITHHOLDING OF 28% OF THE GROSS PROCEEDS OF ANY PAYMENTS MADE TO SUCH HOLDER PURSUANT TO THE ARRANGEMENT. BACKUP WITHHOLDING IS NOT AN ADDITIONAL TAX. RATHER, THE TAX LIABILITY OF PERSONS SUBJECT TO BACKUP WITHHOLDING WILL BE REDUCED BY THE AMOUNT OF TAX WITHHELD. IF WITHHOLDING RESULTS IN AN OVERPAYMENT OF TAXES, A REFUND MAY BE OBTAINED BY TIMELY FILING A CLAIM FOR REFUND WITH THE IRS. THE DEPOSITARY CANNOT REFUND AMOUNTS WITHHELD BY REASON OF BACKUP WITHHOLDING.


13


The Depositary is:
OFFICES OF THE DEPOSITARY
CIBC Mellon Trust Company
By Mail
P.O. Box 1036
Adelaide Street Postal Station
Toronto, Ontario
M5C 2K4
By Registered Mail, Hand or Courier
199 Bay Street
Commerce Court West, Securities Level
Toronto, Ontario
M5L 1G9
Attention: Special Projects
Telephone
(416)643-5500
or
(800)387-0825
E-Mail:
inquiries@cibcmellon.com
Any questions and requests for assistance may be directed by Shareholders to the Depositary at the telephone number and locations set out above.